,0
middle east respiratory,0.005593714667351178
syndrome,0.004466513731826072
middle east_y,0.003708800411472404
mers cov,0.0034248514645679605
syndrome coronavirus,0.003127427731159619
east,0.0030490914809907775
coronavirus mers,0.0027996543949217983
respiratory syndrome,0.0027908298375235517
east respiratory,0.0024904825203909205
respiratory syndrome coronavirus,0.0023323620160404113
respiratory_y,0.002172279757444108
merscov_y,0.0018596468046941522
open reading frame 3,0.0018223995638869366
mers_y,0.0017199184517651628
middle,0.0015491625379651615
substituents,0.001544656607458928
cov_y,0.001521793731772043
zoonotic_y,0.0015094158867988647
crosssectional serosurvey,0.0014950512185356141
results_y,0.0014925272509712048
chemokine ccl2 monocyte chemoattractant protein mcp1,0.0014742292543572799
molecular tests,0.001469061282158228
syndrome coronavirus mers,0.001440679754913584
viral mrnas,0.0014372218364730948
merss,0.0013589624413218773
recombinant attenuated parainfluenza virus bhpiv3,0.0013224857024938092
detergentresistant membranes,0.0013175839125946214
vectored mucosal vaccine,0.0013168357343704392
east respiratory syndrome,0.0013000686875568167
acute_y,0.0012721401427769948
lung examination,0.0012707757729562453
sars_y,0.0012303208443085007
acute respiratory,0.0012148623130138324
activation_y,0.0011928829057425835
vectors vector,0.0011624524639957184
rna molecule,0.0011495211413427924
lifeattenuated virus strains,0.0011283416983417856
novel_y,0.001113210249090838
vaccinia virus vectors,0.0011073601904870675
amino acid substitution,0.0010896732101646398
human cov 229e exon activesite,0.0010866340352162457
hp,0.0010847067331033022
showed,0.0010836521300702144
covs_y,0.001076856246741855
apical aacuaaa heptaloop,0.0010722855624396936
infections_y,0.0010621702295564898
rnp,0.0010553868820251213
tiaubein differential management,0.0010543728920232656
s3,0.001053834854010129
fluorogenic substrate,0.0010457266837698748
doi101038ncomms4067,0.0010445814991715682
f73 r84 w86 r310 d331 g333 p335 y368,0.0010431204892916407
intensification,0.0010283289473186786
reported,0.0010274245717456867
entire coding region,0.0010269293178327274
recombination frequency,0.0010239571305705028
infectious dose,0.0010183230929446297
reciprocal exchanges,0.0010142877671570464
sarscoronavirus transmission,0.0010139058825352784
merscov receptor,0.0010113931562993307
di rnas,0.0010113723239730454
mitochondries,0.0009969693259788974
multiple superspreading events,0.0009962813360418058
early control,0.0009851910617283877
rapid_y,0.0009838919733651938
pair,0.0009828428657860976
spatiotemporally organized,0.0009788772488820434
vesicular stomatitis virus g protein vsvg,0.0009716707545280802
dihc,0.0009710499914858578
human lung fibroblasts,0.000970678877438041
clinical manifestations,0.0009674056920601269
antibody rbs,0.0009671492726511953
coronavirus_y,0.0009669252838808562
human_y,0.000956465498027206
bovine coronavirusspecific antibodies,0.0009548049740941609
antiviral_y,0.0009533866870239406
findings_y,0.0009518669568606791
review approaches,0.0009514455367402625
humans_y,0.0009493777138998619
autographa cafifornica,0.0009476366125042305
sequence_y,0.0009425885478333184
plasmid dna expression vectors,0.0009343448174134392
dcsign dendritic cellspecific icam3grabbing nonintegrin,0.0009227791602071492
sip,0.0009213463723750364
detected_y,0.0009183355661948206
diagnostic tool,0.0009182891379314391
contrast,0.0009139506149846848
helicase activities,0.0009129166248312598
nucleotide positions 2771928104 and spanning open reading frames,0.0009086771872165971
cxc chemokine receptor 3 cxcr3,0.0009082328912485864
used,0.0009077704841223858
immunisation,0.0009039329292131392
cisacting viral proteins,0.000903326178258112
summary,0.0009008555756006139
lung failure,0.0008978158414535842
smallanimal model,0.0008967769917224828
camels_y,0.0008874994925926029
virion envelope proteins,0.000883666877242957
infection_y,0.0008829412100064494
leukopenia,0.0008796273749768106
batcov hku9,0.0008774952991004006
transmission_y,0.0008733843822486328
quantifying,0.0008710013920143245
rna recombination,0.0008674165905822409
calpain,0.0008656049472185441
human coronavirus isolates,0.0008635511304654967
vaccines_y,0.0008581384010331175
severe acute respiratory,0.0008573682228091494
small envelop e membrane m,0.0008505390169221003
antiviral response genes,0.0008495306375135561
pathway_y,0.0008485779057014005
enzyme labeling,0.0008440310436509482
nonspreaders spreaders,0.0008439001764788248
days_y,0.0008414887921149289
using,0.000836870958278925
single nucleotide deletion,0.0008338210764938632
hdpp4 ki mouse,0.0008336950969719636
immunohistochemistry,0.0008334769439794532
sars coronavirus_y,0.000833400345868972
mouse hepatitis virus mhv strain a59 mhva59,0.0008301935581885197
encodes_y,0.0008277797445527869
brain mesenchyme cytokinechemokine,0.0008273494711439062
viruses_y,0.0008251975244458371
brushborder membrane protein,0.0008238599254913291
endosomal cysteine proteases,0.0008225212019870233
injected,0.0008216445751173352
cases_y,0.0008185917769806107
complement fixing,0.0008170928730469554
postnasal discharge,0.0008165924484280329
cov are enveloped rna viruses,0.0008136883856737191
interferon response,0.0008121899308334786
molecular evidence,0.0008088065358316508
purified protein,0.0008068155157614191
intranasal infection,0.0008065552801439612
organ system,0.0008008057614140844
region_y,0.0007988019993255528
permissive cells,0.0007979667259849246
spread2,0.0007972080202966309
present,0.0007951507571105139
coronavirus mers cov,0.0007944576161653269
bcov rbcv wd,0.0007924103498239286
fc receptors,0.0007906837140096117
pyridine noxide derivatives,0.0007906471742561077
slcov s protein,0.0007901774853707476
constitutional symptoms,0.0007885918316778409
therapy_x,0.0007858936784168542
tested_y,0.000784275852543553
nonstructural protein nsp 14 bacterially expressed forms,0.0007742989936600879
saudi arabia_y,0.0007740613728454731
important,0.000773533533210948
neuropathogenesis,0.0007732790051049737
extrapulmonary dissemination,0.0007722084578165939
respiratory tract_y,0.0007720730989374363
flanking sequence,0.0007712512631459014
compensation,0.000770818628594052
liver titres,0.0007697733502717927
dromedary camels_y,0.0007683573593869683
coronavirus merscov methods,0.0007658260182230988
klhyt motif,0.0007654700789627358
primary replication site,0.0007638245210313047
bronchial bln lymph nodes,0.0007636142780112766
residues_y,0.0007555847221853944
comparan,0.0007517665900050269
coronaviruses_y,0.0007512638167154086
experimentally_x,0.0007501427962223904
sirnasilencing,0.0007485387910173047
major viral structural proteins,0.0007450365693308991
hospital_y,0.0007449286513659835
cathepsin b ctsb,0.0007441503299205189
humanmouse hybrids,0.0007437607144030174
cov mrnas,0.0007432772615859101
seattle children,0.0007416548158989292
mouse hepatitis virus_y,0.0007397032057096102
ace2 molecules,0.0007360243038523292
responses_y,0.000733644575612029
transcriptionregulating motif,0.0007335939668103506
particles_x,0.000733286163048537
biological activity,0.000732772882805226
spikebearing pseudoviruses,0.0007320516610284329
reporterreplicase,0.0007315983678565672
sk,0.0007310677485450283
specific_y,0.0007302593044336148
spread_y,0.0007284067896141398
model_y,0.0007261050220246126
methods_y,0.000726004990491286
suggesting,0.0007236565580627616
positive_y,0.0007236525803257332
replication_y,0.0007233867260170184
containing,0.0007229031281503237
severe_y,0.0007172458138922249
receptorbinding site,0.0007170438223616789
global_y,0.0007144417400152456
previous,0.0007093119524206905
activity_y,0.0007058759193529499
antifeline coronavirus fcov antibodies recombinant fcov nucleocapsid protein rnp,0.0007037377187442407
mice_y,0.0007031993721918994
genome leadermrna junction sequences,0.0007018678371297782
nuclear factor kappa b,0.0007013328858029359
assembly polymerase chain reaction,0.0006985244038274228
procoagulation molecule fibrinogenlike protein 2 p  008,0.0006979045333287433
virus transmission pathways,0.0006961590289180065
sars cov_y,0.0006932502064799417
factor_y,0.0006930993356859821
cellular doublestranded rnabinding protein,0.0006909352421323343
infected_y,0.0006893490865680463
demonstrated,0.0006868548845644945
regimen,0.0006866709226867538
coronavirus sarscov infection,0.0006860142271775964
upper respiratory tract infections,0.0006840792001835592
k6c,0.0006840688934998877
indicated,0.0006824470854872983
primary healthcare centres,0.000682383161418346
structural profiling,0.0006814918398960981
group_y,0.0006794797905512254
adult dairy cows,0.0006792573995004293
respiratory pathogen,0.0006782238266287129
evolution route,0.0006768028298400952
membrane_y,0.00067655077192883
fatal_y,0.0006756176839603584
acute respiratory syndrome_y,0.0006742583819398293
effective_y,0.0006731644081901705
double,0.0006716045095947947
structures_y,0.0006709576519700773
evidence_y,0.0006701177320189519
active domain,0.00066964826810043
dna vaccine,0.0006680864143330003
complex_y,0.0006679011491810558
positivestrand rna viruses,0.0006668130716860071
invariant phenylalanine,0.0006657535574736195
reverse genetic approach,0.0006651315204793193
studies_y,0.0006624143263407465
nasal mucosa trachea bronchi bronchioli,0.0006582512788769622
multifocal mononuclear cell interstitial pneumonitis,0.0006559539602102897
middle eastern camels,0.0006546273282832353
data_y,0.0006536411522215049
revealed,0.0006532041605920967
children_y,0.000652728605001103
nextgeneration vaccines,0.0006516782687934239
candidate,0.000651611384375555
viral polypeptide cleavage function,0.0006509636070673625
interpretation,0.000648103319086931
potential_y,0.0006479081244558539
endoplasmic reticulum rer,0.0006470759302796052
chinese horseshoe bats,0.0006467920781008188
mouse hepatitis coronavirus mhv s e m,0.0006461476463691896
especially,0.0006446405845187793
spike_y,0.0006427067974685579
produced,0.0006408553023173356
provide,0.0006406368300806378
sars-cov-infected cells,0.0006404971168356946
gcm3 neuraminidase,0.0006396831868063001
nt test,0.0006394443749803477
sufficient,0.0006387215726785579
nterminal polyprotein papainlike proteinase plp1 cleavage site,0.000637956412510906
spreading,0.000637955926820918
agglutinated,0.0006375100346210009
neuraminidasetreated,0.0006357714376363551
nucleoside analogue gs5734 remdesivir,0.0006347067758730551
evolutionary_y,0.0006323784659839084
nucleotide_y,0.0006313671418715092
assembly_y,0.0006290082841595702
animal application,0.0006272420091699846
e coli expressed n protein,0.0006269774539881676
observed_y,0.0006261489114840773
eukaryotic rna surveillance pathway,0.0006255869499328942
mers cov infection_y,0.0006237670465258222
immune_y,0.0006236314709226721
enzyme 2,0.000623098861085145
high secretions,0.000622697434626995
host cell_y,0.0006220356912947174
derived,0.0006220161393429663
primary bonemarrowderived macrophages,0.0006219267485140952
interferon_y,0.0006217078686656676
diagnosis_y,0.0006196395496797419
balayage,0.0006195772369066558
ic,0.0006188089461073971
method_y,0.0006180861340452973
immunogenic molecules,0.0006171831136322231
coronavirus sarsassociated coronavirus sarscov,0.0006168622220875327
mouse_y,0.0006163084960592771
surface protein,0.0006154986327698653
develop,0.0006131268393966866
recently,0.0006112855604872473
military medical city,0.0006111646569272775
coronavirus 229e infections,0.0006109617081114259
minnesota,0.000609576634157842
health_y,0.0006072438722288288
genetic_y,0.0006050880410328954
predisposed,0.0006041449594666564
hydrocortisone,0.0006021645858629972
dissected,0.0006012972441278454
periodic outbreaks,0.0006003028805864391
ability,0.0006002172611685698
acute diarrhoea,0.0006002076027524148
ii,0.0005990217233783205
study_y,0.000598773001991659
no renal impairment,0.000598075423533602
knowledge_y,0.0005975288422929676
reference hcovoc43 virus rocatcc,0.0005965359702822516
hcov229e hcovoc43 sarscov,0.0005961337838761478
collectively,0.0005956327256668409
16,0.0005926918703324682
new,0.0005925142300767102
sarscov12345,0.0005917605262503195
significant_y,0.0005917048426517102
coronavirus merscov infection,0.0005914960169762559
cebp homologous protein,0.0005905448988895912
slaughterhouse workers,0.000589867933016336
mouse hepatitis virus mhv infection,0.0005896804215638901
play,0.0005873650130737022
cov infection_y,0.0005869797744685996
coronavirus spike glycoprotein,0.0005846349114772244
aminopeptidase n an ectoenzyme,0.0005838159106522865
dpp4 protein,0.0005832689947685649
presence_y,0.000580757759851072
tissue culture growth,0.0005801212563185791
epidemic_y,0.0005792754152467873
transfected 293ft cells,0.000577348539776154
reading,0.0005762693636582804
neutralizing_y,0.0005757353878837238
heavy seasonal,0.0005750739944590087
10,0.0005743693541757725
bovine coronavirus_y,0.0005727603618274871
h52,0.0005727553979533391
investigated_y,0.0005726053217984881
receptor molecule angiotensinconverting enzyme 2 ace2,0.0005725043992116937
sodium hypochlorite,0.0005723217736736713
statistical analyses,0.0005721640080417734
murine glycoprotein receptor ceacam1a,0.0005716740244253211
human coronavirus nl63 hcovnl63,0.000569814008871718
synthetic dna vaccine,0.0005693699073359059
report_y,0.0005681842783248701
coronaviral cell,0.0005675055634461012
structural_y,0.0005672202587325585
respiratory tract illness,0.0005660808379685106
multivariable model,0.0005650534251214735
chain,0.0005648227227903752
passive death,0.0005625542931860275
significantly,0.0005617108458462694
uvinactivated purified sarscov,0.0005607966152193565
amino_y,0.0005593224293139005
genome_y,0.0005584199436770499
antigen_y,0.0005570369362989478
isolated_y,0.000555112545222946
tract_y,0.0005550364045532368
95,0.0005548170305162132
antiviral pathways,0.0005537509488745078
large_y,0.0005520996744733813
cov infections_y,0.0005506830726385201
assays_y,0.0005501784037111801
chemokine receptor 3 cxcr3,0.0005499808619126699
assay_y,0.0005489124164212935
low_y,0.0005475427230674554
treatment symptom,0.0005452989326921819
targets_y,0.0005444878799325338
animal_y,0.0005440607066236615
viral replication_y,0.0005431970569755474
mers coronavirus_y,0.0005422700740910633
medicinal plants,0.0005405871055597331
functional_y,0.0005396031688542131
hydrophobic amino terminus rnas transcribed,0.0005381046341670663
contact_y,0.0005380558093121572
autoimmune tcell,0.0005380362983750482
pcr_y,0.0005379082563846198
proinflammatory cytokine interleukin il6,0.0005376832126100398
homologous interference,0.0005365606271309233
vaccine_y,0.0005338791591775706
nasal_y,0.0005334849299947988
spike protein_y,0.0005323958496128358
temporal pattern,0.0005319341312828769
similar,0.0005315189204609285
fujian china,0.0005309640592115934
comprehensive analysis,0.000529660996735678
unique_y,0.000529171392567139
enzymelinked immunosorbent assay,0.000526704507725102
multiplication sites,0.000526615173916754
obtained,0.0005261642638991302
wildtype di rna ne1 rna,0.0005256774991943182
singlecycle growth assays,0.0005251880994340664
protein_y,0.0005245773556825845
augmentation,0.0005243269790980781
old age,0.0005235462381115469
immune responses_y,0.0005226607988042292
rna_y,0.0005217445303754306
hku4cov 3clpro,0.0005208991976999071
culture_y,0.0005206201891095803
pathogenesis structural proteins,0.0005176883194854021
cycle,0.0005168753398309466
masstype vaccine strains,0.0005165302354321586
medical center hcovemc,0.0005161418643890871
able,0.0005151887720745444
level_y,0.000514156501007447
laboratory_y,0.0005140897972883402
mediated,0.0005132562706064817
second,0.0005132560217644669
restimulation,0.0005125779529442563
information_y,0.0005121634090367342
immunofluorescence microscopy,0.0005120635608855162
rna viruses_y,0.0005107462980325779
cdna_y,0.0005094628881242818
public_y,0.000509338536234238
strongly,0.0005074173460567185
e6_y,0.0005073068578530615
polymerase chain reaction pcr testing,0.0005062081864492368
range,0.0005060378313675449
threat_y,0.0005053703649883388
attachment_x,0.0005052688463902911
case_y,0.0005050170301121246
including,0.0005044731865872041
worldwide_y,0.0005023376230383862
greater_y,0.0005015143613205556
eukaryotic rna,0.0005011979666593239
mx1,0.0005006287493124354
paradigm,0.0005002825936644632
tropism_y,0.0005001968667926729
saudi,0.0004990225685150045
virus interpretation,0.000497614846349579
disease pathogenesis,0.000497252068569391
highly,0.0004968267957317887
unprotected birds,0.0004954523904349501
inoculated_y,0.000494792379533785
review_y,0.0004940662861685255
host factor,0.0004937346643721212
environments,0.0004932307361558443
proteins_y,0.0004926183884576117
populations_y,0.0004923672955592273
generated,0.0004908684922351887
clinical radiological,0.0004897032364755405
systems_y,0.0004895443403955244
exon proofreading,0.0004888697676618186
kinase_y,0.0004880985050010358
interferon ifn_y,0.00048746449458902117
antiviral cytokines,0.00048688206282072427
fold,0.00048606941411930444
upregulated,0.000485690947204344
cell_y,0.0004846421406106087
experimental_y,0.00048438315805608776
peak,0.0004828644243297528
domains_y,0.00048280667601385255
viral rna replicase polyproteins,0.00048000130047640957
neurological symptoms,0.00047878219153178275
helper mhva59 rnas,0.00047772917659031944
signaling_y,0.0004772278250332954
sars coronavirus sars,0.0004768033520002707
open,0.00047659873463392336
myocardial,0.0004764896666882801
virion nucleocapsid protein pp60,0.0004757142803818617
mouse dpp4 locus,0.0004751071949461351
ibv italy,0.0004749721047154643
research_y,0.0004745567319637926
patients_y,0.0004742431166916705
inhibiting_x,0.00047395926503768964
chronic,0.00047314730077028356
cell surface_y,0.00047277053553998466
confirmed,0.00047256926961567624
hepatitis virus mhv_y,0.00047256622086150243
reservoirs_y,0.00047193589193861497
isolates_y,0.0004719281794744888
potentials,0.00047125909862816235
vero,0.0004707526466687965
phylogenetic_y,0.0004701111975631219
illness_y,0.00046849564331718677
animals_y,0.00046819481567299004
quantitative analysis,0.00046796352582544396
comparison_y,0.00046704272621591957
camel pastoralists,0.00046618846262091
porcine blood leukocytes,0.0004657704109775056
antibodies_y,0.00046513605272694163
amino acid_y,0.00046499684250490283
agent_y,0.000464283740725717
mutant_y,0.000464014535750383
evolved,0.0004636489210929122
demonstrate,0.00046329572196081493
surveillance_y,0.00046288776267589205
levels_y,0.0004624867536163458
strain_y,0.000461883837622654
makkah,0.00046182139563169083
s2_y,0.0004616035884791305
viral inactivation methods,0.0004611779707113673
nondenaturing gel system,0.0004611063926516477
outcome_x,0.00046108838601796153
bats_y,0.00046082090947607553
factors_y,0.00046059598200402156
residue_y,0.0004603011050763524
sarscov spike,0.0004602586593607533
independent_y,0.0004592190729693142
cells_y,0.0004562665452305109
involved,0.00045606548489983466
arabia,0.0004554317456560582
cell culture supernatant,0.00045494888451667084
pandemic_y,0.00045458633947033795
human coronavirus_y,0.0004541589434523392
cell culture_y,0.0004529542639292915
disease_y,0.00045155738542534995
region of human myelin basic protein,0.00045138855726611834
oc43_y,0.0004504576055060913
particles_y,0.00044990624380883393
36,0.0004486968962203124
bearing,0.00044854234518321775
suggest,0.00044848865083849435
firefly luciferase,0.00044798841125472425
immune therapeutic,0.0004466852060125287
gastroenteritis_y,0.00044660473390280536
oglycosylated virus,0.00044640329279853276
serummediated neutralizing activity,0.00044564323825484827
barrier methods,0.00044545046378525294
murine_y,0.0004447686500702659
identified_y,0.00044465266186998945
pathogen_y,0.00044435628093988813
rsv influenza virus,0.0004440661742093624
performed,0.0004433711382841837
hab18gcd147 further,0.00044302127730883804
main,0.00044208515061754897
possible,0.00044203641862071636
nt_y,0.0004406961977761983
high,0.0004406523952241524
increasing_y,0.0004402782311658465
response_y,0.00043917667458902597
coronavirus sarscov nucleocapsid proteinbased enzymelinked immunosorbent assay elisa,0.0004381225153942914
evolution_y,0.00043798115987134136
potentially,0.00043739263481788054
coronavirus sars_y,0.00043727152254569626
detect_y,0.0004365379817390985
s1_y,0.0004361725583952554
occurred,0.00043593788217263443
protein gene_y,0.00043581316488627896
observations_y,0.00043539175518163677
peptide_y,0.0004351633515459274
pathogenic_y,0.0004342833998823329
development_y,0.000433907855911854
purified_y,0.0004328308048577161
causative agent_y,0.0004326414678411415
membrane m protein,0.00043263366355137056
design_y,0.00043208701572450096
electron microscopy_y,0.0004315427557547393
hku1_y,0.0004311313489565628
tissue_y,0.00043051251050789515
feline immunodeficiency antibodies,0.00043041797084000756
nterminally truncated,0.00042963247524053166
day_y,0.00042882934960350374
care_x,0.00042867458103181824
infectious peritonitis_x,0.00042867288781874886
collected,0.000428392211921914
known_y,0.00042831213565146324
expression_y,0.0004282294708981697
korea_y,0.00042815093866362065
human immunodeficiency virus type 1sars s,0.00042707293985858
s gene,0.0004267258740375434
bat_y,0.00042629472016124446
early_y,0.0004259403933365168
chemokine receptor 2,0.0004253806297675804
phenotype_y,0.0004251064608504381
effect_y,0.0004247084653540066
cov nucleocapsid antigen,0.00042455402923306546
coronavirus bcov,0.0004242849032928042
nterminally truncated akap7,0.00042365143452150215
limited_y,0.00042361399746900354
bronchitis_y,0.00042318537445781043
mechanism_y,0.00042295226977230984
available,0.00042283960146078666
mouse hepatitis_y,0.0004226929236683992
acid_y,0.00042264949132938005
form_y,0.00042255434380436747
2012,0.0004223779507366282
suicide attempt,0.00042212807056544977
b2 cc50  ,0.0004213769509778512
cellular membranes,0.0004199944457018221
analysis_y,0.0004199941549375521
exchange assay,0.00041970780451016596
12,0.0004189377742694054
order,0.0004187247855281129
acids_y,0.00041864097443261014
higher_y,0.00041848513421478204
rate_y,0.00041842906853678237
robust_y,0.00041841151803456136
syndrome sars,0.0004182036579264009
role,0.00041759131347885245
swabs_y,0.00041715472023032664
causes,0.0004167916958889106
support,0.0004159861853238269
gene initiation codon,0.0004151869396013257
bronchitis virus ibv,0.00041516752686431555
broad,0.00041447665592322285
replicase_y,0.0004143474164626373
ds,0.00041300767268701315
emergence_y,0.00041282355236316274
prevalence_y,0.0004103813574151903
nervous_y,0.0004097175989972643
large open reading frame,0.00040780379026935986
receptor binding_y,0.0004076657417634407
medical,0.00040741924336804415
necrosis_y,0.0004060707169384496
function_y,0.0004056547721129316
putative coding sequences,0.0004052760388030643
closely related,0.0004052027491351058
compared_y,0.0004051038716950506
regions_y,0.00040502136526013506
hepatitis virus_y,0.00040501295438121474
nsp14 exoribonuclease exon,0.0004045968739950205
respiratory syndrome sars,0.00040353459553771066
described,0.0004033712895287042
addition,0.0004032703938809085
polyproteins_y,0.0004026361145298255
infectious bronchitis_y,0.0004026348000854845
t cell chemoattractant chemokine cxcl10 interferoninducible protein 10 kda,0.000402515757728308
currently,0.00040187269560757887
epithelial_y,0.00040169705676588357
upper_y,0.0004014153357482479
consensus heptameric intergenic sequence uacucaaac,0.0004012744914367143
glycoprotein trimer,0.0004004993695197393
period_y,0.0004004961528576151
virus mhv,0.00040025044890288865
linear relationship,0.00040010027936419673
point,0.00039997658868137586
porcine delta coronavirus,0.00039963687043036427
2003,0.00039854095902508343
healthcare,0.00039798567898285383
avian coronavirus_y,0.00039707408218574175
hcov229e strains,0.0003969575743829399
different,0.0003958393905739236
merscov replicase,0.0003956118603219733
wild,0.0003950575106569458
interferogenic,0.0003949508385406534
sensitive_y,0.00039469535607398695
little,0.0003945710154213289
pathogens_y,0.0003945530157945166
online version article,0.0003944640382303186
22,0.00039414841010149913
silverbacked jackal,0.0003933049903042301
emerging,0.00039329535920915477
represents,0.00039288861425923
dogs_y,0.0003928341153441424
detectable_y,0.00039274717434331467
virus entry_y,0.0003925584577500614
thought,0.00039125839451825716
amino acids_y,0.00039117882663185645
rectal_y,0.0003905427391830108
conserved_y,0.00039032293971608627
60,0.00039027278422753913
chimeric spike gene,0.0003897534884948736
phylogentic analysis,0.0003897263176057999
host_y,0.0003894744856483118
site_y,0.00038913546486081903
virus infection_y,0.00038911531577706107
small_y,0.00038856006180729434
infectious_y,0.00038812565715752443
related,0.00038789204601369023
transfected_y,0.000387862473538185
type_y,0.0003840925745902435
serum specimens,0.00038321237879164764
reading frame_y,0.0003832119045814501
number,0.00038308645972504794
homology_y,0.0003822917456489716
virulence_y,0.00038211064980475933
reverse_y,0.000381536878612221
specificity_y,0.0003813350262354888
post_y,0.00038129959525081927
rp3,0.0003807451913917223
oral lactobacillus casei l casei vaccine,0.0003803612538966544
synthetic,0.0003798374068752836
syndrome coronavirus sarscov,0.0003790269411946403
coronavirus sarscov_y,0.00037902516529186685
respiratory syndrome mers,0.00037885556200284177
conducted,0.00037861117485815015
respiratory tract infections_y,0.0003778136388582047
largemedium herds,0.000377274450880162
mhv_y,0.00037557705617496164
antibody_y,0.0003753446124020115
source_y,0.00037469349400591663
mutation_y,0.00037463350571505775
express_y,0.0003745234970743411
responsible,0.00037449330712115646
molecular_y,0.00037440835275123134
inhibition_y,0.00037384922049830954
multinucleated giant cells,0.0003729441100993557
public health_y,0.00037213782921625873
contain,0.0003712247986320109
origin_y,0.00037114797324632354
quantitative_y,0.00037095240875779326
recent_y,0.0003696635662609239
upper respiratory_y,0.0003695971178403565
respectively,0.0003693525505789727
required,0.0003693426625506048
primary_y,0.0003692851976391782
dependent_y,0.00036877942833278104
tgev_y,0.0003685241910499867
genetics_y,0.00036841816919739256
line_y,0.0003680456652941773
significantly higher_y,0.00036789581902760477
mild_y,0.0003668112519807395
selective,0.0003657720003502427
identify,0.0003657414338688212
seasonality,0.00036535885873607214
receptor binding domain_y,0.00036532770032838646
process_y,0.000365298177705589
lethal_y,0.00036409520158817794
spike glycoprotein_y,0.0003638384934321121
determined,0.0003634679175200663
crystal structure_y,0.00036344296938757966
gene_y,0.00036342473355766805
located,0.0003633675600996162
key,0.00036289989301351537
viral rna_y,0.00036254038213881143
membrane protein_y,0.0003623810892938027
p6,0.00036222428793263544
data suggest,0.00036159636488708924
tgev infection,0.00036097969909689587
immunofluorescence assay ifa,0.00036068571398979575
229e_y,0.0003604122095854766
bovine_y,0.0003600429247077986
nonstructural_y,0.00035976390354770305
genes_y,0.00035963498087336843
individuals_y,0.00035864727888028873
influenza virus_y,0.0003582485679771411
entry_y,0.00035785263815540816
receptor_y,0.0003576562729878623
neutralizing mabs,0.00035719790237453346
30,0.0003569187333514997
ergic localization,0.000356798960437936
viral_y,0.0003566875418882921
pathogenesis_y,0.00035663972487222557
glycoproteins_y,0.00035604520201259376
proposed,0.0003560031280238124
bronchitis virus,0.00035598366531919376
tissues_y,0.0003558952990163994
previously,0.00035561899896266485
specimens_y,0.00035538696445486196
recognition_y,0.00035386349547340845
remains,0.0003538197107443287
11,0.0003537713372042239
jhm strain,0.0003534261581330572
virus replication_y,0.0003530856858744874
work,0.00035260189696004885
neutralizing antibodies_y,0.00035174192416292515
inhibitor_y,0.00035146394106054887
titer_y,0.00035084745706764566
anti_y,0.0003508092242359869
metagenomic techniques,0.0003507147431594833
arabian peninsula_y,0.0003504872896589769
serum_y,0.00035018621985941236
respiratory disease_y,0.0003497124992166953
context_y,0.00034830651253469437
putative,0.00034784944805776164
healthy_y,0.00034746691870841587
treatment_y,0.00034617724187534433
lower_y,0.0003461347224937768
jhm_y,0.00034556949094748763
targeting_y,0.0003443148183265045
encephalitis_y,0.0003440980252656376
did,0.00034396741932422333
cause,0.00034386770069983266
modified_y,0.0003437994746178921
intracellular vesicles,0.0003437547655955123
vitro,0.00034344862878957764
conformational_y,0.00034330658622426844
shape,0.00034314944638380785
coronavirus avian infectious bronchitis virus,0.0003427789073679846
delayed_y,0.00034247182926882614
associated,0.00034200965974458687
mainly,0.0003407572028585
surface_y,0.00034057997207831425
medical research council,0.00033988427031743097
infected cells_y,0.0003398774783054321
enteric_y,0.00033943381262848023
single-particle cryo-electron microscopy,0.00033935633874062276
common,0.0003382912898151175
reduced_y,0.00033821285504724124
activities_y,0.00033801908930184023
results showed,0.00033762577910920145
recombinant_y,0.00033714097729265857
detection_y,0.00033714068614725955
sarscov protein_y,0.0003370209244364737
titers_y,0.0003361736047790568
encephalomyelitis_y,0.0003360956811906695
nervous cns,0.0003360419561277261
shown,0.00033594208861555764
nasopharyngeal_y,0.00033580426802558066
diversity_y,0.0003349207605073358
measured_y,0.0003348662530242876
onset_y,0.00033468577931563615
assess_y,0.00033447763441215873
clinic,0.0003344438930529703
rt pcr,0.00033443359594202156
outbreaks_y,0.0003341132104330941
production_y,0.0003337377340019016
ibv_y,0.0003333593015109185
highly conserved,0.0003332245018934453
having,0.00033311379724015785
human cov 229e exon activesite mutants,0.00033309680628437126
avian_y,0.00033300528570935216
studied,0.00033289659266121113
conclusions_y,0.0003328185288620955
induced_y,0.0003322552072901164
recombinant viruses_y,0.00033216917402543273
covhku1 branch,0.00033206646784899945
forms_y,0.0003310365414069358
cell lines_y,0.00033065530586882155
severity_y,0.00033061865171395914
roles,0.0003305157654006625
reduction_y,0.00033018162021585765
induces_y,0.00032986476822562816
indicate,0.0003298154123824587
virions_y,0.00032950440596276053
concentrations_y,0.0003291808972029561
relationship_y,0.0003290996132108419
gene sgmrna transcription,0.00032882331194383286
hepatitis_y,0.00032845130310588724
sars cov protein,0.00032801638841485446
direct,0.00032784511342315954
encoding_y,0.0003278271474384417
species_y,0.0003278193047504204
cell-culture-adapted strains,0.00032774245037360485
differential_y,0.00032733215724904083
feline leukaemia virus,0.00032705570314789964
ty-batcov hku4/pi-batcov hku5,0.000326849335284803
examined_y,0.0003266173685298099
candidates_y,0.00032646146244230017
ergic/golgi membranes,0.00032600937078998903
feline infectious peritonitis_y,0.00032588560517461896
various,0.0003253645805230994
active_y,0.00032517018817440136
outcome_y,0.0003251258152289645
syndrome coronavirus sars,0.00032510089790081326
understand,0.00032459026335435377
regulatory,0.0003244473009655736
measures_y,0.0003235118290373375
mutants_y,0.0003230707936547064
deletion mutants,0.0003229697265642385
rf1,0.00032291460365444364
recombinant hcovnl63 nucleocapsid protein,0.0003220139556033363
peritonitis fip,0.0003218431699805587
wildtype_y,0.0003215944995356098
far,0.00032147411279360945
sequences_y,0.0003213961175894979
sars-cov-infected vero e6 cells,0.00032129519487304086
overall,0.00032088406602470227
antibiotic treatment,0.0003208378372724158
repeat_y,0.000320543227666494
shedding_y,0.00031984700049492794
strains_y,0.0003192752537928774
intracellular pattern recognition receptors prrs,0.00031893385812021055
central nervous,0.00031875231636420567
murine hepatitis_y,0.00031842094067241684
laboratory-confirmed mers-cov infection,0.0003183928395598722
corresponding,0.0003183557618591369
cov protein,0.00031820598916246933
following,0.0003181964683224606
does,0.00031819213736821795
longer,0.0003169434937790095
cov infected,0.0003166708260476391
damage_y,0.00031646290545507045
understanding,0.00031623541855933427
mutations_y,0.00031614639066922625
total,0.00031605932824471466
samples_y,0.00031592671036962257
enzyme_y,0.0003154258462222896
largest,0.00031484441961799383
implications,0.0003145954308870459
understood,0.00031456234774953
resulting,0.00031454616910755074
sites_y,0.0003145260660650946
temperature_y,0.00031441692204686603
years_y,0.0003140462879807086
neuraminidase inhibitors and an association of antibiotics effective against s. pneumoniae,0.0003136482536419888
fecvfipv biotype,0.0003129347733597084
interaction_y,0.00031265757671985556
virulent_y,0.00031262170833166477
produce,0.0003123944973845833
bcv_y,0.0003123899978185675
respiratory coronavirus_y,0.00031187351299835007
diagnostic relevance,0.000311542012533922
mrna_y,0.0003114497003816186
bcov_y,0.0003111903273501193
protected,0.00031058126739986645
involvement_y,0.00031057042946513834
resistant_y,0.0003101771840965825
single,0.0003100106566690036
differences_y,0.0003097106068471211
epidemiology_y,0.00030953364633832213
elisa_y,0.00030951244829645336
lipid channels,0.0003094986539671553
death_y,0.00030928025719102677
absence_y,0.0003092337996371624
coronavirus cov_y,0.0003091814560633028
a59_y,0.00030913562223213657
emerged,0.0003088147675580932
27,0.0003086493397092938
affinity_y,0.0003086152926612251
immunodominant,0.00030850692052635377
results indicate,0.0003081673238184611
epidemiological screening,0.0003078777545434426
cd40mediated,0.0003070886082309213
exposure_y,0.0003070450630630424
swabs_x,0.00030663659680480376
positive reaction,0.00030600731429469217
caused,0.0003055516104939103
susceptibility_y,0.00030552318243095195
synthesis_y,0.00030520412270951887
clinical_y,0.00030519038874925864
efficient_y,0.00030501949511702845
newly,0.00030494507553379383
terminus,0.000304922781959633
engineered_y,0.0003048870627747731
postinfection_y,0.00030449321736743143
expressed_y,0.0003044421137284113
sarsrrhbatcov strains,0.00030415411335058576
domain_y,0.0003041076517633996
compounds_y,0.00030371356573755055
binding_y,0.0003035572120283394
inhibitory_y,0.00030297853635091125
developed,0.0003028999735147115
canine coronavirus_y,0.0003025724811569293
enhanced_y,0.000302311029925748
high levels,0.0003022160033717606
k v holmes j virol 7194999507 1997,0.00030217191463292105
cns_y,0.00030211946324026337
canine_y,0.00030184156686846207
association_y,0.0003007563847755219
drug_y,0.0003005422806883982
suspected_y,0.00030019853570556324
plays,0.00030006315391741705
gait complex eprs,0.00029949131239310036
genomic_y,0.00029893080866659906
cytoplasmic_y,0.0002979209888875911
merscovspecific microneutralization mnt assay,0.00029791771206145437
heterologous_y,0.000297540469617684
synonymous codons,0.0002974122392101991
specifically,0.000297357845279321
26,0.0002970192750506588
15,0.0002963149832725458
putative leaderbody junction sites,0.0002959410365985386
gene expression_y,0.0002957669237590728
transmembrane_y,0.00029562697601843784
virion_y,0.0002944399790005806
highly pathogenic,0.00029414957829342514
background_y,0.0002934038319125279
admitted to,0.00029337217550397135
expressing_y,0.00029327741933819626
highest_y,0.0002930159100192786
hku5,0.00029248956709572606
natural_y,0.00029230984745421345
lesions_y,0.0002919378665265156
indirect_y,0.00029173896290480623
essential,0.000291629758071591
diverse_y,0.0002915780094332122
time_y,0.00029154588750391475
demyelination_y,0.00029121973101093327
increased_y,0.0002911561406775939
faculty,0.0002906753584279791
phosphorylation_y,0.000290343056508625
fusion_y,0.00028975070185882445
baculovirus polyhedrin promotor,0.0002897480165337893
aa_y,0.0002892790368640359
fecal samples_y,0.00028894844570750196
suggested,0.0002887016172629146
clusters_y,0.0002874703458854178
prototype_y,0.0002874297308007309
c-jun n-terminal kinase,0.0002870559135795042
mechanisms_y,0.0002860992519568688
mers-cov case identification,0.00028516814201868254
changes_y,0.00028438038467713643
membrane fusion_y,0.00028437701010607856
crucial,0.0002843609565018163
cloned_y,0.00028427037066287836
substitutions_y,0.00028399640283666757
targeted_y,0.00028330984730350387
sars-associated coronavirus,0.00028289624346027655
1b,0.0002827838814321844
fulllength genomic sequence,0.00028203715630222866
simple antibody test methods,0.00028160313852900376
right lower lobe infiltrate,0.0002815638254954634
codon-optimized human dipeptidyl peptidase 4,0.00028141899847754047
finding_y,0.00028108957237498166
chronic hepatitis b virus infection,0.0002807124607241325
replicate_y,0.0002805615961484516
huh7 cell culture,0.0002804444291036989
synthetic peptide p2,0.0002803874245057105
western blot assay,0.00028022635593308293
deletion_y,0.0002801695689669004
induce_y,0.00027928423153742685
showing,0.0002790913413374361
coronavirus fcov_y,0.0002786266239600488
nuclear_y,0.0002784063249555925
viral exposure,0.00027792100915137474
syndrome mers,0.0002778923559209138
lipid_y,0.00027785021568830164
evaluate_y,0.0002777907424711823
real,0.0002775279108772598
processes_y,0.0002775089807118582
analysis showed,0.0002772845557670921
multiple_y,0.0002771475859459672
ultraviolet light-inactivated virus,0.0002768329194835695
like,0.00027655396142908247
therapeutic_y,0.0002764839827746671
neutralization antibody assay,0.0002764834323610862
particularly,0.00027562812411949277
coronavirus 229e_y,0.0002753313103682912
cytoplasm_y,0.0002752847057302633
activated_y,0.0002750235529294513
porcine_y,0.0002747591795556583
anti-inflammatory cytokines,0.00027438646932063785
untranslated region,0.00027418768921296053
desialylated cells,0.00027305362321302333
7a orf the 7b orfs,0.00027235348237433636
2014,0.0002720236600722594
inhibit_y,0.000271309584903718
2015,0.00027112380707214334
camel_y,0.0002711081667309887
hypothesis_y,0.00027109249979547845
hairpin loop structures,0.000270518695772875
polymorphic region nt,0.0002704774272184658
domestic fowl,0.00027041463779569713
molecular information,0.0002703300582592871
viroporins,0.00027018720036427196
sars_n/human hnrnp a1,0.0002700698469352711
countries_y,0.00027003078869487556
24,0.000269939240626879
strain-specific,0.0002698094803652863
secondary,0.0002696058521750339
outbreak_y,0.00026954330196875763
contains,0.0002694106189117303
salmonella infections,0.0002692436628956444
importance,0.00026904086990460106
users_y,0.00026901382875363226
population_y,0.0002682040442047241
protease_y,0.0002679552267096535
domain rbd_y,0.0002675510388475162
needed,0.00026753379084307844
chain reaction,0.0002675191973359509
pulmonary_y,0.0002674453081658452
reverse genetic system,0.0002667776118926025
3a proteins,0.00026668096055131713
proteases_y,0.0002664882907960958
innate_y,0.00026633430550825315
effects_y,0.0002660013760933082
efficiency_y,0.00026593332026114154
coronaviruses covs_y,0.0002650287251218709
severe respiratory,0.00026499987330345714
kidneys,0.00026452302914784073
established,0.00026446161851994106
prcv specific sequences,0.0002644405293003107
change_y,0.0002637377545712851
mediates,0.0002635364935992664
analyses_y,0.0002630136364365408
release_y,0.0002629781834771528
environmental hygiene,0.0002623885234275729
systematic mutagenesis,0.0002623061108064808
ifn_y,0.0002616722944972699
results suggest,0.0002614147306833639
cd8 cells_y,0.0002612639616603537
step,0.00026091951712449614
mammalian_y,0.0002607518941599368
variety,0.0002607091661046737
strategies_y,0.0002606782676541462
stage_y,0.00026012860430313904
fcov-specific immune response,0.00025999143028516915
drug hexamethylene amiloride,0.0002598973009143038
severe acute,0.0002597609567861556
brain_y,0.0002595621102483913
later,0.0002594122641081802
use_y,0.0002592823466780025
republic,0.0002592255369123363
arabian,0.0002589555644989109
nucleotides_y,0.0002588874115584424
remain,0.00025876786145900913
china_y,0.0002585915391174895
carcinoembryonic antigen cea family,0.00025858823854596296
internal_y,0.00025856946843724705
mononuclear cell infiltrates,0.00025833765978775446
envelope protein_y,0.0002578190117845139
phosphate,0.00025776316531292794
approximately,0.00025768630146476274
cytokeratin 18 promoter,0.0002575051249874329
molecular understanding,0.0002574129920125729
activate_y,0.00025713195092381383
infectious virus_y,0.00025697249228763915
characterized_y,0.0002569715078782119
indicating,0.00025681980840285267
glycosylation_y,0.00025595784370587883
korean winter dysentery,0.00025553717457340057
motif_y,0.0002554444187520869
suggests,0.00025540450875612044
equine,0.000255376443415944
ribavirin lopinavir rimantadine baicalin,0.00025522163468650455
deaths_y,0.00025502936397720736
syndrome sars coronavirus,0.00025471415297031915
blood_y,0.00025462032482090205
hisg15,0.00025376947447480676
immunosorbent,0.00025351732453999707
induction_y,0.00025349684015510957
receptors_y,0.0002533123797543892
feline infectious peritonitis virus fipv ucd1,0.00025273661311235504
negative_y,0.00025271222272442136
terminal_y,0.00025255202743019225
fulllength_y,0.0002523922640771331
intracellular_y,0.00025216616427951573
feline coronavirus fcov_y,0.0002520435469318785
major,0.00025190413770607273
control sirnatreated cells,0.00025170631766526706
igg_y,0.00025155638956726815
charged residues,0.00025142712725731805
mediate,0.00025110985751062654
interfering_y,0.0002508998288890461
sera_y,0.0002507916579323251
molecule_y,0.00025068798234368896
droplets,0.00025068271369148613
bind_y,0.00025018926975958083
strong_y,0.0002501633829988576
1a,0.0002501313743591639
coronavirus mouse hepatitis virus strain jhm jhm,0.0002497364423999117
conferring,0.00024967158014910966
appear,0.00024962368204134726
diseases_y,0.0002494159455833231
insight,0.0002493833455964199
37nt rna,0.0002493758859909828
conditions_y,0.0002492437545486574
necessary,0.00024865528226146634
testing_y,0.0002486230838245853
rapidly,0.0002485638174988171
type ii,0.00024838302744973717
merscov infection_y,0.0002482055583998848
phosphonic acid moieties,0.00024812859210210836
important role,0.000247770922490588
mers-cov serology,0.0002477435506450189
porcine coronavirus leader,0.00024771832221754547
inflammatory_y,0.0002468375069457553
risk factors_y,0.00024626818332664836
structural proteins_y,0.00024617488006240944
intermediate_y,0.0002451831875278801
bsl3 livevirus,0.0002451564847524593
ne1 di rna replication sequence analysis,0.00024484300467018423
displayed,0.00024461920693381444
rat kidney cell,0.0002443165465030048
hong,0.00024419775007615785
limit,0.00024365162768383463
virus_y,0.00024350833875547983
gastroenteritis virus_y,0.00024324733969267426
pathological_y,0.00024285293035149967
decreases,0.0002427491985480273
patterns_y,0.00024264523228455202
lower respiratory,0.00024246877874516105
a9 human coronavirus,0.00024246439433902898
recombination_y,0.00024243691704846801
rna polymerase_y,0.00024215762150126062
syndrome coronavirus merscov,0.00024201370635970178
lines_y,0.0002419909640163714
tumor,0.00024173540824004553
immunofluorescence_y,0.0002416054086205234
open reading,0.0002415886740937219
antinucleocaspid antibody,0.00024149389385828843
17,0.00024133079725899225
25,0.00024131040054125967
mature non-structural proteins,0.00024066043214976656
equivalent,0.0002405807609092124
feline_y,0.00024046123183814702
rt,0.0002404410526658903
transmissible_y,0.00024026334669339
heptad,0.00024024073658063185
pneumonia_y,0.00024018061096259025
rates_y,0.00024000253638997813
macrophages_y,0.0002398093541361503
acute renal impairment,0.0002397745955172932
unclear,0.0002396526190082932
sars-cov-2,0.00023947237412167742
optimal_y,0.00023924890387987718
innate immune_y,0.00023889830482313565
infectious bronchitis virus_y,0.00023879298027746075
cell entry_y,0.0002383977165527855
replicase/transcriptase,0.0002380871139910546
29,0.00023805259493437126
growth_y,0.00023782785031226786
cov spike,0.0002377411158829378
selected,0.00023758612066949246
fever_y,0.00023755769616965217
human coronavirus nl63_y,0.0002374446924131381
tests_y,0.00023734836949447022
genomes_y,0.00023730430068825105
recognized,0.00023685625585243318
additionally,0.00023658802060381862
cat_y,0.00023598369992755517
approaches_y,0.00023553374669453922
groups_y,0.00023511629072879494
dose_y,0.00023468189973417243
central_y,0.0002345613345000267
infiltration_y,0.00023383927250080535
sensitivity_y,0.00023367573833235278
nonstructural protein 3,0.00023356073649074326
end,0.00023325339000363412
chicken_y,0.00023272143468921412
interactions_y,0.00023256590857743866
primer,0.00023245542143574487
catalytic_y,0.0002324383798422977
chemical_y,0.00023227122421409397
glycan structure,0.00023221434371048478
soluble_y,0.00023210250662713026
resulted,0.0002320439182362442
affecting,0.00023194825687694636
cd8_y,0.00023158941827930337
tool,0.00023144601035498646
rna synthesis_y,0.0002313516695234053
blocked_y,0.0002312931817268259
risk_y,0.00023126437583850703
diarrhea_y,0.00023088912919333357
primary middle east respiratory syndrome coronavirus,0.00023020542627089332
tail_y,0.0002301074122065212
exhibited,0.0002299860540457768
bias,0.00022986058812519774
nsp16he junction,0.00022971912058198082
challenge,0.00022917657465501868
workers,0.00022906092835776372
multi-organ dysfunction,0.00022846144103385888
neuropathological examination,0.00022827117623824088
epitopes_y,0.00022819306489848135
live_y,0.00022817724782431476
transmissible gastroenteritis_y,0.00022798280064829278
er_y,0.00022789991783888388
demographic factors,0.0002278091819825346
infect_y,0.00022753043817778942
lung_y,0.00022708406649403064
reverse transcription_y,0.00022665759778659497
laboratory features,0.0002265226038283704
hydrophobic_y,0.00022643572316032154
sars patients,0.00022609800829237546
affected_y,0.00022594730860870524
features_y,0.0002258685928727254
functions_y,0.00022571796409937513
isolation_y,0.00022561187726987447
reservoir_y,0.0002253474912652814
protein coding genes,0.00022500636228806652
predominant products p220,0.0002246569703949834
np21 residues 21,0.0002242711606949542
represent,0.000224107044677053
cytoplasm cell,0.0002237033654323279
protective_y,0.00022335276855342098
transmissions,0.0002233274695454802
structure_y,0.00022306422958846985
vero e6 cells_y,0.00022245462694073
fragment_y,0.00022228231458592157
determinant_y,0.0002219900521978102
nested pcr assays,0.00022191302655478107
novel coronavirus,0.00022187483535092154
transcription_y,0.00022186854061331742
basic,0.00022171640369857772
reaction_y,0.00022155427490202551
models_y,0.00022141121565398599
20,0.00022107623658673583
14,0.0002210641996148163
hospital-based paediatric population,0.00022077097444474857
extracellular signal-regulated kinase (erk) 1/2 and c-jun n-terminal kinase,0.0002204437758213431
epidemiological_y,0.00022032933539045015
mrnas_y,0.0002201847803454745
constructed,0.00021995811125425215
mutagenesis_y,0.00021979627446882204
nonstructural proteins_y,0.00021976029107689736
coronavirus disease 2019,0.0002196619416656929
immune interference,0.00021943356963471415
organ_y,0.0002193728790718207
antigenic stimulation,0.00021926258952936105
regulated,0.00021919372175512633
comparator group,0.0002191069687969837
cats_y,0.00021905634973537553
2013,0.0002188848741135648
trypsin_y,0.00021884546597563558
finally,0.00021877436301435282
enterocyte cultures,0.00021873459193741623
block_y,0.00021860710107906488
synthesized_y,0.00021857947978147407
prevention_y,0.00021813633151720874
betacoronavirus virulence factor,0.00021749320615372378
present study,0.00021704217178093526
crystal,0.0002168785327222112
spike proteins_y,0.00021671383618122883
positive-sense,0.00021661578101625278
domain structure,0.00021646790974020106
generation_y,0.00021639660096001203
particular,0.00021630974058396848
discussed,0.00021588332775992314
fully,0.00021573655176648627
linked,0.00021568251267102166
sialic acid bovine coronavirus,0.00021561302612056534
nsp1nsp3 cleavage site,0.00021556599838891549
cells expressing,0.0002154741963404497
polar hydrophilic residues,0.0002151820468429989
cellular activators of sars-cov,0.0002151097911085662
orfs_y,0.00021496345146421934
neutralizing antibody_y,0.00021482317822861584
feline coronavirus fcov fcov,0.0002147895347573056
reverse genetics approach,0.00021476678398777693
glycoprotein_y,0.0002146935588421829
merscov serologic testing,0.00021452399232454309
highlight,0.00021438317619540005
autumn,0.00021410965222375198
year_y,0.0002138862393940276
bovine coronavirus bcv antigen,0.0002137751285619915
polymerase,0.00021371501495826093
3a_y,0.00021368774720462475
efficiently_y,0.00021363517733308875
apoptosis_y,0.00021340808411439026
neutralization titers,0.00021326533833478076
cysteine-to-alanine amino acid,0.00021319296504447013
conclusion,0.0002131505587049775
angiotensinconverting enzyme,0.00021311792638927473
modified ibv rna,0.00021311511760663642
central nervous symptoms methods,0.0002129308546681943
substitution_y,0.0002125731836273685
transfer_y,0.00021242282857008104
capacity_y,0.0002123717753740335
amplification-based diagnostic methods,0.00021233951486573338
lack_y,0.00021233108351529625
closely,0.00021194354839145803
directed,0.00021193279395459035
elicited,0.0002118645789511298
notification,0.00021166894345875638
amplified_y,0.00021165935711017054
sarscov protein 6,0.0002114309429664693
vivo,0.00021079242366980829
nucleocapsid protein_y,0.00021057485112208348
hcov_y,0.00021055896940079983
systemic coronavirus infection,0.00021047003897956828
oncolytic therapy,0.00021036134809430737
family_y,0.00021028967815461412
frames,0.00021025053802128577
efficacy_y,0.00021024000714426065
critical,0.00021000111038606888
intervention,0.00020954475550262317
cytokine_y,0.00020932840084029056
encode_y,0.00020894718128631863
facilitate,0.00020894554162199968
antibody titres,0.00020799945744581118
coronavirus stress response,0.00020777750289801043
gp180 gp69 gp25,0.00020774452018100086
paramyxovirus f,0.00020743410476626998
von frey filament testing,0.0002068256872036732
inoculation_y,0.00020674202549427913
merscov s,0.0002067159091379422
enzymatic_y,0.00020604333233578554
pseudotypedvirus system,0.00020585226356489362
taken,0.00020575644069682056
cysteine_y,0.00020558007469040837
antiviral activity_y,0.00020516819321925937
hydrophobic anchor sequence,0.00020487322620877247
nucleocapsid_y,0.00020466268749442685
nonstructural protein_y,0.00020450312786938742
surface structures,0.00020440797078249878
geo-positioned mers-cov,0.00020405111632988986
oligonucleotides pcr,0.00020386333046732515
coronavirus merscov_y,0.0002037332220721582
(fret)-based double-strand (ds),0.00020335288637344614
peritonitis,0.00020299424331054973
selection_y,0.00020290999479314137
drugs_y,0.0002026838716219123
lamina propria,0.0002025284862761191
initial_y,0.00020227739327818338
useful,0.00020196990237531214
immunized_y,0.00020193635351371385
sequenced_y,0.00020165141100218962
viral infection_y,0.00020139992299090192
selective index,0.0002011761888514502
chinese reference strain,0.00020110476293303228
immobilized,0.0002009535339052302
influenza a. conclusions,0.00020092444787136695
n-terminal gst-fused sars-cov rdrp,0.00020088937854949283
late endosome,0.00019972077201124887
open reading frames_y,0.00019964436449622751
86 nucleotide sequence,0.00019958471487587428
consensus_y,0.00019924533502758566
"interferon regulatory factor (irf)-3 and -7, activating transcription factor (atf)-2/jun",0.00019912498448525814
proinflammatory proteins,0.0001986979977264644
interacts,0.0001982186191614001
immunochromatographic assays,0.00019812510255024882
techniques_y,0.00019771381333233285
multi-institutional collaboration,0.0001973337413443828
gastroenteritis coronavirus_y,0.00019718763762873774
type i interferon (ifn) response,0.00019700119528729483
individual_y,0.00019691862598945255
viral entry_y,0.00019688342983751705
bcov esterase,0.0001966548829144026
feature_y,0.00019663541903512855
demonstrating,0.0001965338117102184
naive,0.00019645978891684026
inhouse elisa,0.00019625501158190847
led,0.00019617867121484424
recombinantproteinbased wb,0.00019611568770072478
downstream_y,0.00019591356279294553
threading procedures,0.00019563218037287343
polymerase chain,0.00019553581585139048
positions_y,0.00019491596295107366
membraneassociated peptide,0.00019486863217822901
viral protein_y,0.0001948080745954763
bcv spike gene hypervariable region,0.00019472237563222556
complete_y,0.0001945696442336516
rbd_y,0.00019452168772415292
ntu156 28897 nucleotides,0.00019437726422591242
possibility,0.0001941591658173978
internal image monoclonal antibodies,0.00019415563506398954
controlled_y,0.00019413347454749666
feline coronavirus_y,0.00019372451940098936
culturable,0.00019361628708338096
treated_y,0.00019356223417358882
human coronavirus nl63 cn060114 strain,0.0001933333164406211
clones,0.00019331247931303694
binding domain_y,0.00019327747503134984
small angle x-ray scattering,0.00019309817221008728
gastroenteritis virus tgev,0.0001930833177394464
protein negatively,0.0001925700884616063
anti-sars drugs,0.0001919064886292199
reca-like subdomains,0.00019189207190009448
influenza_y,0.00019168425462213386
directly,0.00019123424408445673
residues sequence,0.00019120561743512783
tatase activities,0.00019118163398925144
iga bcv-specific antibodies,0.00019117495588656053
protein kinase a,0.0001910012741786273
subgenomic_y,0.0001909148771974236
date,0.00019088080608508647
occurs_y,0.00019079375508014183
requires,0.0001906011662916127
adult patients,0.00019051831784795768
ccov infection,0.00019043897500646838
tracheobronchial lymph node,0.00019043363414558486
increase_y,0.00019023212667799007
reduce_y,0.00019022935685327565
envelope_y,0.0001898715911993549
inoculated tissue culture cells,0.0001897807518714846
lysosomotropic reagents,0.00018968509487664504
m396binding,0.00018946005611276476
unknown,0.00018942317133135848
cross_y,0.0001891351704031619
merscov rbd,0.0001890574141512026
codon_y,0.00018900378562819228
vesicles_y,0.0001888632892120773
coronavirus infectious bronchitis,0.0001888502739719273
combination_y,0.00018883036145036347
granulomatous necrotizing vasculitis,0.0001886823429136953
antigens_y,0.00018847035878318064
life_y,0.00018815637212188407
sars-cov genomic rna,0.00018811869888350093
natural kittenhood infections,0.00018804489408608742
bodies,0.00018800267691043303
er-associated degradation,0.0001878080297128112
sn2 position,0.00018776276418013628
reading frames_y,0.000187753129941402
manner,0.00018744741870476992
19,0.00018725555867382164
rna genome_y,0.00018715363195970884
importantly,0.00018714958242090033
brsv-related clinical outbreak,0.00018705183916302106
affect,0.00018703039355735842
recombinant sarscov spike polypeptidebased western blot assay,0.0001868874984424539
golgi_y,0.00018680437709958755
formed,0.00018645126483338986
clinical signs_y,0.00018637678023925624
basis,0.0001862092601856808
post-mortem examination,0.0001859792387991022
virus ibv,0.0001859434511362642
lungs_y,0.00018586364254510169
investigate_y,0.00018569237258853156
mers-cov neutralizing antibodies,0.0001856517995600108
test_y,0.00018507046723343707
signal_y,0.00018484202161206945
furthermore,0.0001845803340396039
cell cultures_y,0.00018447029032567642
provided,0.00018443263100369314
index_y,0.00018427828643052916
blood lymphocytes,0.0001842520020260268
ecov-infected mdbk cells,0.00018411905742433826
direct electron microscopy,0.00018392716220901815
proinflammatory_y,0.00018368837886029857
combined,0.00018366430258418505
set,0.00018339656164146633
genomic rna_y,0.000183282666799352
substructure,0.00018323149446284204
compound,0.00018307932171337054
better,0.00018303027271621939
immunoglobulin g enzymelinked immunosorbent assays,0.00018293053315892395
sarscoronavirus sarscov sarscov,0.0001828754300540032
assessed_x,0.00018286903782461367
separate,0.00018277323711282583
renilla luciferase genes recfcovrl,0.0001827496181138575
fip_y,0.0001827404027854438
neutralization_y,0.0001825556586787145
national acute respiratory illness,0.00018172717346877292
sarscov_y,0.00018166373375328338
nsp3_y,0.0001813189086633676
findings suggest,0.00018123035882489539
normal_y,0.00018121490135910662
community-acquired pneumonia,0.00018120743983587287
wildtype plpro domain,0.00018115202255564858
infectious peritonitis_y,0.00018112636587228132
loss_y,0.00018096543187210026
indicates,0.00018094375974266763
polypeptide,0.00018071652854037776
remained,0.00018055272338714243
serial_y,0.00018051113906336722
wiv1,0.0001804638426127135
leading,0.00018023059891838936
healthcare professionals,0.00018020591605865283
zoonotic merscov,0.00018012850741904463
types,0.00017984292570879653
result_y,0.00017970660334383978
control_y,0.00017962470702364409
crosssectional serum samples,0.00017946897855275617
s-dependent membrane,0.00017934393485687694
reveal,0.00017922703121637607
good,0.0001791854873020494
green fluorescence protein-tagged 8b,0.00017909525945863155
diverse host factors,0.00017902366009020125
kinetics_y,0.0001790127007372351
13,0.00017894965059293548
gene genetic,0.00017893834929541924
impact_y,0.0001788870444566244
cell cycle regulatory complexes,0.00017878377031484423
elements,0.00017871509420370636
platforms,0.0001786785149973242
alexa488-qsy7 fret-based peptide substrate,0.00017846943549358168
4/91 vaccine recombinants,0.00017844108259003292
introduced_y,0.00017840021137296525
p9,0.0001781493126717149
recombinant adenovirus 5 (rad5) vectors,0.00017787011057495596
series,0.0001777902186113635
genetically_y,0.00017771039215949802
nl63_y,0.00017769459127642533
putative heptad repeat 2 (hr2) sequence,0.00017768521525363945
months_y,0.00017702131499885813
lacking,0.00017701871018016167
animal-to-human,0.0001769039772052762
merscov spike protein s2,0.00017681774797236583
variants_y,0.000176626151186987
shdpp4,0.0001766058846290541
experiments_y,0.00017640637488384515
fatality_y,0.00017621059228215658
airway_y,0.00017617996446260087
plasma_y,0.00017607714381068237
peptides_y,0.00017587220274653583
extrapulmonary specimens,0.0001758433550020702
delayedtype hypersensitivity reaction,0.00017562878490308236
gel,0.00017533636555750636
human camel,0.00017532200897838517
electron_y,0.00017531166413089727
spike gene_y,0.00017519479827166716
polymerase chain reaction_y,0.00017507367316354044
reactivity_y,0.00017494519948555237
likely,0.0001746541702355433
sars-associated cov (sars-cov,0.00017458560770922243
dbcamp-treated murine astrocytes,0.00017450685624374618
clinical epidemiology,0.00017442458775645514
preoutbreak,0.000174371562795714
target_y,0.00017409664437683793
approach,0.00017399866103923105
prior,0.0001738430093782213
fragments_y,0.00017379136075115452
failed,0.0001735711026102522
cloned genome fragment,0.00017300160774377137
vero a66,0.0001727503849459692
cholesterol-rich microdomains,0.00017270885178420888
probably,0.00017261326095020156
developing,0.0001726021318294599
orf4b,0.00017242917969251443
et,0.00017212820327207703
progression,0.00017210099408623814
luminex xtag rvp fast v1 assay,0.00017201129869480366
act,0.0001719188759646387
tyr,0.000171913185672038
bulged stemloop,0.000171674380372397
iii,0.00017148676806850804
post-inoculation,0.00017141615047629305
cleavage_y,0.00017135770295275372
serve,0.0001713460140463785
mf59,0.0001712579317181613
variant_y,0.00017066509900907778
component clones,0.0001706152407496433
identification_y,0.00017053367112660942
viral positivestrand rna genome,0.00017051387949389144
host/pathogen,0.0001704740990184174
promoter_y,0.0001701118578905959
inhibitors_y,0.00017010588952809171
"3-(4,5)-dimethylthiahiazo(-z-y1)-3,5-di-phenyl tetrazoliumbromide",0.00017009437371692432
bacteriophage rna polymerase promoter,0.00017000071086264594
seven,0.0001699947414547153
transmembrane protein,0.0001699911702969303
rnas_y,0.00016989599633126276
disease control,0.00016984897245476974
secondary idea,0.00016982025162762086
mers-cov s glycoproteins,0.0001697620151194092
swc3a monocytesmacrophagesgranulocytes cell,0.0001696330087713126
despite,0.00016946699201068004
cellular_y,0.0001694086540517885
health surveillance,0.00016931620826134337
3'-most position,0.00016931499046130466
genomic targets,0.00016919590493476349
molecular determinants,0.00016919289562875102
respondents,0.00016889033670518784
processing_y,0.00016887283075388737
influenza-like illnesses,0.00016883189342693019
cultures_y,0.00016881400328468764
human respiratory,0.00016841748982995708
article_y,0.00016827471743126874
side product,0.00016814639762295552
108 sarscov rna copiesml,0.00016797410382965837
transmissible gastroenteritis coronavirus_y,0.000167971472169831
consensus transcription-regulating sequence,0.0001678521610206069
ccov fluorogenic rt-pcr assay,0.00016784845465920545
two-hybrid system screen,0.00016777557025374302
material_y,0.0001677568687683963
hcov-229e/myelin basic protein (mbp) cross-reactive t-cell lines,0.00016772175219858666
concentration_y,0.00016744105840172887
determine,0.00016741085374359136
contained,0.00016685225724640204
bronchial epithelial,0.0001666267917826112
bound_y,0.0001666140578232402
coexpressing,0.0001664232845278332
roc analysis,0.00016622059521417633
systemic_y,0.00016597783364380239
bayesian framework analysis,0.000165797264259268
central core,0.0001657352236796783
natural coronavirus infection,0.0001655135801857881
mature_y,0.0001652825398412301
late,0.00016519906013237468
cell growthcell cycle regulation,0.00016487617340154404
bilateral abnormalities,0.00016479191880043942
viral polyprotein processing,0.00016468056911963348
week_y,0.00016441531825035384
permissive_x,0.00016440151070900831
therapeutics_y,0.0001642805093201722
coupled-transcription translation system,0.00016421585474640058
cocirculate,0.00016408526126404126
causative,0.00016401023367318895
acquired,0.0001639034547859234
size_y,0.00016388440237395056
mortality_y,0.000163605203848175
hosts_y,0.00016345434214897012
ifn lambda 1,0.00016342404128186276
persistence/demylinating-positive strains,0.00016322216264162137
spike glycoprotein ectodomain,0.00016320114601137394
extensive_y,0.00016302975268011214
virus roots,0.00016301257048292856
traveler-associated secondary cases,0.00016292132374785137
nuclease mapping,0.00016291457794685333
regarding,0.0001628521038743059
m396 crossreactivity sequence analysis,0.0001628370255991463
northern hybridization cd91 rna,0.0001627505392130591
cd8(+) t cell responses,0.00016271520279956156
formation_y,0.00016254811320895102
heptad repeat_y,0.0001625243642208264
previously reported,0.00016244637487234078
activated mesothelial cells,0.00016238449326051125
multiple specimens,0.0001620475473510313
tp29,0.00016180471011204855
coronavirus non-structural protein 1,0.00016176302419493668
anti-viral nab,0.00016110625832958244
human coronaviruses_y,0.00016096408340424563
pattern_y,0.0001608483740440099
times,0.00016084601101235422
leader,0.00016074613789781212
touching respiratory secretions,0.00016071831625557556
swallowing,0.00016070246231204743
lead,0.00016069535732048833
total white cell,0.00016066742953198105
amplification_y,0.00016056160072430045
events_x,0.00016032116874642368
ace2 residues residues 31 35,0.00016031019217238604
symptoms_y,0.0001602006578820422
microscopy_y,0.00016019349784975482
aromatic amino acid-nucleobase stacking,0.00015995004358151626
primarily,0.00015987875821121312
temporal-based bayesian approach,0.00015980855680744143
amino acids 1 to 292 and site b,0.00015980429177835865
monovalent cations,0.00015962383385352585
online,0.0001596138016067364
coronaviruses viral spike s proteins,0.00015953335733842348
position_y,0.0001595041272919469
process_x,0.00015935527064572634
nucleic,0.00015934985671786438
nonessential group-specific accessory genes 3 and/or 5,0.00015894178364225895
smallanimal species,0.00015889305774060745
recovery_y,0.0001587593937065503
oligodeoxynucleotide sets,0.00015866472563805725
chrcov hku24 chrcov hku24,0.00015862601113223414
aminoterminal 26,0.0001584719916898438
provides,0.00015839190763022534
samples collected,0.00015816725353860506
loop_y,0.0001580298244567886
respiratory tract disease,0.00015800492297123167
sarscovinduced disease,0.00015795673293340814
brainstem,0.00015790972984799538
circulating_y,0.00015778519105529617
tract infections,0.0001576241158943681
coronavirus mouse_y,0.00015761902353872567
betahairpin structural motif,0.00015730646562594033
king faisal,0.00015723418574555684
plasmid constructs,0.00015720195893088835
protein specific,0.00015698114887549304
monoclonal antibodies_y,0.00015696360451556104
in silico,0.00015687295777999554
human convalescent sera,0.00015679724591113295
fd filamentous bacteriophage,0.00015673242402604822
virusreceptor interactions,0.0001565320813634761
low-pathogenic human coronaviruses,0.0001564570496472373
persistent_y,0.0001564367872999714
correlated_y,0.00015629782581453962
neurogenic bladder dysfunction,0.00015620450980938046
genotype-specific fluorogenic rt-pcr assays,0.00015604112583182512
nuclear ribonucleoprotein q ribosomal protein,0.0001559192130815551
aminoacyl-trna synthetases,0.00015566043793191587
prcvdex pigs,0.00015547157198777696
degradation_y,0.000155408265997456
scientific evidence,0.0001553419488313514
premature stage,0.0001552857632360633
sars-specific celullar immunity,0.00015527849413264763
evolutionary relationship,0.0001552516040592531
synthetic mers s1 fragment,0.00015521505417638148
viral proteins_y,0.00015518083534792442
designed,0.00015504937856508673
free,0.000155041717701753
lung induction,0.0001547462324411933
signs_y,0.00015466793117325416
distribution_y,0.00015427792331972303
coronavirus sars cov_y,0.00015410489341490858
pulmonary lymphocytes,0.0001539335466933648
wide,0.000153887156738703
restricted,0.00015372031559175784
hepatic inflammation,0.0001537130540450329
additional,0.00015350919861932758
transmissible gastroenteritis virus_y,0.00015332463326843046
travel activity,0.00015316077597262215
polyprotein precursor,0.00015281050537829834
majority,0.00015276774249093733
doublemembrane vesicles,0.00015271804302154776
coronavirus hcov_y,0.00015246355511753395
membranes_y,0.00015228926011482915
authorized_y,0.00015221187220218336
28,0.0001521731087233252
orf1a replicase,0.00015211578669700108
wobble base of,0.00015183246414968737
intermediate cleavage product,0.00015180888884737425
potent,0.00015161801597898684
ribonucleoprotein structure,0.00015152070914546247
positivesense genomic rna,0.000151506973216571
persistence_y,0.0001514505655773722
membrane-associated proteins,0.00015144147532763504
discovery_y,0.00015132579091913358
viral host,0.00015110306891029713
slippery sequence uuua aaa,0.00015108694395960968
coronavirus nl63_y,0.0001510657504778055
humancivet sars covs,0.00015105300760204956
pka,0.0001510315531877694
helical,0.00015098947600566455
autographa cafifornica nuclear polyhedrosis baculovirus,0.00015090403495906002
dpp4_y,0.0001508219141114087
enzyme ace2,0.0001507771426465766
laboratory analyses,0.0001507698579649654
variable_y,0.00015012193912638177
ultrastructural features,0.00014993500696564819
mhv genome,0.00014971044006917378
community-acquired infection,0.00014960777470867642
s protein receptor-binding domain,0.00014959374450153448
lettuce surface,0.00014941193339642285
human polyclonal igg antibody (,0.00014935730746591872
identity_y,0.00014923996309410445
coronavirus sialodacryoadenitis virus sdav,0.0001489816302174606
positivestrand rna,0.00014896633606339364
network_y,0.000148964112281917
immunohistochemical analyses,0.0001489083609976895
failure_y,0.00014865313040234374
c6,0.0001485261543025647
rocatccinduced neuronal,0.00014844312871364665
diagnostic protocols,0.00014838337836821825
3clpro,0.000148358268364717
tolllike receptors tlrs,0.0001483101898229035
igg antibody test,0.00014823085190159883
group c betacoronavirus,0.0001480497256561415
diagnostic_y,0.00014796273083031192
bispecific adapter,0.00014792577747364273
poorly neutralizing antibodies,0.00014789493801544747
iga-antibody-secreting cells,0.0001477665622025387
c-terminal hexahistidine tag,0.00014749576412205047
betacoronavirus clade,0.00014748547053649997
sarsr-covs,0.00014738478833482217
host cells_x,0.00014736422565992104
regulate_y,0.0001473546614113441
inhibits_y,0.00014706601792855098
cd4_y,0.00014703703059990917
vero e6 cell culture,0.00014687738174712519
viral spike_y,0.00014671442161083204
coronavirus replication_y,0.00014655031389363435
cd8 tcell priming,0.00014654945177789422
neurological system process,0.0001462655875611856
african bat virus,0.0001461980039103153
viral genome_y,0.00014608330767740352
quantitative real-time polymerase chain reaction,0.00014608330398659298
virology phylogeny,0.00014598755420377064
mutation filtering scheme,0.00014576847296526914
respiratory human coronavirus nl63,0.0001457534825077281
58-kda proteins,0.00014553610654263155
low sensitivity,0.00014538964193983142
microvascular,0.00014536973063872474
june,0.0001453462193554929
sample_y,0.00014507897874397327
underlying,0.0001449979812798041
cov replicase,0.0001449320960853922
intercellular tight junctions,0.00014492484213723668
selftargeted virus,0.00014486809882504194
coronavirus replication cycle,0.00014446640858634723
clinico-epidemiological information,0.00014424458805589377
bovine enteritic coronavirusf15 strain becvf15,0.00014417754053401167
consensus mers spike protein synthetic dna vaccine,0.0001441446165940822
polarized calu3 cells,0.00014413208745853935
response_x,0.00014411729432047305
hydrophobically-modified derivative,0.00014403373338439608
35,0.00014399070618035164
polypeptide chains,0.00014390434013636282
viral genome equivalents,0.00014389660110899048
hcw,0.00014375921665587632
countries/territories,0.00014369745477090822
values_y,0.00014352202458053085
uuuaaag,0.00014347105565345626
neurotropic_y,0.0001433441738634816
respiratory syndromeassociated,0.00014333139048125628
activator of transcription,0.00014313065227295708
case counts,0.00014311025912315648
nonstructural genes orf1 orf3,0.00014304268334106032
calf diarrhea bcov rbcv wd,0.00014302454729686107
-7,0.00014300540909853348
survival_y,0.00014276981775994028
liver_y,0.00014276461903240436
escherichia,0.00014266963560305524
upper respiratory tract_y,0.00014255903350112446
dif-positive specimens,0.0001424895082711079
strategy_y,0.00014246075403252743
accumulation_y,0.00014238652438106587
relevant_y,0.00014208756370349477
amino acid sequencing analyses,0.0001420670168467902
neurotropism,0.0001420171112126373
2004,0.0001419544344980834
coli_y,0.0001419284378780284
poly(ethylene glycol)-block-poly(lactide-co-glycolide),0.0001409570681488402
100,0.00014091600120349766
hcov dans des pathologies digestives,0.000140912362561107
available authorized users,0.00014086148305179934
single-stranded rna genome,0.00014047043587577776
orf_y,0.00014030682724306459
j storz j med virol 44152161 1994,0.0001402401256243191
permeability,0.00014021371467304688
coding,0.0001401896526426912
evolutionary success,0.00014011448729398196
viral fusion,0.00013991635449881555
broadspectrum peptide inhibitors,0.00013987387974343134
mers-cov rates,0.0001398163728116619
subclinical virus infection,0.00013958647343083655
preventive medicine database,0.00013940762577668866
angiotensin-converting enzyme 2 receptor,0.00013928863557490716
substrate_y,0.000139248884990388
mixed population,0.00013912625997751092
infectivity_y,0.00013896446209678458
coronavirus infectious,0.0001387079520908284
monocyte chemoattractant protein mcp1,0.0001387050910528876
stable_y,0.00013860044135485783
cterminal_y,0.00013859331693763548
sars-cov structural proteins m,0.0001385480576948099
characterization_y,0.0001383788623241148
virus tgev,0.00013833326124092994
murine coronavirus_y,0.00013822218419035317
distinct,0.0001382168424575279
purity,0.0001381507385300499
infection-induced apoptosis,0.00013811185305243474
maternal igg1 antibodies,0.00013796709779917722
multiple rnas,0.00013796082986773742
unlike,0.00013791127173678168
yeast twohybrid,0.00013758680398573607
western,0.0001374306558475035
cap guaninen7methyltransferase n7mtase,0.00013742487499977167
supplementary material,0.0001373884234204166
healthcare facilities,0.000137309102963739
rheum officinale baill,0.00013709026115775105
gi-13 lineage,0.0001369386090520542
presented,0.00013692725314605857
postmedial golgi,0.00013688886135546405
fatality rate,0.00013680752169137336
generally,0.0001367823620211846
characteristics_y,0.0001367059058395154
thoroughbred horse breeding region,0.0001365528044333914
zone-interference gel electrophoresis,0.0001365213304027597
frequently,0.00013651835907001867
inducing_y,0.00013651484096494914
wide-spectrum anti-cov drugs,0.00013640641409841183
65,0.00013619268218682657
drug actions,0.0001361190470562673
nucleus_y,0.00013596139623423014
blot,0.0001358667731492329
tripartite motif protein 25 trim25 e3 ubiquitin ligase,0.0001358208393457065
putative protein antip2 antibodies,0.00013579066352443605
rabies virusbased vectors,0.00013566099325909591
nsp1_y,0.00013561489380384758
ci,0.00013544736805021803
suitable,0.0001354259616378747
innate immunosuppressive respiratory virus infection,0.00013539375741379028
coronavirus mouse hepatitis,0.00013533140649871962
enzymatic cis-trans peptidyl-prolyl isomerase,0.00013533090472755442
short,0.00013525025075026813
epitope_y,0.00013511768611891773
antigen folding pathway,0.0001350565096585689
human antibody,0.00013505436993192443
feline infectious_y,0.00013501938340827564
continuous_y,0.0001349624616305291
proliferation,0.0001348408113727955
site-directed mutagenesis studies,0.0001346350300209511
seropositive animals,0.00013463501262383937
resolution_y,0.0001343638656546066
pigs_y,0.0001342945276638844
prevent_y,0.0001342152653384502
isolate_y,0.00013416647521324486
course_x,0.00013415797283045843
shows,0.00013409727984512262
intestinal_y,0.0001340470225296122
human coronavirus vaccine,0.00013384837528956082
crowd-sourced epidemiology,0.0001338475079151728
replicated,0.00013382988539671436
susceptible_y,0.00013382205610400425
merscoronavirus,0.00013376921814033888
clone_y,0.0001336203739101899
biotin,0.00013347325267904682
cofactor nsp10,0.00013336861366004094
mammalian secretory,0.00013330434284911932
cytokine/chemokine response,0.00013318796322593036
variation,0.0001330367258691346
capable,0.0001328492105336414
extent_y,0.00013279160761851282
causes severe,0.00013266677209642378
human pals1,0.00013248941009252752
vector_y,0.0001324142267363623
interestingly,0.00013236346229425678
long,0.00013220816694595606
replication process,0.00013217359580788358
poorly,0.000132093494275453
considered,0.00013208608437617804
ion channel,0.00013192924016277408
methylate mrna cap-0,0.00013181136857644762
highly conserved rna virus proteins,0.00013169203489245114
5'- and 3'-terminal sequences,0.00013167627009267414
highmolecularmass glycoprotein,0.0001316270150892579
occur,0.0001316055061695032
previous studies,0.0001315699434320324
hospitalized_y,0.00013145923499721323
homologous_y,0.00013132242687962414
vesicular stomatitis,0.00013128401739948088
cell killing,0.00013125949927660102
attractive_y,0.00013119959306901081
middle east respiratory syndrome-coronavirus,0.00013117634032699065
membraneassociated 78kda glucoseregulated protein grp78,0.00013113778411878146
peptidebased vaccines,0.00013101261352032042
serological detection,0.00013093567023768576
vacuolar-h+ atpase (v-atpase) g1 subunit,0.00013081941671058955
bat pipistrellus pipistrellus dpp4,0.00013067093092892538
passage_y,0.00013060783576446445
cpg,0.0001305831123075211
mortality rate_y,0.00013058297077102367
correlation_y,0.00013050840174744525
camel handlers,0.00013036692131172331
human merscov infection merscovspecific antibodies,0.0001302582777953424
field_y,0.00013018062595336448
transmembranous region,0.00013013963930384704
cross-protective vaccines,0.00013008107863305524
cells infected,0.00013003997986168507
propose,0.00013002100122386565
vero cells dnsp16,0.00012998909972513413
attenuated_y,0.0001298231997614207
downstream analysis,0.00012977922014097197
care_y,0.00012963987762163687
accessory proteins_y,0.000129621923376054
endosomal microenvironment,0.0001295212751568826
demyelinating_y,0.000129506577511077
permissive_y,0.00012948676183841668
single prrsv infection,0.00012946670567001134
confirm,0.00012937462656461375
predicted_y,0.00012936243292331157
human and animal cells,0.0001292831868924214
analysis revealed,0.00012920820935555843
membrane-bound transcription complex,0.0001289285715103452
50,0.00012888241279394467
lower respiratory disease,0.0001284732219180653
immune response_y,0.00012838661529782712
coronavirus n protein,0.00012833532855343133
conformation_y,0.00012830207708972315
selection pressure,0.0001281856880452388
near,0.0001281829409071004
macrophage inflammatory protein,0.00012807131357709452
recombinant virus icsz16s k479n,0.00012800416145895518
virulent tgev,0.00012799156044066096
"endoplasmic reticulum (rer),",0.0001278990895476596
similarity_y,0.0001278191081549546
rna packaging signal,0.0001277814899363448
blocking_y,0.00012765675367861266
o-acetylated sialic acids,0.0001275177473462398
haematological,0.0001274306136653216
10th fibronectin type iii domain,0.0001273680243656464
peninsula,0.00012731774444280878
primary attachment site,0.00012724538966393524
escherichia coli_y,0.00012712484803951635
ribosome-protected mrna fragments,0.0001271020071972599
consensus transcriptional initiation sequence,0.0001269304552846793
given,0.00012691486256051149
rbd-specific humoral,0.0001268972782306468
fibrosis,0.00012683743066967603
potentiate,0.00012682755337772947
clinical locations,0.00012673845438399684
immunoprecipitation,0.00012657181167544576
saudi ministry,0.00012650178010053335
defective_y,0.00012649918628926374
antagonistic activity,0.0001263948424743469
chlorpromazine loperamide,0.00012630565428130703
neutralization epitope,0.00012621000180640735
pulmonary sars-cov,0.0001260757775578309
rift valley fever virus,0.00012598522563886703
ne1 di rna replication sequence,0.00012589803590539215
jhmvinfected mouse cells,0.00012589346989437365
data indicate,0.0001258494054401559
glycoprotein amino terminal heptad repeat,0.0001257830151787598
human chromosome 15 enzyme markers mannose phosphate isomerase,0.00012571212697070955
hemagglutinin function,0.00012564265983652242
coronavirus seroepidemiological studies,0.00012563362726543552
purinergic response,0.0001254886617193792
cap analog m7gpppa,0.00012543276024824915
completely,0.00012536653883174535
assessed_y,0.00012522930011389538
proteins hemagglutinin esterase,0.0001252008021999433
c3h mice h2k,0.00012508404035513026
wt_y,0.00012495426275351573
providing,0.00012488836112491857
human coronavirus 229e_y,0.0001247510421225159
short linker peptide segments,0.00012471447939244124
computerised quantification,0.00012470258469629846
sars cov infection_y,0.00012466821972972276
yettobeidentified serine proteases,0.00012466374759938188
coronavirus-infected cells,0.00012439122500767334
vaccination_y,0.00012439053778610533
mhv pathogenesis,0.0001242488428026146
reverse transcriptionpolymerase chain,0.0001241003574859064
nature_y,0.00012397162980946487
canine microsomal membranes,0.00012392367802085275
subunit_y,0.00012390593199795808
help,0.00012376470981073537
tissue culture_y,0.0001236262978651695
retrovirus human,0.00012361690475004664
caspase-dependent pathway,0.0001236161902655164
initiation_y,0.00012354102913735539
organization_y,0.000123493751376336
ad5s,0.00012339021796630448
correspondence,0.0001233059621670798
nucleocapsid spike membrane,0.0001232688536930541
innate immune response_y,0.00012326181126850907
immune dysregulation,0.00012316487121820884
educational interventions,0.0001231508793844708
breath renal failure,0.0001231370224392384
targeted recombination system,0.0001231049470095209
mers coronavirus-like particles,0.00012304556408471976
conserved hexanucleotide core acgaac,0.00012303729871934374
nterminal receptorbinding subunit s1,0.00012300955574136565
dromedaries,0.0001230065435908579
components_y,0.0001229870954852397
wild type_y,0.00012274075966481665
wild-type,0.0001227377499457489
lifethreatening,0.00012270547260892053
external receptor binding motif region,0.00012254549992033186
relocalized,0.0001225337993799068
src,0.00012252474663432107
sars coronavirus (cov),0.00012243473364375386
world_y,0.0001224285015742191
clearance_y,0.00012240814819946888
cell line_y,0.0001223639177701498
chicken infectious bronchitis virus,0.00012233366502982274
sarscov nucleocaspid protein np amino acids,0.00012233233291523632
amino acid residue sarscov replicase polyproteins,0.00012232709992475552
defective_x,0.00012232336349004967
glycopolypeptides no. 2,0.00012227914364703726
infectious challenge,0.0001222121547944355
nontoxic,0.00012218231561554203
fulllength genome sequence,0.0001221684142728288
cov s2 fusion proteins,0.00012207196306255312
aromatic amino acidrich region,0.00012204702239769347
betacoronavirus human,0.00012201174831461438
antigenic_y,0.00012201018334939348
rna genomes,0.00012201006515917347
largely,0.00012173685221238855
membrane rearrangement,0.00012167793106535343
glutamyl-prolyl-trna synthetase,0.00012167677243710644
hcov229e replicase polyprotein residues asn 1302 asn 1305,0.00012157339970895286
322nucleotide nt sequence 136 nt,0.00012153748187496105
lung diffusion abnormities,0.00012144731621510821
enzyme glutamine synthetase,0.00012142706519617619
associated coronavirus,0.000121277751235096
sarscov spike glycoprotein s protein,0.00012122935810486176
transcleavage assays,0.00012118844290715897
rational development,0.00012115159113279959
sarscov infection_y,0.00012096314646734383
endoplasmic_y,0.00012086482133959322
vero cells_y,0.00012075160432216532
chemical genetics,0.00012064353549764353
biochemical_y,0.00012045582139286808
genome-length negative-strand rna,0.0001203848456113102
localization_y,0.00012038404276723484
relatively,0.00012037816789729878
embryonated eggs,0.00012025898423313476
general,0.00012022938553466445
current_y,0.00012018861094759961
human cell line 293,0.00012018352729706201
pulmonary neutrophil infiltration,0.00011997789621199826
therapy_y,0.00011988661396894422
viral genetic stability,0.00011959950060511893
infected lung epithelial cells,0.00011957602988021258
immunity_y,0.00011950977878169462
parental_y,0.00011938273140565685
events_y,0.00011937905682268237
sarscov spike s glycoprotein,0.00011936714843050218
patient_y,0.00011930190724321225
expression studies,0.00011928381876011956
deleterious side effects,0.00011926299904444968
cytokines_y,0.00011926018832343113
cell cycle progression analysis,0.00011916844693370799
substrate-binding subsite s1,0.00011913871357756836
mers-cov replication,0.00011903006924905535
coronavirus infection_y,0.00011890361330336108
mebus-induced antibodies,0.00011884050385153923
genetic diagnostic methods,0.00011872927696424527
interviewed,0.00011870861490319655
attachment stage,0.00011870377768966338
splenocyte cell culture,0.00011870106556884185
transmembrane pore-forming viral proteins,0.00011860900035198532
kupffer cells,0.00011855082488076697
golgi complextargeting signal dissecting,0.00011838213172335978
enhance_y,0.00011835376066676209
preclinical model,0.00011817665180702598
feline coronoviruses-specific antibodies,0.00011804408478312999
mutant constructs,0.00011801799956766688
supplementary material available,0.0001179651765363889
wild-type e protein sequence,0.00011744805386637191
serine proteases tmprss-2 or -4,0.00011733343922573858
primary structure,0.00011724781484663832
feline immunodeficiency virus,0.00011716254425455755
gastrointestinal disorders,0.000117115183674839
biosecurity,0.00011709838130452684
exponential modeling analyses,0.00011708915142393142
patients lung,0.00011701511656811692
effectively,0.00011694879944733894
macrophage_y,0.00011688714537923908
lymphocyte subpopulation,0.00011687918021515244
alveolar_y,0.00011686032520376442
genotypic untypable virus,0.00011667067046169108
hcovemc dpp4,0.00011662161590275339
cleaved,0.00011655409979655594
real-time quantitative rt-pcr assay,0.00011651831786467975
encoded_y,0.00011650189913414363
evaluation_y,0.00011643911047597953
nsp16/nsp10 interaction interface,0.00011618193004104975
molecular bat-borne virus databases,0.0001161785166567801
future,0.0001161610642260171
chicken embryonic tissues,0.00011606829468817915
bhpiv3sarss interpretation,0.00011604503359216164
zoonotic coronavirus disease,0.00011599601180371194
hrn2 anti-sera,0.00011586340135170171
membrane (m) protein gene,0.00011578464581215137
chronologically,0.00011576943231689235
mhvs,0.00011572254403499216
supplementary,0.00011564880999836794
major neutralizing sites,0.00011558194069988742
nsp1 mutant nsp1mt,0.00011542900372453425
activating transcription factor 4,0.00011540376708256911
nsp4 glycosylation site,0.0001153963183943264
sars-associated cytokines,0.00011531950367395356
respiratory illness_y,0.00011529881644788335
experimentally_y,0.00011525885492697584
clinical laboratory,0.00011521189725466094
standard suspension test,0.00011518827496154553
binds_y,0.00011509501786832913
hcov229e virus particle,0.0001150340089034702
fecal material,0.00011500931932130511
genomic profile analysis,0.00011498276979867709
sars-associated lymphopenia,0.00011491360189986484
wild-type hcov-229e protein forms,0.00011486336614607762
coronavirus antibody,0.00011469233946196692
amino acid substitution mutation studies,0.00011462288246056851
hcov 229e-based vaccine,0.00011458646482286686
nonnucleoside hiv-1 rt inhibitors,0.000114495651453128
transcription-initiation signal,0.00011443412214088266
host transcription factor runx1b (runt related transcription factor,0.00011440470300462962
screening_y,0.0001143972910013209
convalescentphase serum samples,0.00011438151350860187
designated,0.0001143417672964069
structurebased design,0.00011432657538090907
cloned bronchial epithelial cell line,0.00011425656378566324
non-structural protein 3b,0.00011423336802031121
based,0.00011420000076486881
clinically_y,0.0001141751918932709
internal membrane proteins,0.00011411946643755675
age_y,0.00011409241073197892
g26,0.00011408286652513474
genetic coronavirus,0.00011407044207860845
retinoblastoma proteinbinding motif,0.00011403667246868792
angiotensinconverting enzyme 2 ace2,0.00011396143885231552
nsp14exon,0.00011384210791205997
two-dimensional liquid chromatography-tandem mass spectrometry,0.00011379129875282944
discovered,0.0001137515219357166
calves_y,0.0001137323676207617
acute respiratory syndrome coronavirus sarscov 7a protein,0.00011372337426878854
wb,0.00011371121413415902
reverse transcriptionquantitative pcr,0.00011362022627378095
aldehyde cm-ff-h,0.00011356965172126888
thermal denaturation,0.00011353194586793672
oligonucleotide probes,0.00011352937495172122
diagnostic tools,0.00011348571863745216
template_y,0.00011348533903203368
localized_y,0.000113420281693216
feline coronavirus surface glycoprotein,0.00011330841828135827
molecules_y,0.00011330028322106753
sdssolubilized,0.000113265065540293
replication-deficient dis constructs,0.00011317854474425286
linear behavior,0.00011315550622265243
48,0.00011315432779341831
short carboxyterminal segment,0.00011312596471434554
copiessample throat,0.0001130076590744414
frame_y,0.00011293279634925592
b monoclonal antibodies mabs,0.00011278482465071175
donor sequence acceptor sites,0.00011275492451740936
coronaviral,0.0001127127183847889
methylprednisolone acetate,0.00011269706164053694
hexameric form,0.000112624349508171
n gene trs core sequence csn,0.00011254842573213632
polyprotein_y,0.0001125204021052859
next-generation sequencing,0.00011250500221269911
in situ hybridization assays,0.00011250415261538305
bst2s antiviral function,0.0001124880479360141
fecal_y,0.00011245869861835301
cellular ribonucleoproteins,0.00011224093030387954
lung tissue cytokine,0.00011208008778738184
intranasal,0.0001120793317608624
attachment_y,0.0001120654956439471
avirulent serotype i viruses,0.00011195829507900171
substrate-like aza-peptide epoxide,0.00011182566482309692
macrophages methods,0.00011172556789162896
slippery sequences,0.00011157856849703479
screen_y,0.00011147075359376865
serosal surfaces granulomas,0.00011132614214721308
characteristic_y,0.00011124863141099725
icsz16s k479n d8,0.0001111115563521955
highpathogenicity,0.00011105123358733302
s-protein receptor-binding domain,0.00011103700797282603
fatal disease,0.00011102677649132692
kda_y,0.0001109641515312499
mean,0.00011095303172850687
visualization tools,0.00011090069026214238
single-nucleotide substitutions,0.00011066560784579866
predicted open reading frames orfs,0.00011052425782205308
sarsassociated coronavirus cov amino acid residues,0.00011044644716069487
alcohol-based disinfectant,0.00011043250896076003
translation_y,0.00011037397858050668
fas/fc chimera,0.0001103219064356769
mers-cov recombinant partial spike protein antibody,0.00011025536694146335
glyceraldehyde 3-phosphate dehydrogenase,0.00011023383785877891
polymerase catalytic domain,0.000110172887466266
host cells_y,0.00011005887356325625
coronavirus (cov) causing severe acute respiratory syndrome,0.00010991233111652019
cr3014,0.00010990733188817524
enzyme immunoassay neutralizing antibody,0.00010981060782710915
infection prevention,0.00010976084786351414
radioisotopic-labelled probes,0.00010975893239656676
conserved molecular,0.00010972054963962419
subsequently,0.00010963877435715476
diagnostics,0.00010959694704362534
exon domain,0.00010949982444669953
replicase subunits,0.00010942896811220207
non-immunosuppressive derivatives,0.00010942255926301345
respiratory cov prcv,0.00010941227630856894
molecular genetic analyses,0.00010936176361773061
respiratory symptoms infection,0.00010915238813470207
long disordered regions,0.00010915093785672824
strategy_x,0.00010909470568712924
soluble anti-mhv factors,0.00010898342791121845
sequence analysis_y,0.00010894833854613304
s1 subunit mm56,0.00010888954830636747
coronavirus-like particles,0.00010887760951147308
members_y,0.00010879850698391273
rna stability,0.00010856157429640348
type interferon,0.00010852665971718314
ifn-mediated effector responses,0.00010851425954594245
cell proliferation assays,0.00010836367481525936
posttranslationally modified,0.00010833957265225014
phylogenetic analysis_y,0.00010827663399468018
neurodegeneration,0.00010825374177780062
ocrelizumab,0.0001082517424196215
human coronaviruses (hcovs),0.00010823203271158956
viral variants,0.00010815485869448337
gut epithelial cells,0.00010809513848343219
secondary structure analysis,0.0001080783017646121
mhv transcription consensus sequence,0.00010801213828703785
ibv non-structural proteins,0.00010800151701381754
virus strain_y,0.0001079979147250177
sarscovinfected or 3acdnatransfected cells,0.00010795522252218475
heterogeneous nuclear ribonucleoprotein hnrnp family,0.00010789786472149695
group-specific genes,0.00010786180900376372
replicase/transcriptase components,0.00010769253572439483
subunit vaccines,0.0001075760749822768
elderly,0.00010756764350657831
choroid plexus,0.00010754689079278469
human dpp4 amino acids,0.00010752600265096078
38 monoclonal antibodies mabs,0.00010743090461882336
tyrosine,0.00010731649234222087
8,0.00010721034335193835
rrtpcr assay panel,0.0001071783479695879
appeared,0.00010714333632273393
molecular dating,0.00010707152143820054
socalled earlyphase,0.00010704632346785963
comparative genome analysis,0.0001069642239537522
pseudoknot-independent,0.00010693781639533578
identical_y,0.00010689339470594452
classical calf,0.0001067055186242561
hm5,0.00010664688788332297
native_y,0.00010654615200225088
cd8 tcellmediated demyelination,0.00010649682245260906
anti-mers-cov activities,0.00010638213929158558
dipeptide bond,0.00010635790599831306
brain immune cells astrocytes,0.00010634318348247536
include,0.00010617302779564495
length_y,0.00010612755892219086
reticulum,0.00010590986610768949
rearranged cellular membranes,0.00010582705435306468
comparative molecular field analysis,0.00010572862555222443
40,0.00010559511764432834
pretitrated viruses,0.00010550296825735302
cathepsin proteases,0.00010547348981557818
cytological testing,0.00010543374678939345
ccl5 cxcl10,0.00010540409721592016
cultured_y,0.00010540367382009478
require,0.0001053342370482741
auto-cleavage assay,0.00010531964611203388
conformationdependant,0.00010529113243186663
metadata-driven comparative genomics statistical analysis,0.00010527686439579022
medical institutions,0.00010521333984797071
adapted,0.00010521047124555169
nsp1-mediated translational,0.00010520265447650795
pulmonary viral replication pmndepleted animals,0.0001051761206722504
hcov 229e_y,0.00010516660451041208
adjuvanted recombinant ssol protein,0.00010516604735071278
apoptosis cell cycle control,0.00010506877390516329
hvr,0.00010504318965279511
characterize_y,0.00010494654766249255
hela-epithelial carcinoembryonic antigen-related cell adhesion molecule 1a) cells,0.00010493715174282379
material available authorized,0.000104879262758001
regulation_y,0.00010483236483971552
viral replicase polyproteins,0.00010479608053990435
mers-cov rna,0.0001047253821137844
high mortality rates,0.00010461634469089824
exchange protein,0.00010458007692999377
c multiple alignments,0.00010440100421940093
equine coronavirus nc99 strain,0.00010438329274072304
logistic regression method,0.00010436764063183157
degree_y,0.00010426761106546709
3a protein forms ion channels,0.00010423016902618818
feces samples,0.00010420081996845992
adpribose1monophosphate appr1p,0.00010416921686860757
s-mediated cell fusion,0.00010406201962569017
carboxyl-terminal truncations,0.00010393014905477555
effector memory cell,0.00010385551148765436
conserved single-nucleotide,0.00010384299903727515
protein microarrays,0.00010380547846550138
structural protein_y,0.00010380309126661073
bcvinfected fixed cells,0.00010376523583416267
janus nterminal kinase signaling pathway,0.00010370157479892443
cytoplasmic vacuoles golgi vesicles,0.00010364198149953585
alternative splice variant,0.00010360281616225157
lowpathogenicity,0.00010346836053504779
nonstructural protein 5 nsp5,0.00010346378877700565
endoplasmic reticulum (er) membranes,0.00010343813518700025
kazakhstan bat coronaviruses,0.00010343337237402106
epidemiological profile,0.00010339432610103026
coronavirus e protein forms cation-selective ion channels.,0.00010336126470825163
r0 estimated,0.00010332094402878268
cytokines_x,0.0001032320544081625
enzyme activity assays,0.00010318450276881044
proinflammatory cytokines/chemokines,0.00010315842635298646
patient management,0.00010313088801280078
bilateral atrial enlargement,0.000102927560635372
coronavirus leader rna sequences sequence,0.00010285138157308431
predicted open reading frames,0.000102690935651345
mebus bovine coronavirus,0.00010268417610355635
doi:10.1186/s12917-015,0.00010263876182818956
seen,0.00010260239360025913
infected alveolar macrophages,0.00010247368496619473
german research council,0.00010238638371030579
endonucleolytic cleavage,0.00010236190794375667
tmprss2expressing cells,0.00010227393085415145
fluorescent,0.00010227351226245533
radioisotopic-labelled or,0.00010223024699275328
explain,0.00010222413009914367
orf6 protein microarray analysis,0.00010221964716577044
ubiquitin7amino4methylcoumarin,0.00010217662851170242
peritoneal effusions,0.00010204166380662904
cell entry receptor,0.00010193964056777203
fulllength n protein of sarscov,0.00010187450559847385
cellular palmitoyl acyltransferases,0.00010187015901826631
analyzed_y,0.00010183150717687227
coronavirus sarscov middle,0.00010181354559878781
properties_y,0.00010179074331056803
15h docked,0.00010165454676391484
goat and bat receptors,0.00010165267621375554
implicated,0.00010163866368282742
motifs v and vi and,0.00010162565504489217
vaccinia virus-based sars-cov,0.00010162433998076301
chongqing,0.00010157708140327237
transiently transfected 293ft cells,0.00010154137737851354
promising,0.00010153192290492983
causing,0.00010151453596887482
newly-emerged middle east respiratory syndrome coronavirus,0.00010147299987098811
possibly,0.00010147238071943416
retinoic acid inducible gene,0.00010134309011772457
determinants_y,0.00010127232921263986
structural determinants,0.00010126739512398865
time curve,0.00010124004304629926
effector genes,0.00010099990436899659
nps,0.00010088536880495503
multivariate logistic regression analyses,0.00010081803729858532
occurrence_y,0.0001007972114603445
chimeric sarscovs,0.00010071974933685841
normal breast epithelial mcf10a cells,0.00010070265612042356
protein annotations,0.00010069383006521804
hong kong_y,0.00010067710354228137
polypeptide profile,0.00010064741817265744
antiviral host factor,0.00010059063810239948
microsomal membrane vesicles,0.00010057586748572346
sars-specific t cells,0.00010052833314189689
masking,0.00010051808692769343
boosting,0.00010048361177802957
carboxyterminal segment,0.00010037161981542722
cellular rna-binding proteins,0.00010027927000968692
coronavirus replication transcription complex,0.00010017191148486232
dominant neutralization epitope,0.00010003533084562214
80,0.00010002929726506363
ph_y,9.997808315881467e-05
necroptotic cell,9.996274229164413e-05
state health departments,9.995736270958424e-05
viral infectivity assays,9.986759877245771e-05
mammalianlike,9.974485987154571e-05
animal surveillance,9.961678980538725e-05
supported,9.960222929030053e-05
partially,9.955954537640582e-05
sarscov infected vero e6 cells,9.943378144343423e-05
clinical features,9.941937907240443e-05
recombinant fecvs,9.935328794950512e-05
sars-cov receptor human angiotensin converting enzyme-2,9.927550924508217e-05
protection_y,9.919859372824945e-05
scov sequences chimeric genomes,9.918109423926598e-05
decreased_y,9.913624036898269e-05
viral load profile,9.901469329574518e-05
mutational,9.899744615282226e-05
evaluated_y,9.893773430907281e-05
class,9.879335836893669e-05
alum div vaccine,9.875153912061315e-05
real-time polymerase chain reaction mers-cov tests,9.869884865505604e-05
stability_y,9.862002057390806e-05
released_y,9.859572208873969e-05
individualistic perspectives,9.845338573734011e-05
kidney_y,9.829851356598625e-05
lowmolecularweight nonpeptidic inhibitor,9.821967809854948e-05
human leukocyte antigen,9.818781091980616e-05
hospital_x,9.811458864580504e-05
normal chest radiographs,9.809787487327034e-05
environmental conditions,9.807884818552338e-05
carboxyl-terminal domains,9.79779632967379e-05
global left ventricular systolic dysfunction,9.79520522212448e-05
rnase l murine coronavirus mouse hepatitis virus,9.791885018631957e-05
il17:foxp3 expression,9.789465303003696e-05
u6 promoterdriven,9.787042673712415e-05
anti-cancer,9.778841820296073e-05
vero e6 293t,9.775782847720537e-05
life cycle_y,9.775143571567916e-05
sarscoronavirusneutralising serum antibodies,9.774841763474562e-05
host viruses,9.772056586204878e-05
pathogenicity_y,9.758817404468505e-05
allowed,9.75341883020076e-05
mers spike pseudotyped virus,9.751418708068946e-05
intact_y,9.749678951753649e-05
virus and host factors,9.738357019325268e-05
rbddirected mabs,9.735322612535688e-05
appears,9.731773862620232e-05
compound-based forward,9.70965844097559e-05
shelter intake,9.703414983946554e-05
bat sarslike covs,9.700841341323782e-05
retroviral transduction,9.695722625278437e-05
human betacoronaviruses,9.691062824437576e-05
state_y,9.684348054814944e-05
africa,9.68425556926742e-05
sars-cov non-structural protein 10,9.681574837830716e-05
immunogenic epitopes,9.678677884885221e-05
proximal tubular epithelial cells,9.675792163017715e-05
random analysis,9.670490392181537e-05
cellcell_y,9.669224705232886e-05
construct plasmid,9.668623703521588e-05
active replicasetranscriptase complex,9.662286659026432e-05
host receptor dipeptidyl peptidase 4,9.658253221433032e-05
dromedary_y,9.657489004652563e-05
catalytic functional,9.651038565755747e-05
secondary structures,9.63667935587589e-05
vaccinated_y,9.636137060941907e-05
mhv particles a short cisacting,9.62761732965151e-05
ribosomal frameshift site,9.626947257034175e-05
perinatal disease,9.61736202268843e-05
ifn-inducible genes,9.614495706123942e-05
l13a,9.601364601104562e-05
pipistrellus-bat-coronavirus-hku5,9.599172026215208e-05
viralspecific antibodies,9.593849407351099e-05
exposed_y,9.586808152854743e-05
agents_y,9.584559292401571e-05
inter-shelter variation,9.584316524585354e-05
virus replicase polyprotein pp1a,9.569978381510532e-05
tcell response,9.565385213645421e-05
vascular leakage,9.559606007261859e-05
orf1ab,9.557815667589205e-05
apoptotic cascade,9.552569916690793e-05
south korean outbreak methods,9.550642314983749e-05
experiences,9.550594329297714e-05
cell-surface,9.549221615859788e-05
inhibited_y,9.532860054113919e-05
assembled,9.526835692034362e-05
human coronavirus hcovnl63,9.520014776378056e-05
endotracheal aspirates,9.509100858525241e-05
old,9.498209454553016e-05
wts,9.495142091966167e-05
transmembrane serine protease tmprss2,9.491245254393173e-05
partial_y,9.478381159901457e-05
location of site,9.45494308702291e-05
coronavirus envelope proteins,9.451127054530144e-05
seasonal outbreaks,9.444305438317691e-05
partial nsp1coding region,9.441402468624752e-05
reverse transcription polymerase chain reaction,9.43968306163156e-05
expression_x,9.43967625346904e-05
n-(2-hydroxypropyl)-3-trimethylammonium chitosan chloride,9.431313205207886e-05
membraneactive regions,9.418388732478945e-05
base pairing,9.414937631842535e-05
morbidity_y,9.413480615519176e-05
picornaviral rdrp structures,9.412300077607818e-05
nonnucleoside analog,9.40105426841446e-05
anti-nucleocapsid (anti-n) antibody,9.399890228865795e-05
cellular translational machinery,9.39652659012434e-05
glycoprotein of,9.394866931174771e-05
sarscov s glycoprotein carboxy,9.392968308596256e-05
hepatitis virus strain a59,9.392667613875864e-05
antiviral state,9.381900001867292e-05
s510 epitope,9.37645581983661e-05
aa macrophages,9.374310548547356e-05
short stalk purified viruses,9.374080250735348e-05
viral encephalitis,9.373354393317664e-05
viral tropism,9.372727316673904e-05
ccov_y,9.371618852370325e-05
cellular cytochrome c levels,9.369789635751962e-05
conformational rearrangement,9.368358576449112e-05
endocytosis,9.36617242394582e-05
sars-cov infection pathway,9.354881131101897e-05
renal cells tracheal epithelial cells,9.349956222331174e-05
nl63 hku1,9.34949147279411e-05
fusion protein heptad repeat regions,9.346849128651561e-05
helper dependent,9.341104478937257e-05
toxoplasma gondii antibodies,9.340239429485694e-05
recombinant ibv strains,9.339771127518294e-05
cell surfaces,9.337700672156616e-05
leads,9.332044993581087e-05
race rt-pcr amplification,9.329647994479006e-05
fusion domain,9.329290356947738e-05
affinity chromatography,9.32749909492749e-05
material available,9.321919925841585e-05
apparent_y,9.308101119906079e-05
viral envelope proteins,9.298274199953636e-05
reverse genetics_y,9.29690382236881e-05
prenatal transmission,9.2955634612734e-05
efficiency-improving mutations,9.292168378842558e-05
vero e6_y,9.290709816215012e-05
relative,9.288639427616347e-05
cell surface receptor aminopeptidase n,9.284881378392531e-05
dna_y,9.276271518434624e-05
putative packaging signal,9.272811824196347e-05
transgenic_y,9.268030423150182e-05
aim,9.25886766114959e-05
transmembrane pore-forming,9.256472296017347e-05
23,9.254370322241574e-05
lowgrade fever,9.24084238576957e-05
indeterminate,9.229887904017952e-05
chicken respiratory tract s1 derived,9.22177195936593e-05
signalingcompetent members,9.213427011783258e-05
jhmv,9.211388344813992e-05
wild-type virus,9.205460092725413e-05
cln,9.201269769153197e-05
excellent,9.197016671900349e-05
misdiagnosed,9.196342894188837e-05
coronavirus 3clike protease 3clpro,9.19257767819693e-05
accessory_y,9.19100124076978e-05
amino acid group-specific protein,9.188572857828456e-05
included,9.181694301094613e-05
eptesicus fuscus,9.180755179011582e-05
beaudette strain,9.18053902521058e-05
c-terminal cytoplasmic domain of 3a,9.1805367318693e-05
zoonotic coronavirus infections,9.178504636207198e-05
human coronavirus nsp15 gene,9.176406550024402e-05
reverse transcription pcr,9.174704142428394e-05
corrected sedimentation coefficient,9.174218810257834e-05
use_x,9.168893917388706e-05
epithelial cells_y,9.166862129992144e-05
structural component,9.160822449536027e-05
supplemental oxygen,9.159934957509473e-05
transcriptional_y,9.152448826314285e-05
unknown/confirmed aspects,9.148102052945707e-05
mild upper respiratory tract infection,9.143315794798629e-05
non-sars epidemic region,9.139512164898014e-05
bispecific adapter protein,9.134252079246915e-05
rna-interaction domain,9.13134655476167e-05
phosphorylated sites,9.12972194592912e-05
lower respiratory tract_y,9.124626352859176e-05
sequence specificity,9.12326026841309e-05
immunogold labeling detection,9.122055674898534e-05
stat interactor,9.120980054068862e-05
human rectal tumor cell line,9.111779017506545e-05
charged endodomain residues,9.108405529664283e-05
viral particle,9.103963320962591e-05
mixed consolidation,9.096135327115316e-05
sars-cov pseudotyped virus,9.091927540780656e-05
automated nucleic acid extraction,9.091761830637769e-05
cov replication_y,9.086681701560233e-05
glycopolypeptides,9.086387625159953e-05
immunological selective pressure,9.085710000548561e-05
mouse-adapted sars-covs,9.085209726517161e-05
coronavirus-encoded protein,9.083718287750863e-05
coronaviral m(pro) family,9.076231181463972e-05
surface plasmon resonance biomolecular interaction analysis sprbia,9.074320646499494e-05
cellular oncoprotein,9.073969497754922e-05
mock vaccination,9.072396590887981e-05
224 amino acids residues 21 to 245,9.062296628949792e-05
corticosteroids,9.060727284579318e-05
a1,9.057079369478159e-05
defectiveinterfering di rnachloramphenicol acetyltransferase cat reporter vector,9.048094755308522e-05
recombinant deletion mutant viruses,9.045653205053697e-05
alpha and betacoronavirus s1ntds,9.042444380670104e-05
high resolution computerized tomography,9.037993756815463e-05
a59-de-cat-infected mice,9.036743905639633e-05
hcov 229-e,9.035336156458668e-05
reverse-transcribed-polymerase chain reaction assay,9.031675687729954e-05
clinical use,9.031026228005791e-05
molecular investigations,9.019450901621122e-05
coronavirus china rattus coronavirus chrcov hku24,9.011660351890964e-05
insights,9.010843015736979e-05
ubiquitous structural domain,9.010347428473478e-05
genome structure,9.008139285315548e-05
p166s,9.006253389558598e-05
action mode,9.005194960896566e-05
doi101038nature12005,9.003722044787047e-05
sars-cov construct,9.002446747050776e-05
cooler,9.00083340109496e-05
lysine k aspartic acid d glutamic acid e,8.999438664384154e-05
nsp14 proofreading enzyme,8.999295646002662e-05
green,8.99768337412816e-05
human airway epithelial,8.996464397892617e-05
human monocytes,8.989703604829965e-05
dna vaccine gene segment,8.969213956579318e-05
proton pump inhibitor,8.967260312565548e-05
pro-survival myeloid cell leukemia-1,8.966307953428581e-05
viral s-adenosylmethionine-dependent methyltransferases,8.963571234137307e-05
real-time reverse transcriptase polymerase chain,8.962566570505648e-05
spike protein-derived peptide,8.96190848750519e-05
rna-binding proteins,8.960919534600077e-05
lymphoid tissue,8.954647144439047e-05
sero-surveys,8.954301443616043e-05
open reading frame orf 1a pcr positive samples,8.953949091261789e-05
coronaviral genomes,8.950514910364475e-05
paramyxoviruses types 1,8.943189452836004e-05
cl2,8.940221318190995e-05
civet scov genome,8.934630715873842e-05
nprotein regions,8.931769647764927e-05
denaturing sodium dodecyl sulfatepolyacrylamide gel electrophoresis liposomebinding assays,8.93132902955162e-05
large positivestrand rna viral genome,8.930672508253869e-05
revised merscov r0,8.928937696508047e-05
gicovoh3,8.9283627280566e-05
critical knowledge gaps,8.927632050997947e-05
hcov 229e-based vectors,8.918890076301703e-05
transcriptional gene silencing,8.905529435978055e-05
18,8.905320610200646e-05
cellular cyclophilins,8.897524316855821e-05
linkers,8.896265121453075e-05
merscov receptor dpp4 hdpp4tg,8.890781608872814e-05
substratebinding residues,8.887212208178748e-05
molecular target,8.88613471739657e-05
ordinary differential equations,8.862596123528072e-05
proteinase consensus cleavage sequence,8.858920127729321e-05
cdnaclone inf1,8.855421018798866e-05
hcov229e replicase polyprotein residues,8.849518455588129e-05
immunization_y,8.845862990148512e-05
detected_x,8.839902276328592e-05
astrocytoma cells,8.835839976001618e-05
species betacoronavirus 1,8.835458176281864e-05
assisted,8.833629866530267e-05
need,8.832920149688278e-05
drug administration,8.83181571886783e-05
mers-cov-np-specific monoclonal antibodies,8.82956300723129e-05
cp therapy phase,8.828884974132191e-05
selfassociated,8.82640226445945e-05
heterozygous cw0801,8.823096258290188e-05
promote_y,8.810766304931837e-05
immunodominant cd4 t-cell epitope,8.804847831859379e-05
negative strand sarscov rna,8.80426620826989e-05
sars-cov nsp16/10 complex,8.794449996970982e-05
ssl,8.785810400079751e-05
endoplasmic reticulum_y,8.767660345408797e-05
nprotein c terminus,8.767611849350431e-05
lipid microdomains,8.764937517042069e-05
human rectal tumor (hrt)-18 cells,8.756810260977223e-05
human serum albumin,8.7551640686284e-05
canine covs,8.75496840983134e-05
normal health,8.746610150186664e-05
tyrosineprotein kinase 2,8.742838468182797e-05
putative recombination,8.739191007144441e-05
camel vaccine,8.737095140156678e-05
cytopathic_y,8.736236896519646e-05
transmembrane (tm) domain,8.734676795389671e-05
inflammatory demyelinating,8.718581011627072e-05
viral rna replication andor transcription,8.714623800575479e-05
serum samples_y,8.706394166116338e-05
srr7,8.706045196147299e-05
stranded,8.703230177055034e-05
nsp12encoded rnadependent rna polymerase,8.687731876639332e-05
westernblot assays,8.682994620589532e-05
massachusetts prototype ibv,8.68295342255379e-05
raccoon dogs,8.675902135515134e-05
accumulated,8.66946824271627e-05
noncovalent sarscov 3clpro,8.661253285113877e-05
feed additives,8.659318229235655e-05
"hcovs -oc43, -229e, -nl63 and -hku1",8.658156082515726e-05
laboratory-confirmed mers-cov,8.645878698858077e-05
10 kda ip10 and monocyte chemoattractant protein 1 mcp1,8.645633679303228e-05
oneway hemagglutinationinhibition hi test,8.641368082247233e-05
multiple recombination sites,8.64059162803106e-05
fisher's exact test,8.635884374165261e-05
defined,8.631978233042228e-05
innate immune signaling,8.631584321267831e-05
sia,8.629405992427503e-05
akap,8.620103625443085e-05
no mers-cov receptor,8.609384383981653e-05
england/qatar 1 virus,8.602387994586381e-05
hcov-nl63-negative samples,8.591532471741227e-05
leadermrna junction sequences,8.58840625676754e-05
docking approach,8.57910790791257e-05
lung fibrosis,8.575898621955471e-05
retinoic acid,8.57537207346851e-05
complementation,8.569077122489706e-05
entire,8.566529085101386e-05
minimal_y,8.560678902912835e-05
feline cov,8.560451684603638e-05
experimental conditions,8.554127157010209e-05
high inhibition panel,8.550858575786247e-05
recovered_y,8.542084270429639e-05
filamentous ribonucleocapsid,8.540102267486045e-05
mers-cov infection rate,8.539715918373078e-05
jhmv infection elrpositive chemokines,8.537144011448646e-05
sg formation,8.531930465187027e-05
oronasal inoculation,8.5261193907728e-05
indirect fluorescent antibody,8.524183951534116e-05
ancestors,8.51919369115696e-05
s-gene sequences,8.517749163097386e-05
infectious peritonitis fip,8.516366144306667e-05
american rbcv lsu,8.510763780006265e-05
murine hepatitis virus mhv,8.507345413277113e-05
deltacoronavirus,8.506953453665308e-05
controls_y,8.500552220848208e-05
sambinding site,8.48749155427268e-05
mouse fibroblast cell,8.486368460668026e-05
pathogenicity and associated virulent factors,8.486059104690133e-05
carried,8.482232594523717e-05
respiratory viral infection,8.480602349657182e-05
highly conserved viral antigens,8.478403874935444e-05
mouse antisera,8.475991342047838e-05
melanomadifferentiationassociated gene 5 mda5,8.47221924070133e-05
bak knockdown cells,8.462379169147978e-05
contribute,8.457907913207324e-05
environmental contamination,8.447178068779136e-05
product_y,8.445678302576233e-05
april,8.440629763106333e-05
mitochondriamediated,8.439130672466131e-05
genetic background,8.425266871143673e-05
coronavirusspecific igg,8.421569340209474e-05
multifocal sites,8.413873446858374e-05
virus protein-coding regions,8.410348468516691e-05
antiviral factors,8.404907898689853e-05
proteinase_y,8.403552740335514e-05
vaccination virus,8.403269317924291e-05
breast milk antijhmv antibodies,8.402708552171123e-05
lines_x,8.394803543637305e-05
las,8.370026701729338e-05
predicting,8.364415828899263e-05
homologous spike protein,8.361391246220993e-05
cellular proteases,8.36114178245018e-05
subneutralizing,8.357616705086274e-05
molecule nonpeptide inhibitors,8.347470566575053e-05
co-immunoprecipitation techniques,8.338056158913094e-05
feline coronavirus type i a,8.331522808194574e-05
passages_y,8.32877784883476e-05
virion-associated accessory protein,8.326644848529305e-05
truncated recombinant nucleocapsid (n) protein antigen,8.32012449154156e-05
deviation,8.316874617031113e-05
neutralizing effects,8.313358344696852e-05
morbidity/mortality,8.312713828579927e-05
bcvinfected cells,8.308206842761012e-05
peripheral blood monocyte macrophages,8.30768774024731e-05
coronavirus infectious bronchitis virus,8.306472188419297e-05
membrane fusion functions(1,8.303949698553255e-05
n-terminal cys/his rich domain,8.300163402127872e-05
g.,8.298565882756803e-05
dromedary strains,8.293768283637902e-05
human entry receptor aminopeptidase,8.293686610960373e-05
epigenome reorganization,8.291087862976925e-05
nonessential staff,8.289255115779916e-05
genetic relationship,8.28635019515463e-05
physiology,8.283121058066747e-05
confocal microscopy assays,8.278203259175697e-05
sv40 study,8.278138123438668e-05
nterminal sequence analysis,8.273302655471625e-05
clonal genomic sequences,8.272485192557006e-05
serotype i,8.269638734931505e-05
cell homeostasis,8.269141844244687e-05
corticosteroid,8.268097506174227e-05
cb,8.26562706616632e-05
receptor recognition supplementary,8.256246768947016e-05
rotavirus strain,8.254853280840236e-05
serum antibody,8.250456226125193e-05
epidemic strain,8.246491917892948e-05
niaid-sponsored virus pathogen database,8.244063408434551e-05
human-to-human,8.237209076247266e-05
bayesian neighborjoining,8.235993126677275e-05
mhv2,8.232917905456741e-05
electrophoretic mobility assays,8.225035196849697e-05
coronavirus leader rna sequences,8.224082021694204e-05
"interferon-inducible transmembrane proteins 1, 2, and 3 (ifitm1, 2, and 3)",8.222284960623946e-05
symptomssigns,8.221122920894156e-05
heat treatment,8.220401737995674e-05
lung diploid fibroblast 2bs cells,8.215725179474085e-05
passive immunotherapy,8.21525907549245e-05
infectious bronchitis coronavirus,8.21434130135058e-05
merscov animal hosts,8.210100121329327e-05
virion assembly,8.209706488445553e-05
fcov_y,8.209495910218884e-05
dental team,8.209295167660274e-05
enteropathogenic transmissible gastroenteritis virus tgev,8.186272944100876e-05
sampling occasion,8.186151291425928e-05
epistatic,8.185689578643766e-05
aa residues 435 to 439,8.179847720723626e-05
post-translation modification,8.173869559003422e-05
virusinduced cytopathology,8.166134456880948e-05
l.,8.164477121472539e-05
hepatitis virus mhv nsp10,8.163492675396693e-05
dissecting,8.161620700820963e-05
viral infection assay,8.161316171298458e-05
hla-b* 4601,8.155664196431861e-05
cellular inducible nitric oxide synthase,8.151986132482051e-05
carboxy-terminal end,8.148751525915665e-05
post lethal mers-cov,8.148616440919371e-05
3clpro cleavage sites,8.148221071004559e-05
groupspecific orfs orf3a,8.141857283628554e-05
cw0801 hla allele,8.133909088695751e-05
bovine coronavirus bcov_y,8.125419274252969e-05
repeat region,8.123750031637406e-05
active translation,8.12282970353659e-05
self-reported infection,8.11972040488514e-05
detailed,8.102049634868498e-05
danish herds,8.097857118419785e-05
immunogenicity_y,8.096773796976503e-05
2002,8.095564917671336e-05
small interfering,8.089800086318434e-05
core_y,8.074436240699226e-05
demonstrates,8.073050320887956e-05
immunofluorescent antibody assay,8.066880628990333e-05
dosesparing strategy,8.060734713933344e-05
laboratoryconfirmed primary middle eastern respiratory syndrome,8.059998204732332e-05
mutated messenger rna 4,8.057064822571572e-05
endosomal infection notyetidentified proteases,8.051533350821323e-05
renal_y,8.041936521477103e-05
acute tubular necrosis,8.041370617046658e-05
endosomal cysteine proteases cathepsin l ctsl,8.03848646460283e-05
endogenous ddx1 protein,8.03661840270047e-05
intravenous immunoglobulin therapy,8.033580414410983e-05
recombinant retrovirus,8.033381869836185e-05
ctla4hingesars800 dna vaccine,8.027441803106275e-05
nucleocapsid n protein genes,8.021227591053565e-05
spseudoviruses,8.018196237316522e-05
cytoplasmically,8.016760255501834e-05
biosecurity advices,8.008228842491296e-05
coronavirus spikemediated membrane fusion,8.003657520093158e-05
coronavirus structural proteins,7.998944892640395e-05
hace-2 tg mice,7.998108951128751e-05
al,7.994880189504317e-05
studies_x,7.986892087098807e-05
celltocell fusion coronavirus,7.985307668909596e-05
biotin ligase,7.983177683849631e-05
virus-induced nlrp3 inflammasome activation,7.978581290622433e-05
pig kidney epithelial cells,7.977489548967685e-05
hcovs_y,7.963215201828958e-05
investigation_y,7.96142009125088e-05
pseudotyped_y,7.952217642592193e-05
cell surface serine,7.946276026291644e-05
intracellular compartments,7.944757850321716e-05
molecular libraries,7.943342686402569e-05
proinflammatory factors,7.942050097088462e-05
orf1,7.941009209792151e-05
rabbit polyclonal antibody,7.940047900903204e-05
dromedary camel herd,7.931137001265389e-05
real time,7.930412146560659e-05
polymerase gene sequence analysis,7.930115204954013e-05
respiratory epithelial cells,7.928272913608604e-05
isg15,7.921647499289505e-05
primary human macrophages,7.914354419199386e-05
cathepsin l cleavage site,7.907174489115421e-05
3c_y,7.906783690245087e-05
column-based manual rna extraction method,7.898515335202135e-05
recombinant and plasmaderived,7.896936521578003e-05
liveattenuated vaccines,7.887604178030064e-05
broad-spectrum antiviral drugs,7.886990866291627e-05
neisseria meningitidis,7.876793674737559e-05
positive strand rna coronavirus,7.872202011014151e-05
genechipbased,7.868799337191747e-05
polymorphonuclear cells,7.860996903135682e-05
vaccinia virus expressing epitopes,7.858561709214184e-05
recent_x,7.851653120775131e-05
duplexes,7.850984898089519e-05
problems coronaviruses,7.8455771931263e-05
betacoronavirus lineage,7.840886738625409e-05
developing sars,7.836996704816745e-05
host-damaging role,7.832629876222665e-05
35smethionine,7.828396202572778e-05
host rna,7.825614831895504e-05
"embryo-passaged, attenuated p(115 )stain",7.819067575290086e-05
therapeutic schedule,7.816665522381682e-05
heteropolymeric,7.816618489973181e-05
hcov-nl63-negative group,7.81261266551599e-05
sars-cov frankfurt 1 rna,7.812451454031323e-05
tl/ch/ldt3/03 strain,7.809755799494888e-05
12-nucleotide-long sequence,7.808678733449038e-05
cysteine proteinase,7.807357125994081e-05
cytoplasmic tails,7.80692025895364e-05
cterminal dimerization domain residues,7.802667103936462e-05
bst2s,7.802105251501662e-05
opening reading frames,7.800592899892998e-05
cell mediated,7.799085760740269e-05
putative genetic lineages,7.794331282752048e-05
"group specific genes 6, 7a, 7b, 8a, 8b and 9b",7.794242500799858e-05
canine coronavirus type,7.789501549930923e-05
human receptor binding site,7.785757218814792e-05
rtpcr_y,7.783334538918142e-05
overactive inflammation,7.782095031045339e-05
truncated open reading frame,7.779178042632758e-05
generate,7.778656405469109e-05
virus titration,7.777189163558493e-05
70,7.775854909161526e-05
1step rtpcr and nested pcr,7.775763048953365e-05
monovalent ions,7.772576534292454e-05
whole genome sequences,7.772543545397113e-05
coronavirus swine acute diarrhoea syndrome,7.770761399735238e-05
coronavirus vaccine,7.770186207691683e-05
multiple point mutations,7.759735287417229e-05
modulating,7.75770624666818e-05
reading frames_x,7.757228573373632e-05
linearized plasmids,7.754263909823272e-05
colostrum-deprived calves,7.752619264133221e-05
measured_x,7.75220722744528e-05
reverse transcription recombinase polymerase amplification,7.749619897492026e-05
monocyte-derived-dendritic cells,7.743116376710576e-05
lat assays,7.742259492367905e-05
nsp1 nsp2,7.741796727251239e-05
type i feline coronavirus surface glycoprotein,7.740560109067922e-05
biosafety level bsl 3,7.73940815798023e-05
eukaryotic positive-stranded rna viruses,7.73903489283223e-05
mers-cov-associated publications,7.735020967776338e-05
subgenomic rna,7.732936827101825e-05
readily,7.729630198970448e-05
protein fragment,7.729153258331388e-05
golden hamsters,7.727383947475465e-05
di rna species,7.727051159243507e-05
sars-cov- infected cells,7.724810885158167e-05
neutralizing profiles,7.719835207496963e-05
protein product,7.717699190450551e-05
gicovoh3 bcovent bcovdb2,7.7125833580153e-05
motifs_y,7.712275997340923e-05
ccov envelope,7.71093121051109e-05
spike gene hypervariable region,7.700666382942508e-05
online version_y,7.698876821881453e-05
downstream noncanonical site,7.694351430568311e-05
infectious ibv clone system,7.688431942058923e-05
real-time reverse transcriptase polymerase chain reaction,7.678058194920673e-05
replicative function,7.674895066718399e-05
parallel coiledcoil trimer,7.672206860303726e-05
ns2 mutants,7.667233385011516e-05
enveloped rna viruses,7.662643036433588e-05
weeks_y,7.653467058159994e-05
rna-processing enzymes,7.652023330755056e-05
intracellular membranes,7.648462368151708e-05
sarscovinfected macaques,7.64823843503119e-05
epidemiologic pictures,7.646567057165445e-05
p britton j virol 751235912369 2001,7.644330286557146e-05
q159l amino acid substitution,7.641305579605762e-05
diarrhea virus pedv transmissible gastroenteritis virus tgev bovine coronavirus,7.641071781128095e-05
pi4p lipid,7.640038645408632e-05
chloroform treatment,7.630694822186508e-05
fusioninhibitory,7.628730115635916e-05
estimated glomerular filtration rate,7.622086213316079e-05
virus-centric look,7.617075320319094e-05
familial caregiving,7.611836792908418e-05
human genome,7.609261330884753e-05
congenital immunodeficiency,7.609228862715221e-05
lung kidney,7.604356306306859e-05
mapped_y,7.599277176276707e-05
43,7.599188180727577e-05
dromedary camel coronavirus uae-hku23,7.595109345369073e-05
heavy and light chain sequences,7.592758846408283e-05
sars infection,7.592438046942727e-05
hiv-1 protease inhibitors,7.589022679893593e-05
hcov-nl63 prototype sequence,7.585508203499511e-05
recombinant spike domains s1 of ibv,7.578264417320214e-05
rna overlay-protein blot assay,7.575682682759276e-05
single protein,7.567132285214414e-05
immunological screening tests,7.56046048784933e-05
nonstructural protein 1 nsp1 nsp5 envelope,7.560417475019298e-05
animal-to-human transmission,7.560325266879585e-05
facility,7.559612483501448e-05
n and second domains sor112,7.554584326488641e-05
evaluating,7.551391666333978e-05
cell-invading molecular machinery,7.549081892872646e-05
globular domain of residues,7.546489867495324e-05
lead structure,7.538626778258984e-05
respiratory tract_x,7.538024096432826e-05
activesite residues,7.537904004311829e-05
initiation complex,7.534276974153378e-05
full-length rna synthesis,7.529747927096097e-05
nonstructural ns proteins 3a,7.525283345333454e-05
serodiagnostic antigen,7.511105127955106e-05
vaccine-induced protective immunity,7.508660040675828e-05
central nervous cns,7.501940736749664e-05
salmonella typhimurium,7.499735627429002e-05
putative rnadependent rna polymerase,7.494058789446814e-05
conserved rna virus proteins,7.493589784961838e-05
autophagosome,7.486460993909689e-05
naturally-occurring flavonoids,7.485551239235743e-05
chromosomal condensation dna fragmentation,7.476535250089048e-05
bacbased mhv reverse genetics system,7.472469013593348e-05
laboratory monitoring,7.46812899676939e-05
downstream end,7.464796378444501e-05
charged amino acids,7.462015556026404e-05
receptor dipeptidyl peptidase 4 dpp4,7.455020897100778e-05
bird,7.44073589128711e-05
virus replication protein kinases,7.435892997642029e-05
arab emirates uae,7.422892056395546e-05
epidemiological surveillance,7.419821665244496e-05
virus utilizes,7.41724601957722e-05
nonstructural protein (nsp) 6,7.416778903572942e-05
human leukocyte antigen c hlac,7.41235047328034e-05
s1 extracellular domain,7.406417315142529e-05
molecular pathways,7.406018979929998e-05
acute selflimited infection,7.401670246480215e-05
mouse system,7.396882350677316e-05
coronavirus-induced upr,7.385449179188569e-05
tissue destruction,7.377926239048617e-05
radioimmunoprecipitation assays,7.375958106646716e-05
unique_x,7.375946927160666e-05
protein coinfections,7.372583058805729e-05
innate antiviral signaling,7.369323190666262e-05
antiviral agent,7.364804394082926e-05
vaccine virus genomes,7.357265659718048e-05
infectious-bronchitis-virus,7.354002200732718e-05
viral evolution,7.351749480152478e-05
al(oh)(3)-adjuvanted whole virus sars vaccine,7.348466674102471e-05
ectopically-expressed plp variants,7.346917175860122e-05
component,7.341762628216874e-05
human host dromedary viruses,7.341080661936709e-05
tight junctionassociated protein,7.34083846918567e-05
zincfinger,7.340492225281538e-05
nasopharyngeal swabs,7.337985232810136e-05
plpro domain,7.33686250868607e-05
hypermutation,7.335628918061695e-05
spatiotemporal cluster analyses,7.334264599214175e-05
21,7.333784435240861e-05
transmembrane or membrane hairpin topology,7.331499371881342e-05
compartmentalise,7.331338532841835e-05
pancoronavirus rt-pcr assay,7.325725411130541e-05
transgenic tg mice,7.325340343530666e-05
precleaved mers viruses,7.320089597961495e-05
angiotensinconverting enzyme 2positive ace2 cells,7.31814268763037e-05
affinity equilibrium dissociation constants,7.315890557858495e-05
primary eukaryotic cell lines,7.311032592488446e-05
endemic infection,7.310821873345696e-05
race,7.306861409999195e-05
antijhm serum antibody,7.30306450015831e-05
over-expression,7.302096128455168e-05
nsp5 activity,7.29851706633828e-05
control risk assessment,7.294672258635618e-05
janus nterminal kinase,7.293733628304471e-05
molecular level,7.292924024732218e-05
essential sassembly,7.28524507593455e-05
2bs cells,7.282168294977804e-05
nsp16interacting domain,7.280754374008202e-05
cross-reactive neutralizing antibodies,7.272548765728847e-05
genetic properties,7.27243546325936e-05
chimeric_y,7.27012505143494e-05
organization-recommended singleplex real-time quantitative rt-pcr,7.266745157598174e-05
c terminus,7.262327615582481e-05
reversion,7.26075187054709e-05
upper respiratory tract disease,7.254915111723259e-05
fibrous connective tissues,7.253490440638373e-05
prcvpositive cells,7.250840255041061e-05
activating nuclear factor kappa b,7.242446166343553e-05
95bp,7.240872796811385e-05
europe_y,7.239749603972601e-05
armored rna ambion austin tex,7.237898301343625e-05
vv earlylate gene p75k promoter recombinant,7.234950806425865e-05
transcriptase,7.231505948575392e-05
nonmyeloid cells,7.229650789764786e-05
coronavirus mouse hepatitis virus strain,7.224866169529909e-05
monocyte-macrophage cell,7.224585529751368e-05
cytotoxic t cell responses,7.221635215933723e-05
carboxylterminal intravirion,7.220396660801398e-05
covs sialic acid moieties,7.220212543243306e-05
viral family,7.211453762762072e-05
assay_x,7.210049290632869e-05
comorbid medical disorders,7.205231648689442e-05
causal agent,7.204606237866508e-05
virus surveillance,7.199345003884271e-05
unglycosylated m proteins,7.188555555040239e-05
gargle/mouthwash,7.185943193486046e-05
virion structure,7.185906426621906e-05
human angiotensin converting enzyme,7.18588378770718e-05
syndromeassociated,7.1835263563811e-05
healthseeking behaviours,7.18211275907524e-05
genetic variation,7.175276410845735e-05
genechipbased analysis,7.15345290342812e-05
occurring,7.14767986737323e-05
cytoplasmic signaling domains,7.145899931695585e-05
isopeptide bond cleavage,7.145063223641298e-05
predicted cleavage site,7.142129302904484e-05
rna sequence,7.141914028335496e-05
scotophilus bat,7.139686608283921e-05
human and canine coronavirus spike protein sequences,7.138957718078612e-05
protein metastability,7.13709653896818e-05
interleukin 17 il17,7.130204838105383e-05
transcription factor atf3,7.127933324252886e-05
small ibv proteins,7.119542141917833e-05
proteasemediated cell surface pathway,7.11559605245401e-05
entities,7.115024097327444e-05
il4,7.113137607395195e-05
population-based randomized trials,7.113122942818882e-05
autophagy-sensitive conditions,7.109341087682721e-05
inflammation_y,7.100225582585435e-05
dynamic light scattering,7.099538781272211e-05
cell surface protein,7.096823401006902e-05
feline immunodeficiency virus infection,7.096265995892642e-05
california field,7.093823561483024e-05
histological staining,7.090178588833438e-05
intermediate cleavage,7.088243967186703e-05
scale-manufacture,7.083830135880673e-05
ubiquitinlike interferon,7.082693255545727e-05
cellbased assay,7.074936847515331e-05
agarose,7.074598137293629e-05
worldwide_x,7.072595955178725e-05
interleukin 12p40 il12p40,7.070014210258442e-05
cov infection ptb,7.067687230500838e-05
chiropteran,7.066400563634653e-05
h120,7.059353560194988e-05
green fluorescent protein gene,7.058279538623299e-05
respiratory coronavirus infections,7.058000973548892e-05
eukaryotic initiation factor 4g,7.055514374870454e-05
najran,7.048080857562826e-05
surface sialoglycoprotein,7.046086388998127e-05
intracellular viral rnp complexes,7.044734315808131e-05
ards p0001 sarsassociated coronavirus,7.042834373473726e-05
igg2 responses,7.041098627242465e-05
fulllength spike protein,7.038806170893083e-05
cuban bovine coronavirus sequences,7.038750382528687e-05
mycophenolic acid,7.038587347606688e-05
ultrastructural immunogold,7.038307101455346e-05
clinical follow-up,7.037887366920776e-05
outbreak cluster,7.037458585974868e-05
frame_x,7.037062107283569e-05
realtime surface plasmon resonance,7.036871222665694e-05
papain-like and 3c-like proteinases,7.012583070884687e-05
rrtpcr assay,7.006928762990729e-05
viral pathogenicity,7.006414945826454e-05
comorbid risk factors,7.00551869957039e-05
non-healthcare workers,7.005265254764628e-05
genotype-specific gel-based rt-pcr assays,7.002750341635823e-05
cca4,7.00100225062853e-05
virus type,6.98269659319194e-05
clinical scanner modified,6.982546315147322e-05
cd4 t cell-induced autoimmune murine,6.979958813210442e-05
n1347ainfected brains,6.975285473251852e-05
membraneenveloped vesicles,6.973714879391993e-05
33,6.971095542132129e-05
version_y,6.968173711845324e-05
south_y,6.967350206919711e-05
sars-recovered individuals,6.96406476316381e-05
"10.254 [1.626-64.666], respectively).",6.961748316112125e-05
neurovirulent and cytotoxic hcovoc43 variant,6.950156401756506e-05
rnase activities,6.940902138131494e-05
m.,6.93601786796406e-05
sars-cov accessory protein open reading frames,6.933917342686066e-05
secondary cleavage site,6.931115620695373e-05
full-length nsp13 helicase of sars-cov,6.925320254096986e-05
viral double-stranded rna recognition,6.924840898830301e-05
nonenteropathogenic mutant virus,6.922856601096227e-05
brcv cd,6.92197436702505e-05
editedtype di rnas the original,6.921658204116114e-05
sars-cov open reading frame,6.920630184439631e-05
cellular lipid,6.91636533997479e-05
packageable bovine coronavirus,6.914474007921621e-05
randomized control trial,6.906033869652831e-05
immunoprotection experiment,6.9045778915495e-05
ihc,6.898870861426427e-05
fibronectin type,6.897655147768184e-05
pig coronaviruses tranmissible gastroenteritis virus,6.890793167821543e-05
active fecv infections,6.888893813458095e-05
structural protein production,6.886457946573761e-05
membranebinding,6.88456957350767e-05
diarrhoetic dogs,6.877826145581395e-05
live-attenuated virus vaccines,6.872881423864897e-05
overlapping synthetic peptides,6.862032125417512e-05
tgev m protein,6.858203151728187e-05
transiently transfected cells,6.857877599757488e-05
serological assays,6.85567262579476e-05
ccl2monocyte chemoattractant,6.85554909222537e-05
cyclophilin,6.852428614328491e-05
antiviral immune responses,6.848650282855006e-05
glycoprotein of coronaviruses,6.845016133927913e-05
replicative mismatch repair,6.840679668565429e-05
feline cells,6.833449524374929e-05
leupeptin-sensitive host cell protease,6.827043927814685e-05
image-derived input function,6.823537181845707e-05
n-terminal analysis,6.819138994893071e-05
molecular dynamics procedures,6.817704085329465e-05
betacoronavirus 1,6.811380032274017e-05
hcov-229e n protein mutants,6.80823604160453e-05
biocontainment facilities,6.80191899013848e-05
positivesense rnas,6.798158467656302e-05
cytolytic molecules,6.793457708612744e-05
inhibitors_x,6.78733423357216e-05
diaplex q mers-coronavirus,6.77298635855026e-05
monoclonal antibody-based nucleocapsid protein-capture,6.772603580791448e-05
proinflammatory immune response,6.77082453165875e-05
men,6.7621040152421e-05
encephalomyocarditis virus internal,6.758457941381998e-05
oxygen supplementation,6.757458630288587e-05
oral salmonella-tpa-s-dna,6.756817364892883e-05
heptad repeat peptide,6.751781515931712e-05
bispecific adapter proteins,6.750297444472145e-05
viral spread,6.736812082806981e-05
murine ceacam1a mceacam1a,6.73647834230806e-05
nuclear factor of activated t cells,6.735276248588873e-05
human monoclonal antibodies,6.733864607318109e-05
bcl2,6.732521655356766e-05
platform_y,6.731298448362672e-05
chase experiments,6.730079842687383e-05
porcine and murine epithelial cells,6.728316208426857e-05
acute respiratory syndrome sarsunique domain,6.72692547567623e-05
merscov assembly,6.725812416987267e-05
neutralisation antibodies,6.72272000638823e-05
glycoprotein icsz16s,6.720014734366728e-05
infrastructure,6.717883248983828e-05
coronavirus structural proteins mrnas,6.715230976121963e-05
bcvinfected d 2,6.708532982349309e-05
sputum samples,6.70841423984694e-05
functional site,6.704672518659238e-05
charged residue,6.704178848409728e-05
chain-shuffling,6.704097274573065e-05
nsp10nsp16 complex,6.69636338986071e-05
hematopoietic myeloid cells,6.695956896043353e-05
middle eastern,6.695740375571274e-05
recognition sites,6.69546228257338e-05
southeast asia,6.692238232096038e-05
twothirds,6.685657079223811e-05
full-length n gene of sars-cov,6.681794163234677e-05
290 and 240kda proteins,6.68061366587015e-05
genetic susceptibility,6.674056874251992e-05
national burdenofdisease study,6.670710264359613e-05
alpha and betacoronavirus spike proteins,6.664938822526993e-05
sars-cov lineage,6.664563325843107e-05
acute respiratory syndromerelated coronavirus sarscov,6.660600161152933e-05
kong,6.655940449784633e-05
group 3,6.655322553333738e-05
sars-cov e protein forms protein,6.654987703912285e-05
nucleocapsid proteins bucov hku11,6.652488540675689e-05
controls_x,6.644434474490598e-05
porcine transmissible gastroenteritis,6.635537365549919e-05
m gene sg-mrna,6.632660254012061e-05
streamlines,6.63041499600611e-05
neurotropic mouse hepatitis virus,6.628740985311012e-05
celldeath pathways,6.628602156801117e-05
cov murine hepatitis virus mhv nsp12rdrp structure,6.628049230271461e-05
therapeutic intervention,6.625426024649178e-05
ecov s1-based,6.619897577705802e-05
nucleoprotein molecule,6.617844755364198e-05
nsp10/nsp16 complex structure,6.614874089266306e-05
hrc,6.608776083375687e-05
rotavirus geneencoded pdes,6.606219523369075e-05
phecov challenge,6.604500822341397e-05
virus-encoded functions,6.601915501219846e-05
artus biotech standard,6.598710444080961e-05
intranasaloral,6.597175553057308e-05
mild upper respiratory tract disease,6.596040978543231e-05
hcv 229e orf 1ab-encoded polypeptide,6.59578937832301e-05
evolutionary constraints,6.594336909625976e-05
submicromolar,6.593828425417818e-05
noncoding sequences,6.590758753226528e-05
single particle cryo-electron microscopy,6.584984728021861e-05
tissue sections,6.584177762226353e-05
hypervariable n-terminal domain,6.583784064671493e-05
persistently infected glial cells,6.582679112234419e-05
strand rna viruses autophagosomes,6.582498742094348e-05
real-time quantitative reverse transcriptase-pcr,6.578456885794148e-05
murine hepatitis virus_y,6.57740327004514e-05
polya tail length,6.576802330156525e-05
sarscov receptor human angiotensin i converting enzyme 2 hace2,6.576695673515726e-05
caspase9 inhibitor,6.573226564573435e-05
deduced amino acid sequences,6.571026083163028e-05
combination_x,6.567776577723417e-05
retrospective study,6.567598003951375e-05
polymerization,6.567190515664913e-05
realtime_y,6.565937879717333e-05
endoplasmic reticulum ergolgi membrane,6.56192460320994e-05
serumfree culture system,6.55765447524782e-05
international research collaboration,6.557132256817845e-05
sars coronavirus_x,6.555361912969172e-05
vectors_y,6.55504143879675e-05
locations,6.554902488140784e-05
membraneanchored s2 subunit,6.553012022022667e-05
carboxyterminal region,6.548719338256894e-05
acute respiratory syndrome sarscov,6.545952219791533e-05
autophagy pathways,6.540136401087467e-05
r667a sars-covpp mutant,6.537414686494328e-05
virusplasma membrane,6.536726746919913e-05
transient infection,6.532734368964473e-05
replicationtranscription complexes rtcs,6.53053713263339e-05
clinically diagnosed,6.530021840573449e-05
complex-type,6.528602713005028e-05
isogenic recombinants,6.527960474673728e-05
2b4 bronchial epithelial cells,6.512557818550212e-05
culture supernatants,6.50612455434097e-05
"coronavirus nonstructural integral membrane proteins (nsps) 3, 4 and 6",6.505834626228419e-05
stem,6.500031914931443e-05
bovine coronavirus mebus bcvl9,6.499062581405478e-05
g1,6.497706955502317e-05
iodine-labeled residue,6.494345344047746e-05
sars cov entry inhibitors,6.493670105429173e-05
af1521,6.490279763288633e-05
"nucleotides 15,129 to 15,134 (",6.489647854765315e-05
host gene,6.488696071129383e-05
tcell frequencies,6.480951977263183e-05
pro-apoptotic bak and pro-survival myeloid cell leukemia-1,6.474323428539124e-05
ciliostasis,6.472758335371138e-05
suborder microchiroptera,6.472494839599184e-05
delta inulinbased polysaccharide adjuvants,6.469666610700275e-05
bovine-like viruses,6.468817403813848e-05
mass,6.466507687545669e-05
spseudovirus,6.466021828507182e-05
golgi complex scanning alanine mutagenesis,6.465422699734535e-05
crcov antibodies,6.457249443843146e-05
engineering cell lines,6.455999798334038e-05
primaselike protein nsp8,6.454632206747516e-05
sgmrna 7 3'-terminal region,6.449578074611347e-05
conservative substitutions,6.446892312042554e-05
distant downstream site,6.443761750083641e-05
hcov229e n  1 hcovnl63,6.442715325302321e-05
endodomain mutations,6.442148835254829e-05
hybridoma antibody,6.442011869077238e-05
standardized nomenclature system,6.436457532021936e-05
cd45ro,6.434315717186613e-05
intestinal immunity,6.434155637214765e-05
pneumocytes and ciliated epithelial cells,6.42206083517159e-05
human angiotensin converting,6.419916291535052e-05
western blot array analysis,6.419795999545559e-05
mers infection,6.418738042562384e-05
aromatic,6.418566141440096e-05
sars-cov s2 trimers,6.417977026246801e-05
hcov-nl63 virus,6.410460733780271e-05
m396 crossreactivity sequence,6.408173055174873e-05
false negative,6.405780740409813e-05
down-regulated,6.402635207907581e-05
donor,6.400516342984989e-05
mhv ntd,6.392159273897379e-05
130-kda and 140-kda proteins,6.366200678930358e-05
class 1 viral fusion proteins,6.363636672833932e-05
virusspecific t cells,6.359518703453955e-05
bs,6.358405724775061e-05
two-way repeated measures analysis of,6.356230543807328e-05
transcriptiontranslation system,6.354549410622531e-05
31,6.354195445514045e-05
bronchiolitis,6.353385499117304e-05
virusneutralizing antisera,6.350762875498136e-05
products_y,6.34723969465034e-05
subgenomic transcription,6.343290969227925e-05
respiratory bcv infections,6.339786734519219e-05
culture media,6.336848122045437e-05
slaughterhouse,6.335417701397726e-05
ac22 mice,6.329537697128054e-05
chromatography purification,6.328524283470847e-05
hydrophilic short epitope tag,6.325742711259771e-05
q6327n,6.324113602487584e-05
vrp3014based vaccines,6.324097711841293e-05
quantum mechanics simulations,6.323464142327066e-05
accessory and structural gene sequences,6.314378381259685e-05
extracellular medium,6.313647905779143e-05
merscov nsp1,6.311258791745074e-05
sequencing_y,6.30992607031323e-05
virological surveillance,6.307660118707257e-05
vulnerable populations,6.306649428071909e-05
hcov co-circulent avec une,6.304097545290875e-05
tissue localization,6.302919048237549e-05
virus survival,6.30149539776039e-05
picomolar dissociation constants,6.300894964763331e-05
mcp1,6.29983052774917e-05
pretransfer mers-cov testing,6.299573391319956e-05
leukocyte populations,6.298962810181596e-05
broad-range cov inhibitors,6.298284950510167e-05
bovine virus,6.29695926131683e-05
two-stranded coiled-coil template,6.296585589293356e-05
tighter complex nsp10(y96f)/nsp16,6.29588030687009e-05
sialic acid recognition,6.295285264343873e-05
conformational neutralizing,6.29286023695315e-05
overlapping_y,6.291755310971219e-05
albany 18 alb 18,6.284895881399567e-05
cardiopulmonary resuscitation,6.280834960324066e-05
neutralizing polyclonal antibodies,6.280364699744577e-05
pet,6.276579119200093e-05
amino acid position 528 a528v,6.27607559247647e-05
anti-coronaviral,6.276011030781704e-05
pseudostratified hae cell cultures,6.275832294931532e-05
bloodderived inflammatory,6.274396293916076e-05
predicted sequence aa,6.274157987853297e-05
acute enteritis,6.273438920935172e-05
interferes with,6.271391411081269e-05
avian coronavirus n protein,6.270861768579563e-05
dynamics_y,6.268711681355233e-05
fecal droppings,6.261914433990067e-05
viral glycoproteins ultracentrifugation,6.25785548668073e-05
stain vero e6 cells,6.256053199384986e-05
died_y,6.255976037357856e-05
virus-induced membrane structures,6.251356460101954e-05
melanoma differentiationassociated protein,6.250850992457834e-05
recombinant hcov-hku1 nucleocapsid,6.247621044968408e-05
conserved n-terminal transmembrane domains,6.245171658881672e-05
hcov nl63_y,6.242993136225282e-05
npipb3 nuclear pore complex interacting protein family member b3,6.24035174957658e-05
coronavirus-induced acute encephalitis,6.23920574261438e-05
urgency,6.238949431080063e-05
negative-strand genome,6.236381400813844e-05
nonstructural proteins 49 kda 27 kda,6.231668536967047e-05
rat brains mm78,6.228826005562105e-05
peptide vaccine,6.228659341983198e-05
rbd residues residues,6.22725183503316e-05
cell surface cpl,6.226905958186636e-05
immunosorbent assay_y,6.225888429254975e-05
vaccine regimens,6.22548046668775e-05
p001,6.223182527831707e-05
adaptive genetic change,6.219933511970173e-05
platform strategy,6.214209476500075e-05
tropism1 transmissible gastroenteritis virus tgev,6.213488287012347e-05
interferon ifndeficient vero cells in,6.213236580163536e-05
receptor-binding site,6.211438270906836e-05
rnasynthesizing activity,6.211189974380556e-05
shedders,6.207840627352266e-05
biochemical studies,6.205354224071684e-05
inflammatory chemokine,6.204306646789963e-05
arabia dromedaryalhasakfuhku132013 ah13,6.203666746053542e-05
porcine aminopeptidase n,6.191423250198208e-05
caspases,6.189275874090273e-05
archeoglobus fulgidus af1521,6.178542853471994e-05
block infection,6.176644249912025e-05
proteolytic_y,6.174865858567577e-05
double-stranded dna unwinding activity,6.170116569650143e-05
cytoplasmic tail domains,6.164738090486231e-05
human cd26/dpp4 receptor,6.164425596218464e-05
conserved nonmembranespanning,6.164264684721746e-05
golgi membrane,6.161161741683693e-05
inositol-requiring protein 1,6.157355844092106e-05
noncanonical base pair near a35,6.154856463979107e-05
viral fusion inhibitor,6.154517425072455e-05
antiviral and inflammatory mediators,6.148731377176443e-05
cisacting element,6.146590350026818e-05
viral-specific immune response,6.138619646241881e-05
protein-based antiviral agents,6.136695366715628e-05
world health organization website,6.133303707493641e-05
oacetylated sialic acid residues,6.130382176365351e-05
cov nsp5 protease 3clpro mpro processes nsps,6.129000256697447e-05
syndromeassociated coronavirus,6.12556352741905e-05
poly(adp-ribose,6.124799189173864e-05
fip-associated meningoencephalomyelitis,6.12436858634942e-05
nsp4 glycosylation site n176,6.118660115841833e-05
coronavirus accessory protein orf6,6.116812123462733e-05
neurotropic virus,6.115693531276174e-05
cd8 t cell response,6.113876394458746e-05
nonglycosylated polypeptide p58,6.11321717954759e-05
hcovnl63 coronavirus spike,6.110023512828226e-05
viral reactivation,6.107619908969312e-05
22 genomes,6.1016475552767785e-05
primary alveolar type,6.099455127370408e-05
recombinant sars 6 protein,6.0976748914649277e-05
respond,6.0965895723823526e-05
adenovirus transduction,6.095450058729462e-05
nonsegmented linear pluspolarity rna virus,6.09508476494842e-05
adp-ribosylated,6.0896753625983485e-05
protein 8b/8ab-induced degradation,6.087530222462161e-05
three-stemmed pseudoknots,6.085336527439384e-05
decanoylargvallysargchloromethylketone,6.084705775135862e-05
mean knowledge score,6.0827521721311124e-05
powerchek mers assay,6.081872869042399e-05
viral rbd fragment,6.081292189353815e-05
nonsarspneumonia,6.079085901854138e-05
disseminated intravascular coagulation,6.0751082546427506e-05
super-spreader specimen,6.070320720528292e-05
retinoblastoma protein prb,6.068001072306554e-05
adverse effects,6.0677486198091955e-05
cytokine tumor necrosis factor alpha,6.056660526251668e-05
orthologous entry receptor dipeptidyl peptidase 4,6.0562662565498974e-05
subsequent,6.053771189746799e-05
localizations,6.0530622944979785e-05
tge iem assay,6.049542142225143e-05
viral spillover,6.04924327873123e-05
truncated products,6.0425366648999923e-05
tail_x,6.041758550134273e-05
standardized uptake value,6.0399157112605656e-05
feline coronavirus type ii strain 79-1683,6.039126995516881e-05
mouse adenovirus,6.032564175316382e-05
single trna,6.032514241987417e-05
val42 met44,6.031555128929515e-05
smediated membrane fusion,6.03154136237765e-05
fulminant fatal encephalomyelitis,6.023405048851376e-05
amino acids 351 to 403 domain,6.0218470870439785e-05
antimerscov neutralizing antibodies,6.0214382524719795e-05
viruses_x,6.018384099509472e-05
haemadsorptionelutionhaemagglutination,6.018005086373894e-05
pan-coronavirus inhibitors.,6.017240799886038e-05
cough fever rhinorrhoea bronchiolitis,6.015099588838884e-05
supporting lysosomal,6.012504446804224e-05
extracellular signal-regulated kinases 1/2,6.011554159856703e-05
middle east respiratory syndrome coronavirus merscov antigen,6.010761870652794e-05
n-terminal gst-fused sars-cov,6.006612686168672e-05
anti-nucleocapsid (anti-n,6.005566105085378e-05
acute respiratory syndrome-related coronaviruses,6.001424630442957e-05
interferon secretion,6.000093852765457e-05
risk prediction model,6.000048234519343e-05
bat cov genes,5.996442432864463e-05
coronavirus cov nonstructural protein 14 nsp14 is a 60kda protein encoded by the replicase gene that,5.9947138624823786e-05
washes,5.985218214697034e-05
nucleotide excision,5.981759266954092e-05
recombinant modified vaccinia virus,5.980244512431856e-05
high-titer neutralizing antibodies,5.97892826203685e-05
double-stranded segmented rna virus,5.976519622935776e-05
acute respiratory syndrome-coronavirus nucleocapsid,5.974203798003893e-05
hybridoma clones,5.973465748121806e-05
recombinant mers s377-588 protein,5.972164649636834e-05
signaling chain homooligomerization,5.967455336340039e-05
r0 of coronavirus disease 2019,5.966691315022137e-05
interventions,5.9664392093919476e-05
hrc2,5.958962968757152e-05
interacting,5.9578499309835765e-05
viral reproduction residues,5.9478154448436444e-05
chimeric s constructs,5.9458546654970286e-05
quercetin derivatives,5.940621836606633e-05
cr3022,5.938235313581734e-05
betacoronavirus subgroup,5.936956579863158e-05
l. pneumophila,5.9325013059474494e-05
lysmstat1 mice,5.931938821296015e-05
hibatcov hku10,5.931693832386273e-05
clinical data,5.923554788579855e-05
phdependent endocytosis,5.921826835208035e-05
cysteine-to-alanine amino acid replacement,5.919248781094824e-05
genome cdna fragments,5.9133970773781895e-05
cov murine hepatitis virus mhv nsp5,5.912623569433926e-05
chinese hamster ovary (cho) cells,5.9117604890376025e-05
bayesian phylogenetic inference approach,5.910687828052053e-05
fcwf4,5.909930342130109e-05
stagespecific embryonic antigen 1 ssea1 stem cell antigen 1 sca1,5.907346850694483e-05
p1glu substitution,5.8926696068855026e-05
ace2mediated virus infection,5.889292703927676e-05
dipeptidyl,5.887991046394506e-05
electron microscopy analyses,5.884591073151288e-05
enteric mers-cov infection,5.881844280794988e-05
voiding function,5.875897305341457e-05
sofaruncharacterized domains,5.8758179978716564e-05
hamster dpp4 amino acids,5.87483778392089e-05
envelope membrane protein,5.87382274328669e-05
membrane permeabilizing activity,5.8719754394167304e-05
transcriptional profiles,5.8716807340995724e-05
guangzhou china,5.8703440927714774e-05
hospitals,5.869383307883503e-05
hypervirulent strain,5.868588501621976e-05
transfected human embryo lung fibroblast,5.8667453950810474e-05
methylotrophic yeast,5.864115956880748e-05
post-weaned calves,5.8596944299358217e-05
persistence-associated s glycoprotein point mutations,5.859343876781106e-05
virol,5.85458298661053e-05
ucuaaac transcription consensus sequence,5.851813099795029e-05
uvinactivated sarscov microarray analysis,5.850379789818558e-05
recombinant n protein,5.848716045424248e-05
antihace2,5.847625147317259e-05
hemagglutinating encephalomyelitis phe,5.845020877484527e-05
foreign gene,5.8406821806881656e-05
comparative protein expression profiles,5.8367784257241145e-05
membraneanchored fusion subunit,5.833883835408641e-05
ifnstimulated,5.8314504077522546e-05
simian virus 40,5.831080064108961e-05
virus c/d hemagglutinin-esterase-fusion glycoproteins,5.8281426525175727e-05
j. m. rottier,5.8274188087217084e-05
subgenomic rnp complexes,5.8265033776811906e-05
contrast variant,5.8187009031158014e-05
ibvinfected veto cells,5.818304826608664e-05
aromatic amino acid-nucleobase,5.81691261254222e-05
full-length gst-rdrp,5.8148747253060305e-05
pathology_y,5.814021821793113e-05
perinuclear space,5.8132765252479974e-05
economic impacts,5.812000996256663e-05
false-positive,5.811262178318489e-05
non-health-care,5.809432725485708e-05
protein receptor murine carcinoembryonic antigenrelated cell adhesion molecule 1 ceacam1,5.806354990706999e-05
amount,5.8044077638912133e-05
multiprotein complex,5.8012618174934696e-05
bcovs,5.795490444011066e-05
non-structural protein genes orf1a and 1b,5.792471695967808e-05
anti-sars-cov drug design,5.7919632500867706e-05
interferon restricted a59,5.789289240185008e-05
heterogeneous nuclear ribonucleoprotein a1,5.786955718209634e-05
proteinprotein interaction assays,5.780501014056947e-05
ddx1,5.779336509502891e-05
viral protein processing machinery,5.778142018634956e-05
receptor-binding (s1,5.777755357866284e-05
infectious disease_y,5.772331529197576e-05
relative synonymous codon,5.768531063570787e-05
covid-19 infections,5.765296556437504e-05
coronavirus double membrane vesicles,5.764593012319922e-05
itraq technology,5.764108656050569e-05
polymerase chain reaction products,5.762901801070341e-05
clinical findings,5.760018153384375e-05
thrush coronavirus,5.758883945738361e-05
genomes_x,5.7553060701386466e-05
cov e protein,5.751533018083869e-05
nucleoside phosphates,5.750500835283014e-05
partial sequence analysis,5.7501718423387014e-05
receptor-binding,5.744967136614165e-05
host shutoff,5.741599114227354e-05
caulis polygoni multiflori,5.741371074848105e-05
horseshoe bats,5.7350446569191414e-05
consistent,5.7289523439856204e-05
macro-h2a-like fold,5.725761350744058e-05
host-to-host,5.72425363852577e-05
public health professionals,5.722472664018291e-05
posttranslationally glycosylated,5.715795894253594e-05
proteinase domains,5.7137198024884175e-05
subcellular fractionation studies,5.713517966042246e-05
late phase of infection,5.7118776819364535e-05
neurotropic murine coronavirus (mhv-a59),5.7091364000628466e-05
c-terminal hydrophilic part,5.702710987082639e-05
cysteinerich region,5.701801440750003e-05
inactivated_y,5.700989894778685e-05
faecal material,5.698219850787066e-05
human herpesvirus,5.6978363092310506e-05
intracellular precursor protein,5.693743103881971e-05
nucleocapsid protein gene v81a,5.6878701509796867e-05
gene ontology,5.6825340060523264e-05
cell cytotoxicity,5.6799756410090775e-05
hku39849 sarscov strain,5.679813887062305e-05
postmortem tissue,5.677251899887211e-05
lowpassaged d52 strains,5.669930878578486e-05
tolllike receptor tlr agonists,5.6642464710836046e-05
inhibitory subunit,5.6631185897137304e-05
surprisingly,5.657890440725979e-05
rna-dependent rna polymerase,5.651042159828181e-05
cov antiviral therapeutics,5.645976587909677e-05
microglia marker fluorescenceactivated cell sorter,5.642991066887586e-05
asparagine residues,5.639763187625036e-05
batcov hku10 strains,5.6396360856096225e-05
acute respiratory syndromerelated,5.635196433580677e-05
virus chloroquine,5.62822684898027e-05
mitochondrial permeabilization transition pore mptp,5.628176674858193e-05
high performance liquid chromatography,5.626645239754698e-05
double-stain immunohistochemistry,5.619139675811587e-05
hr2based fusion inhibitor drugresistant variants,5.618141736783415e-05
broad-spectrum activity,5.617988800765363e-05
microtubuledependent,5.614267664110523e-05
laboratory abnormalities,5.6129907035279897e-05
researches,5.6116926586719796e-05
canine aminopeptidase n,5.6107618047983455e-05
human airway epithelial cultures,5.610093449050831e-05
3acdnatransfected cells,5.6099781732322646e-05
mouseadapted strain,5.6047427113863754e-05
sars-cov igg antibody,5.602897918711137e-05
hemagglutinininhibiting hai antibodies,5.6025379921836626e-05
kb long,5.599971949771775e-05
coronavirus-induced encephalomyelitis,5.599073592857629e-05
rna extraction methods,5.59863044245046e-05
exposures,5.598356928227955e-05
housing conditions,5.5968842599951336e-05
enzyme-linked immunespecific assay,5.596515976842662e-05
nonprofit product,5.59316644096905e-05
masp2 polymorphisms,5.585218511989423e-05
area,5.584629181904624e-05
molecular diagnostics,5.578619239848039e-05
feline infectious peritonitis viruses,5.578096697394601e-05
ciliary,5.576609390155866e-05
immune response_x,5.575836274841814e-05
cultured human lungbronchial epithelial cells,5.570100755888412e-05
giant replicase gene,5.566035119414532e-05
virus uncoating,5.5629119182786245e-05
acute lymphoblastic,5.5628672465977275e-05
viral accessory proteins,5.5609132067873235e-05
antigone,5.560690251944322e-05
replicative-intermediate,5.5585153355792526e-05
angiotensinconverting enzyme 2 ace2 receptorbinding region,5.557115021777995e-05
coronavirus family group 2 and 3 e proteins,5.555772048440341e-05
homotetramer complex,5.554711296870923e-05
cd13,5.554588111533293e-05
subgenomic viral rna,5.553793446308233e-05
host innate,5.546039764535325e-05
replicase polyproteins pp1a,5.5448810823889016e-05
small plant monomeric lectin,5.5433076069541084e-05
neurogenic detrusor overactivity,5.540973752400696e-05
mouse hepatitis coronavirus strain a59,5.5357614029301124e-05
neighbour-joining method,5.5341516210637317e-05
rsars-cov-infected cells,5.532893222837253e-05
genetic interactions,5.530412453310059e-05
gm-csf,5.5299037433698075e-05
168 positivetesting samples,5.5294470111454135e-05
peptide stemloop,5.527322860006791e-05
pyogranulomatous enteritis,5.523337362408943e-05
imino proton solvent exchange,5.521695784257486e-05
primary sarscov infection,5.5182771673124036e-05
available authorized,5.5159266729157775e-05
sizeexclusion highperformance liquid chromatography hplc,5.5142223556385983e-05
genome copies,5.51329706450077e-05
acute kidney injury,5.5110061519944635e-05
type2 pneumocytes,5.508774031750147e-05
cluster_y,5.507610754840252e-05
cell cycle regulatory pathways,5.501718945666751e-05
n proteins,5.499720393678736e-05
replication-transcription complexes,5.498913749234182e-05
translating mrnas merscov nsp1,5.498399122865375e-05
occurs_x,5.493159918815234e-05
serum proinflammatory cytokines,5.492910774238108e-05
mutated viral,5.492352918500295e-05
necrosis and viral antigen,5.4917770596127005e-05
prototype coronavirus,5.486315302182577e-05
cns pathogenesis,5.483641866007649e-05
nucleocapsid n protein gene,5.4819958576063284e-05
recombinant vaccines,5.481835437579975e-05
gcn2 protein,5.4817171924525764e-05
influenza virus hemagglutinin,5.481306410971351e-05
escherichia coli cells,5.481305455990865e-05
furin inhibitor,5.4807248340501353e-05
acute multifocal interstitial pneumonia,5.476679948659623e-05
rat oligodendrocyte,5.472937662399784e-05
ubiquitin conjugation,5.47162927018103e-05
chemokines cxcl10 ccl2 ccl3,5.469132890080375e-05
n7mtase domain,5.466637560102145e-05
transcriptionregulatory sequence,5.459436329632516e-05
rbcvspecific hai antibody,5.4555743567966336e-05
jump barrier,5.4546998041773096e-05
chronic demyelinating encephalomyelitis,5.4523012420200406e-05
deletions_y,5.451691567969996e-05
yeast two-hybrid system,5.4494698003245776e-05
leader switching,5.448827389054427e-05
laryngotracheitis virus,5.4469780267708764e-05
proinflammatory chemokine,5.446641384077644e-05
ancestral,5.446565076536189e-05
[35s]methionine-pulse-labeled viral proteins,5.444343924145577e-05
avoidance measures,5.444222918678738e-05
antigenic proteins,5.443705502584589e-05
helper-independent,5.440210319350161e-05
pur46,5.438232237383079e-05
3a_x,5.4378733141835015e-05
m protein amino terminus,5.437169323784988e-05
disease-associated,5.4349466327758876e-05
predicted transmembrane,5.434546827179966e-05
nonredundant nsp5 primary sequences,5.4316810374001884e-05
merscov sequence,5.431526966698242e-05
cis rna attenuator,5.430770635407684e-05
angiotensinconverting enzyme ace2,5.4240250378086105e-05
atp1a1,5.4225434046473185e-05
hcov oc43,5.421715546168755e-05
catalyze,5.421325720527565e-05
replication/transcription multi-protein complex,5.420974424071577e-05
lateral spread,5.420493592275033e-05
spike protein of mers-cov,5.4203284804300826e-05
recombinant mers-cov,5.410017058670196e-05
mdpp4,5.4050946435042546e-05
adjacent viral protease,5.4049201017826994e-05
membrane-anchored sars-cov spike (s) protein,5.404495460888132e-05
cov nsp1,5.402099764890266e-05
extramembrane cterminal tail,5.401884659110317e-05
orf7borf8 region,5.400706937198015e-05
nucleocapsid (n) protein genes,5.3998547380707113e-05
receptorbinding_y,5.399848566713059e-05
http://covdb.microbiology.hku.hk,5.398158916317717e-05
viruses lp,5.392791660793244e-05
recombinant fcov nucleocapsid protein rnp,5.390165171416761e-05
antilectin antibodies,5.3860907645484694e-05
gadd153knockdown cells,5.384346373827905e-05
non,5.383372435991831e-05
immune-mediated inflammatory disease,5.382716274539949e-05
ectodomain transmembrane domains,5.382568998043399e-05
region molecular,5.381638457963962e-05
renal_x,5.3806609965246944e-05
weight,5.375545055277686e-05
positive-strand [(+)-strand] coronaviral genome,5.374217136799536e-05
n gene coding sequences,5.37184755419837e-05
viral and cellular determinants,5.3681920400843075e-05
nmr chemical shift perturbation,5.367906658910763e-05
nonnative receptor,5.3677816504998306e-05
quaternary rnaprotein structures,5.366676870152656e-05
molten globule state,5.3655867349897654e-05
conserved amino acids,5.3605233978472853e-05
spleen tracheobroncheolar lymph nodes,5.358699906041566e-05
type ii transmembrane serine protease,5.358531322427792e-05
nested reverse transcription-polymerase chain reaction,5.3566943842712627e-05
biological_y,5.356499887215525e-05
implementing,5.3551326569995766e-05
dayold mice,5.353122945171667e-05
stereo-array isotope labeling,5.352801924323169e-05
enteric coronavirus_y,5.349031087859834e-05
denoted strain bj232,5.3443679079137354e-05
viral proteolytic priming,5.342989508668008e-05
protected cells,5.342225171426982e-05
c-terminal p64 fragment,5.338112330987663e-05
bcv antigen,5.332278862114881e-05
membrane-bound organelles,5.326169082151409e-05
nucleoprotein gene,5.324061100000884e-05
groupspecific open reading frame orf,5.322851858589099e-05
well-protected hcws,5.322724842875952e-05
structural data,5.319513444850345e-05
healthy persons,5.3163050223700015e-05
respiratory syndromeassociated coronavirus,5.313421652462815e-05
onestep polymerase chain reaction onestep pcr detection assay,5.312422530767961e-05
cathepsin b inhibitor,5.309615002350307e-05
basal detrusor tone,5.308798437915729e-05
sars-cov 3a protein,5.306588117703071e-05
template strand,5.299675145392628e-05
conserved core sequence,5.2968496990447973e-05
type i transmembrane protein,5.294837538268056e-05
mhv a59 infectious clone mutant viruses,5.292893270712044e-05
chargerich carboxyterminal,5.292442735904535e-05
absorbed,5.291966104058194e-05
nasal turbinates,5.289288236510971e-05
replicase gene,5.2840162155082204e-05
immune activation,5.283479357074411e-05
peptidespecific igg antibodies,5.282723384232195e-05
followed,5.277386930366616e-05
single-stranded rna viruses,5.274637714378569e-05
deisgylase,5.272126766928883e-05
hcovoc43 n protein,5.2699022536479625e-05
randomized control trials,5.2686768688292106e-05
leader trs trsl,5.26529683614246e-05
golgi vesicles,5.263669882221498e-05
intercellular membrane,5.2633778172142395e-05
major immunodominant antigen,5.263137078605997e-05
primary human respiratory epithelial cells,5.2619163686608896e-05
treating,5.2609618675049813e-05
replication organelles,5.258464932727295e-05
fulllength s gene,5.256845843733957e-05
membrane translocation,5.252677124000819e-05
fibronectin type iii domain,5.248746144250731e-05
infectious viruses,5.2480984585185604e-05
small glutamine-rich tetratricopeptide repeat-containing protein,5.241783979099191e-05
principal antigenic determinants,5.241294892571206e-05
monoclonal,5.2405005074582285e-05
290kda product,5.239062088160379e-05
live vaccine,5.23747609273572e-05
lateral flow platform,5.236304362017114e-05
human embryonic kidney 293 (hek-293) cells,5.235345753104901e-05
structural requirements,5.233386489891837e-05
neurotropic mhva59,5.231470619582406e-05
nested rt-pcr assay,5.231342007396102e-05
acute respiratory syndromecoronavirus sarscov nucleocapsid protein n enzymelinked immunosorbent assay,5.2306274591669766e-05
infected ciliated cells,5.228178488013275e-05
chicken kidney tissues,5.2273769261446764e-05
host-based antiviral agents,5.226841605842707e-05
transmission-based precautions,5.2266414555214935e-05
ards pathology,5.226373413373488e-05
postchallenge,5.2237110620829725e-05
wildtype protein,5.223464535537441e-05
mutant virus,5.223306032730817e-05
natural infection antibodies,5.220550933879282e-05
caspase activation,5.2194614712374775e-05
cellular stress response pathways,5.2174802297136786e-05
self-interaction,5.215349643553845e-05
mucosal immune,5.213599087000646e-05
hcov-oc43 surface glycoprotein,5.211526254936172e-05
fipv-specific antibodies,5.2061033929858e-05
reproductive syndrome virus,5.2045599441707224e-05
16 gene products,5.204457638522956e-05
hepatitis c virus (hcv) helicase,5.203432699582634e-05
late phases,5.19999606135382e-05
interspecies,5.195968744851821e-05
central and western regions,5.195298258008671e-05
coronavirus fcov strain fipv,5.192838942654954e-05
differentially,5.1918869253722706e-05
conformational transition,5.191514178055416e-05
merscov interpretation,5.1906487834665913e-05
hot-spot cdr mutagenesis,5.189801130728915e-05
melanoma differentiationassociated protein 5,5.187736404244812e-05
diabetes decompensation,5.18554680913535e-05
west nile virus influenza virus norovirus,5.185438430657724e-05
nipah viruses,5.18246991378345e-05
interferon regulatory factor (irf)-3/7,5.181881837902713e-05
nonviral rnas,5.1810789524062366e-05
infection-induced,5.174744687925605e-05
experimentally shed type i rna,5.173270015850767e-05
proinflammatory il6,5.169594063852979e-05
mucosal surface,5.1591647462941986e-05
ifnifit,5.15629273178202e-05
prototype jhm,5.1542407368144983e-05
late 1800s,5.153202691378521e-05
receptor-binding edge,5.145290268093958e-05
translated short open reading frames,5.145081937356487e-05
cterminal transmembrane and cytoplasmic tail domains,5.137855662110913e-05
sars-cov spike,5.1321335913127526e-05
nproducing strain mg1363psecn,5.130041240514035e-05
primary type infection,5.129910465948063e-05
mv and merscovneutralizing antibodies,5.1245994238122375e-05
putative lung stem/progenitor cells,5.120416791840023e-05
notyetidentified proteases,5.120299552401619e-05
nl63_x,5.119753186962985e-05
herpes simplex virus type 1 glycoprotein d (gd-1) anchor,5.1179574270035794e-05
cellular source,5.117547357023572e-05
small intestine diarrhoea,5.116258939559745e-05
primary entry port,5.11433809939726e-05
mhc class-ii peptide ycileprsg,5.108509132169913e-05
lysosomal/endosomal functions,5.107779424528388e-05
human anti-sars monoclonal antibody,5.107304174472952e-05
haemagglutination-esterase and spike proteins,5.104791427233381e-05
codon transversion,5.101060258734837e-05
flow cytometry staining,5.0950547528660437e-05
smallangle xray scattering,5.0940960948046115e-05
resident,5.091782192435026e-05
no rain,5.089480999946079e-05
gene subgenomic messenger rna,5.087609871168471e-05
establish,5.087128466382351e-05
peripheral gc,5.086841433901074e-05
modification site,5.086796432075372e-05
anti-mers-cov antibodies,5.0866715886688414e-05
plasma donation,5.085848312445672e-05
plaque-forming units,5.085310683285033e-05
lipid composition,5.0801031408976016e-05
virus-specific antibodies,5.078407790991072e-05
homologous viral strains vaccine,5.0775131499585425e-05
protective_x,5.071930878463657e-05
jhmwu structural protein m,5.0689024867175595e-05
headache,5.062497533374094e-05
immune escape,5.0592172811868866e-05
ibv e protein,5.058258852834634e-05
furin-like cleavage site,5.0577352689994804e-05
fragmentation,5.054432084640403e-05
clinical spectrum,5.053540349374973e-05
ib-like avian coronavirus,5.051774259268047e-05
general population,5.050570641251478e-05
chemokine homing receptors,5.0500677801367164e-05
disease progression,5.0489117931777886e-05
surface spike protein of,5.048772444426687e-05
"virus, angiotensin-converting enzyme 2",5.047793088607591e-05
epidemiologic risk factors,5.037892341485505e-05
tissue culture_x,5.030886438462923e-05
31-mer peptide,5.0236990171960685e-05
chloramphenicol acetyltransferase reporter gene,5.0202393807262304e-05
vaccinia virus system,5.019568314339785e-05
central nervous system disorders,5.018071898948447e-05
neurovirulent mouse hepatitis virus mhv,5.017004852079263e-05
jhm spike protein,5.016569077661821e-05
accumulates,5.015218229605276e-05
ibv nonstructural proteins nsps,5.01475723650351e-05
alternative_y,5.0135355669794194e-05
angiotensin iconverting enzyme 2,5.01129776512783e-05
q-s (q3462s3463) dipeptide,5.0103273183501676e-05
immunoglobulin gene sequence,5.009528751283979e-05
negative-pressure rooms,5.008291649532212e-05
nucleotide selectivity,5.0077973230693926e-05
gp69,4.997168266477804e-05
epacspecific,4.995258882369891e-05
edta,4.994251808025525e-05
transmissible gastroenteritis virus tgev,4.9875560770289456e-05
cysteine acylation,4.985888435289968e-05
field-deployable system,4.984740712591373e-05
divergence,4.9826743971621756e-05
bat coronavirus hku4,4.981717181207336e-05
sarscov receptor angiotensinconverting enzyme 2,4.9765108633206524e-05
acute respiratory syndrome sars network laboratories,4.972035718946722e-05
enveloped singlestranded positivestrand rna viruses,4.966917344921877e-05
sarscovinfected cell,4.965251662774169e-05
territorywide,4.964602362964795e-05
proteins protein 6 p6,4.9635113851975375e-05
hp concentration,4.9633824496347536e-05
coronavirus nonstructural protein 9,4.958217306682479e-05
maternal antibodies,4.9580112586512165e-05
stakeholders,4.954651280320597e-05
university community,4.954604771168871e-05
papainlike proteinase domain,4.9508881716630434e-05
discontinuous rna,4.948592482726866e-05
suppressive effect,4.9481991813710394e-05
virionincorporated protein,4.943837618729558e-05
therapeutic aroma,4.940808264254353e-05
transmissible gastroenteritis virus tgev canine coronavirus,4.940098112320543e-05
macrophages kupffer cells,4.940009773233805e-05
distributions,4.935264756120533e-05
heptad repeats,4.9325712561665224e-05
transmembrane fusion subunits,4.9302635341757276e-05
orf9b,4.922035743978795e-05
realart hpa cov rtpcr assay artus,4.9181372926975625e-05
muscle,4.917969216147495e-05
merscov spike s protein,4.917826094207135e-05
single residue substitution,4.9154996358782626e-05
carboxyterminal domain of n protein n3,4.9127540303747014e-05
symptom,4.9123754566349796e-05
acute selflimiting infection,4.912005794759954e-05
virally,4.911920844474271e-05
ifitm-mediated inhibition,4.911495711142539e-05
mhvscov chimeric genomes,4.909693944755549e-05
cell-mixing experiments,4.907594097400239e-05
copy number,4.90628154268238e-05
cellular proteases furin,4.901630145068508e-05
triage systems,4.900279771296437e-05
19 temperature-sensitive (ts) mutants,4.9000739069361014e-05
yunnan china,4.899528306529819e-05
receptorprimed s protein,4.887288556570697e-05
known rna genomes,4.883731267544678e-05
cq,4.883470567327788e-05
family member,4.881612269596689e-05
retarded,4.8807816922631635e-05
triton x100resistant membrane microdomain,4.8798990946174085e-05
travel history,4.874555819196199e-05
hydrophobic patch,4.872313399098257e-05
c-terminal tail peptide,4.871545780730736e-05
cathepsin l cpl,4.867639064434912e-05
adaptive responses,4.867021084498918e-05
recombinant s450650,4.862480728144924e-05
mammalianlike origin,4.8593403004256696e-05
hydrophobic residues,4.857153571071591e-05
control precautions,4.856079360345983e-05
pathogenic processes,4.8542793888992194e-05
gene 5 products,4.8536201287523254e-05
administered,4.851436427954631e-05
sarscov orf6 protein,4.851314706252771e-05
multiple rna viruses,4.847324375378519e-05
hierarchical mixed generalized,4.846319980804855e-05
124 kda glycoprotein,4.845071810853795e-05
rabv infections,4.838064798757063e-05
s1 subunit,4.831121527871599e-05
host receptor protein,4.829727598503406e-05
coronavirus-hku1,4.8261593888882887e-05
doi:10.1186/s12917-015-0372-2,4.824578925231933e-05
http://www.biomedcentral.com/collections/annualupdate2016,4.820190226822938e-05
g11,4.815444983469282e-05
radioisotopic virus,4.8145095386510526e-05
coronavirus membrane fusion,4.813728008382927e-05
3cl(pro) active site,4.813673622500968e-05
resistant cc003/unc,4.8114996652544985e-05
yonsei university medical center,4.80953201868317e-05
evolutionary rate,4.806825223896599e-05
celltocell spread,4.806550503606169e-05
escherichia colisynthesized,4.8048610216331774e-05
100foldhigher,4.804529925141898e-05
balb/c-derived macrophages,4.798169333398798e-05
coronavirus cov designated sarscov,4.794593324308175e-05
mouse oligodendrocytic n201 cells,4.793034612459305e-05
pcr human herpesvirus 6b,4.7912694019952765e-05
zinc finger cchc-type and rna-binding motif 1,4.790304132529053e-05
sarscov papainlike protease plp,4.790290728391479e-05
186 korean people,4.789820194010039e-05
hexamethylene amiloride,4.789048561244674e-05
quantitative reverse transcription,4.788781444516985e-05
sars cov proteinase,4.786713734253787e-05
codon-optimised spike glycoprotein,4.7854876811207874e-05
virion hemagglutinin immunoblotting studies,4.782775629740926e-05
adpribose,4.7804325127425415e-05
pseudoknot loop,4.779396316987552e-05
nucleolar-cytoplasmic distribution,4.778536382352088e-05
live mers-cov,4.7783795884276696e-05
septemberoctober,4.7735642836281035e-05
rectal temperatures,4.7699387598711846e-05
viral replication/transcription complex,4.7693363961175026e-05
identification_x,4.768799227361106e-05
nuclear localization sequence,4.7687731272620934e-05
nabmediated escape pathways,4.767855141325498e-05
sars-coronavirus target cells,4.766621751111688e-05
coronavirus replicasetranscriptase complex,4.764517480418229e-05
host-cell proteins,4.763307387375519e-05
hcov-229e receptor function,4.762436901665331e-05
virus replication analysis,4.76208601215858e-05
fulllength genomes,4.7590313852029764e-05
polymerase-like domains,4.7588475157805e-05
gst pull-down approach,4.755584251087009e-05
nterminal processing,4.7547406939987835e-05
chicken embryonated eggs,4.753572780849741e-05
covencoded ribonucleases,4.7534925839176764e-05
two-hybrid analysis,4.749622252141256e-05
ethical principles,4.738334098854828e-05
merscov hosts,4.737868681297777e-05
ptec,4.732524396881422e-05
vesicular stomatitis virus g,4.731631856971857e-05
pathogen sarscov,4.728963694855862e-05
hospital length of stay,4.72718571402985e-05
tmprss2 ciscleavage,4.7230791399803004e-05
wong,4.720047621541006e-05
immunized_x,4.7192753813006093e-05
geographical groupings,4.717609900220508e-05
risk_x,4.7165456037179624e-05
promonocyte cell line quantitativepcr,4.7165456037179583e-05
cov replication nsp14 n7mtase,4.7142778538710175e-05
cyclosporine,4.713292812851862e-05
pressures,4.706691502238285e-05
migration,4.698050719227536e-05
solvent-exposed substrate-binding region,4.6968536847334573e-05
serum rna extraction procedure,4.696745598619684e-05
nephropathogenic,4.6959775501408345e-05
differentiated b cells,4.692179539047623e-05
native spike protein,4.6914466371839366e-05
reagent,4.686393875792663e-05
bone-resident macrophage function,4.686147698808197e-05
mhv particles,4.683493615601158e-05
sedimentation-flotation technique,4.680970897690097e-05
autophagy cargos,4.6792714950236555e-05
catalytic loop residues,4.678478089062124e-05
dimeric papn ectodomain,4.677775618859148e-05
human isg15,4.6767238105603195e-05
high-income countries,4.676270553445071e-05
viral positive neurons,4.674679831820865e-05
replicase polyprotein precursors pp1a,4.671851720828481e-05
immune pups nursed,4.671613316676771e-05
amino-terminal signal peptide,4.6655395756706655e-05
percoll gradient,4.664864051287164e-05
viral replicative,4.664691081067233e-05
vrp3000based vaccines,4.662715028131751e-05
domestic cat,4.6624278734796074e-05
sarscov open reading frame orf 3b orf 6,4.6623878569677795e-05
human coronavirus 229e hcov229e aminoproximal pp1app1ab region,4.661568520231628e-05
cmv,4.656053003775657e-05
molecular clone,4.654375200361679e-05
genus coronavirus,4.6524648215655215e-05
peripheral vascular,4.6499526445362967e-05
cell membranes,4.6487414941312766e-05
cross-sectional surveillance,4.647148281982039e-05
mouse hepatitis coronavirus mhv a59 e protein alanine scanning insertion,4.645560471209492e-05
continuous open reading frame,4.642245422741281e-05
unfolded protein response,4.6408551191348816e-05
middle east respiratory syndrome coronavirus merscov nonstructural protein 16 nsp16,4.6392179421082753e-05
papainlike protease plpro domain,4.6352598083960496e-05
potassium tartrate,4.631572449828379e-05
human corona virus,4.6303737534762254e-05
wildtype titres,4.629153307467421e-05
sf9 cell-produced full length,4.628022434150611e-05
virus-infected vero cells,4.6254211685495137e-05
sarscov orf6interacting proteins,4.625331524427608e-05
fluorogenically quenched,4.624700337418196e-05
single-nucleotide substitutions predicted,4.622567588325719e-05
unvaccinated controls,4.6222596063037726e-05
phylogenetic conservation,4.6199989261088766e-05
neuronal response,4.6158416850951503e-05
avian infectious bronchitis coronavirus,4.614824456859977e-05
"ultraviolet light (uv) at 254nm, heat treatment",4.614142732599116e-05
second open reading frame,4.613826060708038e-05
admitted,4.607284772873603e-05
recombinant jhm rjhm,4.605992662124249e-05
proinflammatory cytokine tnfa il6,4.605014375525846e-05
trimeric spike transmembrane glycoprotein,4.6021818971759494e-05
imino proton solvent,4.5999439993409584e-05
biochemical complementation analysis,4.599605818562699e-05
il23,4.5994485986604455e-05
doi101128mbio0051512,4.598631963625013e-05
non-immune porcine sera,4.5982831086059565e-05
uncertainty,4.5956886532302984e-05
mammalian cell,4.592442074673164e-05
ace2-expressing cells,4.586862186294562e-05
unitcell,4.5866800516906484e-05
coronavirusmediated diseases,4.575641320531349e-05
receptorindependent spread,4.574672734295815e-05
broadspectrum antivirals,4.5725274288429006e-05
primary cell types,4.565919195956814e-05
close,4.565317571149397e-05
bcovseronegative gnotobiotic calf gicovoh3,4.562218680098382e-05
sarscov receptor human angiotensinconverting enzyme 2 hace2,4.5611515562498686e-05
open reading frames 7a,4.5608192499618806e-05
dromedary_x,4.559105293009119e-05
population infection,4.558901796349965e-05
zoonotic reservoirs,4.55548936896669e-05
viral frameshift signals,4.5538750662742696e-05
infection-free herds,4.5522241254404016e-05
fcov type i. seroconversion,4.5505750637640904e-05
alpaca coronavirus,4.549679512298251e-05
nucleic acidbinding function gel shift assays,4.545260717180726e-05
amantadine,4.545154109959542e-05
human immunodeficiency virus type-1 and hepatitis c virus envelope proteins,4.544462032617722e-05
single-stranded positive-sense rna viruses,4.5418817342872865e-05
host-range restriction,4.539900062868198e-05
paired immunoglobulin gene sequences,4.539428759222294e-05
protein overexpression studies,4.538740170301339e-05
enteric viruses,4.5364757238300975e-05
hsct,4.53582010899921e-05
coronavirus nucleocapsid (n) protein,4.535656720187309e-05
physicochemical,4.528118829151867e-05
membrane-associated replicase complex,4.5234537202867836e-05
fibroblast cell lines,4.522996030369004e-05
oc43 spike protein,4.522011086478517e-05
sars-cov mpro,4.519208757739413e-05
natural host,4.5164073955166986e-05
coronavirinae a subfamily,4.515105284733307e-05
colonystimulating factor 1 receptor csf1r,4.512043584511927e-05
subgenomic-length negative-strand rnas,4.5112139242984037e-05
sars-cov infection,4.510895401049495e-05
distended cisternes,4.510792290379468e-05
dna immunization,4.5070175907624486e-05
host cell type,4.503899266822807e-05
human n7mtase,4.5026973586235264e-05
angiotensin-converting enzyme 2,4.502229457370595e-05
mitogen-activated protein,4.500242993601158e-05
serumplasma samples,4.49822636829517e-05
cartilage damage,4.497827397408202e-05
sev,4.4963265048995084e-05
clustered sars-cov s2 trimers,4.494698596136317e-05
fluorescent resorufin,4.493936801083986e-05
hcovemcinfected,4.4938018791645265e-05
lowph shock viral rna replication,4.492309476996083e-05
dsrna-encircling ring structure,4.4856229469159154e-05
recombinant baculoviruses monoclonal antibodies,4.484794901264203e-05
type i ifn-dependent genes,4.482546777276249e-05
transcriptionassociated sequence,4.48036144008949e-05
irf7 interferon regulatory factor 7,4.4796331984558336e-05
cell surface receptor molecules,4.47902369268318e-05
dna vaccination,4.474873195259828e-05
influence_y,4.4702699495807367e-05
open reading frames 3a 3b and 3c,4.468770667201087e-05
western blot_y,4.4663522013792146e-05
cytotoxic tlymphocyte,4.465908890775139e-05
lethal influenza virus,4.465700964655966e-05
coronavirus sarscov m protein,4.464535225479844e-05
glucocorticoids,4.4634222063510504e-05
co-localized,4.462488806314998e-05
characteristic heptad repeat regions,4.461088737837864e-05
destination,4.460634188311456e-05
standardized immunological assays,4.459404539755481e-05
hypervariable region 3 site,4.458580768609639e-05
modular,4.457971759649132e-05
virus-infected chicken kidney,4.4490513793075884e-05
cterminal region,4.442121309974647e-05
vulnerability trafficking,4.43818980032192e-05
hlaa2 sarscovinfected,4.4378956441817674e-05
published reports,4.43787631838982e-05
conformational feature,4.437326979103876e-05
sequence regions,4.435914269164689e-05
tolllike receptor recognition,4.4332435338805717e-05
m gene subgenomic messenger rna,4.427154960207936e-05
six-helix bundle structure,4.426739369521129e-05
nosocomial outbreak,4.418841337439139e-05
catalytic nucleophile lys 289 points,4.418561484751905e-05
atypiques entre novembre,4.418407727870311e-05
highly polarized calu3 cells,4.4152613070237216e-05
korean healthcare system,4.414706723135898e-05
biological signal transduction,4.4145661266019974e-05
students ttest,4.41421505253508e-05
neuroinflammation,4.412501141268729e-05
distribution_x,4.411888309784393e-05
calprotectin leukocyte protein l1 myeloidhistiocyte antigen,4.411794591928078e-05
hybridization assays,4.411232120799212e-05
mers-cov-specific neutralizing iga antibodies,4.4101470988525995e-05
interstemloop domain nt 142 to 173,4.4077594394945385e-05
sars coronaviruses slcov,4.4073062594583945e-05
open reading frame_y,4.398884038568024e-05
upr-activating domains,4.398295380277794e-05
unadjuvanted doubleinactivated sarscov div vaccine,4.398175165586692e-05
antinucleocapsid protein iga antibody,4.396997485625952e-05
ibv genome,4.3927906479043434e-05
hcov 229e-based vector rna,4.392482318178506e-05
cellular receptor dipeptidyl peptidase 4 dpp4,4.3914048114682675e-05
surface glycoprotein,4.3904602835643903e-05
metadata-driven,4.384510131378432e-05
macrophagemicroglia,4.384075984271784e-05
extra-respiratory tissues,4.383227176682488e-05
disordered putative rna-binding domain,4.3816512259360664e-05
enzyme-linked immunospot,4.3802812192763434e-05
n-terminal two-thirds,4.3797658555945936e-05
clinical respiratory specimens,4.377758058286244e-05
dendritic and epithelial cells,4.376798852832255e-05
3j,4.3761062923784134e-05
ntu156 28897,4.376033331956959e-05
or15 p07319,4.3748657406073605e-05
ns2h126r replicate,4.374335790698064e-05
hipposiderid bat,4.3739392252915285e-05
cellular cathepsin activity,4.3727308567348705e-05
murine coronavirus mouse hepatitis virus,4.36889304860797e-05
bovine virus diarrhoea virus,4.368719390250949e-05
laboratory tests,4.3670983101832255e-05
cathepsin lmediated,4.3633293696330785e-05
healthy eclectus,4.362217080788565e-05
pathways_y,4.361750944412913e-05
receptor-mediated transduction,4.3617010886787165e-05
high-throughput screening,4.3614211345955784e-05
multigene expression vector,4.3611567453546804e-05
fast renal clearance,4.360808461001547e-05
clinico-epidemiological significance,4.3578720607643105e-05
sars-cov accessory proteins,4.3524314874098724e-05
multifunctional cellular immunity,4.351860562222309e-05
sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis,4.3513102411082756e-05
sarscov predicted replicase protein,4.3440092917030546e-05
palindromic small rnas,4.343526167086205e-05
viral and cellular membrane fusion proteins,4.343492990565708e-05
discrimination,4.339900005823316e-05
pathogenic molecules,4.3396614201791324e-05
7oarylmethylquercetin derivatives,4.334390047117361e-05
sars-cov 3b protein,4.332537905029164e-05
n-terminal octapeptide n8,4.3297450397116205e-05
haan z li e te lintelo b j bosch b j,4.329464761468031e-05
t cell hyperplasia,4.327556904893043e-05
plp recognition,4.324434302449116e-05
infective bcov,4.3200282327522736e-05
fragments residues,4.318918263877699e-05
adpribose1monophosphate,4.318197426165785e-05
np amino acids 216,4.317047746802847e-05
brd,4.316306494423893e-05
coronavirus proteasedub,4.311321330170194e-05
spike transmembrane domain,4.310197590436465e-05
pv,4.3057225291568094e-05
course_y,4.301058828378269e-05
iav,4.300334613687961e-05
simian adenoviral vaccine,4.299494719208735e-05
syndromecoronavirus sarscov nucleocapsid protein n enzymelinked immunosorbent assay elisabased antibody,4.299475041425808e-05
coronavirus (cov) envelope (e) protein ion channel,4.2972587035531365e-05
h89,4.2967383858267096e-05
pathogens bovine coronavirus,4.296399980272271e-05
leukocytes,4.296364111730657e-05
rs igg elisa p  0001,4.296145362545501e-05
age-matched controls,4.295202156929281e-05
polyethylene glycol,4.294623784420849e-05
pmn,4.294282424378782e-05
reverse transcriptase-polymerase chain reaction,4.292672762321417e-05
e protein ion channel,4.2921902211481486e-05
structural and antigenic proteins,4.289226456597243e-05
anti-severe acute respiratory syndrome,4.287627566791488e-05
inoculation mild bronchointerstitial pneumonia,4.2874699400238736e-05
fip pathogenesis,4.2873684257952106e-05
genome-length rnp complex,4.283500372295199e-05
genome encapsidation,4.282913420591495e-05
broussonetia papyrifera-derived polyphenols,4.282734516180436e-05
human angiotensinconverting enzyme 2 hace2,4.281307961135062e-05
animalhuman zoonotic,4.2779827515488585e-05
transcription factor interferon regulatory factor 3 irf3,4.277608082675207e-05
leadermrna junction sequence,4.275816403808281e-05
poults,4.275479958143712e-05
highly labeled,4.2740060255916536e-05
human peripheral blood lymphocytes,4.272871405548171e-05
second rt-pcr assay,4.271096266294576e-05
histological types,4.267023090029899e-05
il2expressing plasmids,4.265360161476999e-05
intestinal cell line caco-2,4.2641279452911746e-05
conserved viral,4.26304534224323e-05
two-dimensional difference gel electrophoresis,4.26250280009733e-05
murinerestricted,4.259848160926546e-05
agonists,4.259341290533473e-05
cysteinerich c terminus,4.2579150938990805e-05
4.7-kda nonstructural protein,4.2564470133978366e-05
singlestranded positivesense viral genomic rna gene 1 encodes 16,4.2558385363071235e-05
papainlike cysteine proteinases,4.255332187478895e-05
minussense genomic rna,4.251706961676518e-05
bfa-resistant guanine nucleotide exchange factor gbf1,4.2473178090819244e-05
human bronchial epithelial cell line,4.243013755780164e-05
coronavirus mouse hepatitis virus strain a59,4.2411580618406406e-05
extrinsic factors,4.240493854278508e-05
human embryonic kidney 293,4.239572769424281e-05
negatively-charged lipid membranes,4.2374202716565415e-05
rnaencoded subgenomic mrna,4.235097080888386e-05
purified recombinant viral proteins,4.233055754933656e-05
slcov,4.231952159875942e-05
autopsy study,4.231587329507758e-05
regulatory genomic clusters,4.230579299579351e-05
merscov macro domain,4.22796055571251e-05
orf7b protein,4.2260136286229195e-05
fulllength merscov spike s glycoprotein,4.225299667171821e-05
triple ccov-i/ccov-iia/ccov-iib infections,4.225257079798029e-05
recombinant mhv strains,4.222509130190405e-05
alveoli,4.222237483362137e-05
family coronaviridae group 2,4.221210765531102e-05
saccharomyces cerevisiae vts1p protein,4.2199210960323626e-05
adenoviral vaccine vectors,4.215955073247882e-05
mers-n-specific immune responses,4.215215710695527e-05
700-nucleotide tgev-specific rna,4.213638354683305e-05
surface plasmon resonance sedimentation equilibration analysis,4.212366288617471e-05
coronavirus rna recombination,4.21205879522305e-05
protein-expressing cultured cells,4.211164537824527e-05
pattern_x,4.2099164482592603e-05
enzymelinked immunospot assay,4.206089377784683e-05
bovine coronavirus bcv spike glycoprotein precursor,4.198007959915892e-05
unglycosylated s0 140k s10,4.196761619237443e-05
internal coiled,4.1958511917149445e-05
national awareness,4.194566396325093e-05
proximal convoluted renal tubules,4.192879969535839e-05
conserved cytotoxic t-lymphocyte epitopes,4.192002125809598e-05
beaudette,4.191957738371645e-05
donor sequence acceptor,4.189827545989951e-05
serodiagnosis,4.187096912024643e-05
genomic mechanisms,4.1848804953949806e-05
prosurvival xbp1s protein,4.184646930055624e-05
fragments_x,4.1843429747325175e-05
hemagglutination inhibition test,4.184239088225736e-05
interferon production,4.183362801295685e-05
tgev rna packaging,4.1807802802318846e-05
stagespecific embryonic antigen 1 ssea1 stem cell antigen 1,4.180042195975317e-05
subgenomesize,4.178824049726611e-05
real-time rt-pcr (rrt-pcr) assays,4.1770341196159753e-05
murine coronavirus jhmv,4.175452753797613e-05
competitive binding assays,4.1731993963565274e-05
cns infiltrating bmdm,4.1719826243735734e-05
cterminally truncated protein,4.1719497687384094e-05
transmembrane plus,4.1716972223095485e-05
bacterially expressed hcv 229e 3c-like proteinase,4.1711423564990794e-05
rna chaperons,4.167402842166887e-05
laboratory response,4.167386621505188e-05
recombinant receptor-binding domain (rrbd) protein,4.167362188976021e-05
ccl2monocyte chemotactic protein 1,4.1604678286022445e-05
cell surface protein labeling,4.159319928709451e-05
protein self-multimerization,4.15911300308215e-05
cterminal cytosolic domain,4.158302379744378e-05
spike-mediated membrane fusion,4.15385331687365e-05
proteinbinding domain,4.1493538536238e-05
microarray analysis,4.148392799970311e-05
influenza b.,4.1463898769598505e-05
health organization announcement,4.1429886515839565e-05
phecov dna vaccines,4.141022575120506e-05
viruslike particles expression vectors,4.140426982918357e-05
autoab production,4.13907353023557e-05
recombinant partial nucleocapsid (n) proteins,4.138136959978775e-05
substrate-recognition pocket,4.137956172645168e-05
rrbd vaccination,4.133366724599038e-05
hematology,4.132646412725292e-05
genome-length replicative form rna,4.13246024412393e-05
neutralizing activities,4.130966185547734e-05
deoxynucleotides,4.130368971853089e-05
bioinformatics analysis,4.125220122480001e-05
ceacam1b producing mceacam1b,4.12366951390602e-05
cellcell membrane fusion,4.123573614716051e-05
dipeptidyl peptidase 4,4.123319163835003e-05
conserved antigenic sites,4.116944503919124e-05
dromedaryderived,4.1162767295242815e-05
oligonucleotide strategy,4.116063456572391e-05
pancov functions,4.114745606865347e-05
center,4.1142582375637325e-05
monoclonal antibodies mabs_y,4.113143876774361e-05
lipid-mimic detergent dodecylphosphocholine,4.105415849815288e-05
human respiratory syncytial virus,4.100840284400681e-05
human populations,4.099764730448253e-05
regulators,4.098484754897066e-05
lplcontaining membranes,4.094221868470327e-05
alternative open reading frames,4.09420272727987e-05
purified protein components,4.088761388449924e-05
hcov-229e-specific enhancer regions,4.0886345159312964e-05
sizeexclusion chromatography,4.085212728411473e-05
fibrotic lung disease,4.083418520957391e-05
ezrin membrane-actin linker,4.081616577415636e-05
22nucleotide nt donor sequence,4.079915905388959e-05
dihydrofolate reductase-deficient cho cell line,4.0788662865627984e-05
gfpndomain fusion proteins,4.076555311709586e-05
carboxyterminal domain 3,4.076041485693603e-05
paramyxovirus f structures,4.0723886636531795e-05
enveloped_y,4.070857493035972e-05
avian coronavirus ibv,4.068471937102952e-05
higherorder structures,4.06832629841171e-05
korea hospital,4.066901534057566e-05
bat receptors,4.060744133179556e-05
hcov-229e e protein derived peptide,4.06065416725512e-05
health careassociated clusters,4.060025819005509e-05
truncated orfs,4.057616438492658e-05
e3-specific monoclonal antibodies,4.056709869534006e-05
c56bl6j,4.0564424027515445e-05
swine enteric viruses,4.055754668348203e-05
lead compounds,4.0557244986651975e-05
mers-cov-infected rats,4.0555430291747675e-05
super molecular assembly,4.0553604147382386e-05
environmental studies,4.054969972016455e-05
asite codons,4.052378264447741e-05
b.,4.050149494153791e-05
intracellular genome-length rnp complex,4.048618570689628e-05
viral 7a7b open reading frame orfs,4.04589033648829e-05
nonprotective,4.0449214528045215e-05
positive function,4.042819291722888e-05
virus-specific antigen,4.0416109949071414e-05
peritonitis coronavirus vaccine,4.04060933930505e-05
partialduplex rna,4.037881740101712e-05
hong kong special administration region,4.037820650725204e-05
receptor functional mimicry,4.0369005230543936e-05
single precipitin band,4.036573280263597e-05
coronavirus replication machinery,4.0335554233232414e-05
canine coronavirus type ii (ccov-ii,4.03333805128433e-05
covid-19 pneumonia,4.033187242405247e-05
enteric coronavirus_x,4.032633091855567e-05
hafr al-batin region district,4.029344703244177e-05
multiple ground-glass opacities,4.028240316467227e-05
hcov229e sprotein 229es,4.027483721497096e-05
cterminally truncated s,4.02676142499683e-05
recombinant native full-length s-protein trimer,4.026662843375306e-05
human cellular proteases,4.0236082133279296e-05
outcomes_y,4.0234402056919666e-05
ecov-induced cell death,4.0215361578310614e-05
proinflammatory host response inflammatory cytokines,4.016421350894141e-05
enzyme linked immunosorbent assay,4.0145788486458094e-05
newcastle disease virus,4.0134765704242435e-05
"single-stranded, positive-sense rna",4.012763953411566e-05
lectin affinity plasmapheresis lap methods,4.012749195566308e-05
respiratory parents,4.011114017975205e-05
real-time pcr assays,4.0107378648891634e-05
fetal spleen,4.009374916221986e-05
epidemiological details,4.006059927888451e-05
log-likelihood ratios,4.0037206077360996e-05
detection methods,4.002178087069902e-05
affinity-purified polyclonal antibodies,4.002064217056068e-05
lung_x,3.998588134520444e-05
realtime reversetranscription quantitative pcr,3.998026691615716e-05
multigene,3.9940772467393125e-05
insertion mutation,3.994016538531847e-05
inositolrequiring enzyme 1,3.993927408245687e-05
spike genes orf 3,3.991754771337828e-05
genome sequences,3.987847723422332e-05
rna-binding groove,3.9866071801444145e-05
(rt-rtpcr)-based,3.981653074503299e-05
sequon,3.978606232332683e-05
platform technology,3.9781291620115226e-05
antivirals ribavirin,3.973340761252126e-05
proinflammatory il10,3.9719509960222356e-05
nsp10nsp14mediated,3.9698734601009286e-05
apcs,3.969653392946606e-05
non-segmented,3.9658376064542224e-05
200 basepair region,3.9644975341894125e-05
primary neuronal,3.962662017780067e-05
mouse hepatitis cov a59,3.9615061120485097e-05
rnaprocessing enzymes exoribonuclease endoribonuclease,3.9612086063794484e-05
therapeutic efficacy,3.9595947035382565e-05
bovine enteric coronavirus,3.957995222533095e-05
vaccinia virus-based sars-cov reverse genetic system,3.957349160592381e-05
kinase inhibitor h89,3.9545853106375576e-05
camel-derived virus sequence,3.949140194902893e-05
arenavirus lymphocytic choriomeningitis virus,3.948632388396924e-05
complexes_y,3.9486193706679116e-05
putative open reading frames,3.948143329567792e-05
coronavirusbased vector rna,3.9463656656151416e-05
body weights,3.945619398402275e-05
virus binding,3.944820488594501e-05
adaptive immune system,3.9401506608441474e-05
late demyelinating encephalomyelitis,3.9395939711630855e-05
alanine substitutions,3.938381386039965e-05
s subunit proteins,3.93799007822278e-05
conformational mimetics,3.9378525226922143e-05
monospecific antiserum,3.937635349976841e-05
cellsurface metalloprotease,3.93715476192596e-05
extracellular domain,3.936024114027197e-05
child,3.935447588138249e-05
octapeptide avlqsgfr,3.933275791717189e-05
positive strand rna viruses,3.932776402037304e-05
coordination,3.932028987450674e-05
leukocyte antigen class i,3.9303266675146795e-05
operating,3.928216263469965e-05
avian gammacoronavirus,3.928184861070383e-05
neuronal cell,3.9259464168588126e-05
receptors cxcr3,3.9232229395751065e-05
lp,3.9229379468286004e-05
inter-family recombination,3.9224250169996985e-05
recombinant vaccinia virus,3.922223236683315e-05
protein binding sequence,3.9220486841535585e-05
green fluorescence protein,3.921444511068725e-05
microvilli,3.919753209380859e-05
mammalian cell line,3.9189231991386354e-05
pdcov spike protein,3.918448332974739e-05
cterminal domain,3.91551398731004e-05
gfpexpressing reporter virus,3.915289226290314e-05
immunoprecipitation analyses,3.9134986912073394e-05
virus-induced apoptosis,3.9091902417912005e-05
mhv g f wu a dandekar l,3.9073654707169355e-05
infected epithelial cells,3.907358410990796e-05
sl4 nmr,3.905456023129432e-05
sl-cov,3.905388538361251e-05
enzymes_y,3.901319978926656e-05
murine carcinoembryonic antigen cell adhesion molecule 1a,3.899725296255654e-05
heat sensitivity,3.898762820971882e-05
leschenaults rousettes,3.894284837231818e-05
korean peninsulas,3.893788120458775e-05
recombinant mouseadapted sarscov,3.8930326555447615e-05
loop residues 276 to 295,3.8916833575767715e-05
catalytic dyad (his-41/cys-145) site,3.8912510005341394e-05
point mutations,3.890065523813611e-05
scov-specific neutralizing antibodies,3.889699082430746e-05
reverse-transcriptase quantitative-pcr,3.887216329553706e-05
ubiquitin7amino4methylcoumarin ubamc,3.887000832866369e-05
binding conformation,3.880632627927903e-05
lysine-flanked isotopically labeled etm peptide,3.879889472924398e-05
human coronavirus sequences,3.8797835116461595e-05
nationally recommended therapy,3.876263873522665e-05
clinically significant,3.874233860755346e-05
negativestrand antimrna,3.8729857343339105e-05
allow,3.872113446859453e-05
rna primases,3.8685508184424954e-05
rtcassociated proteins nsp8,3.866490277792149e-05
mhva59infected dbt cells,3.8659066100580356e-05
natural course,3.8653375025018856e-05
covalent inhibitors,3.864553003265634e-05
s protein encompassing,3.864515676879186e-05
e reh proteins,3.862847856628678e-05
human intestinal tract,3.861025177746195e-05
mrna processing,3.85705401011151e-05
factual material,3.851373090727139e-05
spa,3.85049441207225e-05
multiplex real-time reverse transcription pcr,3.8478298488033627e-05
antigen monomers,3.847618782882423e-05
sl-covs,3.8467431632756334e-05
rn igm elisa 552 p  001,3.846571833840268e-05
high frequency,3.846417591225628e-05
hr1 side grooves,3.845751849442681e-05
ts mutant-infected cells,3.844257097664689e-05
interferoninducible protein,3.8418355738719905e-05
contains supplementary,3.8414084150459186e-05
10fn3 intrabodies,3.841185857739709e-05
a59-de-he-infected mice,3.841081747742987e-05
rabbit coronavirus hku14,3.8391628382154944e-05
antibody-phage library,3.836761440528475e-05
acute respiratory disease syndrome,3.8366993865651214e-05
sarscov orf8,3.836344191695315e-05
vts1p protein,3.835263837013899e-05
rna-dependent rna polymerase gene,3.8305857346584765e-05
clinico-epidemiological,3.829542539598538e-05
mitogen-activated protein/extracellular signal-regulated kinase,3.828100587794645e-05
conserved hydrophobic domain,3.8265971917590165e-05
mn2dependent endoribonuclease nendou structure studies,3.824225518688786e-05
fusogenic activation,3.822963142816197e-05
mers-cov s protein epitopes,3.821652536497066e-05
tmprss2,3.8192401741624345e-05
poliovirus 3clike proteinase domain,3.818765619983285e-05
affinitypurified antirbd antibodies,3.817940920951429e-05
ifn signaling pathwaymediating protein nmyc,3.817483780331096e-05
multiple renal cortical infarcts,3.816435516806337e-05
nuclear/nucleolar localization,3.8136653949338835e-05
fractionations,3.813076285967315e-05
sarscov s glycoprotein,3.812187748982902e-05
acyl chain adducts,3.8114897305295904e-05
sb residues 264,3.8111968721694395e-05
classical anti-tgev neutralization test,3.806266450684108e-05
viroporin,3.805783938611162e-05
feces_y,3.802884518918769e-05
rigid sequence,3.802418520528528e-05
cysteinerich domains,3.80230624283326e-05
90,3.801644953426993e-05
hcov-229e infection,3.800976846839163e-05
known individuals,3.8000292202019154e-05
metabolic processes,3.79850950333054e-05
p j m rottier j virol 791445114456 2005,3.7965420918571766e-05
m amino acid sequence,3.792067601196142e-05
transfect,3.7899494182877146e-05
acute respiratory syndrome cov sarscov mpro,3.787828481050859e-05
treated rat oligodendrocytes,3.787043431138179e-05
nonisotypeswitched memory,3.786509574261259e-05
bovine fetal spleen bfs cells,3.7764139901340295e-05
disturbance,3.775496499356238e-05
merscovinfected macrophages,3.771977544031763e-05
calcium-calmodulin-activated serine/threonine-specific phosphatase,3.770400584126727e-05
complex crystals,3.770069252579369e-05
luciferase reporter,3.767652395817538e-05
type i interferon protein,3.763359285826344e-05
replicase 1a/1b gene products,3.762931802295931e-05
membraneinteracting capabilities region,3.757795811368241e-05
young_y,3.755885744472683e-05
clade 2c viruses,3.754464919178355e-05
consensus heptameric intergenic sequence,3.7536548168223644e-05
residues 527 to 651 sudm527651,3.750920956558388e-05
expression vector,3.749038652194162e-05
tgevspecific antibodies,3.748097798881801e-05
itraq-based quantitative approach,3.747744754215094e-05
sialic acid binding activity,3.744187366690775e-05
version article,3.7412216019659246e-05
coronavirusinduced encephalomyelitis,3.741154785900853e-05
causadas por coronavirus,3.7406876429450993e-05
intramolecular substitutions,3.7397265505144266e-05
neural progenitor cells,3.7385153050544496e-05
ubiquitin ub,3.7377200532094644e-05
n-acetylglucosamine-like residues,3.736037673573959e-05
sars-cov frankfurt-1,3.733928443740457e-05
innate antiviral signalling pathways,3.733338842313101e-05
replication complex machinery,3.7300347155073296e-05
initiation codon,3.729817676243239e-05
baculovirus expression vectors,3.7290750135324154e-05
portable fluorescence reading device,3.726995602943334e-05
canonical dilysine signal,3.726488780246674e-05
immunofocusing,3.7263907526276505e-05
subgenomic rnas substitution mutation,3.726356559110556e-05
positive rheumatoid factor,3.725761373748461e-05
deltacoronavirus spikes,3.723521288010054e-05
peripheral immune tolerance,3.7228316674732054e-05
enzymelinked immunosorbent assays,3.7210494778903766e-05
socs3,3.717988961443705e-05
full-length coronavirus helicase,3.713222929234607e-05
native locations,3.712843068883283e-05
base-paired stem,3.7122848028730966e-05
affinity-mediated immunoblot analysis,3.709553458546043e-05
human angiotensin-converting enzyme 2 receptor.,3.708080510776431e-05
kinome protein kinases,3.7057841610058236e-05
serumneutralizing antibodies,3.704554734987719e-05
health care contacts,3.7044705965493874e-05
ibv-beaudette spike propolypeptide,3.70312236050519e-05
differential diagnoses,3.701784635038384e-05
recombinant batsarscov nucleocapsid protein,3.7016533343306706e-05
sob,3.700380342645173e-05
ion channel inhibitor hexamethylene amiloride,3.6958578676650456e-05
membrane curvature,3.6945579763618007e-05
synergy,3.6929205466422066e-05
respiratory cov infections,3.692792498298709e-05
intestine segments,3.6918143798204126e-05
determination,3.691316947494181e-05
virusspecific,3.6901209852413195e-05
specimens_x,3.6888346602926986e-05
epithelial mucosa cells,3.6858617689913695e-05
chimeric viruses,3.684629128592966e-05
phosphoinositol 3kinase pi3kserinethreonine kinase,3.683820524437962e-05
group c mers-cov spike protein,3.682919517168088e-05
serum sars-cov,3.6799193188425704e-05
hcovnl63 coronavirus,3.6784153315588055e-05
peptide-directed secretion,3.676972856758899e-05
viral nucleocapsid,3.6752603398701525e-05
sequence variations,3.6747319478263044e-05
b of the tgev s protein a 6nt,3.6741455060537625e-05
host immunity,3.673530813298476e-05
gene 1 replicase,3.672148250162033e-05
adaptive immune response,3.670224670247582e-05
rvn,3.6695098641798634e-05
inflammatory mediators,3.669009268668423e-05
intracellular virus-specific mrnas,3.665714209117245e-05
hcov-nl63,3.664125597042462e-05
muscle-mediated contractions,3.6623426080137255e-05
enzyme inhibitors,3.661746394089134e-05
discontinuous epitopes,3.6616817656543665e-05
dipeptidyl peptidase,3.6613744268623955e-05
virus yield reduction assays,3.660921439797374e-05
korean health care settings,3.660419986805107e-05
ifitms,3.659847474220959e-05
samsah,3.658605871945657e-05
receptor-destroying sialate o-acetylesterase,3.6584874302313186e-05
mutant virus jhmv,3.657612917061073e-05
dna vaccines,3.657612917061068e-05
rrbd protein,3.656150244386237e-05
non-synonymous amino acid,3.6525680719746515e-05
316aminoacid catalytic core domain,3.6515076656794605e-05
protein receptor-binding domain,3.65079239827417e-05
animal covs,3.648054984249637e-05
internal cleavage,3.647151980420585e-05
homologous gene,3.6463986126886013e-05
nucleocapsid protein_x,3.6445903550937914e-05
contains supplementary material,3.6429560484878025e-05
transcription base pairing,3.639971418568366e-05
noncytopathic sindbis virus replicon psinrep21,3.6379476606426314e-05
realtime quantitative reverse transcriptase polymerase chain reaction rtpcr,3.6372640603163496e-05
experimental animal,3.6354767965818926e-05
rectal temperature,3.6346545743598296e-05
enzymelinked immunosorbent assays elisas western blot assays,3.6300478127133786e-05
coronavirus outbreaks,3.629902351703091e-05
wildtype trsl,3.6283825949156486e-05
sars coronavirus 3cl protease,3.626860017756503e-05
electron microscopic studies,3.625248300729671e-05
sars coronavirus scv helicase bananin iodobananin,3.6244474091187966e-05
enhanced_x,3.619063248419073e-05
glycosylation sites n227,3.6174809613091794e-05
recombinant and native nucleocapsid protein,3.61529883405999e-05
human interferonstimulated gene product 15 hisg15,3.614669188384387e-05
therapeutic compounds,3.6145157192888535e-05
virus-induced cell-cell fusion,3.612848977144618e-05
pcrbased assays,3.6122585720401025e-05
interferon receptor,3.610454143146943e-05
crossneutralizing,3.609521685442554e-05
integrity,3.609508229743537e-05
hcovhku1 genome,3.6071204561643016e-05
influenza a virus,3.6047176768859305e-05
mrna mrna 7 sequence,3.602948374466111e-05
putative polymerase-encoding gene,3.6001165102315476e-05
mitochondrial antiviral signaling protein,3.599862395248578e-05
viral factors,3.5986851011800706e-05
tgev envelope,3.598217551098657e-05
cytokeratin 18,3.5974636589442575e-05
coronavirus small envelope e,3.593278842340853e-05
mhvinduced p38 mapk activation,3.590818134322298e-05
feedlot calves,3.5903715086455414e-05
phosphorylated-n-containing complex,3.588940210306847e-05
sarscov plpro processes,3.587580111951387e-05
medial turbinate epithelial cells,3.587443144035338e-05
serum protein free vero cells,3.587386325859023e-05
apical plasmalemma,3.587359669539076e-05
acute respiratory syndrome-like coronaviruses,3.5865853681054235e-05
bcv_x,3.585789653808864e-05
salt,3.585699967505224e-05
fibrosisassociated chemokine cc motif ligand 2,3.584106956922091e-05
murine hepatitis coronavirus,3.584064234740559e-05
virus celltocell,3.582277421104506e-05
coexpressed viral structural proteins,3.582179075562534e-05
fcov-positive,3.581717388410997e-05
hrc1,3.577276001664184e-05
primeboost,3.5719335137576166e-05
availability of,3.57108984163758e-05
host receptor angiotensinconverting enzyme 2 ace2,3.5702497283422324e-05
shortened n-terminal segment,3.566659040848752e-05
animal receptor,3.566069601799376e-05
upstream_y,3.5643490659116714e-05
63aminoacid multifunctional golgiendoplasmic reticulum er membraneassociated protein,3.561792453811433e-05
clinicaltrialsgov,3.557092276155834e-05
reverse-transcription polymerase chain reaction,3.556167800287411e-05
sars-coronavirus (sars-cov) genome,3.551938482518921e-05
replicase_x,3.551530149176128e-05
bcov infections,3.5506341451299874e-05
epithelia undifferentiated cells,3.5504716099976e-05
truncated protein s547,3.5492397718990776e-05
distantly related arterivirus,3.549128532886923e-05
analytical ultracentrifugation analyses,3.548580600590846e-05
natural host rat,3.5484495339304426e-05
neutralizing monoclonal antibody,3.54805881677283e-05
sarscov disease,3.5405182193713286e-05
virus load,3.53550158444662e-05
chymotrypsinlike main protease and papainlike accessory proteases,3.534376915959712e-05
evolutionary analysis,3.534181265064677e-05
second heptad repeat,3.533659841288823e-05
i529t,3.5323491426743144e-05
hepatitis coronaviruses,3.5305741175263716e-05
cellular n7mtase,3.5284054962498064e-05
protein epitopes,3.525394241063523e-05
immunopathologic-type lung disease,3.522436861562965e-05
angiotensin-converting enzyme-2,3.522401660347172e-05
macrodomain mutant virus,3.521336293497524e-05
influences,3.520184056147229e-05
carbohydrate moiety,3.5154104319985094e-05
co-stimulatory molecule cd86,3.515375350242131e-05
portable point-of-care,3.5150034707571866e-05
protein modified,3.5114239600561555e-05
reservoir/s,3.511372986228614e-05
s1 specificity,3.508991751209191e-05
serological confirmation,3.5086072478993784e-05
ibv-infected or transfected cells,3.506564601305514e-05
imino protons,3.5062692654395304e-05
chimaera s genes,3.50575307992207e-05
sar analysis,3.504339528219119e-05
natural transmission,3.503077976438623e-05
deubiquitinating enzymes,3.5022446103874027e-05
pseudostratified,3.497351701783137e-05
temperaturesensitive mutant,3.494864348929162e-05
neutralizing domain,3.494425236309154e-05
proteins sequence,3.491684216216847e-05
helper peptides,3.4906506691693425e-05
population prevention,3.488711755824288e-05
patienttostaff,3.488450306293099e-05
bufalin,3.487364778943371e-05
group-specific monoclonal antibodies,3.486600502087954e-05
monoclonal antibodies recombinant n protein,3.483825454168138e-05
rnadnabinding activity,3.481840686211211e-05
helix-specific antibodies,3.481055401876203e-05
n aminoterminal half sequence,3.480215540609066e-05
study revisits,3.4793049890006775e-05
sialoglycans,3.478885069718798e-05
amino acid position,3.473443259299384e-05
yeast-two hybrid interaction,3.472988746925042e-05
lsec,3.471281973859257e-05
histidinetagged,3.4702089656179034e-05
toll-like receptor (tlr)2 ligand,3.468897216015638e-05
neuroadapted jhm strain,3.467307719504415e-05
encephalomyocarditis virus internal ribosome entry site (ires) region,3.4664224855605746e-05
eastern region,3.465992462900085e-05
tissus terminaux,3.46455048755829e-05
suppressing,3.4644930465922046e-05
ace2 mrna levels,3.4641196792797996e-05
bnip3-promoter-luciferase reporter system,3.46009931546645e-05
ha3g packaging,3.4581330695601626e-05
nps screening,3.457486141313873e-05
tgev serology,3.4548932379166463e-05
highpassaged purdue115,3.4525659731506234e-05
pathophysiological significance,3.449392823119087e-05
mutation analysis,3.448597350674083e-05
p65-bound enhancers,3.448133033400301e-05
subcutaneous sc intravenous,3.4478998140165326e-05
coronavirus terminal genome regions,3.446724476213985e-05
spike genes,3.444255101650576e-05
lung failure8,3.4434085433239025e-05
wild and synanthropic birds,3.443149329318585e-05
fipv infection,3.44283676584371e-05
chymotrypsinlike domains d1,3.442798446425495e-05
substantial amounts,3.442768296999016e-05
ts mutant virus-infected cells,3.4386286046186174e-05
diagnosing,3.435636623750134e-05
functional receptors,3.434631326850265e-05
gps,3.4342686344451194e-05
significantly higher_x,3.432831741082138e-05
hrn and hrc coiled-coil surface residues,3.430616632525528e-05
cxcl2 protein,3.430513824966705e-05
humantohuman transmission,3.4296091745772185e-05
"human angiotensin converting enzyme ii (ace2)(9,10",3.4260404446966864e-05
acute respiratory syndrome sars coronavirus nucleocapsid rscovn protein,3.4259667994799095e-05
multiply mutated octapeptide s24,3.425082417914614e-05
abortive infection,3.4219689888029684e-05
protective monoclonal antibody,3.4202035319916746e-05
viral infection coronaviruses,3.419373376644018e-05
hiv-1 virus,3.418370463705039e-05
immunoglobulin,3.417483368391068e-05
viral replicationtranscription complex,3.4156079091556495e-05
vector system,3.415048127259132e-05
molecule inhibitors,3.41270630727673e-05
chemical inhibitors,3.410650958334206e-05
raftassociated,3.4087130735613356e-05
doi:10.1186/s12871-016-0198-x,3.4076805966519344e-05
membrane proximal cysteine-rich motif,3.4011363802929144e-05
genomic positive-stranded rna,3.3982704138630874e-05
nsp,3.396817153481478e-05
validated,3.3930260438861675e-05
enteric pathogens,3.390344777897559e-05
sars-cov-infected caco-2 cells,3.388526630403618e-05
nterminal domain ntd residues 45 to 181,3.387141905744379e-05
vsars-cov-5prime,3.386408245405982e-05
subunit dissociation,3.385238037707572e-05
coronavirus bcv,3.3825141174307035e-05
icu stay,3.3789844026096604e-05
atropine-resistant,3.378396878460417e-05
moreextensive viral replication,3.375031565771515e-05
ovo,3.37492225884757e-05
ifn response,3.374824253523397e-05
control groups,3.372354751477732e-05
ovation method,3.369953462431573e-05
short interfering rna,3.369359853586384e-05
rna structural elements,3.369211888512754e-05
alphacoronaviruses,3.3670425115456815e-05
active domain primary sequence,3.364217210186935e-05
membrane-actin linker,3.364183178489614e-05
nonimmune females,3.360872641712655e-05
sarsassociated coronavirus sarscov nucleocapsid protein immunoglobulin g enzymelinked immunosorbent assay elisa,3.359217213440688e-05
coronavirus spike proteins,3.358536566159683e-05
animal models_y,3.351479339401391e-05
free charges,3.351411141212367e-05
p150 nsp4,3.3504831574405916e-05
hiv-1 vpu virus ion channel,3.348374119335797e-05
exponential adjustment model,3.344510985356567e-05
hematopoietic cells,3.343306279139762e-05
protein/rna interactions,3.343274246412238e-05
hcov-229e-infected cells,3.341985739064376e-05
health authorities,3.3412869175873634e-05
respiratory syncytial virus,3.3408633300509205e-05
virus n protein coexpression,3.3407532141890815e-05
first gaitlike motif,3.339856776513228e-05
asparagine linkage,3.339038617900859e-05
receptordestroying,3.338520390420222e-05
pakistan,3.338310481797687e-05
surveillance studies,3.336880996393831e-05
wildtype sequence,3.3366186527880935e-05
murine cells mfipv,3.336056786334494e-05
protein antip2 antibodies,3.331872949350071e-05
fulllength cdna clone,3.328686264873973e-05
netherlands human coronavirus,3.328512149653222e-05
conventional polymerase chain reaction,3.328280324489311e-05
saudi arabia ksa,3.32331560125951e-05
viral neutralizing antibodies,3.3230335113409636e-05
randomized double-blinded,3.322792512957361e-05
caspase inhibitors,3.3215527031502485e-05
transmissible gastroenteritis virus tgev fs77270,3.320643619860397e-05
mammalian-cell activate promoter element,3.320151519429998e-05
nglycosidase f,3.319239454480505e-05
western region makkah,3.318505870834745e-05
oligoadenylate synthetase oasrnase,3.317474644384144e-05
green fluorescent protein ra59gfpgp33 p14,3.3162789486491324e-05
plp-mediated anti-ifn difference,3.315931709205519e-05
homologous proteins,3.314269252911145e-05
sars-cov s-protein receptor-binding domain,3.313594785068934e-05
clinical settings,3.3107378041696085e-05
mbl-associated serine protease-2 (masp2) gene,3.308639369055108e-05
sting-mediated ifn induction,3.308491522866763e-05
comprehensive studies,3.30807555067688e-05
multiple protein products,3.306205960740993e-05
genetic interaction,3.3059131634516895e-05
polygonum multiflorum thunb,3.304560793510182e-05
retrospective assessment,3.30416323596743e-05
homozygosity,3.302895043213429e-05
physicians,3.302265479164376e-05
sequence residues,3.3019750169903244e-05
mtransfected cells,3.3000817553537675e-05
canine parvovirus type 2,3.2995548496929027e-05
ibv e,3.2975577368786436e-05
cell-surface expression,3.29634389104507e-05
general public,3.296243556117945e-05
scovinfected cells,3.2956805226703946e-05
inhibiting_y,3.294720027052862e-05
extrapulmonary mers-cov antigens,3.2941457494876254e-05
k(i,3.292505109524915e-05
peplomer glycoprotein mrna,3.2918516253549627e-05
hela-epithelial carcinoembryonic antigen-related cell adhesion molecule 1a,3.29121696935434e-05
tissue culture propagated virus,3.290771527418185e-05
rna proofreading,3.289733935781911e-05
amino acid aa residues 324,3.288632973202392e-05
laboratory diagnostic,3.2880840148664496e-05
sls,3.286867639374167e-05
src signaling,3.285683488486024e-05
immunopathological,3.2797963402539187e-05
viral binding,3.2759740040301306e-05
homooligomeric,3.274000100544892e-05
phosphorylated protein,3.272641643135357e-05
coronavirusspecific antibodies,3.271606646204395e-05
uvinactivated viruses,3.270831039143119e-05
sarscov replicase proteins,3.269733874821136e-05
results demonstrate,3.269661158286454e-05
precision,3.269586058764245e-05
coronaviral 3clpro cleavage sites,3.267868744185686e-05
human respiratory samples,3.2657588262160144e-05
mhvs sequence,3.260442502267317e-05
crude tissue culture proteins,3.2589648274067636e-05
mva,3.2587625293828304e-05
cov sarscov intracellular,3.2575640270955055e-05
immobilized cell surface proteins,3.2550261140714316e-05
maternal immunity,3.25320551072532e-05
dominance,3.2529351821111496e-05
virus neutralisation assay,3.2497262163530614e-05
sars-covs and sars-like covs,3.247557196711023e-05
bhk,3.246502169388479e-05
coupledallostery,3.245738720535353e-05
viral replicase proteins,3.245002491177204e-05
genotype-specific real-time reverse transcription-polymerase chain reaction,3.2443372655246004e-05
green fluorescent protein (egfp) gene,3.243678565506726e-05
interact_y,3.241759565104708e-05
16 recurrent variant sequences common variant sequences,3.240456234808729e-05
9oacetylated sialic acids 9oacsias,3.238694306956996e-05
transcriptional profiling,3.23684457750836e-05
sample analysis,3.235560001544459e-05
klinikum schwabing munich,3.235539957750499e-05
lightcycler sarscov quantification kit,3.2351533962107984e-05
spatiotemporal clusters,3.23322944472633e-05
n and cterminal domains ntd residues 10 to 140 and ctd residues 221,3.231839392882249e-05
radiological infiltrates,3.2313672972383136e-05
protease ciscleavage assays,3.231304196450612e-05
bilateral infiltrates,3.231166598556012e-05
caco2 cells,3.2295982629490134e-05
origin_x,3.2295682547829706e-05
strains vaccine platforms,3.2274225217499276e-05
multinucleated syncytial cells edema,3.227358865866743e-05
humans bats camelids,3.22286320783969e-05
multiple signaling,3.222273905937462e-05
clathrinmediated endocytosis pathway,3.221944471146429e-05
antiviral pharmacologic classes,3.2218332616147694e-05
activating transcription factor (atf)-2/jun,3.221717295928992e-05
live-attenuated s. typhimurium,3.21920384652101e-05
xray crystallography,3.2130420960696517e-05
mouse hepatitis coronavirus a59 e,3.212874739904721e-05
primary hepatocytes,3.2126992722967006e-05
nuclear translocation,3.212157285351349e-05
betacoronavirus s1ctds pdcov s1ctd,3.211011166787188e-05
contagious respiratory disease sars,3.2109346827126284e-05
rnadependent rna polymerase rdrp,3.210058532989089e-05
cd8 cytotoxic t cell clone,3.20973966694737e-05
cterminal region amino acids aa 362 to 412 and middle region aa 153 to 178,3.208567802487747e-05
photobleaching experiments,3.206533133813565e-05
fine,3.205358411708634e-05
hku24 chrcov hku24,3.2047932078689004e-05
hcovnl63 nucleocapsid,3.204259557612738e-05
mhv e protein ion channel,3.203307758242531e-05
serum sars-cov rna rt-pcr test,3.203278644648539e-05
global village,3.202213050737187e-05
viral testing,3.2013580566388224e-05
elispot assays flow cytometric analysis,3.20035740872139e-05
comprehensive update,3.200000606493494e-05
barriers,3.199901798844242e-05
pid 5,3.1962851064377964e-05
apical mers-cov inoculation,3.195252196470729e-05
sars cov orf6,3.194870631914435e-05
np111 residues 111,3.1948034767443956e-05
genome-wide gene,3.1944539678949564e-05
alphacov,3.1938515080000256e-05
blood relative,3.193066232107899e-05
coronavirus cov nucleocapsid,3.1890953571600216e-05
amoy gardens housing complex,3.189076730363017e-05
genomic organization,3.188242221068349e-05
secrete,3.185662863246742e-05
mosquito cell,3.1856295374062436e-05
betacoronavirus_y,3.183371862922008e-05
rotavirus-inoculated calves,3.1829942598371856e-05
s.,3.182578300821439e-05
real-time fluorogenic rt-pcr assay,3.182410961599262e-05
full genome sequences,3.182302091831409e-05
infected cells_x,3.181791869929793e-05
class i fusion proteins,3.179122091575643e-05
sars-n protein,3.1765338150200595e-05
negative-strand,3.1701919379732854e-05
di expression system,3.1698780971407146e-05
network analysis,3.169527073472072e-05
reverse transcriptase real-time polymerase chain reaction,3.169267815154434e-05
proapoptotic viral proteins,3.1680728690741504e-05
truncated amino acid sequences,3.1673326289593536e-05
interferon ifn gene expression ams,3.16078938383761e-05
disulfide bridges,3.157920537642503e-05
mouse phagocytic cells,3.157248771663416e-05
two-dimensional fluorescence difference gel electrophoresis,3.157131518089876e-05
renal pathogenicity,3.152360658859096e-05
administrative controls,3.1515781136240434e-05
infectious bronchitis coronavirus ibv,3.150215132132817e-05
prcvinfected,3.148893531817022e-05
single agent,3.1483979164671304e-05
respiratory therapist,3.148021321511267e-05
virusinduced interferon,3.145838442169535e-05
adult_y,3.145150682827114e-05
mutant replicon genomes,3.1449763343118556e-05
cytokine-induced t cell responses,3.1438192673166876e-05
enhancer regions,3.142928765584445e-05
extracellular virus,3.14196050797729e-05
immunohistochemical peroxidase technique,3.141790877432521e-05
coronavirus hku13,3.141338394542156e-05
viral genomic rna,3.1404733068974873e-05
avian coronavirus spike proteins,3.140068986937425e-05
reversetranscriptase pcr,3.139923022390587e-05
primary human alveolar epithelial cells,3.1378092425952366e-05
terminal 17 amino acids,3.1377076056459614e-05
endosomal cysteine proteases cathepsin b,3.137676782547381e-05
randomized trials,3.135521297124773e-05
polyclonal antisera,3.1342589824652145e-05
endou activity,3.13335330631574e-05
sars-cov nucleocapsid protein,3.133083297373086e-05
rrna degradation,3.132129428006055e-05
fecal specimens sheep erythrocytes,3.131038035694085e-05
mucinproducing goblet cells,3.130359617875773e-05
truncated_y,3.129141323237108e-05
open reading frame orf 1 b overlaps orf 1,3.1242016698837676e-05
lysmstat1,3.1225743144332496e-05
cellular palmitoyl acyltransferases pats,3.120689483985784e-05
boundaries,3.120217463587057e-05
priming components,3.118814714640155e-05
major histocompatibility complex class i c molecule hlac,3.118596276652066e-05
lysosomal damage,3.116116861624607e-05
human sars,3.1159072469712906e-05
mhv-jhm orf1a polyprotein,3.1141602211775095e-05
clinical consequences,3.112723200784483e-05
ace2_y,3.1063113829481327e-05
human metapneumovirus,3.103824652583236e-05
open reading frame 7a7b orf7a7b,3.1034921174463357e-05
rnase treatment,3.1033815266461666e-05
bdcov hku22,3.1010743977306725e-05
forward and reverse,3.100782025500387e-05
hnrnps,3.099796766053212e-05
mouse coronaviruses,3.099269951981027e-05
genetic factors,3.0988506047836646e-05
lelys,3.0973491461732e-05
heat-inactivated dccov uae-hku23,3.096168212368745e-05
ifns,3.0930493201545465e-05
dicistronic rna template,3.092001109155562e-05
pbmc and thp-1 cells,3.090054890305055e-05
human pathogens,3.089993046418546e-05
slippery sequence,3.089892657722347e-05
0c43,3.085098306954553e-05
degrades,3.084785834363268e-05
short time frame,3.083461259339268e-05
jnk,3.082272654555963e-05
lung specimen recombinant protein 3a,3.081866016262315e-05
baculovirus-expressed type-specific domain,3.0787331096430805e-05
tgev miller m60,3.0770251923832664e-05
anti-sars coronavirus igg,3.075265829202951e-05
crossreactive region,3.0748010847003184e-05
lymphatic tissue,3.0747176533630876e-05
workers group,3.073951847342918e-05
smallmolecule inhibitors,3.072835531915902e-05
protein-pseudotyped retrovirus,3.0704273722488675e-05
analytical studies,3.070093628767349e-05
abl kinase inhibitors,3.068309572800783e-05
receptor carcinoembryonic antigen cell adhesion molecule 1 ceacam 1,3.067644393511209e-05
permissive cells genomes,3.0657546424166787e-05
homologous human genes,3.0648389756813496e-05
postarrival,3.0646777055300657e-05
coronavirus-induced er stress,3.063028564743346e-05
sudden emergence,3.062767891098519e-05
om,3.0624997690012776e-05
market civets,3.06242710105884e-05
virus replication lower virus,3.061754188050489e-05
predicted replicase protein,3.0615596982059955e-05
hr2 q159lr654hh716de1035d,3.058628449339047e-05
auscultatory findings,3.0560154581634506e-05
internal sequence domain,3.053567152209519e-05
personal protective equipment,3.050926407223199e-05
protein e forms,3.050852583992284e-05
translational regulation,3.0505040785601547e-05
coreceptors,3.0494160077094043e-05
enteric bcovs bcovent,3.04856719827623e-05
5h,3.0467043369631144e-05
public health response,3.0446715459528203e-05
gene 7,3.0442039896482867e-05
susceptible-infected-removed (sir) model,3.040703333124456e-05
gammacoronavirus,3.0360397770517944e-05
ntransfected cells,3.034363342382881e-05
mers-cov active circulation,3.0342053749510514e-05
hypophosphorylated retinoblastoma,3.033343403946676e-05
renal complications,3.0314900781232938e-05
mavs,3.0309627874549062e-05
neurologic diseases,3.0285134236746822e-05
real-time reverse transcriptase,3.0276322080624886e-05
mrna7 sgmrna7,3.027315410914393e-05
protein forms ion channels,3.027267623242614e-05
laminated structures pleomorphic double membranebound vesicles,3.026810432241132e-05
mers-cov-specific cellular immune responses,3.025642020260698e-05
hypothetical 78-amino acid protein,3.02539730221714e-05
genus rheum and polygonum,3.0238866623757095e-05
heterologue recombinations,3.0235056765091824e-05
mucosal secretions,3.0207526806287392e-05
insectivorous bat species,3.0192271941449077e-05
human lung cdna libraries,3.019033522644796e-05
deep compartments,3.015571242939606e-05
elisa-positive cases,3.014852092678775e-05
microtubules,3.0138713108121942e-05
primary household,3.0133234453996163e-05
regulates,3.0110296183756457e-05
lipid bilayer,3.010331539442909e-05
icsz16s k479n,3.0089849354099666e-05
aerosolized contamination,3.0076305034969138e-05
structural functions,3.006864876295923e-05
monomeric enzyme,3.0042060150587895e-05
immune recognition,3.0021876956664587e-05
pro-inflammatory response,3.001965498230257e-05
exon activity,3.0019260150662353e-05
caveolin1positive area electron microscopy,3.0015481627920556e-05
ribosomal rna,3.0015481627920546e-05
transcription factors cytokines,2.9983851690846586e-05
endemic coronaviruses,2.9981704759975398e-05
dc,2.9979753855189412e-05
ribonucleoprotein lattice formation,2.997328579764043e-05
stress response pathway,2.995912157402801e-05
docking model,2.994300942716194e-05
virus-specific cd4 t-cell epitope,2.992272393796956e-05
cov receptor,2.9904247531178308e-05
biosynthesis,2.989935969705958e-05
cov molecular,2.989378160909361e-05
virus neutralizing vn antibodies,2.9890675067660423e-05
2amino35methyl3oxo12oxazol4ylpropranoic acid ampa receptor antagonist gyki52466,2.9861410632033565e-05
detergent-resistant membranes,2.9838665809482798e-05
di rnachloramphenicol acetyltransferase cat,2.983326203226635e-05
sarscov e,2.9824348982242628e-05
resialylated erythrocytes,2.9823842238998832e-05
dna electroporation,2.9822356688697475e-05
foreign sequences,2.9776723508087396e-05
mers-cov hr1-derived peptide,2.9773927788134322e-05
proteomics,2.9769664864575944e-05
th17,2.9758507477314127e-05
ovariectomy,2.975150584142624e-05
central unstructured region,2.973709904998953e-05
biochemical analysis,2.9735497543071497e-05
n1347ainfected brains tumor necrosis factor tnf,2.9719461880794094e-05
postmedial golgi compartment,2.9713887718264784e-05
eukaryotic initiation factor,2.9706357738693103e-05
ck5/6,2.9704366597279215e-05
olivares l shi d look t gallagher,2.9699201059388913e-05
gel-shift experiments,2.96919515127865e-05
exon,2.9679719204943306e-05
native sars-cov s protein,2.9677497288062143e-05
core replicase domains,2.9673870949312737e-05
batscov spike receptorbinding,2.9669057414882493e-05
chimeric protein,2.9658414389519135e-05
balbc mouse model,2.9656179897017115e-05
mitochondrial aif,2.965596679702896e-05
fusion-defective mutants,2.9646804073514243e-05
infectiousness,2.9613522505391455e-05
cytotoxic,2.960520505586668e-05
toxic region,2.9598279573717502e-05
gene mutated fcovs,2.959480709104006e-05
twoyear,2.959308794135522e-05
body transcription regulatory sequence,2.958688319985322e-05
intraviral protein,2.957786675924892e-05
hcovoc43 14 adenovirus 9 human parainfluenza virus 1 0 and respiratory syncytial virus 8 infections covhku1,2.9575539361989554e-05
ibv viruses bcv mebus strain,2.9520865238887318e-05
group 2,2.9518729467898813e-05
substrate binding site,2.9514576137569763e-05
nested pcr,2.9507437382811363e-05
bovine coronavirus bcov_x,2.949669156953063e-05
proinflammatory cytokine tumor necrosis factor alpha,2.9471715934296093e-05
central-linker region,2.9435075380158145e-05
sarscoronavirus spike protein trimeric recombinant proteins,2.9431806298394347e-05
affinities,2.9423030148332736e-05
cysteine rich motif,2.940023634914476e-05
sarscov papainlike protease,2.9387553810723594e-05
host-directed therapies,2.9347605541899184e-05
acute respiratory syndrome coronavirus sarscov hcovemc,2.933677803556793e-05
mouse fibroblast cell lines,2.933257810043696e-05
cell surface aminopeptidase n,2.9319171832199275e-05
bronchovascular lung markings,2.931905191269596e-05
rt-qpcr-positive,2.9310632891202007e-05
cis-acting rna structures,2.9277905499493235e-05
liver derived genomic rna,2.926475848843786e-05
hcov229e_y,2.923431567617735e-05
filovirus glycoproteins,2.9214752235746524e-05
progenitor,2.9201136911184986e-05
jackal coronavirus rna,2.9199698570605316e-05
pseudoknot rna structure,2.9195894043488945e-05
inability,2.9192198834392765e-05
civethuman sarsrcovs,2.9180469869974267e-05
inflammatory cells,2.916055282654118e-05
p38 mitogen-activated protein kinase,2.9158071634542686e-05
antis antibodies,2.9154179000720468e-05
1ab spike1,2.9145205771094835e-05
stagespecific embryonic antigen 1,2.9133715227496773e-05
digestive system,2.91319397228104e-05
sars diagnosis,2.910826233658027e-05
viral spike protein sarss,2.9098072437056057e-05
canonical rnadependent rna polymerase rdrp,2.9076951987302476e-05
alphacoronavirus transmissible gastroenteritis virus tgev nsp1,2.907522144743556e-05
human immunodeficiency virus type 1sars,2.9056758734748194e-05
cell surface acid phindependent,2.9054779143201532e-05
gcc,2.9050398731066524e-05
multiplex reverse transcriptase polymerase chain reaction rtpcr,2.9043566133688834e-05
structural reasons,2.90421598229755e-05
clinical phase,2.9011787703287323e-05
ccr5 signaling,2.8994281003482074e-05
genotype c,2.898961098372699e-05
hydrogen bonding networks,2.898823546781591e-05
virus entry_x,2.8969417635355284e-05
proinflammatory response,2.895970972047373e-05
nproteinrna binding,2.8957767803040437e-05
urine,2.8951582026559626e-05
12monthold mice,2.8948015368574094e-05
relational autonomy,2.8935271448323756e-05
fcov c1je genomic rna sequence,2.8935014363197765e-05
attachment factors,2.8934527248757848e-05
rabbit antitcv,2.8929658858498792e-05
antiviral alphabeta interferon,2.892387717301899e-05
germinal center,2.8919919845299345e-05
laboratory-confirmed,2.890023232960166e-05
dynamic exchange,2.8892013224352258e-05
hcovhku1 s1600 glycoprotein,2.8891907449335288e-05
devastating,2.888590168167945e-05
ethiopian dromedary camels,2.8884178260346903e-05
research model,2.888106402714849e-05
monensin-treated ibv-infected cells,2.8878172777883933e-05
viral replicasetranscriptase complex,2.8867874248259527e-05
gc,2.8865581571904728e-05
profiling,2.885695016173245e-05
mhv subgenomic mrnas,2.8840197162531488e-05
stemloop structure,2.8823156740787628e-05
rna metabolism,2.8806154633598e-05
optimized,2.8785149124935727e-05
fcov-infected cats,2.877977507107896e-05
chicken kidney tissue,2.877466273872751e-05
tl/ch/ldt3/03-like virus,2.874572818770365e-05
hydrophobic heptad repeat regions,2.874440483046778e-05
manipulations,2.873264112837926e-05
a59 and 1hm e2 proteins,2.8718267191174183e-05
alkaline ph,2.8703956929799435e-05
linkage-specific polyubiquitin (polyub) chains,2.8691629374140407e-05
feline aminopeptidase,2.8690445764005452e-05
infectious bronchitis virus_x,2.865491661616778e-05
prb tumor,2.8643182558592307e-05
macrophage infection,2.8640155354974728e-05
isogenic recombinant viruses,2.862310125800129e-05
subgenomic mrna analysis,2.8600359665313795e-05
nanoparticles,2.8582006421098626e-05
hr2p spanning residues,2.8572788305726787e-05
non-vaccinated,2.8535650800813624e-05
1618mer sars cov spike glycoprotein peptide library,2.847330139803963e-05
tight junctions,2.8471108488405368e-05
reverse transcriptional pcr rtpcr,2.8461412062434014e-05
sequence polymorphisms,2.84533537165533e-05
bnip3 promoter,2.8440041639738897e-05
ser5-phosphorylated rna polymerase,2.8423385296873693e-05
cell cytoplasm,2.842140321911006e-05
enzyme immunosorbent assay,2.8418464510999355e-05
sarscovinfected,2.83964637338936e-05
recombinant chimeric murinized,2.8380731545736158e-05
gnotobiotic calf,2.836157253711872e-05
health care institutions,2.8356888463871515e-05
molecular identification,2.834800735806986e-05
bat slcov 3a dna vaccines,2.8342253306015805e-05
endoplasmic reticulumgolgi intermediate compartment,2.8336998416658652e-05
intracellular viral genomic,2.8333193334638295e-05
viral genome sequences,2.8324297584038234e-05
transgenic mouse,2.830598172630482e-05
case detection,2.826575305127533e-05
anti-mceacam1a antibodies,2.8251513948843883e-05
high-density oligonucleotide array analysis,2.8250322218127013e-05
jhmv infection,2.823453457814736e-05
s-adenosylmethionine binding pocket,2.8231363792780603e-05
z1thiophen2ylethylideneaminothiourea,2.8225999410202716e-05
proteasedependent cell,2.8220895468468216e-05
influenza_x,2.8215264406847982e-05
lamina propria mucosae le virus,2.817708678700047e-05
disease morbidity,2.8172647981566733e-05
rna structure,2.815642626322596e-05
"3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide",2.8140134838700676e-05
vesicular stomatitis virus g protein spseudotyped mlv,2.8132710230467246e-05
rectal tumor,2.8126426200413288e-05
catalytic domain,2.812100600276079e-05
diseased,2.8120035778680886e-05
spatiotemporal,2.8112675591657763e-05
molecular diagnostic assays,2.811171133577317e-05
proximal upr transducers,2.8103563630357757e-05
receptor egfrexpressing cell cultures,2.810024378263604e-05
mhv igg,2.8098738822609914e-05
mouse hepatitis virus n protein both n protein and,2.809853414684805e-05
uspecific metaldependent enzyme,2.808730719326985e-05
bcov n substitution mutant,2.8040629565870755e-05
nterminal domain s1ntd,2.8032396152024157e-05
cellular pathways,2.8030256750715795e-05
core sequence,2.8027108575105044e-05
orf1 translation,2.8022613584944667e-05
human serotype 5 and chimpanzee derived adenoviruses,2.8014184347335448e-05
local health departments,2.8006224073639942e-05
spin column method,2.8002564297197823e-05
hiv-1,2.7977426477159e-05
zoonotic origin,2.7967197651057188e-05
cell subsets,2.793024900212241e-05
oxygen,2.7909017304311497e-05
deletion mutant,2.7906624792860434e-05
genotypic relationship,2.7902721811755167e-05
putative receptors,2.7875983135102618e-05
diarrheal outbreak,2.7843655437172264e-05
brsv,2.78197685667648e-05
health care systems,2.7819172015215083e-05
rna unwinding activity,2.78048464251706e-05
human and civet sarscov genomes,2.7802533523824552e-05
conserved regions,2.7773833089146452e-05
lethal infection,2.7761495918508272e-05
subunit vaccine rbds,2.7750425666351078e-05
acidic ph-dependent mhv mutant oblv60,2.7728679802991947e-05
r.,2.772800452120471e-05
cell epitopes,2.771710834009428e-05
catalytic dyad,2.7716966325157605e-05
cre recombinase,2.771215228146271e-05
shrew virus,2.7705976385871497e-05
anticoronavirus drugs,2.7678048915382187e-05
cellular receptor dipeptidyl peptidase 4,2.765380153739251e-05
huh7 cells recombinant merscovs rmerscovs,2.7645334110397494e-05
fipvs,2.7644331871866216e-05
protein ion channel activity,2.7636407141468696e-05
serum igg1 antibody,2.763412764325584e-05
human coronavirus oc43oc43 hcovoc43,2.7634088947952126e-05
prefusion intermediate state cp1,2.7628249690462808e-05
recombinant sars virus nucleocapsid protein,2.7625602083899786e-05
negativestrand rna,2.7625240934743233e-05
reporter gene detection,2.7621483700807664e-05
sud,2.761977346721049e-05
semi-conserved ile (i95) residue,2.7613304049188538e-05
low vector,2.760904743639778e-05
translation studies,2.7605991364178633e-05
goal,2.7602040186041436e-05
adaptive cellular processes,2.7598945030239036e-05
drug resistance,2.757895549488803e-05
endou-deficient coronaviruses,2.75749352863162e-05
recognize,2.7565741612444345e-05
canine coronavirus ccv hemagglutinating encephalomyelitis virus,2.756445254902612e-05
uv-inactivated virus,2.7560083333481663e-05
china_x,2.7545370429998112e-05
serum neutralization,2.7521981138510934e-05
interferon regulatory factor,2.749885524550559e-05
bovine coronavirus (bcv),2.749538852901964e-05
hae sarscov structural proteins,2.748926369515943e-05
agerelated,2.7483882859249978e-05
mvas produced serum antibodies,2.7456831863185272e-05
middle-east respiratory syndrome,2.745650652403765e-05
orf 3 protein,2.745617988921939e-05
treatment supplementary,2.7455600023628037e-05
nasopharyngeal aspirates npas,2.745494154940215e-05
monoclonal antibody_y,2.7452419331196147e-05
humanadapted sarslike coronavirus,2.7441137572385254e-05
direct enzymelinked immunosorbent assay,2.7433617344539156e-05
spur development,2.7430103879418217e-05
viral subpopulations,2.7410988944421834e-05
glomerular pathology,2.7384538430892917e-05
lipid droplets,2.7376950652074774e-05
structural constraint,2.7363354521239695e-05
viral antagonists,2.7356801731152695e-05
site-specific infrared dichroism,2.7342681140200703e-05
pulmonary hemorrhage,2.73411566000378e-05
w45,2.7340455422853725e-05
bcv 95kda protein,2.7329012812400116e-05
cov spike protein,2.731298889640875e-05
areas_y,2.730602761338746e-05
non-structural protein,2.7299851606874802e-05
induced-fit reorganization,2.7299377647386538e-05
n7specific mtase,2.7281370530878212e-05
nonlinear n epitope,2.7269886001047813e-05
sarscov virusspecific memory,2.7265538716886168e-05
acute respiratory syndromeassociated coronavirus sarscov rna,2.72558184258944e-05
electrophilic character,2.7251259012117005e-05
membrane-associated replicative organelles,2.7240241828142797e-05
host transcription factor runx1b,2.723823882476308e-05
sars coronavirus proteins,2.7208320856906597e-05
viral endoribonuclease endou,2.7206149899157818e-05
243ysteart249 (1c3) and 243ysteartdnlseqekllhmv262 (4c7,2.720335092683618e-05
laboratory personnel,2.719691294467021e-05
canine coronavirus ccv 171 strain,2.7187812841586556e-05
health morbidity,2.718646619964574e-05
flow cytometry assays,2.718304450907925e-05
microtubulemediated transport,2.7166627621266675e-05
human fetal lung diploid fibroblast 2bs cells,2.7163683366266634e-05
immune complexes,2.7155976539735652e-05
ala,2.713726018961452e-05
cd9,2.7106283027331122e-05
etiology,2.709291045292565e-05
isopeptide bond cleavage sarscov,2.7083743438267157e-05
oncolytic activity,2.705249730450936e-05
e protein ic,2.7052097689999354e-05
immunodominant t-cell elispot,2.704955624777033e-05
ibv accessory proteins,2.7042820312976034e-05
rat roc1 astrocytomaoligodendrocyte cell line,2.703927261433934e-05
short interfering rnas,2.703470009116756e-05
monoclonal antibodybased antigen,2.7024516132524592e-05
prrsvrelated pulmonary alveolar macrophage pam,2.7019274209810108e-05
antiviral defense programs,2.70091799783973e-05
virus isolation study,2.7009030965851934e-05
pancreas,2.6977959029396942e-05
national guard hospital,2.696676460622461e-05
structural signature,2.6963670404466742e-05
membrane-proximal cysteine cluster,2.6943056765738136e-05
posttranscriptional,2.6942350390495007e-05
bronchiolar lavage specimen,2.693980775973036e-05
endoplasmic reticulum er upr,2.6930054851175568e-05
nucleotide species,2.6913763340020535e-05
free leader rna species,2.6908598217628307e-05
receptor-associated snps,2.6908321487854594e-05
genbank kp876546,2.6872996676736835e-05
virusencoded proteinases,2.6864786388380418e-05
tertiary rna structure,2.6846665207670204e-05
pathogenicities,2.6839693531934537e-05
virusspecific cd4 t cells,2.6820260903981024e-05
cov_x,2.679265661213896e-05
elongation factor 1alpha,2.6789614860427483e-05
spanish camels,2.6780088510835503e-05
golgi modifications,2.6778460941199953e-05
encodes_x,2.6769481240986155e-05
orf7a expression,2.6765614725858337e-05
acylated carboxylterminal intravirion tails,2.67570569732656e-05
hr1hr2 s core fragment,2.674840947743456e-05
lungderived cells,2.6742431591978382e-05
high-quality solution structure,2.6738497151631257e-05
fecal iga antibody,2.6734913907824325e-05
acute respiratory syndrome coronavirus sarscov infection,2.6715111281954565e-05
nucleoside triphosphatebinding,2.6696211895987898e-05
sars-cov n protein,2.668559787329688e-05
"mhvr-negative, non-permissive bhk cells",2.666142058076712e-05
region fragments scfvs,2.6654132336737532e-05
signal peptide sequence,2.6648030520507833e-05
host-protective,2.6633496502687394e-05
fatality_x,2.6632812022083456e-05
hoechst 33342,2.660848577636723e-05
anti-bcv serum antibody,2.6607193798057186e-05
calu3 cells human,2.659449581486859e-05
subgroup,2.6581553361047395e-05
transferred jhmvimmune splenocytes,2.6576364014240528e-05
prcvpbs pigs,2.6568142139351908e-05
iondependent,2.6567900752525968e-05
phosphorylated nucleocapsid protein,2.656786180414335e-05
amino_x,2.6564708304806726e-05
yellow fever virus yfv dengue virus serotype 2,2.6544376170741036e-05
nuclear ribonucleoprotein hnrnp a1,2.6521442930727868e-05
bcv s1 subunit,2.6517132290714398e-05
cytotoxicity assay,2.6508937329579284e-05
ribozyme sequences,2.6489484519421712e-05
antiviral effector proteins,2.6487736113890823e-05
green monkey kidney epithelial cell lines vero vero e6,2.6458570012706062e-05
cap analogs gpppg gpppa,2.6452379132316674e-05
lithium salts,2.6443898262838386e-05
cysteinecoordinated,2.6432692670770734e-05
nucleustocytoplasm rna,2.6402904028013513e-05
self-association,2.6402129914813074e-05
phosphatidylinositol,2.638917698979291e-05
genetic material,2.638713667564743e-05
rna cleavageinducing function,2.6386143967016322e-05
acidic amino-acid cluster,2.637198100688983e-05
human england/qatar 1 virus,2.6367701717554757e-05
furin transmembrane protease serine 2 tmprss2,2.6358952562055737e-05
nterminal 41aminoacid region,2.6319223323756392e-05
2-substituted benzoxazinones,2.6297993854240448e-05
k v holmes j virol 7194999504 1997,2.629487732398818e-05
cricket paralysis virus crpv,2.6294474185281324e-05
prosurvival member,2.627324718105516e-05
history_y,2.6250418509290182e-05
drug concentrations,2.6249194443644144e-05
leader-primed transcription,2.624266457733835e-05
human demyelinating disease,2.623365295952114e-05
proteinbearing,2.622299665043831e-05
revertant viruses,2.6220560500736972e-05
apoptotic effect,2.6219584317541114e-05
sadenosyllmethionine sambinding pocket,2.620081206959184e-05
roche molecular diagnostics,2.6196787110904657e-05
public health management,2.6196179578358715e-05
third transmembrane,2.617697290675662e-05
monocyte chemoattractant protein 1 mcp1,2.6152930871919775e-05
miniopterus bats,2.614493910352876e-05
neuroinvasive neurotropic,2.6132586298902118e-05
aerosol-generating medical procedures,2.613162840924867e-05
laboratory outcomes,2.6125806550436242e-05
spike protein s1 fragment membrane protein,2.6125479289690054e-05
quebec turkey,2.6111337111485765e-05
virus replication complexes,2.6100511653107172e-05
glycoprotein mutations,2.6088815960293e-05
differentiationassociated gene 5 pathways,2.6073527609530026e-05
multifunctional nucleocapsid protein,2.6061180316630025e-05
acidifiers,2.6058514544203794e-05
prcv infections,2.6058361241859427e-05
papainlike protease plp,2.605115774548454e-05
replicase gene 1bderived sequences,2.6023641529344955e-05
"vm, rm",2.6013365078530107e-05
receptor binding domain rbd,2.6007901172291965e-05
rnabinding protein complex,2.598722571401351e-05
sarscov pseudovirus,2.593983502850813e-05
human coronavirus 229e proteins,2.5934975036049e-05
4 nucleotides flanking,2.593207181355362e-05
sarslike infections,2.593198882259386e-05
questionnaire survey,2.589908759974703e-05
leaderbody junction,2.586971068117709e-05
patient convalescentphase,2.586063874083003e-05
rna-binding activity,2.5852654709924098e-05
insulated isothermal pcr,2.5846361625621778e-05
endoribonuclease endou,2.5836170130205843e-05
central nervous system cns,2.5829077041386504e-05
natural infection,2.5821995793216744e-05
transmembrane proteaseserine subfamily member 2 tmprss2,2.5761177453093252e-05
parental mhv genomic rna,2.575090345081857e-05
hostdirected,2.573405281651537e-05
b (r1020/h1020) strains,2.572549618803011e-05
pl1pronegative mutant,2.5712146351362226e-05
esterase active site,2.5706210209829186e-05
baxdependent,2.5705344615946984e-05
immunosuppressive,2.5703488209783674e-05
glutathione-s-transferase (gst) pulldown assay,2.5700679139330356e-05
totally nonconforming downstream motif,2.56683668370537e-05
comparative studies,2.5639956919135805e-05
protein ic,2.5623781922246473e-05
adenovirus-based vaccines,2.5615490107507128e-05
glial reactivity,2.5613165587810414e-05
nucleic acid_y,2.5603126814628126e-05
bovine coronavirus human coronavirus,2.559529730457552e-05
recombinant his-tagged protein,2.5580232511905406e-05
monomeric homologue,2.5566429949059024e-05
sugar coreceptor nacetylneuraminic acid,2.5563020668574656e-05
membrane anchoring,2.556175427158945e-05
mammalian dpp4 orthologs,2.5549190886255447e-05
nafamostat,2.552107945447118e-05
mhvbinding regions,2.551347945842115e-05
predicted cleavage sites,2.549707425491214e-05
alveolar epithelium,2.5491156470297155e-05
shelter,2.542551929016057e-05
viral spike glycoprotein gene,2.541461105080849e-05
coronavirus nonstructural protein 15 nsp15,2.5401218773142037e-05
primary neurons,2.5398980875995352e-05
respiratory viruses_y,2.539744082941874e-05
two-dimensional nuclear magnetic resonance studies,2.5380638472906124e-05
cytokine interleukin4 il4,2.5378404425241753e-05
"sars_cov, sars 3c-like protease",2.5352499223200773e-05
cisacting rna,2.531213133139271e-05
hcovnl63 replicase gene,2.5309170828523034e-05
hexameric endoribonuclease,2.528526253403221e-05
batsarscov and sarscov genomes,2.5275568706329575e-05
proximal and distal elements,2.5252522545691377e-05
murine coronavirus e,2.524839005718093e-05
freeze substitution methods,2.516355434796162e-05
membrane glycoprotein,2.5159967143915048e-05
murine dcsign homologue,2.5124136871679293e-05
bcvinfected,2.5110776551638597e-05
seroconverted,2.5107131763076892e-05
epidemiological characteristics,2.5091821476329225e-05
localization studies,2.5090340679685907e-05
coronavirus tgev trsl,2.5087369736056315e-05
nucleotide and deduced amino acid sequences,2.506384939098839e-05
gene silencing,2.505359718308208e-05
motif krkte u122,2.505114775513977e-05
bdcov hku22positive,2.5023994453287537e-05
reactive samples testing,2.500844854687514e-05
nucleotide and amino acid sequences,2.500377671329886e-05
initiate,2.499133407142688e-05
spike truncation,2.4987509735032273e-05
text integrin i domain,2.4980210689876395e-05
ecov seroprevalence,2.496949784677919e-05
created substitution mutants,2.4948050820569143e-05
beta-coronavirus viral loads,2.4937390687984275e-05
receptor first,2.4933788948936824e-05
rousettus bat coronavirus gccdc1,2.492271392629441e-05
membrane protein 6,2.492144477566948e-05
mhvr-independent infection,2.4901138244309376e-05
hku14,2.4898240441904564e-05
small cov envelope e protein,2.4893761197294365e-05
mmoll,2.4867308074918225e-05
u18666a-induced dysfunction,2.4864257213253956e-05
nucleustocytoplasm rna transport,2.4856418136776957e-05
mouse central nervous system,2.4851396107996738e-05
peritoneal,2.4797019584307564e-05
host response,2.4783976986650912e-05
olfactory bulb,2.4766700828148325e-05
maximal di rna,2.4765011856435044e-05
aminoterminal gene 1 polyprotein cleavage product p28,2.4744834823310807e-05
viral activity,2.4729647701397904e-05
antiinflammatory effects,2.470404132127178e-05
intensive care department,2.469829344783295e-05
tree,2.468993519948136e-05
homogenized,2.4688887190162218e-05
mitochondrial cytochrome c,2.4683815516984798e-05
46-lrlgsqlsl-54 amino acid sequence,2.464911402447706e-05
marv gps 4 lap devices mini hemopurifiers,2.4626752386020844e-05
doi101038nature12328,2.46194605443856e-05
matched,2.4591526617414886e-05
coronavirus 3clpros,2.45688489568061e-05
immune homeostasis,2.4558233103652027e-05
sarscovsusceptible vero cells,2.4550194551246075e-05
oral,2.453514683203684e-05
reverse genetic mutagenesis,2.4533588259142333e-05
non-structural protein 3,2.4515751795668845e-05
image,2.4495955974536357e-05
hcv ires,2.4492637521230036e-05
permissive human cells,2.4489536353327754e-05
mhv leadercontaining mrnas,2.447781984411171e-05
cd8 t cells,2.4468104816344677e-05
infection-limiting pathway,2.444749826991726e-05
north china,2.444730550222614e-05
polyadpribose polymerase,2.44454315797527e-05
detrimental effects,2.4435453082739972e-05
convalescent b cells,2.4435048216422678e-05
block predictpdf2180,2.4430074782610993e-05
non-immunosuppressive cyclosporin a-analog,2.4425321944797255e-05
quantitative reverse transcriptionpcr,2.4412995997992695e-05
structurebased,2.4411553452603643e-05
sarscov s2,2.440592476041788e-05
virus spread,2.4390831085938254e-05
ifn and ifnresponsive genes,2.438995971728652e-05
human angiotensin converting enzyme 2 (ace2) receptor,2.4386524652823075e-05
vaccination groups,2.4382040911873127e-05
retina,2.4381899002417664e-05
rhinolophus blasii rhi bla,2.4377661569785185e-05
n gene,2.4374830147162692e-05
cp,2.4374611464093576e-05
deltacoronaviruses,2.4367216525592092e-05
virus-infected nasal epithelial cells,2.435007093669557e-05
maps,2.43030548642039e-05
coronaviral proteases,2.4295062871549042e-05
cell-based receptor binding assay,2.4294071524742266e-05
indigo sinigrin aloe emodin,2.4289445845500998e-05
mutation rjhmn514s,2.4279096120148525e-05
serine_y,2.4274268524570775e-05
effector and target cells,2.4264708720294728e-05
cytotoxic tcell response,2.4257506106918586e-05
aspartic acid residues,2.4254743088430217e-05
diagnostic approaches,2.4248240281770493e-05
endoplasmic reticulum (er)-golgi,2.4224358222824797e-05
cleaved glycoprotein,2.4214483457929078e-05
38,2.418817751851201e-05
lactobacillus plantarum probio38,2.4176507209320964e-05
e1,2.4171693965125822e-05
ib,2.4157304171980317e-05
peptide neutralization interference assay residues,2.4127972944152166e-05
nlrp3 inflammasome assembly,2.4126667808700715e-05
pseudotype,2.4107846512099866e-05
laboratoryconfirmed,2.4094711289458167e-05
wellstudied alpha,2.4072755506381298e-05
fabricius,2.405737032163807e-05
systemic spread,2.4039475322040277e-05
nsp7b,2.4035445014196116e-05
neonatal infection,2.4030502849242096e-05
open reading frame 3 orf3,2.398791519165601e-05
cxr,2.3987257911582464e-05
sars-cov rdrp elongation,2.3968416480981096e-05
nterminal polyprotein papainlike proteinase plp1,2.3928488727737027e-05
hypophosphorylated,2.3914793938725427e-05
3a's potassium channel,2.3912651979624925e-05
bacterial and mammalian cells,2.3908867768177443e-05
mucosal immune system,2.38709966387435e-05
hospital hygiene,2.387099663874332e-05
genomic rna packaging,2.3866556941086756e-05
vectormediated,2.3863688687381867e-05
enhance_x,2.3861307359154327e-05
experience,2.385992700148758e-05
international significance,2.3858397145200106e-05
virus-specific cd4(+) t cells,2.3853549623912585e-05
multiple logistic regression,2.3841259825360972e-05
sars-cov harness,2.3825421599739166e-05
-4,2.3803462617423867e-05
control mers-cov infection,2.3797032813809093e-05
comparative sequence analysis,2.379576245654706e-05
orf1ab proteins,2.3789948273852652e-05
galanthus nivalis agglutinin,2.3778459609312277e-05
oligcsaccharide,2.3767061782820113e-05
phylogenetically,2.3746619655697514e-05
immune cell population,2.3742394819584165e-05
bis-benzylisoquinoline alkaloids tetrandrine,2.3725326515390623e-05
cellular factors,2.371973587777029e-05
spike_x,2.3719468073273826e-05
zincfinger domaincontaining 1,2.369343709241857e-05
eukaryotic translation initiation factor,2.369120692203442e-05
recapture,2.3686930413432964e-05
minus strands,2.3684572121882753e-05
concentrate,2.3683393984035212e-05
moderate diffuse interstitial pneumonia,2.3681045547757944e-05
polypyrimidine tract-binding protein,2.367172299286264e-05
antibody epitope,2.3670936029754667e-05
vaccines stimulated gamma interferon,2.3668015983291325e-05
x domain homolog,2.3665389591589432e-05
g-quadruplexes,2.364806788391315e-05
spike s proteins,2.364481847427933e-05
intermediate hosts,2.363035846330654e-05
polymerase chain reaction_x,2.362560861669456e-05
stimulatory subunit,2.3621565143480563e-05
s-nitroso-n-acetylpenicillamine,2.3618369305760675e-05
solid foundation,2.3608772839200373e-05
prcv pneumonia,2.3595270784094827e-05
lowabundance,2.3589079605293478e-05
civet cats,2.3581203467964824e-05
manipulating,2.3581014287220245e-05
cd8 tcell epitopes,2.3575363240492955e-05
7b-specific monoclonal antibodies,2.357229864322314e-05
human embryo lung cdna library,2.35722986432231e-05
sars cov replication,2.3569297580819775e-05
bats-hosts-reservoir-people,2.3547576327308305e-05
merscov nucleocapsid n gene,2.3544778137318364e-05
central australian aborigines,2.354401167426558e-05
receptor binding_x,2.3512931360721023e-05
sarscov replicative polyproteins,2.348587105193475e-05
heparan sulfate,2.3462675355260905e-05
chloroquine chlorpromazine loperamide,2.344578066694265e-05
liquid column chromatography,2.3432397921727997e-05
economic losses,2.3427100218488623e-05
exogenous furin,2.340999957924617e-05
liquid chromatographytandem mass spectrometry,2.3403441361987928e-05
nsp14 amino acid sequence,2.3402156603557478e-05
bat-sars-cov,2.3400369755165298e-05
north american viruses,2.3398179512498177e-05
recsars-cov reporter virus expressing renilla luciferase,2.3386224596073608e-05
switzerland fcov type 1 viruses,2.3380472313090585e-05
virionderived gp100 spike subunit,2.3376084909766732e-05
iem assay,2.3350482604540727e-05
interconnectedness,2.3335635550791837e-05
bone marrow stromal antigen 2 bst2,2.3332617283239243e-05
brazilian,2.3326240676806636e-05
infectious bronchitis virus-type pseudoknot,2.3318998920715685e-05
borate gel electrophoresis,2.331192346807935e-05
real-time reverse transcription polymerase chain reaction,2.330784260115807e-05
cytoplasm cell cycle analysis,2.3293219103388938e-05
b and c,2.3288393606592345e-05
surface antigen,2.3287673635653612e-05
geographical variability,2.3285535658939407e-05
pi,2.328066035385088e-05
mice bcelldeficient mice,2.3275332834489963e-05
basolateral surface,2.3271143088031246e-05
compact structure,2.3267880742392764e-05
pulmonary tissue repair,2.3258859190916466e-05
cns_x,2.3258859190916445e-05
roost,2.3233946776537126e-05
cellular cyclindependent kinase cdk inhibitors p21cip1 p27kip1,2.3218068545983848e-05
hcovnl63 replicase products,2.3212872275558977e-05
betacoronavirus spikes,2.3209747958154326e-05
casei,2.320030685759104e-05
viral enzyme complex,2.319567568626008e-05
antiviral mediator,2.3191012005101064e-05
coronavirus nonstructural protein,2.319094395273242e-05
p38 mapk mitogenactivated protein kinase pathways,2.3188948169070977e-05
interferon induction,2.3174548471450486e-05
ileal enteroids,2.316785887597201e-05
clinical investigation,2.315414014118196e-05
vaccine-mediated protection,2.3142234591731684e-05
nonfatal pulmonary coronavirus infection,2.3138771485488687e-05
clone 4 b 3,2.313823730215914e-05
svsvtmdcyt trimers,2.3136504434474422e-05
human neuronal and glial cells,2.3126105449730807e-05
473 intrahost single nucleotide variants,2.3093967424250698e-05
hamster guinea,2.309361957639435e-05
case recognition training,2.3091113248537e-05
antibody-dependent,2.307782376891819e-05
subgenomic rnas substitution,2.307388257457205e-05
interferon antagonist,2.3072063358621255e-05
t cell suppression,2.3064563506187738e-05
ectopically expressed proteins,2.3064496622853997e-05
c-terminal fc tag,2.305796610136914e-05
developing neutralizing monoclonal antibody,2.3038242804672247e-05
healthy rabbits,2.3032582667406178e-05
major immunodominant site,2.303057323034996e-05
3oh position,2.3012754819298546e-05
validation test,2.3005007479415837e-05
extracellular viral,2.3004928480891603e-05
sucrose gradient ultracentrifugation,2.298809936720762e-05
nucleotide and amino acid,2.298272620609075e-05
scientific community,2.298236505174204e-05
multiple virusinduced,2.295600952725677e-05
virus-induced host response,2.295467006035598e-05
platform_x,2.2948875081936405e-05
small molecule inhibitors,2.2935101294375516e-05
spatial clusters,2.2933114283056697e-05
controlled genetic background,2.2922411634069355e-05
human merscov strains,2.2919586104389514e-05
taqman real-time fluorescent pcr,2.2899660073827775e-05
mice genes,2.2880645836662952e-05
reverse transcriptase pcr assay northern blot analysis,2.2878851542033088e-05
baseline,2.28647481548558e-05
cell function,2.2840498600805366e-05
interferon responses,2.2824359501747768e-05
national guard health affairs,2.2821472464395888e-05
northern sweden,2.282045016362227e-05
infection consortium,2.2787042720452945e-05
signaling pathway,2.2779191797786908e-05
european union european centre,2.2768194443010185e-05
inflammatory monocytes,2.274121225002495e-05
cmi,2.2737449313826443e-05
sars-coronavirus isolates,2.2727774190617767e-05
non-cholesterol-accumulating triazoles,2.2716117105030816e-05
29bp deletion fusing orf8ab,2.2713764036009513e-05
igg immunofluorescence assay,2.2684561494543198e-05
gastrointestinal complications,2.267320265032459e-05
tg lineages ac70,2.26349310622023e-05
pharmacokinetics,2.262599112548237e-05
"crcov-k9, -k37, and -k39",2.2619138348183554e-05
coronaviruses bootscan analysis,2.261617293303241e-05
mixed neuronglia culture,2.261469059760108e-05
nucleotide positions 11750 and 11892 and a 29bp region,2.2610569362514454e-05
trim56mediated inhibition,2.2602987011825655e-05
ribosomal proteins nucleolar proteins translation initiation factors helicases,2.259924343257044e-05
hydrophobic membrane domain,2.259458098960035e-05
human bronchial epithelial cell line 16hbe,2.2581260241203695e-05
minimal receptorbinding region,2.258001368074593e-05
quaternary prevention,2.2573658676261614e-05
conserved nucleocapsid protein region,2.2563970476176303e-05
uk,2.2557455442366354e-05
n-met-ser-ser-thr-thr for mhv,2.2557063590022738e-05
allele,2.2548226865890204e-05
cell surface serine proteases extracellular trypsin,2.2519572193527727e-05
virulence factor,2.251084579280772e-05
cellular proliferation,2.2508431580259674e-05
new-type ibvs,2.250075388938149e-05
respiratory coronavirus 229e,2.2497267255845904e-05
n-linked glycosylation sites,2.2475454839353004e-05
protective capacity,2.246850606272843e-05
virusbinding domains,2.246243497382395e-05
phosphotungstic acid,2.246214022562858e-05
healthcare system,2.2453402956621304e-05
coronavirus human coronaviruserasmus,2.2448534126141163e-05
cytoplasmic and nucleolar compartments,2.2448534126141163e-05
mitogen-activated protein kinases,2.2433534546356005e-05
acute respiratory syndrome coronavirus papainlike protease sarscov plpro,2.2428664349935876e-05
hepatitis cov mhv infection,2.2427823108021978e-05
"virus-encoded, non-structural proteins",2.241642949237277e-05
polypeptide products,2.2412638693651367e-05
nucleocapsid (n) protein gene,2.2391449827468324e-05
standalone vaccine strategy,2.238179232884748e-05
cns cell type,2.2378219794568476e-05
serum levels,2.2372560029991513e-05
western immunoblotting analysis,2.2356330143880974e-05
coronavirus replicase gene,2.235133132735802e-05
serum/plasma samples,2.234944075138827e-05
amino acid replacement,2.2331708245953906e-05
substrate recognition sites,2.2318379057210803e-05
fusionactive subunit,2.231362319718368e-05
immunologically,2.2302186106253354e-05
human coronavirus nucleocapsid protein mrna,2.2298822344345802e-05
users_x,2.2298822344345775e-05
virusspecific mrnas,2.2294742608515635e-05
influenza clike he fusion protein hef,2.2284108647244046e-05
glycopolypeptides s1 and,2.2269325255834466e-05
mulatta sars model,2.2269221080219378e-05
orfs_x,2.226619734643721e-05
mers-cov m(pro,2.2250083111570196e-05
case 3,2.224622499388469e-05
ifn proinflammatory factors,2.223419034878373e-05
cal type viruses,2.2232335371721035e-05
mtor,2.2214920814590018e-05
alphacoronavirus (alphacov) genus,2.2198511758237454e-05
multivariable logistic regression,2.217414408123584e-05
sars 3cl proteinase,2.2172911130634414e-05
viral membrane proteins,2.2166746787651196e-05
methodological framework,2.2148114914968673e-05
amino acids a288l,2.2123724152860474e-05
stat1 complex,2.2104357491068046e-05
phenolchloroform extraction,2.2087741032593737e-05
mtase inhibitors,2.208163214883322e-05
breast epithelial mcf10a cells,2.207322950373598e-05
multiplex pcr,2.2073113428242276e-05
gutassociated,2.2064589931302658e-05
eukaryotic translation initiation factor 2,2.2040632592975763e-05
furin transmembrane protease serine 2,2.203550141539344e-05
anti-inflammatory processes,2.2033722235397e-05
environmental risk factors,2.2032601439662317e-05
acute respiratory syndrome sars coronavirus cov nucleocapsid protein,2.2025389679877342e-05
northern blotting,2.2024891057399135e-05
protease cleavage,2.2001774929010865e-05
anticodon structure,2.1996294643392713e-05
virus-like particle,2.1988115468728116e-05
sars-cov 3a-induced,2.19819526313893e-05
mouse hamster guinea pig,2.197998458304174e-05
coronavirus nsps,2.1976049252399537e-05
neutralization antibody assays,2.1963454707985623e-05
microscopy_x,2.195666307216921e-05
molecular orbital molecular mechanics,2.1932686103130313e-05
nuclear factor kappa-light-chain-enhancer of activated b cells,2.1926354023958965e-05
peptidase4,2.1926309635934734e-05
human coronavirus hcov229e spike glycoproteins,2.192540878126754e-05
immunopathogenic events,2.1920435338887535e-05
hipposideros batcov hku10,2.190925674770567e-05
ksa mers,2.190300271840017e-05
singlesubstitution viruses,2.1898785526207245e-05
sars coronavirus main proteinase dimer,2.1892581847837147e-05
rad/spike,2.1840093074703405e-05
translation product deduced,2.1838328527342032e-05
phosphodiesterase pde,2.1834756009229375e-05
y195,2.1822297427186492e-05
cre recombinase rjcre,2.1822180742568074e-05
bateared,2.1808308833939374e-05
infectious cloning system,2.1802951010481705e-05
membrane permeability,2.179602986839605e-05
769p,2.179291191784238e-05
chimaera,2.1752928949532255e-05
cytochrome c procaspase9,2.172885900349616e-05
onestep reverse transcription polymerase chain reaction,2.1713382038456684e-05
uvvimmunized mice,2.1711041336669015e-05
chargedresidue substitutions,2.170762510590684e-05
immune-mediated demyelination,2.1698307100895642e-05
serum alanine aminotransferase activity,2.1696042519815397e-05
nsp12rdrp,2.167928517870859e-05
recognition membrane,2.1674028033206506e-05
bat-sars-cov and bat-cov hku2,2.165380775449359e-05
human respiratory infections,2.164315331758199e-05
antibody_x,2.1600240739440647e-05
acute respiratory syndrome-coronavirus,2.159163485694266e-05
nucleocapsid (n) proteins,2.1570390356305357e-05
evolutionary distances,2.1551897394106807e-05
hiv hepatitis c virus,2.154020314305278e-05
protein nuclear export,2.15342912925397e-05
recombinant inbred ri strains,2.152721879035046e-05
nsp1-40s ribosome complex,2.152448175441144e-05
synonymous marker,2.150933293464319e-05
structural proteins hemagglutinin esterase,2.1507508496277074e-05
retinoic acid-inducible,2.1504753670252576e-05
brsv-related clinical outbreaks,2.1498548452937213e-05
gastroenteritis coronavirus_x,2.148932833095193e-05
cellular uptake,2.1466376878117114e-05
bird coronaviruses,2.1461922043855784e-05
exposed to,2.145841595997931e-05
closed,2.1453790881133576e-05
human nasal mucosa,2.1447378522507382e-05
fluidigm dynamic array nanofluidic chip,2.141694816078877e-05
secretory immunoglobulin,2.139249620870036e-05
natural receptor murine carcinoembryonic,2.1387270199785825e-05
human h7n9 influenza viruses,2.1380343968735014e-05
cellular proteins,2.1372843409480078e-05
watery,2.1345394876603387e-05
procoagulation molecule,2.1343448012182598e-05
hospital center,2.133468487848409e-05
nucleolus nucleoli,2.1300506388085848e-05
motifdependent,2.1287416027466086e-05
months_x,2.1275371520932835e-05
rn4tertbutylphenyln2tertbutylamino2oxo1pyridin3ylethylfuran2carboxamide,2.126222534846317e-05
small sequences,2.123938462085778e-05
pedv infection,2.1236260389892297e-05
s450650based elisa,2.1222329570579524e-05
major immunodominant epitopes,2.1204345559233513e-05
ns129 gene,2.1191117176118002e-05
helical oligomer,2.1169499557652044e-05
fecal-oral transmission,2.1159684263843424e-05
nonhuman,2.1145643643530958e-05
isogenic sars coronavirus sarscov,2.114508668810819e-05
monocytes/macrophages,2.1139268004938763e-05
dead box rna helicases ddx3x,2.1126196746496882e-05
transmissible gastroenteritis virus tgevrelated coronavirus,2.109530204676537e-05
internal protein,2.108017093537869e-05
nterminal exoribonuclease exon domain,2.106600654989219e-05
hek293t cells,2.104087413905667e-05
homologous xdomain,2.1007043611080873e-05
cellular receptor hcovhku1,2.0998158730271807e-05
ace2binding domain,2.099664920221305e-05
open reading frame orf 3b orf,2.0994978785104042e-05
replicating virus,2.0990077797377295e-05
ucuaa sequence,2.097796634849333e-05
co-circulating,2.0974922810854505e-05
forms pentameric ion channels,2.0969628623301313e-05
igem technique,2.0950466801044743e-05
smallanimal models,2.0949428475966254e-05
cross-reactive tcc,2.0945654235211914e-05
viral exposure until,2.092588042506946e-05
japanese pipistrelle pipistrellus abramus,2.0921877944502493e-05
human airway cell cultures,2.0904726696634642e-05
single amino acid substitution,2.0894120248633025e-05
antibody secreting cell asc,2.0893075275690573e-05
etiopathology,2.0889690794063746e-05
phage-displayed human lung cdna library,2.08534119666694e-05
horizontal transmission,2.084408446383367e-05
microglia,2.0840693926171303e-05
tcell epitopes s1203,2.083681094488015e-05
carboxypeptidase angiotensinconverting enzyme 2,2.083238030783375e-05
foreign antigens,2.081484828015005e-05
vaccinia virus vv thymidine kinase,2.0814795389453737e-05
mouse hepatitis virus a59 mhva59infected dbt cells,2.0806542850567642e-05
dual luciferase reporter assay,2.0794577331402572e-05
replicase nonstructural proteins nsp3,2.0792096273557845e-05
lkr,2.0784886225875596e-05
ns2h126r infection,2.077994881932961e-05
genotypes b and c,2.0768752362138896e-05
young animals,2.076562156411169e-05
middle east respiratory syndrome coronavirus merscov infection,2.0731181114920315e-05
quantitative real time pcr,2.0725503844575306e-05
recombinant elisa,2.0722346663211364e-05
coronavirus cv,2.070937005972268e-05
coronavirus jhm omp1,2.0680346857283894e-05
transmembrane protease tmprss2,2.0671804794264243e-05
mers-cov antibody response,2.067150909960115e-05
cellular and viral s-adenosylmethionine-dependent methyltransferases,2.0665621465891816e-05
ic50,2.0659320868426315e-05
camel milk,2.0647790259215143e-05
ready-to-use real-time rt-pcr kit,2.0626793240059882e-05
molecules_x,2.0619937555504017e-05
mapkinteracting kinase 1,2.0602513061511214e-05
glucoseregulated protein,2.0591087691184815e-05
sliii domain nucleotides 1,2.0567439510874094e-05
colony,2.054207067668263e-05
xenograft mouse,2.05361585089746e-05
chloroacetate esterase activity,2.05312856306584e-05
virus assembly site,2.0510736546940082e-05
phosphatidylinositol 4kinase,2.0504676267581355e-05
doi:10.1186/s13029-016-0049-7,2.0502341297939154e-05
goat,2.049419219581773e-05
nglycosidic bonds,2.0493315229866412e-05
atiie brain virus,2.048756791175379e-05
poor survival,2.0487563043119183e-05
compositional constraint,2.0476182674767384e-05
ibv virus',2.0463856563103263e-05
asymptomatic infection,2.0455662036586677e-05
wildtype wt mice,2.045309841217207e-05
interferon gamma interleukin6,2.0439900243228e-05
provisional,2.043625865181535e-05
sars-cov group,2.038753776274162e-05
nsp1516 site,2.0374282101823806e-05
chemokine receptor,2.0370914636446594e-05
vero cell s10 extracts,2.035674824794155e-05
virus neutralizing antibodies,2.0356176173757612e-05
abelson abl kinase inhibitor,2.0351628909240612e-05
kiv,2.0349287558436865e-05
sars-cov nucleocapsid,2.033534757756517e-05
luciferase assay,2.032433279298042e-05
sucrose gradient,2.0310859436102113e-05
merscov spike sera,2.0295963136263405e-05
incubation,2.028555132210322e-05
coronavirus sarscov bone marrow stromal antigen 2 bst2,2.0269275994962834e-05
medications,2.0263632325035444e-05
indoor environments,2.026285945379594e-05
sputum,2.0246888869578313e-05
agent_x,2.024605503935428e-05
lentivirus pseudotyped,2.024416140117629e-05
sa and spike b sb proteins,2.0222251348465987e-05
high survival,2.022109650938027e-05
vinyl sulfonebased inhibitors,2.021369556722356e-05
cytoskeletal proteins,2.020371394133976e-05
marmoset animal,2.0197541138381666e-05
intracerebral,2.019753602486389e-05
immunoprecipitate radiolabeled proteins,2.0177671647417303e-05
intestinal brush border membrane proteins,2.016701911479673e-05
nl63cov spike protein receptorbinding domain rbd,2.0143194990860955e-05
disordered conformations,2.0141869007571732e-05
rcovinfected alveolar epithelial cells,2.0133646150179205e-05
camelexposed,2.0120474605580074e-05
sucrose solution,2.009936862357047e-05
immunofluorescence immunofluorescence,2.009301955509129e-05
endoplasmic reticulum golgi intermediate compartment,2.0088745305322576e-05
multiple sequence alignment,2.0071941908875188e-05
murine and human neuronal cells,2.0069461061231065e-05
semi-quantitative method,2.0056472901112305e-05
mers-cov igg,2.0046649362413715e-05
united arab emirates,2.0040298845913942e-05
bovinelike cov transmissible,2.0036210657504992e-05
1-step quantitative real-time reverse-transcription pcr assays,2.0036170880600905e-05
oacetylesteraseinactive hku1he mutant,2.002844639854155e-05
cis-acting rna elements,2.001539562572473e-05
sars coronavirus main protease,2.0005016123245343e-05
abi prism 7500 sequence,1.999860635280894e-05
microvascular thrombosis,1.9990550283216438e-05
bats molecular,1.996576308972981e-05
structure-based design,1.9965629799731077e-05
inpatient contacts,1.9965299493484652e-05
copb2related proteins,1.9955598181777418e-05
phylogenetic sister,1.994817773654813e-05
enteropathogenic coronaviruslike agent,1.9934481368014015e-05
fusion state,1.9931491970116344e-05
wh-human-1 coronavirus,1.9895126248920533e-05
infect bat cells,1.989430670676658e-05
recombinant sarscov,1.9893389656799835e-05
cdna encoding sarscov e protein,1.987704847678618e-05
e coli,1.9865020292635472e-05
accessory and structural genes,1.9862547355804094e-05
antiviral intervention,1.9851200480298934e-05
histocompatibility complex class,1.9849667393102933e-05
orf 3b protein,1.9813510622268394e-05
chloramphenicol acetyltransferase cat,1.980419478144518e-05
cov rnadependent rna polymerase,1.9801749510063767e-05
hku24,1.9799467372925922e-05
antibiotic resistance/reporter gene dna,1.978255465734065e-05
cov he receptorbinding site,1.9781383984185224e-05
human immunodeficiency virus type 1 reverse transcriptase,1.9779279712841486e-05
human amino acids,1.9773039770433744e-05
t cell epitopes,1.9765152648798873e-05
hafr-al-batin-1_2013 clade,1.9756612916088636e-05
coronavirus cov replication,1.9752369673271696e-05
arg132 residue,1.9751494425701045e-05
mutant aminopeptidase,1.973182832807569e-05
aac and uuua aau (underlined codon,1.970069267635724e-05
antibodies viral,1.9680821687706633e-05
pi3kaktmtor pathways,1.967680007415938e-05
ifnproducing cells,1.9673845021484707e-05
betacoronavirus genomes,1.965203082136908e-05
homosexual men,1.9633919248764002e-05
virus-infected cells,1.962747795054542e-05
coronavirus tgev,1.9623164004316297e-05
influenza a/h1n1,1.9614972683686324e-05
rna synthesis_x,1.960071255117928e-05
loop-mediated isothermal amplification,1.9598336917809035e-05
southern taiwan,1.9586010974894687e-05
predicted 154-amino acid protein,1.9583844592612162e-05
p28,1.9570879724863212e-05
crossprotective dna vaccines,1.9554101008194087e-05
high-throughput pharmacophore modeling,1.9545466557470067e-05
vacuolar proton pumpatpase,1.9539349931288387e-05
angiotensinconverting_y,1.9536211360087914e-05
natural sarsspecific memory,1.9521366707796387e-05
crypt,1.9514979045308065e-05
nucleic acid isolation,1.9475723952571006e-05
complementfixation tests,1.947108771830231e-05
non-infected hrt-18 cells,1.9463848744806465e-05
m1,1.9447450578165292e-05
protein-coding region,1.9447371097403744e-05
structured,1.9446584443928965e-05
membrane fusion s2 subunits,1.9431293816330455e-05
cterminal ublike domains,1.943013718072989e-05
growth factor signaling pathway,1.94271941153513e-05
protein s450650,1.9403272750244076e-05
molecular characterization,1.938234291829203e-05
live-attenuated ibv vaccines,1.936606483108249e-05
nuclear localization signal,1.9355056927585936e-05
turkey,1.9349829669612188e-05
middle east respiratory syndrome-associated coronavirus,1.934509042368736e-05
hla peptide binding predictions,1.9336300048489004e-05
n-terminal globular (s1) and s2 subunits,1.9314635698763305e-05
orf1a proteins,1.9312783089681042e-05
kinase activation,1.930776249458235e-05
unglycosylated m polypeptide,1.930669717302648e-05
laboratory responses,1.9281072884235997e-05
study disciplines,1.9271652758655016e-05
ifn_x,1.927145585467725e-05
m carboxyterminal endodomain,1.9264286059647904e-05
cleavage events,1.92570094401298e-05
punctate perinuclear,1.9250441276765288e-05
mhv infection_y,1.9242240623552164e-05
massachusetts type strain,1.922168296463114e-05
switch,1.9213625484042426e-05
interaction domain,1.9205435953058263e-05
biotinylated recombinant plasmids,1.918468284963427e-05
cultured human and animal cells,1.9160700602192142e-05
immunoprecipitated annexin a2,1.9152903792208888e-05
synthetic replicating,1.9150181149748093e-05
colonic carcinoma cell line genes,1.914390980205077e-05
article_x,1.910753340897542e-05
unglycosylated m polypeptide 26k,1.9107210945695304e-05
neuronal expression,1.909635072083494e-05
spikebearing,1.9087436716445574e-05
calf feces,1.9086876494120718e-05
pro-active surveillance programme,1.907479691344811e-05
"n-(6-oxo-5,6-dihydrophenanthridin-2-yl)(n",1.905928945747728e-05
renilla luciferase-encoding sars-cov replicons,1.9058107821064254e-05
colonoids,1.9056107476407448e-05
neutralizing effect,1.904879598413521e-05
immortalised feline cell line,1.904843266130674e-05
ribosome pause sites,1.9038189967636314e-05
authorized users,1.902832185249794e-05
viral expression,1.8999526171039694e-05
specific nucleotide sequence,1.8997708925386657e-05
anti-hcov-emc neutralizing antibodies,1.8994524517099897e-05
non-health-care workers,1.8972775799665473e-05
hef,1.8961641605937057e-05
envelope proteins,1.895744518272076e-05
gav,1.895698461917695e-05
amino terminal s1 subunit,1.8944411570339675e-05
n195spike recombinant baculovirusinfected,1.891380291470391e-05
monocytederived,1.890541239008923e-05
nonstructural protein 15 subunit,1.8902500938211098e-05
ibv-infected cells,1.8885752343926686e-05
virus replicates,1.886989627606945e-05
geographic area,1.8862832329414965e-05
nonconservative amino acid,1.886092579216534e-05
viral envelopes,1.884887838186018e-05
subgenotypes,1.88463100313153e-05
hae cell cultures,1.884062181321085e-05
glycyrrhizin acid derivatives,1.883200685763367e-05
intermediate position,1.881824634869118e-05
tl/ch/ldt3/03,1.88131710203332e-05
somhvr,1.8813067425887747e-05
endodomain cysteine-rich motifs,1.880756064727314e-05
nterminal segment of,1.8796352828865517e-05
adjuvant tolllike receptor tlr agonists,1.8795748282439306e-05
transduced cells,1.879443508179606e-05
2019-ncov,1.8790978133276152e-05
gav replicase polyprotein precursors,1.878523417797741e-05
electron microscope,1.8781760016537387e-05
sequencespecific oligonucleotide probes,1.8778807574924887e-05
immunoperoxidase technique,1.8770988808473623e-05
ace2binding domain amino acids,1.8762246362349396e-05
human primary intestinal epithelial cells,1.875662453355413e-05
large_x,1.8755657145725093e-05
coronavirus cis-acting rna elements,1.8744424565816906e-05
induction phase,1.8734387917564262e-05
anti-coronavirus activities,1.873356997246459e-05
sequence elements,1.8729424105101003e-05
sarscov spike s protein,1.872842540890493e-05
within-shelter transmission,1.8721433428590235e-05
mtase domain,1.8704674185796565e-05
axillary lns,1.8703495439524445e-05
microrna mir mir30a5p,1.869070788538522e-05
spontaneous,1.8669065930832547e-05
pseudotyped vesicular stomatitis virus,1.864465561155185e-05
karolinska insitute hpyv,1.864409997760945e-05
chfjwt2018,1.8636130339303714e-05
nucleocapsid ii,1.859542701531047e-05
uorf auginitiating codon,1.8589429082390598e-05
gxxxg motif,1.8580264555380137e-05
coronavirus cov lsign,1.8577894975345802e-05
mhv packaging signal,1.8560143414640944e-05
older students,1.855724178986859e-05
antinucleocapsid protein,1.8536647930358902e-05
recombinant nucleocapsid protein,1.8535038564371858e-05
small nonenzymatic viral protein,1.852506697635948e-05
correlates,1.8515862294738283e-05
sars coronavirus nucleocapsid,1.8513452350452804e-05
rjhm,1.851254471961161e-05
decoy peptide inhibitor,1.851230184392354e-05
rt-pcr plus nested pcr techniques,1.8505694457814655e-05
ground-glass opacity halo,1.8501792276455373e-05
punctate labeling,1.849420926739176e-05
complex type glycosylated forms,1.8478070504607793e-05
irremediable,1.8463512599546122e-05
clade b,1.844866632373138e-05
riyadh,1.8444282709440546e-05
cellular tropism,1.843927745496469e-05
merscov s1,1.8430983567201902e-05
rtc function,1.8416804895800514e-05
hydrophobic n-terminal signal sequence,1.8373275369547255e-05
prcv mrna 2 polymerase chain reaction pcr,1.8349150620135718e-05
heptad repeat 1 hr1 substitutions q1067h q1094h and,1.8342105438329327e-05
tender leaf,1.8329665582343123e-05
upstream canonical site,1.832702482911099e-05
ubiquitin-proteasome-dependent,1.832492170483861e-05
nouzilly strain,1.8292850548168958e-05
vrp3000 vaccines,1.8276189183326176e-05
reactive consensus pcr primers,1.827107565621841e-05
intestinal segment cultures,1.8268637992404358e-05
hepatology,1.8261507522811426e-05
polymerase chain reaction taqman assay,1.8253734618792077e-05
mouse hepatitis virus mhv rna,1.8249370685321642e-05
fusion protein_y,1.8247364874073982e-05
type i interferon,1.824170182655261e-05
macrophageattracting chemokine,1.8236146479197213e-05
chymotrypsinlike protease 3clpro rnadependent rna polymerase pol helicase spike,1.8234945605678495e-05
single nucleotide polymorphisms,1.8221361875450328e-05
betacoronaviruses sarsrrfbatcov,1.8198718049193066e-05
protein e arbely z granot i,1.81881471460151e-05
intercommunicating alleles,1.815960025147277e-05
nlrp3 inflammasome,1.8152202220030294e-05
respiratory immunization,1.814820225238868e-05
hcov respiratory specimens,1.814046531526148e-05
wildtype levels,1.8132930300838767e-05
upe and the open rading frame,1.813102215370622e-05
firstgeneration tests,1.812877047384447e-05
international patent wo 97/20054,1.81155465706119e-05
respiratory coronavirus oc43,1.8084426317635258e-05
nsp7nsp8 complex,1.807059612643567e-05
sarscov genomic sequence,1.8067364951949474e-05
peptidase,1.804791522031172e-05
anti-sars-cov s antibody,1.8040528757097802e-05
c strains bootscan,1.8034253398160023e-05
murine and non-murine cells,1.8030451500127245e-05
pseudoparticle neutralization test,1.8003268768170914e-05
human leukocytic cell lines,1.8000947214293204e-05
immunoprecipitation studies,1.7984781716107392e-05
lentiviral transduction,1.7954775558534116e-05
immune cells astrocytes,1.7944652749771576e-05
coronavirus m proteins i,1.7937864745231508e-05
area under curve,1.7935176676436437e-05
predicted oglycosylation site,1.7929290376774486e-05
specialized,1.7920765447757375e-05
wild type sars-cov,1.7916025373760424e-05
viral nucleocapsid (n) protein,1.7910770793964344e-05
blastogenic response,1.7896881899343828e-05
regulatory t cells,1.7894519685010555e-05
chronically ill,1.7889515150178874e-05
tgevprcv strains,1.7882856421139747e-05
recombinant coronavirus vaccine,1.785535012684352e-05
sars-cov replication cycle,1.784603359127081e-05
gastrointestinal tract,1.7818959206428026e-05
sarsrrhbatcov rp3,1.7817966898788447e-05
zoonotic human,1.781011888105047e-05
coronavirus n proteins,1.7808053846249717e-05
amino acid (aa) sequences,1.7805152635596402e-05
carboxy-terminus of e protein,1.7804322569587632e-05
denaturing gel electrophoresis,1.7795688863313544e-05
enterohaemorrhagic escherichia coli o157h7 infection,1.7795283347902082e-05
interferon-related genes,1.779504807795019e-05
methyltransferases nsp14,1.7787756784232917e-05
abdominal organs,1.7786979412117047e-05
coronavirus replicasetranscriptase,1.7784052375380228e-05
chicken embryos,1.776806023112207e-05
membranebound proprotein convertases pcs furin,1.7762701389567886e-05
regulatory sequence,1.7757875904458118e-05
bioproject accession,1.7756674813994655e-05
virus database,1.775458438341209e-05
mutant deleted,1.7737817916173897e-05
nucleotide substitutions,1.7733608723692347e-05
open reading frames ns5a ns5b ns5c ns6 ns7 ns8 ns9,1.768125312368649e-05
groupspecific gene cluster open reading frame 3abc,1.7675827234076232e-05
1146nucleotide gene fragment s1b nt 1185 to 2333,1.766509831189293e-05
posttranslational modification,1.7658746740319962e-05
coli_x,1.7653561401524737e-05
ns129 accessory protein functions,1.7652142581638285e-05
respiratory viruses primary human monocytederived macrophages,1.76465848877976e-05
sars coronavirus (sars-cov) spike protein,1.763056650937099e-05
ligand-binding pockets,1.7627311551954038e-05
streptococcal toxic shock syndrome,1.7614051298498304e-05
fusion tripeptide,1.7603751628853677e-05
hydrophilic residues sequence,1.759819868239234e-05
hamster ovary cho cell line,1.759149106398273e-05
receptorbinding interface,1.7588245213831044e-05
live-attenuated salmonella typhimurium,1.755841295202278e-05
trypsintreated retrovirus,1.7533350455444114e-05
106-kda non-structural protein 12,1.7525555735338816e-05
hepatitis coronavirus nonstructural protein 4 nsp4,1.7523580702564293e-05
recombinant s protein fragments,1.751682468646751e-05
nonstructural protein domains,1.751344355514949e-05
prrsv-infected pigs,1.7502700859526698e-05
7b glycoprotein,1.7502599177699084e-05
anin vitrocell-to-cell fusion assay,1.7479435413682346e-05
hydrophobic domain,1.74679632336875e-05
inflammatory settings,1.7467724944726723e-05
fcov spike gene mutations,1.7457311487694964e-05
interferon ifndeficient vero cells,1.744298255140751e-05
roosting behavior,1.742941597819377e-05
p1 and p2 positions,1.7425309865118312e-05
experimental validation,1.7396756764695072e-05
proinflammatory cytokine interleukin6,1.739022559006979e-05
hybridization,1.7386994937324317e-05
viral population,1.7379652447554097e-05
urine specimens,1.7360879316795646e-05
eukaryotic mrnas,1.7360518072591337e-05
drugresistant sarscov,1.7360518072591337e-05
human coronaviruses (hcovs) infections,1.7356745939490367e-05
sar,1.735261940766454e-05
parrot/indonesia/bx9/16,1.734776474481687e-05
medical condition,1.7347362563860186e-05
immunofluorescence assays,1.7346995022137773e-05
lys48-linked polyub chains,1.7342569905146154e-05
dsrna-binding proteins,1.734182961986068e-05
basepairing,1.7318545897367443e-05
cov nsp14 exon,1.7296786731767537e-05
568bp nucleotide fragment,1.7278077313630287e-05
brown bats sequence,1.7261408604236017e-05
epigallocatechin,1.7260918753858942e-05
non-native 3d structure,1.7251712200810067e-05
anti-lys48 and anti-lys63 ubiquitin antibodies,1.7244000177618516e-05
crossprotection,1.7236332569113272e-05
oxidized glutathione,1.7232815339953736e-05
rm,1.721517461591663e-05
anticeacam5 antibody recombinant ceacam5 protein,1.721206208805706e-05
longitudinal noninvasive approach,1.720791225613893e-05
receptor-binding domain (rbd) protein,1.7207689757387823e-05
carcinoembryonic antigen-related cell adhesion molecule 1a,1.719553502826277e-05
spinal cords virus,1.7195033930075262e-05
nlinked,1.7195033930075252e-05
rbd infected cells,1.7189834248141957e-05
eukaryotic initiation factor 4,1.7187449124864544e-05
human coronavirus genome,1.7183552924703708e-05
multifunctional glycoprotein,1.7157597708005626e-05
conserved negatively charged amino acids,1.7145222821489608e-05
surface structure,1.7128614598139006e-05
instantaneous,1.711721373656509e-05
agarose gel electrophoresis,1.7116057269155174e-05
receptor-binding (s1) and fusion (s2) domains,1.7110359031399267e-05
contagious gastrointestinal swine disease,1.710981615982869e-05
prrsv-infected alveolar macrophages,1.7096764628219885e-05
eosinophilic immune,1.7092444057503775e-05
human sarscov strains,1.70895293467833e-05
coronavirus sarscov hcovemc,1.708365786194825e-05
persistently infected murine cell cultures,1.7074696031295337e-05
bottlenose dolphin cov bdcov hku22,1.707393365284293e-05
upstream consensus sequence,1.7072274169708755e-05
national quarantine system,1.706658528746617e-05
animal-to-animal transmission,1.7061348700800014e-05
coronavirus cov lung,1.7057328733829935e-05
noncanonical site,1.7038402983259696e-05
pachypus coronavirus hku4,1.7015355041557974e-05
predicted phosphorylation site,1.7014865986426062e-05
trim25mediated rigi,1.7006352788072843e-05
membranespanning segments,1.6998576057558282e-05
alpaca virus,1.698650265532072e-05
arbovirus,1.6954942816349352e-05
genomic features,1.694416991001426e-05
inter-species adaptation,1.6921138194143543e-05
delta inulinbased polysaccharide adjuvant,1.691607035727212e-05
murine coronavirus mouse_x,1.689979075862106e-05
chinese health officials,1.689876762535895e-05
minimal furin consensus motif 758-rxxr-762,1.6880133882963317e-05
fusion protein heptad repeats,1.6873520408254046e-05
transduced,1.68655030457408e-05
automatic rna extraction,1.685969343992009e-05
reporter molecules,1.6859647265401374e-05
n7,1.6826406694643624e-05
singlestranded rna,1.680713465694638e-05
intranasal challenge,1.6792467901662593e-05
viral diversity,1.6785219930924434e-05
nasopharyngeal mers-cov rt-pcr tests,1.6783602295266285e-05
bovine coronavirus bcv,1.6754893618348084e-05
responsibility,1.6746378617459825e-05
viral entry/fusion inhibitors,1.674246117301193e-05
cleavable spike glycoprotein,1.6740685807775612e-05
orally,1.673429009218381e-05
serum sars-cov rna rt-pcr,1.6732718015776066e-05
mrna destabilization function,1.6721222809312468e-05
e3 ligase activity,1.6719487949774634e-05
anti-canine coronavirus antibody,1.671815197305005e-05
genetic organization,1.6708222645318082e-05
ubiquitinproteasome system,1.6700545952169533e-05
structural genes,1.668632697449631e-05
sensitivity_x,1.6672468217180538e-05
primer extension analysis,1.6669694190079954e-05
interviral gene exchange,1.6665733125268278e-05
emperie,1.6662839199712702e-05
canine fibrosarcoma cell line,1.6649263297769156e-05
mucosal immune response,1.661863935451234e-05
tgttt motif predominanted,1.6615451980204575e-05
human alpaca,1.6566158165776358e-05
mockimmunized hamsters,1.654807915429448e-05
sarscov recombinant murine coronaviruses,1.6541768236918097e-05
small interfering rnamediated,1.6508461053857956e-05
immunoglobulin g2a,1.6498524265943026e-05
major glycopolypeptides gp180 gp69 gp25,1.648735641496985e-05
cellular factor,1.6486709368806386e-05
phylogenetic markers,1.64661679539485e-05
antibodies mabs,1.6461168135963137e-05
intravirion subgenomic,1.6460186038760343e-05
rotavirus antigens,1.645220341960079e-05
human blood mononuclear cells,1.6451143991507495e-05
experimental model,1.642825280327462e-05
asymmetric amplification,1.6407560760149074e-05
primary cerebral explant cultures,1.640727073324912e-05
indirect immunefluorescent tests,1.6402598026681062e-05
ribosome leaky scanning,1.639825232154681e-05
rt-pcr assay,1.6397024637371284e-05
granulomatous necrotizing,1.6389838798705558e-05
profibrotic environment,1.6389713409928458e-05
hcov-oc43 n-ntd,1.638806963791586e-05
cellular receptor mceacam1a,1.6387982126622536e-05
tracheal aspirate/sputum,1.637660838571689e-05
hematologicalbiochemical,1.6367703551268708e-05
rna affinity protein purification,1.6363196175971862e-05
plp,1.6362347118895134e-05
s-pseudotyped particles,1.6338234169960307e-05
identities,1.6330786795177202e-05
deduced,1.6315489820810664e-05
disseminated,1.6309995771864368e-05
sero-epidemiological survey,1.6291011818180942e-05
molecular modelling studies,1.6281201433641552e-05
antiviral heptad repeat peptides,1.6278850240771017e-05
porcine hemagglutinating encephalomyelitis coronavirus,1.6268125249045684e-05
bcells,1.6260889193183708e-05
eosinophilia,1.6254565208980324e-05
endosomal pathway,1.6240575249084427e-05
mabs_y,1.6240067653649166e-05
ifn products,1.6239076693386733e-05
high selectivity index,1.6237408716378115e-05
gst,1.620715555761469e-05
heterotypic live mhvs,1.620669968061675e-05
ifitm,1.6200130233202258e-05
faeces samples,1.6199564214212076e-05
ns129,1.6189326440116733e-05
liver macrophages,1.616108684049021e-05
frugiperda sf9 cells,1.6154930235979563e-05
viral envelope_y,1.6145468814229112e-05
recombinant s1 protein,1.613890667480622e-05
p53 tumor suppressor gene,1.6121334656121076e-05
neutrophils tumor necrosis factor alpha,1.6114330714865e-05
technologist,1.6108894989549325e-05
highthroughput testing,1.6095211872687557e-05
biochemical experiments,1.608068882864503e-05
phosphate buffer ph,1.608014685278888e-05
african stakeholders,1.6045539886330828e-05
america grading system,1.603075364652873e-05
cdna sequences,1.6028027170368243e-05
hcov-nl63 sequences,1.602131681565658e-05
sars-cov,1.6007963275455652e-05
proinflammatory responses,1.600230110035976e-05
bacterioferritin,1.6000349925035202e-05
merscov ct,1.5986609261932286e-05
mers-cov entry/fusion inhibitors,1.5983141621573412e-05
bulbul cov hku11 bucov hku11,1.5975421598049317e-05
arabian peninsula merscov rna,1.597538168363139e-05
16 nonstructural proteins nsps sarscov nsp12,1.597077748381183e-05
chimeric spike protein,1.5958692362275305e-05
monomeric subunit,1.5955521558492303e-05
structurebased optimization,1.5949233533660406e-05
replicase domains,1.5926302411407635e-05
non-inflammatory apoptotic cell death pathway,1.5925512062274982e-05
cterminal human,1.5915394390966363e-05
pseudotyped lentiviral particles pseudotypes,1.591462875276322e-05
prototype ccov-i strains,1.591269346898474e-05
neuraminidase inhibitors,1.5900866147487524e-05
wildtype murine,1.5891828737438545e-05
realtime pcrbased virus cell entry assay,1.583265278224131e-05
basto y,1.583047678016767e-05
uorfharboring stemloop 4 structure,1.582953047705671e-05
sars-cov-specific antibody,1.5826064506300228e-05
destruction,1.5826064506300143e-05
rrs,1.58242656301224e-05
m aminoterminal 50 residues,1.5814951038716415e-05
replicase 1ab,1.5783920595350325e-05
translation initiation factor,1.5778727015920674e-05
genome hnrnp a1,1.577071866890419e-05
receptordestroying 9oacetyl esterase,1.5762574839827664e-05
protein kinase rlike er kinase perk,1.5748947941628234e-05
reverse transcription-polymerase chain reaction,1.574861904770384e-05
mouse astrocytes,1.5715107393514418e-05
dual vaccines,1.5701982360436308e-05
amino acids 224 and 225,1.569998898788695e-05
human and bovine macrophage and,1.569242285029171e-05
bonemarrowderived macrophages,1.5683659614693658e-05
incompatibilities,1.5675960300065793e-05
rabbit,1.5668534319324808e-05
multiple lineages,1.5659090843265744e-05
seroconversion,1.5656619433258742e-05
biases,1.5655527556933643e-05
recombinant sarscov n gstn protein,1.5653087178797558e-05
protein receptor aminopeptidase n,1.5645129487996057e-05
hemagglutinin activity,1.564176019621766e-05
crimean-congo haemorrhagic fever virus,1.563846181696129e-05
"cd45+, cd3+, cd4+, cd8+, cd19+ and cd16+/56+ cell",1.5630520444628448e-05
enteric coronavirus infection,1.5628351369779403e-05
cation-selective ion,1.562200605897399e-05
usingtranscleavage assays,1.5612418648834928e-05
intercellular adhesion,1.5611127478748383e-05
middle east respiratory syndrome-related coronavirus,1.55840710780284e-05
phosphodiesterase,1.5574063812639756e-05
tandem copies,1.5557267922360855e-05
transcription associated sequences,1.554954683762384e-05
ibv nsp9 homodimer,1.5544766436728674e-05
europe tissue samples,1.5542649929619124e-05
biologicals,1.5521616702880866e-05
dual luciferasebased reporter plasmid,1.5519200697065156e-05
n-acetyl-l-cysteine,1.551240460159401e-05
ibv-induced s-phase arrest,1.5481780083678842e-05
viral material,1.5461206138213334e-05
cell lines huh7,1.5438073864842767e-05
structural comparisons,1.5430702933714887e-05
transmission electron microscopy,1.5419076821600218e-05
hcov 229e-based,1.5382578608311253e-05
membrane microdomain,1.5382205135094572e-05
macrodomain fold,1.5379767767271525e-05
protein-angiotensin-converting enzyme 2,1.537834336886146e-05
associates,1.5371574098183352e-05
palmitoylated s protein cysteines,1.537098108821634e-05
nosocomial,1.536406334357505e-05
preventive strategy,1.5360889274694523e-05
biological function,1.5349709588128024e-05
protein domains,1.5331790724306388e-05
disulfide-linked homodimer,1.5322009177610467e-05
humans coronavirus consensus pcr,1.5297012408498853e-05
receptor-binding ability,1.5290615774328735e-05
cellular response,1.528793246168664e-05
trim56 domains,1.528007729081727e-05
green fluorescence protein (gfp)-fused s protein of scotophilus,1.5263878182667898e-05
psoralen mice,1.52611722176411e-05
matrix protein e1,1.5232258799662674e-05
protective immunization,1.5226675773243422e-05
crossinfection,1.5221216028323367e-05
carboxylterminal half sequence,1.5219391259875196e-05
viral fusion inhibitors,1.5189409290127487e-05
postchallenge control,1.5185833576715225e-05
prokaryotic ribosomes,1.5179902752794491e-05
btm,1.5177493537609419e-05
homologous virus,1.5164777623289097e-05
three-dimensional structure,1.515763176111272e-05
neutralizing sars-cov infection,1.5117981060898723e-05
reverse transcriptionpcr analyses,1.510098744202409e-05
nycteris sp. bat coronavirus,1.5099785197272533e-05
liveanimal market,1.509954841596473e-05
purified virus,1.5093559922888066e-05
cholesteroldependent,1.5093003813750135e-05
microbiologic documentation,1.509220911682693e-05
variable_x,1.5080814347047841e-05
essential function,1.5072679645450978e-05
human ace2,1.5059082062781833e-05
virus infections,1.5046650750808071e-05
sars virus,1.5039702367621322e-05
carboxy-terminal charge-rich motif,1.5038295697107624e-05
ubline molecule isg15,1.5033042762912482e-05
culture fluid,1.5030381917423515e-05
infectious mhv,1.5026397543736921e-05
synthetic sirna duplexes,1.5020939587721715e-05
long-term,1.5020355053835855e-05
tolllike receptor tlr adaptor proteins,1.5017854776725984e-05
airway proteases,1.5012570533414196e-05
mouse hepatitis virus a59,1.5010988188365387e-05
full-length mers-cov s protein,1.5010573925583267e-05
u122,1.5010413431185364e-05
humanpathogenic coronaviruses,1.4999048318800965e-05
octylglucoside,1.4998882230772121e-05
dna unwinding assay,1.4987175327860724e-05
epidermal growth factor,1.4978613703269562e-05
primary mouse,1.4971134421017038e-05
protective response,1.49671693749673e-05
affymetrix hgu133a microarray,1.4964101201036205e-05
recombinant (vsv-s) expressing,1.4953364392952982e-05
bhk-r2 cells,1.4951832069430507e-05
protein binding,1.4947230861770992e-05
position 637,1.4944108039049759e-05
active drug sab301,1.4934309813619933e-05
antigen activation,1.4926250092978432e-05
sarscov 7a protein,1.4913317099471409e-05
crowded settings,1.4909847362559706e-05
mutant-infected cells,1.4904897586439795e-05
sarscov receptor angiotensinconverting,1.4903960184758464e-05
nsp14exon proofreading activity,1.4901360918907975e-05
immune evasion,1.488685411158448e-05
soluble spike proteins,1.4881224834282184e-05
jmd,1.4879190382453593e-05
metabolic labeling,1.4879159413797917e-05
sarscov genes open reading frames orfs,1.4855647583475768e-05
transmembrane anchor,1.4855647583475768e-05
eosinophilic immune pathology,1.4838476596445405e-05
block sarscov infection,1.4822371798237686e-05
bacteriophage rna polymerase,1.4814536537888804e-05
major neutralizing epitopes,1.4795366880503044e-05
bovine respiratory syncytial virus,1.4792848076116691e-05
750-kda precursor polyprotein,1.4790868494743415e-05
cryo-electron microscopy,1.478299417100668e-05
singlenucleotide mutations,1.4778809010564074e-05
adrp domains,1.4776747587919904e-05
genetic studies,1.4752135585214304e-05
cell motility,1.4738600511493135e-05
hepatitis delta ribozyme sequences,1.47364003392754e-05
c.,1.4732747346963427e-05
bovine cov n protein,1.473269375838968e-05
peptide kinome arrays bioinformatics analysis,1.4730367819659887e-05
acute respiratory syndrome virus,1.4730300791827848e-05
luciferasebased reporter gene,1.4719988166985114e-05
cell surface proteases,1.4715250379671125e-05
(246)vtrfygarsssa(257,1.4705591065627668e-05
activation type i ifn,1.4704624033814604e-05
type iii interferon,1.4678998889947986e-05
cho cell line,1.4671734004861054e-05
lesions focal,1.4662627689522144e-05
replication cycle intravenous immunoglobulins heptad repeat 2 peptide small,1.466089587118324e-05
retrospective studies,1.466075483985271e-05
dodecylphosphatidylcholine micelles,1.46600829392801e-05
genetic basis,1.4646932071562159e-05
multiple membrane topologies,1.46444943321651e-05
coronavirus-mediated pandemic,1.4643243240478649e-05
mers-cov-specific immune responses,1.4638924487131518e-05
inflammatory cell response,1.4632996266564636e-05
heparan sulfate proteoglycans,1.4629943808959641e-05
fcov_x,1.4623039868133807e-05
peripheral blood mononuclear cell pbmc,1.4618989315623743e-05
function(s,1.461320558092191e-05
immune electron,1.4601887095472872e-05
signature,1.4580016029658225e-05
35smethionine residues,1.4564633340795495e-05
core leader transcriptionregulating sequence ltrs forms sl3,1.4564436185389592e-05
coronavirus merscov helicase,1.4551452363780466e-05
ace2 binding,1.4547221764998144e-05
enteric fcov,1.45463893346888e-05
cloned gene strain,1.4543832572065972e-05
pp1ab-specific monoclonal antibodies,1.4542120432144191e-05
continuous virus,1.453887255595959e-05
dead box rna helicases,1.453861413511737e-05
i.v,1.4532295438242e-05
hku1 infection,1.4530449348907355e-05
branched polyubiquitin chains,1.4527179073534025e-05
granule markers,1.4522028056028632e-05
recording,1.4518454877475082e-05
39-,1.4509805728217428e-05
spseudovirus spseudovirus,1.4501147279661176e-05
4weekold lewis rats,1.4496435984097367e-05
environmental origin,1.4487362811572384e-05
bamboo bat,1.447754906724363e-05
fms-like tyrosine kinase 3 ligand,1.4450645413665833e-05
multifocal nodular consolidations,1.4445256439684822e-05
healthy blood,1.443751076131622e-05
laboratory strain fcov fip virus,1.443600848917757e-05
subgenomic rna sgrna transcription,1.4433526467340665e-05
murine dendritic cells merscov,1.4427927913564206e-05
virus surface cores,1.4427195584185604e-05
small animals,1.441941362099387e-05
virus overlay protein binding assay,1.4397007616572749e-05
postnatal,1.4393509660030991e-05
inactivation,1.4386299007079195e-05
cell-free translation,1.4381770989407271e-05
intestinal epithelial cells,1.4367803466654443e-05
sars-cov protein,1.4342007875601739e-05
intestinal cells,1.4315886300566285e-05
systematic approach,1.4310865508388284e-05
protein families,1.4305097230506921e-05
long g-stretches,1.4297760495262607e-05
nasopharyngeal aspirate npa,1.4287793727393031e-05
cov e protein ion channel,1.4286206443462121e-05
jhmvspecific major neutralizing epitopes,1.4278047238059568e-05
newborn gastric sample,1.427302371878316e-05
1a and 1a/1b polyproteins,1.4270314754580563e-05
human spleen cdna library,1.4268457500242405e-05
hv4,1.4262484489457247e-05
proteases block virus infection,1.4258180133190587e-05
fipv_y,1.4217638560543031e-05
mannose-rich-type oligosaccharide side-chains,1.4208690377362219e-05
fox analysis,1.418086222053957e-05
subgenomic mrna coronavirus,1.417461868743565e-05
bats himalayan palm civets,1.4170012676312243e-05
reorganization,1.4167690238201414e-05
standardized real-time pcr assays,1.4157566576942365e-05
replicase polypeptides 1a and 1ab,1.4149636811153881e-05
phase histological analysis,1.4143829043898176e-05
evolutionary origin,1.4123054471199708e-05
transcription consensus sequence,1.4123054471199708e-05
host_x,1.4114018202323303e-05
cholesterol depletion,1.4112999705101358e-05
vero-to-human,1.4100188873969679e-05
coronavirus cov 3clike protease 3clpro,1.4098651191878032e-05
transcription factor 6,1.4093799859126343e-05
gene trs core sequence csn,1.4090436837505993e-05
cocirculating,1.4072410266187453e-05
"enterovirus 3cpro (6b, 6c and 6d",1.4066006366624749e-05
rna interference,1.4057059170304737e-05
cterminal dimerization domain,1.4049408262910777e-05
poult enteritis,1.4036919106003402e-05
sitedirected mutagenesis analysis,1.4031776983095701e-05
mhv discontinuous transcription,1.4028551694549016e-05
sarslike covs slcovs,1.402506655836204e-05
sarscov replication electron microscopy,1.3994592153861496e-05
leukocyte populations lungspecific cytokines,1.3988184403195247e-05
primary embryonic cells,1.3987902438562654e-05
exited,1.397794804089732e-05
polymerase and zn-finger regions,1.39770496163295e-05
respiratory tract diseases,1.3971501191433052e-05
nonviable,1.3957950364815051e-05
mhv and tgev receptor glycoproteins,1.3957317653721164e-05
reverse transcriptase pcr rtpcr,1.3941030768616578e-05
pro-apoptotic protein,1.3935198416535094e-05
tyrosineprotein kinase 2 abl2,1.3929476282676364e-05
cv bcv hev turkey cv,1.3929413499088677e-05
temperature-sensitive mutants,1.3920504150718343e-05
oglycosylated glycoprotein,1.3905907996430514e-05
liver parenchymal cells,1.3886916544573226e-05
glycosylation status,1.3885805033846653e-05
mhv-jhm amino-terminal proteins p28,1.3877358250951009e-05
coronavirus nsp8 proteins,1.3864876298099935e-05
swine testes st cells elongation factor 1alpha,1.3861658631010757e-05
viral polyprotein cleavage,1.3810648764348577e-05
hcov-nl63 infections,1.3803196157570845e-05
c-terminal alternative splice variant,1.3792806785094082e-05
ultrahighthroughput screen,1.378927072288863e-05
precipitating antibodies,1.3771481344454786e-05
adjuvanted mers-cov spike protein subunit,1.3739388030471244e-05
bh3 bcl2 homology domain 3 of bclxl,1.3731498817089535e-05
transcription_x,1.3726738353028424e-05
singlecycle pseudotyped virus,1.371062850961895e-05
assembly machinery,1.3706791780571565e-05
hcovoc43 hcovhku1,1.3705841155397212e-05
short oligou stretch,1.3705656897044596e-05
pro-inflammatory mediators,1.3704643627643765e-05
host-directed antiviral drugs,1.3702560299758369e-05
polymerase l genes recombinant vectors,1.3679696864869114e-05
dual percoll density gradients,1.3677854871187761e-05
clade c bat covs,1.3666132074434576e-05
crcov proteins,1.3665164195995092e-05
viral rnas,1.3663198229853144e-05
immunoprecipitation tests,1.3655010516969498e-05
factors_x,1.3654220889159235e-05
serological antibody,1.3650153745962525e-05
antibodies merscov neutralising antibody,1.364139648310931e-05
pentameric ion channels,1.3628258421605721e-05
sarsrelated cov open reading frame 8 orf8,1.3624542842100711e-05
conclusions_x,1.3617923529485046e-05
immunofluorescence antibody assay ifa,1.3611023347744366e-05
antiparallel twostrand,1.3569542557384413e-05
naturally occurring mutations,1.3558824918055386e-05
phosphoinositide 3-kinase,1.3553275100320212e-05
nucleotide identities,1.3552291506755383e-05
endogenous cytoplasmic protein,1.355180990432361e-05
site b residues 97 and 144 site c residues 50 and 51 and site,1.3546730298146908e-05
virusinduced cellular,1.3523788454595623e-05
pharmacological,1.3514887628126863e-05
sars-cov membrane,1.351179693332017e-05
np91 residues 91 to 105 np331 residues 331 to 345 and np351 residues 351 to 365,1.3493902124048717e-05
virus-like particle formation,1.3492908974565383e-05
variation residues snvs,1.3488690274225678e-05
cysteine protease inhibitor k11777 2sn1e3s1benzenesulfonyl5phenylpent1en3yl2e4methylpiperazine1carbonylamino3phenylpropanamide,1.3486391868197232e-05
membrane m glycoprotein,1.3484558041759053e-05
glycerophospholipids,1.3484048471153166e-05
golgispecific brefeldin aresistant guanine nucleotide exchange factor 1,1.3471348371542023e-05
membraneanchored fusion subunit s2,1.3467946403715318e-05
mhvinfected cns mice,1.3444576916520128e-05
pegylated interferon,1.343030718857731e-05
metalloprotease adamfamily zinc metalloproteases,1.342824037194592e-05
betapropiolactone,1.3420099549044111e-05
transmissible gastroenteritis virus cluster,1.3409670807201368e-05
fragmentspecific amplification,1.3399350987488622e-05
organelles,1.3397764909441565e-05
p4b,1.339632830606948e-05
sera-positive,1.3392462710843977e-05
discontinuous transcription i,1.3389183003890135e-05
leptomeninx bcells,1.3370919220601094e-05
species_x,1.3368879619058931e-05
respiratory droplets,1.3367085443974193e-05
4/91 vaccine,1.3363894123270092e-05
piglet,1.3361587523253972e-05
research designs,1.3355664529747061e-05
influenza virus_x,1.3352133491769991e-05
small autophagosomes,1.3341286904265946e-05
intermediate_x,1.3334402334724898e-05
acute respiratory syndromeassociated,1.332132573208136e-05
herds,1.3303896970090564e-05
gastrointestinal diseases,1.330064855107998e-05
pentapeptide aldehydes,1.3284715730013778e-05
alveolar type ii cells,1.3283371240185706e-05
apical chamber,1.3280605194866567e-05
polyclonal igg antibody,1.3278277855903673e-05
nomenclature system,1.3272119699662958e-05
cerebral cortex,1.3258883541510573e-05
chemoattractant protein1,1.3257312466163897e-05
type iii ifns,1.3253538555912113e-05
ubiquitinlike,1.3244060055240046e-05
gene functions,1.3236473435997142e-05
postchallenge spleen cells,1.3232591698902597e-05
heterologous envelope glycoprotein,1.322808504227344e-05
immunogenicity studies,1.3220269477161955e-05
nucleotide composition,1.32171460887133e-05
quantitative real-time reverse transcription-pcr,1.320271982433304e-05
nsp1 protein,1.3197951172294095e-05
clones 3 e 3,1.3197193696114389e-05
multivariate logistic regression analysis,1.3178132188422875e-05
glycosylphosphatidylinositol anchors,1.3171612052218282e-05
antibovine coronavirus rabbit antibodies,1.3170757389065143e-05
polyclonal antibody,1.3159800372399e-05
plasmodium falciparum,1.3157392066629536e-05
transduce,1.3147951435690073e-05
viral control,1.3145288773672692e-05
ifn alpha-receptor subunit 1,1.3143549002558903e-05
immunofluorescence_x,1.3135627616371223e-05
enzymatically active dimer,1.3132787514671205e-05
molecular structure,1.3125851522669844e-05
health professionals,1.312469767329615e-05
prophylactic vaccine,1.3111323900399678e-05
immunosuppressive disorders,1.3108790006720686e-05
trim56 curbs,1.3104559614650154e-05
indiana hospital,1.3102605109495713e-05
glycopolypeptides gp180 gp69,1.3101681474065924e-05
blocked_x,1.3094157239889505e-05
spike proteinmediated cell,1.3092121267865449e-05
cytoplasmic fluorescence,1.3088126670450502e-05
sars-like cov,1.3086103917445283e-05
removal,1.3083728312592154e-05
n-terminus,1.3082118206833517e-05
human immunodeficiency virus1,1.3070376255640195e-05
cloacal swab,1.304190668618115e-05
human coronavirus229e,1.3038555559574823e-05
amino acid sequence analysis,1.3026230532682335e-05
icurbani strain,1.3023026724590365e-05
alveolar_x,1.3020028547835497e-05
human lungderived cells,1.3009743268189101e-05
ultraviolet light-inactivated mouse hepatitis virus,1.3003492426921327e-05
disease recipients,1.3000933717890204e-05
107plaque-forming units,1.2979749159203537e-05
rna transcribed,1.2960456130002246e-05
lymphocyte subsets,1.2941631931717294e-05
coronavirus polymerase polyprotein,1.2926094064430967e-05
antileader,1.2906902514743769e-05
conformational differences,1.2904307099277005e-05
antagonistic mechanisms,1.2895668454310168e-05
oligonucleotide attachment sites,1.2892406858193418e-05
terminal glucose moieties,1.2881834621806413e-05
mers-cov rbd-based subunit vaccine,1.2880395566100619e-05
nasal swab,1.2879648645529136e-05
regulatory transcription,1.2877193116464132e-05
live-attenuated coronavirus vaccine,1.287172630989069e-05
fulllength s protein,1.2844025463768942e-05
genome-length replicative intermediate,1.2840983077746318e-05
28s and 18s rrnas,1.2838953746563478e-05
avirulent,1.2838511730267105e-05
s-adenosyl-l-methionine (adomet)-dependent (guanine-n7)-methyltransferase,1.2819452924468388e-05
tnf-related apoptosis-inducing ligand,1.2814266486517596e-05
gene expression studies,1.2809083656028279e-05
pilot study,1.2794911741103034e-05
interferon subtypes,1.2754387550489667e-05
ck/ch/ldl/97i-type strains,1.273388701168125e-05
hcov murine hepatitis virus,1.2728723982042196e-05
merscov receptor dipeptidyl peptidase 4,1.2710732483379474e-05
mouse hepatitis virus strain a59 mhva59,1.2704920784838381e-05
camel dairy,1.2697141983512e-05
rna sequences,1.2693889134955653e-05
high-efficiency n-binding site,1.2690911052808756e-05
proinflammatory cytokines interleukin 12,1.2689552206981129e-05
detecting,1.266096778982679e-05
cellular receptor angiotensin-converting enzyme 2,1.2651131178194608e-05
rn igg elisa 947,1.2643228654623956e-05
antimhv antibody,1.2642483169941008e-05
carboxy terminus of mhvy,1.2635512872168015e-05
4-o-acetylated,1.2620078255006038e-05
cyclic antimicrobial peptide,1.2615059563727284e-05
intubation group,1.2602626736651294e-05
glycosylated integral membrane protein,1.259550851167139e-05
real-time electronic isolation flagging system,1.2593010285278574e-05
gut contents,1.258951374571779e-05
disease origin,1.2580899626569596e-05
nonproductive infection,1.2573971753220312e-05
peripheric catalytic sites,1.2560483918479007e-05
intraperitoneal,1.2552173522762278e-05
sixyear epidemiological study,1.2549933048415856e-05
positive strand rna virus,1.2542153116181492e-05
undifferentiated cells,1.2531389997680852e-05
s-expressing cells,1.2526658730428156e-05
frugivorous bat,1.2522631660940636e-05
p-sg-qpcr method,1.2512711464629911e-05
transmembrane-protein gene,1.2501924362387504e-05
transcriptase activity,1.2494936602163953e-05
mcalpain,1.2467366436748227e-05
ifitm proteins,1.2466278172219782e-05
microtiter method,1.246006374143306e-05
lethal coronavirus,1.2459280575635944e-05
japan,1.245905085500876e-05
cov nonstructural proteins,1.2458290856784766e-05
mutant s protein,1.2433941691729114e-05
substrate analog,1.2425337792104687e-05
rpha method,1.2420098450777168e-05
oc43 s glycoprotein trimer,1.2405142314612662e-05
machinery,1.2384058721348141e-05
punctated perinuclear,1.2376981842094903e-05
pdcov,1.2371785455770661e-05
coronavirus mouse hepatitis virus strain a59 mhva59,1.235787094941725e-05
carboxyl-terminus,1.2336601360452832e-05
integral membrane protein genes,1.2325246044658632e-05
equilibrium,1.230454573728467e-05
coronavirus replicase gene 2,1.2301721223845282e-05
s1n330-iii,1.229183669136705e-05
s gene deletion region,1.2289000300416078e-05
putative multiple sclerosis,1.2285040630164159e-05
rnaindependent sarscov m,1.2264477502697703e-05
viral envelope glycoprotein,1.2261056222063155e-05
catalytically incompetent,1.2232544486259837e-05
biochemical_x,1.2226767081855068e-05
histochemistry,1.2220749598532641e-05
wholegenome phylogenetic tree,1.2204030673991776e-05
immunoreactivity assays,1.2202196244178703e-05
ibv spike glycoprotein,1.2192164448535145e-05
southern,1.2188236811702618e-05
therapeutic regimens,1.2186641550798907e-05
heat shock protein 90 alpha,1.2185351109156939e-05
white interfacial hydrophobicity scale,1.217722634670494e-05
viral mrna,1.2174879489410709e-05
mouse erythrocytes,1.2168087876433673e-05
dephosphorylated sars-n protein,1.2164537613943173e-05
virology field,1.213497528476138e-05
emergence_x,1.2132031468524943e-05
merscov spikebinding antibodies,1.2131306532869955e-05
putative origin,1.2130255429427825e-05
expressedin vitrowith,1.212799579800626e-05
host cell factor,1.2125544650620152e-05
proinflammatory cell death,1.2125431430676732e-05
tgev orf 7 gene,1.211892518714448e-05
deisgylase activity,1.2114268752441066e-05
v,1.2105475261028332e-05
quantitative reverse-transcriptase polymerase chain reaction,1.2104708353002563e-05
economical,1.2100097272947375e-05
retinoblastoma rb,1.2081900029058855e-05
jhmv-infected glial cultures,1.2073443598919222e-05
pancoronavirus small molecules,1.2070489431050683e-05
type i membrane protein,1.2069231459376977e-05
ub-like interferon-stimulated gene product 15,1.2065861889142978e-05
virus-neutralizing antibodies,1.2053668328275442e-05
chick kidney ck cells,1.2052119125176284e-05
virus culture,1.2046368470961604e-05
overlapping sequences,1.2030376899576781e-05
coronavirusinfected crfk,1.2027387392875608e-05
mers-cov case algorithm,1.2025045726868473e-05
e1035d,1.2023428704396703e-05
nsp9 nonstructural,1.2022662986821377e-05
major histocompatibility complex class i-restricted epitopes,1.200521471467349e-05
monoclonal antibody therapy,1.2001508574915556e-05
mutational analyses,1.1999154757709738e-05
replicase/transcriptase gene,1.1995616031795445e-05
coronavirus replication viral proteins,1.1994925954172662e-05
continuous screening,1.1992784034519775e-05
hemagglutininesterase,1.19827465893265e-05
primary bone marrowderived macrophages,1.1975720033487167e-05
laboratory-confirmed infections,1.1964514280900996e-05
sam,1.1962806340322053e-05
hcov229e replicase geneencoded nonstructural protein 13 nsp13,1.1958828003653473e-05
packaging cell lines,1.1957865565130273e-05
coronavirus poly(a,1.1939622293421161e-05
fluorescent antibody staining,1.1935971564572404e-05
cell surface entry receptor dipeptidyl peptidase,1.193145201983826e-05
intercellular membrane fusion,1.19292726553299e-05
mmediated,1.1922750614300439e-05
health systems,1.1919082075649878e-05
realtime pcr,1.1914290285237632e-05
hcov-oc43 and sars-cov,1.1913093229364386e-05
genetic manipulation,1.191168471503981e-05
nsp4 proteins,1.1907843501179272e-05
primary cell culture cek cells,1.1892705250317764e-05
hydrophobic virusreceptor interface,1.1882497646030997e-05
protein-driven,1.1867938096205785e-05
nb nbms10,1.1864582500635612e-05
transgenic drosophila,1.1858589941401371e-05
colonizing,1.1854446982035076e-05
peripheral activation,1.1838732649730003e-05
acute respiratory syndrome-associated coronavirus),1.1836404291543673e-05
double antibody sandwich method,1.1833829010905676e-05
cell-permeable agent,1.1825053620750048e-05
hcov229e fusion,1.1824855100784274e-05
synthetic overlapping peptides,1.1824451437090901e-05
doi101007s1137300892783,1.1822054953610486e-05
surface glycoproteins,1.1816836024300495e-05
antiviral antibodymediated suppression,1.1811464285777912e-05
cytosolic protein complex,1.1810485159750082e-05
adohcy,1.180889341675222e-05
cell-free system,1.1804739518320962e-05
case clusters,1.1803214307934641e-05
computational,1.1801262418255922e-05
cttaacaa,1.1799224899394977e-05
highestaffinity antibody,1.178782868938342e-05
shipping fever pneumonia sfp cattle,1.1786078506744612e-05
complaint,1.1785009891908193e-05
glycine codon substitutions,1.1784199034893108e-05
receptor angiotensinconverting enzyme 2 ace2,1.1775247867451505e-05
licensed kinase inhibitors,1.177174498479242e-05
rrt-pcr assays,1.1764584046054327e-05
cysteinecoordinated metal ionbinding domain,1.1750020950626985e-05
syncytia,1.1744299848710912e-05
sars-cov e protein,1.1709668935298742e-05
gastroenteritis virus_x,1.1708067796159796e-05
inoculum,1.1693147485913071e-05
mouse lung,1.1692822979441481e-05
antibodies m336,1.1684001326878188e-05
subclinical respiratory infection,1.1680019922615275e-05
acute respiratory syndromeassociated coronavirus sarscov,1.1670188125431755e-05
virion protein,1.1669686654707416e-05
common leader sequence,1.1666925730812062e-05
interstitial pneumonia,1.1664947062851548e-05
tgev subgenomic rnas,1.1664768542870949e-05
allogeneic hematopoietic stem cell transplantation,1.166425764873742e-05
tetratricopeptide repeat 2,1.1659387646200389e-05
positively,1.1658608329918022e-05
sarscov receptor human angiotensin i converting enzyme 2,1.1651972681646112e-05
gastroenteritis_x,1.1649214904051274e-05
cov sarscov mpro mutant,1.1646394468154025e-05
major histocompatibility complex class i/ii-restricted t cell,1.1641313968417016e-05
pro- and anti-inflammatory cytokines,1.1630191874748466e-05
nurse-to-patient ratio,1.1630121226766749e-05
healthcare-associated mers-cov,1.1629928624271807e-05
sequence type (st) 42,1.1625359514647524e-05
antiviral role,1.1620040280654418e-05
coronavirus merscov_x,1.1618361860194181e-05
oligoadenylate synthetase,1.1617459256924554e-05
neutrophils tumor necrosis factor alpha interleukin6 chemokine,1.1614459969894554e-05
vacuolar proton,1.1604783343308913e-05
immunological depletion,1.1602237199849599e-05
cell-free protein synthesis system,1.158702817059926e-05
nucleotide and amino acid sequence,1.1579774096498187e-05
radioimmunoprecipitation,1.155289336263702e-05
murine coronavirus jhm,1.154595145037027e-05
pl2pro activesite cysteine,1.1545144064784357e-05
classical theoretical calculation,1.1544693009768245e-05
recombinant sars-cov spike protein,1.152943846589571e-05
mpa,1.1522797730393757e-05
ifninducible transmembrane ifitm proteins,1.1520685816624063e-05
template_x,1.151893260227114e-05
respiratory specimens,1.1507600989248581e-05
rsv infections,1.1496938092361124e-05
coronaviridae-wide conserved domains,1.149449477094036e-05
deterioration,1.1492627736835333e-05
microwell immunoperoxidase test,1.1483368055617388e-05
reverse-transcription-polymerase chain reaction,1.147736415576953e-05
cells coimmunoprecipitation,1.1476539192385087e-05
wild-type or attenuated-type 2575/08,1.1473672042599137e-05
viral polyproteins pp1a,1.1471935261234815e-05
heterologous sequence,1.1471284440605319e-05
oglycosylation assay,1.1470903454708767e-05
antiviral t cell,1.144513864273387e-05
p100 transcriptional co-activator protein,1.1441695725847405e-05
hcov229e nsp13,1.1430699605452608e-05
clinically_x,1.142440458740672e-05
disulfide-bonded form,1.1420981250632485e-05
modified intracellular membranes,1.141890989835644e-05
peak levels,1.1403008683774136e-05
perished animals,1.1388614090513971e-05
aromatic substituent,1.1385967278183723e-05
animal origins,1.1383744244085982e-05
exposure of,1.1380920321334118e-05
combat,1.1378819879437042e-05
amino-terminal peptide,1.1373983276080745e-05
genetic marker sequence analysis,1.1369511959999943e-05
coimmunoprecipitation,1.1367591966259416e-05
rbd-specific antibody,1.1353162726294616e-05
rat small intestine epithelial cells,1.1346394702084323e-05
next generation matrix,1.1345201772858743e-05
wildtype deubiquitinase,1.1344689776431724e-05
parent virus,1.1337736278058064e-05
medical students,1.1337218444479253e-05
val42,1.13284832729267e-05
cellular development,1.130393551961987e-05
receptor-binding specificity,1.1298443576959803e-05
igg1,1.1295645812224024e-05
rabbit antisera,1.1290231610639346e-05
lethal virus,1.129005876173318e-05
rna binding assays,1.1285023461932492e-05
colocalized,1.1277866668229184e-05
surface plasmon resonance analysis,1.1271786965662464e-05
charged residue r227,1.1271675849644112e-05
mtase activity,1.1265415037017735e-05
rnadependent rna polymerases,1.1260792862886946e-05
quebec enteropathogenic bcv,1.1248893011247016e-05
gicovoh3 spike gene,1.1246063501709127e-05
27 coronavirus genome sequences,1.1239323402824166e-05
alphacoronavirus alphacov,1.1231566997482675e-05
enzymatic collaboration,1.1221152121033223e-05
breeding facility,1.121700336654069e-05
selective agent,1.1215082917531485e-05
construction,1.1215082917531448e-05
conserved core sequence cs,1.1213570234592399e-05
viral protein behavior,1.120079450916492e-05
ibv beaudette strain,1.119595969804961e-05
nterminal hydrophobic signal sequence,1.1187248398475806e-05
giraffes,1.1184506004397828e-05
rnabinding protein,1.1179280811103355e-05
sdspage,1.1177353888279935e-05
pups coronavirus,1.1176642423838413e-05
fp5,1.115912936617491e-05
sme inhibitor 15h enzyme ic50  056,1.1144929399122821e-05
searching,1.1136260260283378e-05
small airways,1.1135534087344714e-05
ibvinfected cells fractionation,1.1125697704294085e-05
assayed,1.1122517941317969e-05
calicivirus infection,1.1121897443848616e-05
ace2 amino acids 697 to 716,1.111557499958226e-05
interferon-inducible transmembrane (ifitm),1.1108132182917956e-05
ligating,1.1105428418464861e-05
extracellular signalrelated kinase,1.1103467783935411e-05
short amino-terminal ectodomain,1.1102411455037513e-05
p4a suppressing,1.1092805932318793e-05
functional studies,1.1067474117649906e-05
papain-like protease (plpro) domain,1.1066857247716943e-05
rna stemloop structure,1.1063991361128585e-05
extension,1.1063678777836451e-05
immune neutralization,1.1056389256946628e-05
caspasedependent pathway,1.104777586474494e-05
relative affinity assay,1.1041642035690622e-05
transmembrane protease serine type 2,1.1028634887600738e-05
antiviral drug screening,1.1024703423561034e-05
spleen cells,1.1017589973357717e-05
intestinal enterocytes,1.1015794345724389e-05
standard donation criteria,1.1015573865977643e-05
infected langerhans cells,1.1014540321275447e-05
nsp1-mediated translational shutoff,1.1014477157611342e-05
singlestranded positivesense rna,1.1005843762550642e-05
open reading frame 1a (orf1a) rna transcripts,1.0998673212269431e-05
crcov 4180,1.0962494142768427e-05
amino acid deletion aspattic acid,1.0942992811192854e-05
stimulates,1.0927317537819507e-05
rna splicing membrane,1.0919579025330387e-05
risk assessments,1.0915277897746786e-05
surface desinfection,1.0912481866874193e-05
cov plpros,1.0906872632497358e-05
haemagglutinin,1.090415441696971e-05
m protein recognition,1.0902890109948767e-05
foxp3cd4 t cells,1.0891430287981716e-05
amino acid synthetic polypeptide,1.0891430287981716e-05
c-terminal domain-truncated enzyme,1.0876993213873727e-05
restriction activity,1.0862116955735795e-05
picornaviral 3clike protease,1.0858884993152143e-05
data safety,1.0856703300658407e-05
il-11-induced stat 3,1.0849153550447807e-05
genetic inconsistency,1.0828095825368176e-05
likelihood phylogeny,1.0822161346925145e-05
tripartite motif protein 25,1.0816558296829368e-05
mutant mceacam1a,1.0806121437442775e-05
hrt18 cells bcvhrt18,1.0804835913930308e-05
tumor cell growth inhibitor,1.0803322574617872e-05
thr487,1.0799709476141434e-05
apical cell membrane,1.0787625042374573e-05
reservoir-people,1.0783597255976108e-05
alphacoronavirus,1.0783486450206562e-05
s1n330 receptor-binding site (s1n330-iii),1.0778922133213678e-05
cell cycle progression,1.0775755767718167e-05
m gene,1.0761853356789392e-05
veterinary medical teaching hospital,1.0753459553522974e-05
sialic aciddependent binding,1.0747541687838946e-05
leaderless genomic rna,1.0738222836527579e-05
fcov nsp8 like its sarscov counterpart,1.0721193414215844e-05
coronaviruses hku4,1.0719814867114479e-05
autophagosomes,1.0714566236363903e-05
dromedaryalhasakfuhku19d2013,1.0701551862457523e-05
primary susceptible cells,1.0697473676888524e-05
cov lineages,1.0681379498739384e-05
receptor-destroying enzyme of influenza c virus,1.067359395673531e-05
ribonucleoprotein (rnp) structure,1.0673029523412717e-05
dromedary merscov strains,1.0671711864067573e-05
circulating_x,1.0657634193520736e-05
replication-competent mvvac2-mers-s(h,1.0644757177273797e-05
intravacuolar,1.0638907398388923e-05
preclinical screening,1.0635275030164784e-05
reproductive number,1.0623780939546721e-05
nakatpase,1.0616169302323616e-05
endoplasmic reticulumgolgi,1.0597940729668843e-05
cellular unfolded protein,1.0596186703340117e-05
ubl domain residues 785 to 787,1.0596138327133004e-05
sars-coronavirus genotypes,1.058366084999423e-05
s1 protein mod4fepi4r,1.0581248633285282e-05
heterodimerizations,1.0574983940094792e-05
hippocampal neuron cultures,1.057485451348837e-05
structural similarities,1.0570622318612007e-05
nxtag respiratory pathogen panel multiplex assay,1.0552866842051147e-05
multiple proteins,1.0548501903090072e-05
aldehyde warhead,1.0545950255158831e-05
dipeptidyl peptidase 4 receptor,1.0544662372552084e-05
cross-neutralizing activity,1.0537056197183077e-05
expectorated sputum,1.0528938191489005e-05
alpha and beta t cell receptors,1.0521107256200765e-05
c-terminal 209 amino-acid region,1.0511921426588841e-05
e6 cells_y,1.0504711994605412e-05
viral positive,1.0500655546068451e-05
cv challenge,1.049907936513593e-05
"recombinant ibv expressing proteins 8a, 8b and 8ab",1.0491808837386867e-05
human coronaviruses hcovs,1.047651422821748e-05
carcinoembryonic antigen cell adhesion molecule 1a,1.0474049675458742e-05
galt lymphoid tissues,1.0462094876021743e-05
hn99,1.0459890453040694e-05
canine coronavirus (ccv),1.0457429233480009e-05
orf 7b deletion,1.0450322620174502e-05
tonsils spleen,1.0429583809696673e-05
101007s1225001637424,1.0420346963085661e-05
mers-cov pseudoviruses,1.0415471112412678e-05
deubiquitinating enzyme inhibitor ubiquitin aldehyde,1.0414670705982724e-05
fecal specimens,1.0399298961729052e-05
sarscovinfected vero e6 cells protein 3a,1.039582103585891e-05
cation channel,1.037197087971954e-05
prototype_x,1.0371511948240586e-05
ccov-iib strains co-circulate,1.036576722387889e-05
protein evolution,1.0365470517223324e-05
positivity rate,1.0347672654298324e-05
immediateearly reaction,1.0328560475041939e-05
damageassociated,1.0328542801892613e-05
"fas, fas-associated death domain",1.030764368893461e-05
mhva59 spike glycoproteins,1.0307086201214393e-05
antigenic domain d,1.0291850127437447e-05
redistribution,1.0284207577684291e-05
porcine respiratory coronavirus prcv induces,1.0274979824361646e-05
virulence coronaviruses,1.0274054653500022e-05
alphacoronavirus porcine transmissible gastroenteritis,1.0270328241939024e-05
enteric coronavirus fecv,1.0245049835348558e-05
temperature-sensitive mutant,1.0240589200460677e-05
enzymatic cleavage,1.0212195370688108e-05
resistant_x,1.0210968047480302e-05
amino acids 1,1.02099088347239e-05
foamy faeces light brownyellow,1.0208281537715636e-05
ccv isolates,1.0197946952072251e-05
rna replication phylogenetic analysis,1.0191673411105556e-05
diarrhea-recovered calves,1.0185321965453428e-05
chimeric construct,1.0183732183904449e-05
nterminal region,1.0182240249535425e-05
nucleotide positions 4330 and 9230,1.0169661552205395e-05
gep ii,1.0169515231424437e-05
nterminal epitope,1.0159028864003402e-05
orf1a fragment 940 nucleotides,1.015553150326609e-05
sars-cov membrane protein,1.0149514290920642e-05
angiotensinconverting enzyme 2 ace2 receptor,1.014194266903899e-05
mrna levels ams,1.0119415445406081e-05
cov budding site,1.0112992420249116e-05
deleted,1.0109976178498478e-05
cov infection cycle,1.0095986250177735e-05
gross,1.0087925707753453e-05
doi:10.1186/s13550,1.0067324961349393e-05
reverse transcription-pcr-hybridization assay,1.0066468695990806e-05
highestaffinity antibody fragment,1.006615496371405e-05
serotonin antagonist,1.0055742009357994e-05
discontinuous sucrose,1.0051475921775731e-05
coronavirus n protein inhibitor,1.0050340497854478e-05
tandem affinity purification system,1.0048332489374277e-05
balanced control,1.0042997226980563e-05
clinical treatment,1.0027628926084027e-05
eonycteris bats,1.0008349129161165e-05
src kinase inhibitors,1.000713859622598e-05
sarscov replicon,1.0006310342648285e-05
endosomal acidification,9.996904772914905e-06
hcov-229e,9.994865460707982e-06
angiotensinconverting enzyme 2 ace2 ace2,9.992415681901354e-06
transcriptionpcrs,9.982649746742348e-06
cellular signaling pathways,9.976828618152572e-06
cattle,9.974565480053045e-06
physical fence,9.962721368410763e-06
real time reverse transcriptase polymerase chain reaction,9.962107729853621e-06
type i alphabeta interferon ifn system,9.961559976119424e-06
antigenspecificity,9.955216300511014e-06
protein oligomerization,9.953626840088638e-06
balbc mouse lung,9.946940861529937e-06
secondary infection,9.946496240655031e-06
orf4bencoded accessory protein p4b,9.94471639745838e-06
quercetin,9.933870059434577e-06
animal cells,9.928013936657508e-06
mink lung epithelial cells,9.9129193786808e-06
glycoprotein vaccine,9.912867651790573e-06
regions of sequence,9.907836541709815e-06
doi101038nature02145,9.904907264721066e-06
adapter protein,9.903859442176408e-06
clustered,9.895716028586662e-06
intrinsic disorder,9.893033220042622e-06
diluted antibodies,9.88697183257019e-06
mersma,9.876660573117924e-06
modular organization,9.87585498904142e-06
cellular akt prosurvival pathway,9.863873201138737e-06
multidisciplinary global mers-cov response group,9.860221412620767e-06
seasonal patterns,9.859288919749661e-06
ccv,9.842550017083605e-06
virological findings,9.837374297862462e-06
g1 cyclins cyclins d1,9.826860073010296e-06
vw572,9.823086172520436e-06
mitochondrial aconitase,9.822235718974291e-06
enzootic covs,9.81856024058139e-06
positivestranded rna species,9.81630137782046e-06
linear,9.813395214285214e-06
human merscov receptor,9.810720505481498e-06
background_x,9.808482711426152e-06
caco-2 and n2a cells,9.80686580046125e-06
80s initiation complex,9.804513408032767e-06
viral rnadependent rna polymerase,9.800078783048239e-06
8.8kda,9.787720911732027e-06
pefp core amino acid sequence,9.784318155989308e-06
prrsvprcv dualinfected pigs,9.781860649957733e-06
peribronchial lymph node,9.772268257282018e-06
myeloid,9.752998801592705e-06
coronavirus nucleoproteins,9.749138235207689e-06
activated t and b lymphocytes expressing cxc,9.739479299321106e-06
exposure rates,9.734217167562987e-06
http://thr.cit.nih.gov/molbio/hla_bind/,9.727754075359237e-06
older camels,9.725479916652626e-06
pro-survival myeloid cell,9.714996615105074e-06
temporal progression,9.713986655297926e-06
antibodybased immunotherapy,9.71148514280874e-06
laboratory confirmation,9.711281264958282e-06
hostdetermining spike protein,9.702899570640434e-06
local mucosal antibodies,9.6900706495759e-06
rna secondary structure,9.678739786524113e-06
compensatory mutations,9.678637467832748e-06
real-time rt-pcr kit,9.677828490467346e-06
predicted polypeptide products,9.668438412332272e-06
nosocomial settings,9.66458609056613e-06
pro-apoptotic function,9.66418393835856e-06
nsp3 construct,9.64929426420374e-06
virus transcription,9.642635025278787e-06
coronaviridae families,9.628590326155846e-06
urea,9.62004455772342e-06
nidovirus,9.620044557723408e-06
technical hindrances,9.603858172940082e-06
nonstructural protein 14,9.594280362534319e-06
packed cell,9.592001419849885e-06
intramolecular networks,9.582107863560329e-06
global scale,9.581975485873517e-06
epitope mapping study,9.574590616116783e-06
nasopharyngeal aspirate specimens,9.57050722748492e-06
astrocytes demyelination,9.564935542195879e-06
adjacent cells,9.5420960783247e-06
immunopathological disease,9.54105269405002e-06
infectious peritonitis virus tsfipv,9.535953259141873e-06
human respiratory virus pathogens,9.529366293577477e-06
enzymatic functions,9.510570252277669e-06
baculovirusinsect cell,9.493657169272622e-06
protein complex,9.491340595967672e-06
np331 residues,9.481503792208498e-06
mers response task force,9.469487524220345e-06
po,9.468386163726445e-06
mannose-rich-type oligosaccharide,9.467608577845488e-06
highly selective monoclonal antibodies,9.465861062245368e-06
a59 genome,9.461449222245512e-06
j774a.1 macrophage cell line,9.448550208814546e-06
laboratory capacity,9.448190076152292e-06
respiratory faecal,9.442656428997183e-06
host genetic variant,9.435023749460015e-06
porcine kidney epithelial line pk15,9.428919457289235e-06
mrna capping,9.428207949657341e-06
non-structural protein genes,9.417563665497981e-06
subgenomic mrna,9.415351302453262e-06
human and nonhuman primate origin,9.401929072915879e-06
i.m,9.378615182566796e-06
real-time reverse transcription-polymerase chain reaction,9.366314628144088e-06
nonessential upstream genes 4 and 5a,9.356504475905279e-06
mers-cov replication cycle,9.355957356150384e-06
flanking nonstructural protein,9.352388306956235e-06
autophagosome membranes,9.350116926922866e-06
turkey flocks,9.344363811579215e-06
s1 recombinant proteins,9.338324036002436e-06
hku9 robatcov,9.32849651454041e-06
virus btcovbm4831bulgaria2008,9.308463406302907e-06
plusstranded rna viruses,9.30505730363642e-06
cellular protein response,9.290023882365172e-06
open reading frame9b orf9b,9.286738842120552e-06
mers-coronavirus,9.284538413439705e-06
immune whey,9.280730802216291e-06
readilyavailable,9.273084671660246e-06
tissue tropisms,9.234646300514192e-06
cysteine residues,9.228495776650858e-06
internal aug initiation codon,9.218300681030486e-06
coronavirus nucleocapsid antigens,9.214716314029856e-06
treebuilding methods,9.202115015066967e-06
rnadependent rna polymerase helicase,9.198461056299437e-06
n putative spacer regions,9.19793124826518e-06
delta value,9.187367589253226e-06
nl63 y 229e pacientes y,9.18518367758411e-06
pregnancy status,9.176006653812661e-06
zoonotic coronaviruses sarscov,9.174678722513746e-06
genetic divergence,9.17289309432011e-06
oligo,9.169196514332134e-06
octapeptide interface inhibitor,9.169026250682056e-06
age group,9.164316705363524e-06
hcovs respiratory infection,9.149498900008684e-06
reservoir_x,9.144032292652646e-06
non-structural protein products,9.139373247725508e-06
sars-cov neutralizing antibodies,9.135316560140299e-06
sars-like coronavirus (sl-cov),9.111062600170249e-06
conserved genes,9.10917556273513e-06
ccl2 tg mice,9.109096061320841e-06
feline porcine murine chicken,9.107368480684114e-06
[3h]leucine-labelled ibv-beaudette membrane (m),9.102598469818208e-06
therapeutics_x,9.086677498477867e-06
cap0 rna recognition,9.08033503445031e-06
dual luciferase reporter assays,9.076426316103681e-06
healthcare facility,9.072642667565234e-06
proteinase k protection assay,9.067780421425038e-06
runx1b transcriptional activity,9.064541019110237e-06
canine enteric coronavirus,9.061671100190288e-06
trypsindependent,9.043549769009539e-06
zoonotic origins,9.040764979409175e-06
host galectin,9.040073824293543e-06
mouse hepatitis coronavirus,9.030696134660333e-06
nosocomial transmission,9.00679746735672e-06
coronavirus sgmrnas,9.000122176454753e-06
antemortem confirmatory test,8.99921088440221e-06
sarscov receptor angiotensinconverting enzyme 2 ace2,8.974974379526468e-06
deficient,8.948818231114263e-06
hr1,8.940532530943178e-06
hydrophobic arylmethyl substituent,8.93741568108746e-06
coronavirus genotypes,8.921700448915058e-06
heterologous integral membrane protein,8.915796386893425e-06
data surveyed,8.912228632569205e-06
peripheral,8.902911686490084e-06
rna-binding controls,8.894808347664602e-06
helacd26 cells,8.886130417142003e-06
virusinduced cell fusion,8.880770792842577e-06
early times,8.88003376753366e-06
coronavirus virions,8.86943370368435e-06
sarscoronavirus beneath vero e6 cells,8.868189072047543e-06
sars virus nucleocapsid protein,8.862014126293655e-06
european communitys,8.859245965987479e-06
hcov229e fusion core,8.844813713673423e-06
pro and antiviral host factors,8.83783755974292e-06
chronic demyelinating encephalomyelitides,8.832791194744482e-06
disulfidelinked regions,8.814255924607355e-06
enterocytes,8.809446721501082e-06
chinese ibv,8.802027864827041e-06
antigenspecific t cells,8.795936074010244e-06
alanine substitution mutations,8.783460471741717e-06
coronavirus cns,8.77834190503327e-06
diagnostic test,8.776505826039317e-06
adaptor proteins myd88 tirap,8.775910997938847e-06
sarscoronavirus sarscov testing,8.766885955652142e-06
direction,8.761631546678385e-06
coronavirusinfected cells,8.761023271032258e-06
pharyngeal swabs,8.757968799465939e-06
intraleader open reading frame,8.746390768363155e-06
prevention methods,8.736130082621082e-06
memory cd8 t cell,8.72997651119277e-06
bronchial epithelial cell line 16hbe,8.723323533575711e-06
ciliated epithelial cells,8.706396163947678e-06
french guinea fowl virus,8.696651666756618e-06
nonderepressible2 kinase gcn2,8.689858441168718e-06
immune miniswine lymphocytes,8.682996054581255e-06
affected_x,8.680512663798544e-06
virusbinding hotspot,8.666301212047381e-06
histidine residue,8.646826214557694e-06
multi-disciplinary intensive care team,8.621662957786915e-06
septic shock merscov,8.616584938430776e-06
clusters genotype,8.61512022765756e-06
porcine kidney cells,8.614859926936703e-06
ungrouped species,8.61351733614516e-06
virus replication cycle recombination,8.61331526346396e-06
drug_x,8.613125111049517e-06
codon-optimized sars-cov spike protein,8.613025679813211e-06
protein complex assembly,8.608081489079862e-06
mirror,8.590968481473487e-06
pkr-like er protein kinase,8.568649073199088e-06
miniopterus bat coronavirus,8.566140398715578e-06
d2 of nsp5,8.566124065884775e-06
copathogens p  65,8.543812066847663e-06
reciprocal coimmunoprecipitation,8.540429651445635e-06
residues k45 d129 k169,8.539475458637805e-06
sequence divergence,8.537072961009572e-06
fibroblastlike cell line,8.536257482619985e-06
enzymes exoribonuclease endoribonuclease,8.53187242744607e-06
chinese medicinal herbs,8.52955951156152e-06
nsp1mt protein sarscovmt,8.522530956685776e-06
microdomains,8.516377644925522e-06
antiidiotypic internal image monoclonal antibodies,8.515436941234558e-06
epidemiologically-linked household contacts,8.512983721835035e-06
emc and amibara s proteins,8.511302593213495e-06
coronavirus membrane m protein carboxy tail,8.510101087158255e-06
hr1 region np1 cp1,8.50851733232379e-06
nasalfecal prcv,8.508517332323776e-06
proteolytically,8.506152986315029e-06
shelter environment,8.497517590030535e-06
inflammatory monocyte macrophages,8.488931828231829e-06
c2,8.485933029797177e-06
reverse-transcribed-polymerase,8.47583615136899e-06
interferon therapy,8.475138627386064e-06
realtime reverse transcription polymerase chain reaction rtpcr,8.47513862738603e-06
punctate perinuclear sites,8.463984312390456e-06
nonoverlappig antigenic domains,8.463011737195625e-06
autologous,8.458366838446644e-06
legionella pneumophila,8.451127688863588e-06
swine testicle,8.433351315163408e-06
virusspecific iga antibody,8.433330277592358e-06
instability,8.426742957091372e-06
public health infrastructure,8.416955986684861e-06
dna plasmids,8.416059257153199e-06
group b monoclonal antibodies mabs,8.412266752962553e-06
human rectal tumor hrt18 cell line,8.409185617544352e-06
sars-cov proteins,8.408015408053266e-06
cross-reactive antibodies,8.401510519155816e-06
carbohydrate chains,8.384258858439344e-06
single genomes,8.37956855078503e-06
transmission electron microscopic tem studies,8.364618461169894e-06
lymph nodespecific,8.352707008068073e-06
mhv gene 1 product,8.352583279672575e-06
bovine coronavirus bcov strains,8.351187797060202e-06
ace2 mrna,8.349533573446815e-06
newborn mice,8.346943021474054e-06
face,8.343307026017587e-06
human astrocytic cell,8.33588231781818e-06
mouse hepatitis virus mhv strains,8.32257867842535e-06
1step rtpcr and nested pcr assays,8.322482184540965e-06
species barrier,8.308020652681126e-06
technical problems,8.2969656297955e-06
protective local,8.295486558700032e-06
human aminopeptidase n,8.28191769454252e-06
infectious respiratory disease,8.281730079011055e-06
uninfected population,8.280875602976875e-06
human angiotensin converting enzyme 2,8.278483644014807e-06
alecto,8.275317784500572e-06
tgevimmune pigs,8.271973511363203e-06
fibrillaringreen fluorescent protein fusion protein,8.265661240828185e-06
response elementresponsive firefly luciferase,8.250350889780452e-06
secreted cxcl2 protein,8.246718506065551e-06
ubiquitinlike domain,8.23592321168302e-06
trimer of dimers,8.231802947486727e-06
differential testing,8.228350077060175e-06
authentic sarscov infection,8.221595136698218e-06
low plasma albumin,8.213916686009668e-06
multiplex realtime pcr assays,8.192530788564997e-06
hepatitis c virus hcv helicase,8.19178505248193e-06
scissile amide bond of,8.188472666932536e-06
scv,8.183183934716529e-06
membrane-associated papain-like protease plp2,8.18159808798592e-06
review_x,8.180980792434407e-06
human dpp4 virus binding site adenosine deaminase ada,8.164453558510311e-06
thr378 and ser379 sites,8.164398439063337e-06
lactococcus lactis,8.161002379282552e-06
coronavirus e proteins,8.160655272589683e-06
glyceroltartrate gradients,8.156588230055256e-06
ifit family,8.153242118950118e-06
pepscan analysis,8.144059593408201e-06
coronaviruses sarsrcovs,8.126574149754617e-06
active dimer structure,8.099782107106087e-06
cauliflower mosaic virus 35s,8.096911110545278e-06
genomewide sirna,8.095246020240998e-06
sequence insertion,8.093234101345776e-06
postfusion paramyxoviruses f proteins,8.081619035897508e-06
rbds,8.080752731343731e-06
multiple classifiers,8.079229527143985e-06
inflammatory response,8.057724357012884e-06
autopsy,8.051542527262438e-06
hcov-oc43 np of betacoronavirus,8.04094704339925e-06
lactogenic immunity,8.036620957586871e-06
hrn,8.035166248132441e-06
lethal infections,8.025382277973632e-06
lethal models,8.020262723497925e-06
papain-like coronavirus cysteine proteases,8.01993203473418e-06
absolute,8.018821105135721e-06
acute respiratory syndrome sars coronavirus nonstructural protein 1,8.010523768332328e-06
escherichia coli maltosebinding protein mbp,8.005677285017668e-06
hig,8.000483532225708e-06
sialic acids 9oacsias,7.98740300955229e-06
sarscov batsarscov,7.963865122980672e-06
ergolgi intermediate compartment,7.960775103814513e-06
circulating human coronaviruses,7.957136608482009e-06
sarsrcov strains,7.95627463764745e-06
maternal antibody,7.954337217359563e-06
hcov229e virus,7.95078704446111e-06
environmental factors,7.945097961862883e-06
coronavirus merscov nonstructural protein 16 nsp16,7.92873233470857e-06
protein orf5,7.9283751295445e-06
endosomal acid,7.92093006960334e-06
chimera,7.906265745265608e-06
th1-related cytokines,7.901637177284528e-06
viral virulence factor,7.900296751076322e-06
eif4e phosphorylation mapkinteracting kinase 1,7.893748987232263e-06
hind,7.883903888309121e-06
metalloprotease adamfamily,7.882115879814638e-06
synthetic oligonucleotide,7.876617597584431e-06
n5,7.875914123588875e-06
descriptive statistical analyses,7.875635343907307e-06
evolutionary origins,7.871958086547111e-06
diagnose,7.86433754356733e-06
recombinantdirected expression products,7.856432526939995e-06
full-length misg15 protein,7.8561730842139e-06
nonrecipients protection,7.855747463904479e-06
hcovnl63 plp,7.854620338204486e-06
evolution_x,7.848259379106155e-06
nephropathogenic tl/ch/ldt3/03 strain,7.848149215845604e-06
multifunctional,7.845448290423224e-06
pulmonary infiltration,7.834382580762277e-06
mild upper respiratory symptoms,7.830755356851733e-06
propensity,7.81239367764253e-06
sars cov nucleocapsid antigen,7.8112748792588e-06
cterminal antigenic sites,7.809658559348143e-06
ptb cytoplasmic,7.798895702765139e-06
cell source,7.787576240917557e-06
block coronavirus infection,7.787576240917557e-06
homologous prime,7.7686875547567e-06
neurontoneuron spread,7.766201337994731e-06
recombinant spike polypeptide,7.765777144600564e-06
s510,7.765084503699392e-06
accessory genes 3a 3b 5a,7.746705092707368e-06
class i viral fusion protein,7.736509558967775e-06
unpasteurized,7.731891895420064e-06
virus neutralization tests,7.730350085790395e-06
actin reorganization,7.727285018266329e-06
anti-mers-cov mabs,7.726968097792708e-06
recombinant adenovirus serotype 5,7.719792631374312e-06
seabird species,7.717225169336323e-06
palm civet,7.714078197243846e-06
lyra11,7.70981347429418e-06
chimeric mhv4mhva59 spike glycoproteins,7.70086414056627e-06
whole-genome expression profiling,7.699071570723798e-06
oligosaccharideoligonucleotide foldlike,7.693581420120564e-06
aspartic-acid side-chains,7.692618795510031e-06
proventiculitisassociated,7.680061740184697e-06
lymphopenia 16 34 interpretation disease,7.677877562734414e-06
postfusion conformation,7.667233385011534e-06
coronavirus hku1 cov hku1,7.666989867577885e-06
sars coronavirus replicase products,7.65147314281897e-06
endoplasmic reticulum rergolgi retention,7.646801465676775e-06
coronavirus specific antibodies,7.645565602094803e-06
cluster 2,7.63085001450206e-06
destabilize,7.629260525795149e-06
mature protein product p65,7.6287935694139725e-06
stages,7.620319431270465e-06
antigenically,7.61906442521031e-06
coronavirusinduced,7.607180732693699e-06
cultured neural cells,7.587388279252014e-06
17 homogeneous amino acid residues,7.583319866637233e-06
virusinduced ifn,7.579322375395353e-06
replicative polyproteins,7.575997388870965e-06
locally,7.54313556583135e-06
trimeric membrane-fusion s2 stalk,7.5339375896513385e-06
merscov 4a accessory protein,7.532247920235456e-06
clinical fip tgev,7.513888717311253e-06
virusinfected mice,7.5135789965644e-06
avian gamma-coronaviruses,7.504777723654129e-06
carbohydrate modifications,7.499827241883489e-06
camel sequences,7.499342403668544e-06
coronavirus merscov antigen,7.497584677798135e-06
fusioninducing s2 subunits,7.497405195485352e-06
monkeys,7.495086269539489e-06
realtime quantitative reverse transcriptase pcr,7.484636461801935e-06
ion channel inhibitor,7.480288301805919e-06
neurotropic human coronaviruses,7.479786692105419e-06
rat coronavirus sialodacryoadenitis virus,7.471855514688808e-06
ccov fluorogenic assay,7.466575324143894e-06
immune mediated disease,7.460417655568343e-06
endoribonuclease nsp15,7.4556662143521346e-06
cp1,7.449852040277291e-06
demyelinating encephalomyelitis,7.4490824767419474e-06
immunologically crossreactive hcvoc43,7.4321058221520734e-06
lung proinflammatory cytokines,7.431428528931124e-06
parainfluenza virus canine adenovirus canine herpesvirus chv,7.43122866334491e-06
hemagglutininesterase precursor group,7.4291019227496205e-06
rnaassociated translating complex,7.428938214109245e-06
recombinant scovn rscovn protein,7.425274072615294e-06
human coronavirus oc43 hcovoc43,7.422380188875286e-06
surveillance approaches,7.420864244987435e-06
ezrin dominant negative ferm domain,7.419540666076357e-06
imperfect,7.418467737328161e-06
immune cell migration,7.412330890514703e-06
antigen-capture elisa,7.407527081740204e-06
real-time reverse transcription pcr,7.400901223392151e-06
bayesian coalescent inference,7.394618457496011e-06
16 protein domains,7.391844025776647e-06
canine viral enteritis,7.391421405914454e-06
2 functional domains,7.385841093284472e-06
conformational flexibility,7.381987923708516e-06
lymphoproliferation assay,7.37838224183743e-06
first 20 n-terminal residues,7.370881679388072e-06
procoagulation,7.3696307684326385e-06
antinucleocaspid antibodies,7.363529114586993e-06
cellular fractionation analyses immunofluorescence microscopy,7.363328934152458e-06
sars covinfected cells,7.360544049611048e-06
nsp13,7.3584601479038065e-06
sars-cov spike s2 sequence,7.357811141800041e-06
auginitiated uorf,7.356639262360531e-06
breathing dysfunction,7.347741117381804e-06
escherichia coliexpressed denatured spike,7.345141169457702e-06
cov rdrp nucleotide,7.337564641337663e-06
immunomodulating respiratory,7.337076421209097e-06
mycophenolic acid mpa,7.33443148789097e-06
sirnamediated,7.334314956071113e-06
gfcov,7.3328390114756264e-06
population_x,7.328448205188364e-06
cellular defense,7.3258763325087624e-06
7b,7.31680271804001e-06
dna complemented palindrome,7.3127872777142775e-06
major hcovoc43 orfs,7.301281237792315e-06
brsv-,7.288319180533071e-06
chronic carriers,7.286489234075408e-06
genome sequence 30738 nucleotides,7.284520310839599e-06
mucosal immune responses,7.276366310298896e-06
monocyte-derived infiltrating macrophages,7.275972345729441e-06
entry-efficient s gene template,7.260953525321131e-06
receiver operating characteristics,7.256314369976938e-06
anticxcl10 neutralizing antibody,7.247191251594066e-06
alpha,7.240351711633834e-06
sarscov nucleocapsid protein antibody,7.222935886214495e-06
folded properly trimerized,7.219375278677312e-06
c-terminal s2 subunit,7.205527846728221e-06
coronaviruses cv,7.205259625874869e-06
right-hand fold,7.20297763582961e-06
protective functions,7.196955572503527e-06
allelic discrimination approach,7.1875113087432885e-06
no symptoms,7.186029487753729e-06
kinase inhibitor,7.184946604514721e-06
ubiquitously expressed protease,7.172776609226922e-06
transcriptional initiation sequence ucuaaacu,7.171854551459513e-06
orf6,7.16844392417669e-06
phase of,7.161380394366396e-06
chromosome associated proteins,7.161248538246314e-06
anticov drug design,7.153898652338851e-06
anti-viral medication,7.1514060223007635e-06
alveolar epithelial type ii cells,7.145634768941698e-06
review precautions,7.140948244451319e-06
ancestral origins,7.14087708187217e-06
phylogeographic studies,7.137014701298373e-06
reinfections,7.13217239023544e-06
evolutionary change,7.126792295450643e-06
human angiotensin converting enzyme ii,7.123444499790731e-06
genetic determinant,7.11819077581176e-06
competition assays,7.115353015608527e-06
tripartite motif protein 56,7.109303316204333e-06
nuclear export signal (nes),7.104032904164956e-06
key structural elements,7.102762294809418e-06
constitutively,7.096570011663961e-06
modified_x,7.0944957893459286e-06
comparisons,7.0861425571142714e-06
lipopolysaccharide-primed macrophages,7.0831138439020955e-06
laboratory-confirmed 2019-ncov infection,7.0723570983368864e-06
m(pro)-inhibitor complexes,7.061633534125114e-06
autophagic vacuoles antibodies,7.059337339733935e-06
internal control mrna nd5,7.058964944498493e-06
lower cycle,7.058736268492253e-06
human mers-covs,7.055735545543267e-06
confirmatory western blotting test,7.054920895451362e-06
co-infection,7.052992783930087e-06
alphacoronavirus s1ctds,7.0507733196836214e-06
longdistance communication pathways,7.049688559256704e-06
experimentally test,7.046938423100067e-06
hcov229e seropositive,7.045392041649965e-06
cytochalasin d,7.0441327295056665e-06
antigenic similarity,7.031034225976143e-06
virus rna andor antigen,7.0171243507982275e-06
pleiotropic effects,7.014843678196865e-06
non-synonymous mutations,7.012452366804324e-06
piglets,7.00920829729074e-06
dental students,7.0009944052926e-06
rhesus,6.9824876002805995e-06
spike polypeptidebased western blot assay,6.97055792381059e-06
httpdxdoiorg101371journalppat1002294  ,6.952046091846507e-06
dpi,6.949099206382707e-06
hotel m contact isolates,6.943458272286648e-06
sp4,6.934310674459993e-06
rad/spike administration,6.930915990618463e-06
hepatic dysfunction,6.927297191403547e-06
korea 259  ,6.926736558964094e-06
site-directed mutagenesis,6.921527548448929e-06
influenza-like illness,6.91257111434202e-06
hepatitis b virus,6.906698656827119e-06
wildtype jhm spike protein rjhm,6.904684345650335e-06
immunostaining virus rna andor antigen,6.896543013690048e-06
dna characterization,6.893453806512504e-06
sarscovinfected and transfected cells,6.884918432114958e-06
central hydrophobic cavity,6.879654954432807e-06
acute middle east respiratory syndrome coronavirus,6.879357902789122e-06
cholesterolrich microdomains,6.864893525549419e-06
p38 mapkdependent,6.858418091767874e-06
mv,6.855883206582721e-06
tyr6398hisleu94pro substitutions,6.848540775979961e-06
dromedary camel sera,6.823257201733228e-06
lactam bridge constrained analog,6.811362860762572e-06
acute respiratory syndrome sars coronavirus cov lung disease,6.8072802720508944e-06
sarslike cov,6.7950939486135865e-06
frameshifting product,6.787980054075984e-06
clubshaped type,6.787216275299982e-06
yeast twohybrid system,6.782683811914786e-06
mhvinduced apoptosis,6.746572266967735e-06
porcine enteric alphacoronavirus,6.744345137112845e-06
peptidases,6.743575636014565e-06
dibasic motif,6.735919001709559e-06
peptidylprolyl cistrans isomerase ppiase,6.719220440319923e-06
sspecific monoclonal antibodies mab,6.7190590398645775e-06
redmediated recombination,6.7190105979543696e-06
sds-polyacrylamide,6.70150806078133e-06
3clike nsp5 proteinases,6.700344891298118e-06
unglycosylated,6.699780162100871e-06
cellular carcinoembryonic antigenrelated cell,6.6902340101309075e-06
twentyfour,6.687235812196104e-06
three-stemmed structure,6.6711496414673914e-06
cell surface structure,6.666382385198382e-06
negativestranded genomic rna replication,6.659908418340456e-06
l929 cells,6.6429877457906185e-06
coronavirus sarscov nonstructural protein 14,6.6390866731672136e-06
icsz16s k479n strain,6.63634743926647e-06
moraxella catarrhalis,6.631293907686669e-06
chemokine ligand 2 ccl2 monocyte chemoattractant protein1,6.616849715783056e-06
lung pneumocytes,6.605705627802476e-06
cleavage site_y,6.601992549329464e-06
serotype-specific neutralization epitopes,6.596924688356911e-06
lactic acid bacteria,6.594193544291699e-06
oacetylated sialic acids,6.5887385693464455e-06
viral isolates,6.586578990494776e-06
phagocytic profile,6.572709055749894e-06
genotype,6.569474233750031e-06
peripheral blood mononuclear cell,6.5609951181327875e-06
severe illness,6.555967865660043e-06
16 autoproteolytic cleavage products,6.546011922382219e-06
virus surface,6.536528176326418e-06
wheat germ cell-free protein,6.535080335131965e-06
jhmsd,6.5345927763892524e-06
autophagydeficient,6.523626574954397e-06
detection rate,6.5212980900677095e-06
nsp15 mutant mouse coronaviruses,6.520026640227885e-06
delays,6.508871696213201e-06
natural_x,6.507855175137456e-06
antiviral helicase inhibitors,6.500529504598516e-06
human coronavirus strain,6.498924721595043e-06
haemorrhagic lesions,6.482481799824699e-06
enteroviruses/rhinoviruses,6.4755386902330125e-06
tracheobronchial,6.4713021795771815e-06
fcov membrane (m),6.4625328349406e-06
cov virulence,6.456254348990351e-06
acute sars-cov infection,6.4516576372789686e-06
controlled release,6.451549896464346e-06
difference_y,6.443087975263604e-06
dual enteric,6.442044334028102e-06
translation membrane,6.4411899711589716e-06
s-pseudotyped lentiviral,6.4374901288215885e-06
mers-cov main protease,6.42862310841358e-06
ubiquitin-independent proteasome,6.4279902493144565e-06
subgenomic rna species,6.421985639965449e-06
geographical differences,6.421135639904837e-06
sars-cov-2 pneumonia,6.401850513656761e-06
protein production,6.393910278317358e-06
orf33a,6.390272647526593e-06
characteristics_x,6.382655509948749e-06
balbcbyj mice,6.37839658464496e-06
coronavirus subgenomic mrna sgmrna transcription,6.373755170207735e-06
cell surface protease tmprss2,6.37233455473065e-06
vn antibody,6.37200374798636e-06
positivestranded,6.356301907706417e-06
beaudette full-length cdna,6.3477730467442305e-06
non-intervention,6.345156751980855e-06
virus 27615,6.342101296697076e-06
viral membrane protein,6.341640571248177e-06
translocon subunit,6.330253756651224e-06
cc chemokine ligand 2 ccl2 monocyte chemoattractant protein1,6.326103726991687e-06
syndromecoronavirus sarscov avianorigin influenzas h7n9,6.3251307196750446e-06
bcov rna,6.323593999447107e-06
sars-cov encodes several,6.3096450771762655e-06
bovine coronavirus bcov haemagglutinin esterase surface glycoproteins,6.294457474096668e-06
nucleotide sequence,6.277256602098112e-06
open reading frame orf 1b,6.2733989197623355e-06
highorder rna structures,6.2713602839923015e-06
waning,6.27055368390208e-06
nterminal rnabinding domain rbd residues,6.2596197532412385e-06
tetratricopeptide repeatsbased mechanism nsp16 mutants,6.252862376939226e-06
crystallographic approaches,6.252478726865494e-06
single-stranded rna of mhv,6.249053380414027e-06
gastrointestinal swine,6.2448878636360614e-06
insect cells,6.243934407279076e-06
qualitatively,6.242397361103776e-06
plasma glucose fpg,6.2411604635088134e-06
methylation,6.240879808869091e-06
t cell response,6.236278216095025e-06
spikepseudotyped lentiviral particles sarscovpp macrophages,6.2265462622406775e-06
primary mouse astrocytes,6.22140862522131e-06
doublestranded rna,6.220137810222171e-06
hcovnl63 replicase gene products,6.218895322358939e-06
virus inactivation curves,6.217906574691511e-06
hr2 domains,6.21668426774995e-06
nucleocapsid and orf1a sequences,6.2087935582322635e-06
mean age,6.204844551043443e-06
tracheal,6.194177279024288e-06
serum neutralizing antibodies,6.193959665975529e-06
accessory gene,6.181870663980518e-06
endoribonuclease activity,6.173967869826433e-06
naturallyoccurring viral infection,6.173855842588957e-06
conserved coronavirus proteins,6.171262557795017e-06
cytoplasmic n molecules,6.157503029059897e-06
colon,6.156658350601635e-06
elevated,6.154867577737007e-06
enzyme immunoassay,6.151469078620442e-06
corelike structure,6.143390928319525e-06
partially duplex rna,6.141933894647914e-06
matsuyama j virol 76950958,6.137387194265922e-06
antigenic_x,6.127200743779803e-06
type viral pneumonia,6.116450658203814e-06
envelope e2 glycoprotein,6.114764178730875e-06
rituximab,6.105245023483929e-06
ala 828,6.0966311632057035e-06
hcov229e antibodies,6.089438733155229e-06
north american,6.087421504287469e-06
overlapping rna pseudoknot,6.077512380231284e-06
ards pathophysiology,6.0762024175102045e-06
host-species and 36 coronaviruses,6.075258243505195e-06
lung mononuclear infiltrates,6.072599072766635e-06
recombinant baculovirus-infected insect cells,6.07099741504374e-06
epidemiologic characteristics,6.053856248932567e-06
nucleotide variation,6.052022654331429e-06
receptor aminopeptidase n,6.050068077923329e-06
pcdnam pcdnan,6.035794167637862e-06
stocks,6.024598454796393e-06
mucosal pathogens,6.023257875820254e-06
monocyte/macrophage,6.020505872632594e-06
extraintestinal tissues,6.019147385278171e-06
c terminus of orf6,6.018719607346838e-06
dissection,6.014062374333005e-06
mhv e,6.008891301726028e-06
evolutionary history,6.006629893589839e-06
lymph node cells,5.994307081813337e-06
nsp1nsp2 cleavage site,5.988435655940018e-06
small open reading frames orfs,5.9872659429075684e-06
coronavirus rnas,5.985091996950157e-06
adaptive immunity sarscov,5.982453202737327e-06
hku39849 its reactive epitope,5.974707496428622e-06
direct rna sequencing,5.97302918299359e-06
human rhabdomyosarcoma cell line rd,5.965484670370283e-06
n8,5.965283012666358e-06
age dependent,5.956137108719265e-06
antihcov229e antibody s proteins,5.953923691586414e-06
intestinal_x,5.949382955870907e-06
cell-to-cell,5.947512251081948e-06
hlaa2 healthy,5.946425656489534e-06
lymphoproliferative assays lpa,5.940029019772943e-06
prime-boost vaccination protocol,5.938765641836307e-06
hrn2 anti-serum,5.936787721522463e-06
viral genomic rnas,5.9347946982030265e-06
pdcov spike,5.9250486352103974e-06
oligonucleotides,5.923482553694065e-06
canine parainfluenza virus canine,5.915107182746289e-06
reverse transcriptionpolymerase chain reaction rtpcr,5.912526810375043e-06
lys48-linked ubiquitin chains,5.896532410564308e-06
agrose overlay,5.88925857616974e-06
active process,5.885292282474813e-06
alexa488-qsy7 fret-based peptide,5.868916710531177e-06
interferonstimulated antiviral genes,5.864821886475232e-06
cryoelectron,5.864581213673938e-06
mouse hybridoma antibody,5.864496342515857e-06
nc protein multiple regions,5.858601219951334e-06
bacterial and viral rnadependent rna polymerases,5.850880141561836e-06
"human cov-229e and -nl-63, feline cov",5.8465737429565466e-06
adhesion kinase,5.840813571781196e-06
apical,5.839215792836501e-06
cc t lymphocytes from,5.83037109491042e-06
mutant ubl domain,5.828240627462339e-06
live_x,5.828025141008803e-06
mrna5 and genomic di rna,5.827870361459052e-06
caveolar region,5.819579649585112e-06
prospective survey,5.818550421404769e-06
healthcare providers,5.811443178091277e-06
mhv fipv middle east respiratory syndrome,5.8054902597201975e-06
rmerscov northern blot analyses,5.802506122806911e-06
calves_x,5.800193907097757e-06
repertoire,5.800082328991092e-06
virus neutralisation,5.797789904025819e-06
polymerase chain reaction pcr,5.792890252504849e-06
recombinant a59 virus,5.792878601714313e-06
sputum sample,5.788089510408683e-06
tyrosine residue,5.775210262845902e-06
open reading frame_x,5.7751782900963974e-06
fcov infections,5.77234213834859e-06
multivalently,5.765512395366527e-06
clinical diagnosis,5.764879067114615e-06
amino acids residues,5.760046305138545e-06
coronavirus-based gene delivery vectors,5.755200851909926e-06
pulmonary lymph nodes,5.752198971306608e-06
l2 fibroblasts,5.744327978717688e-06
central players,5.743761396880466e-06
merscov kidney epithelial cells,5.7316779766917475e-06
viral proteins_x,5.7271186615901385e-06
epidemiologists,5.709139935916255e-06
p53mediated antiviral response,5.708537901516496e-06
nucleocapsid surface,5.707105747537455e-06
recombinant mv expressing merss,5.698831100519256e-06
filamentous actin factin,5.680294866264917e-06
merscov dpp4 receptor,5.6667477004845496e-06
random digit dialing,5.649810858142599e-06
human cov 229e,5.647669553357573e-06
amino acid 547,5.6425824703582985e-06
immunodeficiency virus type 1derived reporter virus,5.635184247423278e-06
immune modulation,5.631285252645174e-06
renal tissues,5.629456666728032e-06
galt gut lamina propria lp,5.6186536101688215e-06
endoplasmatic reticulumgolgi intermediate compartment,5.616588991408688e-06
worsening,5.614659676574879e-06
inner-filter effects,5.611216139750372e-06
tm1,5.610576060516628e-06
cys2968his2879 catalytic dyad,5.607809905556957e-06
transcription factor 4 (atf4) mrna,5.605210897243503e-06
irf3 n protein,5.602346826406946e-06
interhuman,5.599454558922109e-06
standardized data collection,5.5972016610868585e-06
restrictions,5.5943230714059375e-06
antisarscov activity,5.589176578618365e-06
polypeptide profiles,5.583871003781774e-06
human kidney cells llcmk2 vero,5.580345813028089e-06
africa methods,5.57711712895638e-06
beagle pups,5.576499949312627e-06
health moh,5.572627052792725e-06
odds,5.568731087434488e-06
u48a,5.56245383494146e-06
345dimethylthiazol2yl53carboxymethoxyphenyl24sulfophenyl2htetrazolium inner salt mts assay,5.551445876160381e-06
ccl2monocyte chemoattractant protein 1,5.543241070237947e-06
ouabain,5.539382523090409e-06
guinea pig,5.5354092757742096e-06
antiviral innate immunity,5.529382265800684e-06
interacted,5.525926533155724e-06
non-immunoglobulin component,5.515328108147893e-06
avian infectious bronchitis virus,5.5060982062568815e-06
bat coronavirus,5.499583765659246e-06
mouse angiotensinconverting enzyme 2 ace2 receptor,5.498385811818502e-06
viral envelope glycoproteins e1,5.489662794838513e-06
cellular unfolded protein response,5.484646543860664e-06
mouse and human ceacam1a proteins,5.481024119903291e-06
recombinant human singlechain variable region fragments,5.476995974447939e-06
homopolymeric rna templates,5.47068215561999e-06
acute tcell lymphopenia,5.4691348975438525e-06
viral rna positive strands,5.4675388729790584e-06
high s1 gene sequence,5.451423755727991e-06
realtime quantitative rtpcr analysis,5.445284711852727e-06
endosome-lysosome fusion,5.440906030140274e-06
human peripheral blood monocyte macrophages,5.435600617286787e-06
homogenizing,5.4163632657121925e-06
peritoneal membranes,5.415192069595985e-06
nodular lesions,5.413475371613957e-06
howard mueller jhm,5.4112705770908295e-06
mouse hepatitis virus genomic rna,5.402216860613882e-06
bone marrow chimera experiments,5.401028739469042e-06
effectiveness,5.3943536986233425e-06
bone abnormalities,5.3914398269831935e-06
vaccine failure,5.388296702053107e-06
multinucleated pneumocytes,5.3852254319976e-06
mers-cov genomic loci,5.3791015587346755e-06
continuous renal replacement therapy,5.3791015587346755e-06
fluorogenic peptide assays,5.373636228802037e-06
membrane m protein mutant e proteins,5.365315520415128e-06
merscov genomes 21,5.358531322427779e-06
gastrointestinal tract specimens,5.356159497975622e-06
breeding,5.346817549946479e-06
nucleocapsid protein-capture,5.346817549946467e-06
counteraction,5.336139071104121e-06
carcinoembryonic antigenrelated cell adhesion molecule 5 ceacam5,5.334301255320952e-06
standard serological method,5.332076883909407e-06
vl chain repertoire,5.327303336120479e-06
therapeutic antibody,5.323587765021528e-06
predicted transmembrane domain,5.3155475795924895e-06
protein heptad repeat,5.311766657896805e-06
rtpcr assays,5.306130288172304e-06
pcd,5.2988824527602405e-06
hand washing,5.296819649890568e-06
projections,5.277933609182683e-06
hospital personnel,5.277853250451217e-06
p089982,5.267059479342994e-06
interferon immune pathways,5.261916368660871e-06
national circulation,5.249879069318484e-06
mhv nsp3,5.249879069318465e-06
coronavirus ribouncleoprotein,5.249831770830449e-06
laboratory cats,5.246358672395899e-06
analytical performance,5.246358672395887e-06
therapeutic agents,5.245222626907956e-06
3'-terminal sequences,5.239487220584419e-06
murine coronavirus mouse_y,5.236215628264074e-06
carboxy-terminal amino-acids,5.214340180676851e-06
coronavirus cov genome,5.2073300718160625e-06
diacidic motifs,5.206904501512906e-06
innovative pcr detection method,5.206338500834009e-06
acute respiratory syndrome coronavirus nsp16 protein,5.205520900697325e-06
potassium sensitive,5.196053258558136e-06
hairpin (h)-type pseudoknots,5.194824061170607e-06
highly conserved core sequence,5.19292741612976e-06
experimental settings,5.1874580475917294e-06
spearmen's coefficient,5.178488882036084e-06
forms_x,5.176565179710084e-06
interferonbeta1a leukocytic interferonalpha,5.176126682868549e-06
hcov-oc43 infections,5.172712941133755e-06
cotransfected cells,5.170940154166847e-06
perinuclear region of mhvinfected cells,5.170086714321008e-06
plasma membrane microdomains,5.164904530778106e-06
murine hepatitis viruses,5.155222254727236e-06
venezuelan equine encephalitis virus replicon particles,5.148307102769122e-06
pandemic threats transmembrane protease serine type 2 tmprss2,5.14688560189786e-06
betacoronavirus infection,5.141846093519766e-06
resolution phase,5.141532849036797e-06
respiratorytype mhvjhm,5.135976843946826e-06
convalescent-phase sars,5.135862279688773e-06
collaborative,5.133747483435869e-06
commercial assay,5.13294484794861e-06
viral restriction factors,5.132071370833405e-06
lethal model,5.13124565113909e-06
recombinant n-terminal domain,5.130851560328293e-06
sarscov s2 subunit,5.12790072268948e-06
health care facility,5.126343775981156e-06
bovine coronavirus bcv genome,5.124597260633659e-06
concentration_x,5.122953865461619e-06
batborne viruses,5.122145669857771e-06
amc,5.097407816957825e-06
coronaviral polyprotein 1a/1ab (pp1a/1ab,5.095803545154276e-06
therapeutic measures,5.094274199919894e-06
immunization_x,5.090290650795243e-06
papain-like proteinase domains,5.08759333536067e-06
latent cellular transcription factor,5.078432004876089e-06
debranching patterns producing monoubiquitin species,5.0783242233223964e-06
central australian,5.07389871293378e-06
pseudotype assay,5.068550717569019e-06
immunoelectrophoresis tests,5.06538697680006e-06
northern italy,5.063544741551635e-06
spike glycoprotein gene,5.059534969866199e-06
nucleocapsid gene realtime rtpcr assay,5.04763431016148e-06
mva-mers-n expressing recombinant n protein,5.045572116768905e-06
vacuolar proton pumpatpase inhibitor,5.0423789468223045e-06
fecal virus,5.037505374930803e-06
feline coronavirus fcov strain fipv,5.0367176712041974e-06
enzymes_x,5.03436265952274e-06
human monoclonal antibody m336,5.023586949984946e-06
spt fusion studies,5.018771076701984e-06
sarscovinduced golgi fragmentation,5.017400930557809e-06
hla-a2.1 positive human peripheral blood mononuclearcytes,5.017235027477804e-06
putative orfs,5.016989757076684e-06
institutional review board,5.0141203813680825e-06
sarscov surface glycoprotein,5.011087800486702e-06
tgev nprotein deletion mutants,5.010611787370375e-06
protein 6mediated nuclear import blocks,5.009773947985409e-06
porcine coronavirus,5.00187615897767e-06
viruscell,4.995918338777212e-06
alpha and beta coronaviruses,4.995185989948026e-06
intranasal doses,4.9923899301220764e-06
lipid electropherograms,4.991985037770532e-06
ph values,4.982297624432499e-06
transmissible gastroenteritis virus infection,4.973248120327516e-06
proteinase digestion test,4.97030982030064e-06
receptorproximal cellsurface,4.969150616725495e-06
brainstem spongiform,4.961064055460166e-06
jhmv infections,4.959613051633302e-06
mers-cov transmission,4.953301955165703e-06
mhva59s chimera,4.952141062578793e-06
substrate-binding loop,4.935351104688274e-06
third transmembrane tm domain,4.934525633732084e-06
paleotropical forest,4.932544250733602e-06
nterminal_y,4.922845863947184e-06
deep branch,4.916428703821365e-06
intercellular spaces,4.911198371357839e-06
sars coronavirus protease,4.902335245049451e-06
biophysical bases,4.898909024988145e-06
n-dimethylamino)acetamide hydrochloride,4.89575424945689e-06
sinusoidal endothelial cells,4.895657141310072e-06
coronavirus transmissible gastroenteritis virus,4.8648923251289665e-06
immunofluorescence testing,4.863550247465605e-06
genera,4.863241919617281e-06
vomiting diarrhea,4.8490336353846315e-06
host cellular membrane,4.845687356280984e-06
anti-s and -m monoclonal antibodies,4.8420104905396075e-06
heparan,4.837457417403034e-06
gene 3 transcriptionassociated sequence western blot analysis,4.833479245184809e-06
coronaviruses (covs) circulating,4.830148337287721e-06
m and n genes,4.830074296601543e-06
case distribution,4.8276347736816125e-06
q chong kh chang hh leung b ling ae wei t chan sw,4.819094210279796e-06
molecular components,4.818555183946928e-06
structural protein m,4.809296054094506e-06
gp100,4.806220574313307e-06
pooled sera,4.793331159274226e-06
1000fold,4.789973249850396e-06
carcinoembryonic antigenrelated,4.78981275432606e-06
2,4.785542064063447e-06
or15,4.785022593137951e-06
rbv sarscov,4.781366359718133e-06
virus assembly,4.780101430476243e-06
human dipeptidyl peptidase 4 hdpp4 receptor,4.777491515981489e-06
immunofluorescence antibody,4.774294955072532e-06
pregolgi membranes,4.7741993277486735e-06
acute respiratory tract disease,4.773753410468323e-06
respiratory bocv strains,4.76797298250613e-06
strand,4.763137400471709e-06
acute gastroenteritis,4.761872145256052e-06
receiver-operating characteristic,4.759532943130534e-06
protective antigens,4.745677614821457e-06
lung eosinophilic,4.745408892773933e-06
haemagglutination,4.736179666135284e-06
pulmonary damage,4.735638851109118e-06
immunodeficient mice,4.724453194011388e-06
gene 1 polyprotein,4.7170572813768615e-06
coronavirus nonstructural protein 9 nsp9,4.716545603717956e-06
commercial serine protease,4.716165603143513e-06
mid-december,4.715204322603104e-06
real-time sequence-specific verification,4.7116496928391625e-06
replicase 1ab and spike protein,4.694786944203127e-06
merscov nucleocapsid protein,4.693857951535263e-06
rfp-bound green fluorescence protein,4.693073440245584e-06
osteonecrosis,4.68984611347061e-06
sars coronavirus sarscov_y,4.664864051287149e-06
catalytic activity,4.657321973852822e-06
sarshcov,4.65378453561898e-06
late events,4.652136533335502e-06
opsonic,4.649154542473057e-06
nsp8mediated tatase,4.647263532995421e-06
early stage,4.6450661388450284e-06
surveillance activities,4.6450661388450284e-06
analysis of variance,4.641721407428003e-06
gcm3 western blot analysis,4.627807176910906e-06
tgevinfected swine testis cells,4.622571377642906e-06
coimmunoprecipitation assay,4.61413746475748e-06
sars coronavirus receptor angiotensin,4.597602261697982e-06
rapid immunochromatographic assay,4.596499275159828e-06
dimeric assembly,4.593026847795258e-06
nasal mucosal immune system,4.581888807083285e-06
multivariable models,4.5809035466900816e-06
nonpermissive cell line,4.578649109819022e-06
batcov hku9 hku9rbd,4.57833623589134e-06
type i membrane glycoprotein,4.567926156402362e-06
murine carcinoembryonic antigenrelated,4.561573166461457e-06
knockout mutant,4.558273381330214e-06
m336rbd complex,4.55566461606589e-06
herd-level,4.555088140619621e-06
cell middle east respiratory syndrome,4.549084179600779e-06
hnrnpa1specific monoclonal antibody,4.537737259877224e-06
mers-cov plpro,4.5358075325056935e-06
teicoplanin derivatives,4.533890210712541e-06
mouse hepatitis virus mhv l kuo,4.528687528802595e-06
s3a,4.5220197369243455e-06
coronavirus cov genome around 30 kb,4.51873747582802e-06
coronavirus convalescent sera,4.5173469232307275e-06
accessory protein 3a,4.510214030280769e-06
vaccination strategy,4.507202387445783e-06
x boxbinding protein 1,4.503930937421804e-06
neuronal degeneration,4.50351110729992e-06
balbb mice,4.482584632278944e-06
welldefined rna motifs,4.465106997424699e-06
recombinant vaccinia virus dna,4.464315387823836e-06
multifunctional viral gene product,4.463755935993294e-06
control vector,4.458580696717993e-06
receptorbinding site amino acids 270,4.45723277688499e-06
sars-cov gene,4.45514075107257e-06
x15,4.4447092047842686e-06
protein amino acid substitution,4.444134745068616e-06
mutagen,4.4432124064983234e-06
interleukin 6 and 8,4.441997441179272e-06
internal core,4.433913573240574e-06
plasma membrane cholesterol,4.430735443294078e-06
merscov plpro,4.429622982993763e-06
mhv lesions,4.4292991071667125e-06
panel of cells,4.4235058126405284e-06
hemagglutinating encephalomyelitis virus,4.422631939703807e-06
alpha and beta t cell,4.4212719757477006e-06
transgenic lineage,4.410903231977746e-06
intergenic sites,4.410312407844178e-06
nucleolar localization,4.407350780692119e-06
south korean outbreak,4.40513736357361e-06
screening indirect immunofluorescence,4.395837971823386e-06
rbddirected nabs,4.387765252213043e-06
coronavirus swine,4.374616402139999e-06
coronavirus replicative apparatus,4.370016322498367e-06
protein 1b light chain 3,4.36856496612467e-06
amino terminal s2 protein 4f4r,4.362708890150234e-06
adjacent downstream pseudoknot,4.360242712769835e-06
mers-cov disease,4.359851167479771e-06
western immunoblot-negative mabs,4.358110003749971e-06
gcc countries,4.357694715247071e-06
adherent dihydrofolate reductase-deficient cho cell line,4.3453762013605805e-06
interferon gamma,4.340262716777288e-06
proteinase_x,4.327439513441439e-06
quantitative test assays,4.325736047410692e-06
catalytic cysteine residue,4.323835693964892e-06
highly conserved core sequence cs,4.311515754252759e-06
liveattenuated vaccine,4.310049193183022e-06
cterminal dimerization domain ctd residues,4.297203711121086e-06
"bat sars-like cov (sl-zc45,",4.2922688320379e-06
rna structure elements,4.289084059418963e-06
coronaviral diseases,4.287875661393442e-06
acute respiratory syndrome sars coronavirus sarscov nucleocapsid protein enzymelinked immunosorbent assay,4.284568946670763e-06
gene deletion,4.283839438365597e-06
drug development,4.275605469600986e-06
rafmekerk signaling pathway,4.266448331262482e-06
convalescent human,4.263648559205477e-06
rm and gnn,4.262981636317566e-06
antisarscov agents,4.245443564445902e-06
negativesense subgenomic rnas,4.244133785953559e-06
frameshifting 3b,4.2432176191988486e-06
immune sera,4.241147344162837e-06
sialateoacetylesterase rde,4.227832472180987e-06
cell surface receptor aminopeptidase n binding,4.221153645323052e-06
am2 virus,4.218416574587204e-06
secondary transmissions,4.215038403342404e-06
transmembrane glycoprotein,4.214369815544277e-06
realtime quantitative pcr,4.212114981111919e-06
inflammation stress response,4.2048869030238344e-06
physical interaction,4.20330237823063e-06
cat sars-cov-like,4.194323840704935e-06
hemagglutinin-esterase-fusion glycoproteins,4.193582392114858e-06
glycopeptide derivatives,4.189220156736937e-06
type iii ifn,4.185562307100572e-06
proc natl acad sci u,4.181245505686791e-06
cyclindependent kinase 6 cdk6,4.169295976103507e-06
sars-associated cov (sars-cov) strain,4.166570689935316e-06
60-nucleotide leader sequence,4.162787633455023e-06
infc,4.1573420640042836e-06
viral envelope protein,4.152937725543187e-06
subpleural locations,4.138453519217374e-06
actual infection,4.137819722659512e-06
genome replication,4.131417120757036e-06
niemannpick c1,4.1307377173759476e-06
mrna coding sequence body transcriptionregulating sequences trss,4.114318789384694e-06
inflammatory infiltrates,4.11297690535239e-06
dromedaryegyptnrcehku2702013 nrcehku270,4.112813702234598e-06
mouse hepatitis virus strain jhm,4.107160007220281e-06
sarscov plpro inhibitors 6mercaptopurine 6mp,4.106575574629568e-06
glycoprotein fragments,4.08215727350567e-06
eukaryotic cells cell,4.069971135144364e-06
murine hepatitis virus strain 3 mhv3 coronavirus,4.069209010924139e-06
protein residues 344 360,4.068066541145287e-06
virusbinding site,4.049773149440216e-06
amino acid residues,4.03928400590754e-06
electrophoretic motility,4.038716784313296e-06
european miniopterus bats,4.0322856300289525e-06
serum_x,4.026929984539776e-06
turkey coronavirus tcv genome,4.022926757010364e-06
real-time quantitative(q) rt-pcr,4.022268026777135e-06
5a,4.012094453189042e-06
mitochondrialassociated adaptor molecule mavs signalosome,3.9908898378821396e-06
cholesterol synthesis/transport,3.98666068469432e-06
golgi plasma membrane,3.983891076556021e-06
liver pathogenesis m protein,3.983831256822604e-06
classification,3.978041295215076e-06
disulfidelinked dimeric structure,3.973390808088465e-06
wildtype sl form,3.973305814961949e-06
acute respiratory coronavirus,3.971498959770131e-06
community,3.970217373705048e-06
gene transcriptional regulation,3.9665388358286206e-06
multiple effector cytokines gamma interferon,3.964733005742851e-06
sars-associated service,3.963346433320549e-06
professional antigen-presenting cells,3.951608227864086e-06
foldon domain,3.941970534970782e-06
xray structures,3.9416845402500205e-06
repeat pcr polymerase chain,3.940261579907957e-06
virus permissive huh7 cells,3.939573904083285e-06
tmprss2 th1prone,3.9367458650635e-06
enzyme activity analysis,3.935883767884667e-06
hvr deletion mutant,3.9335011364328995e-06
ip,3.932005166791581e-06
chr,3.923070686444425e-06
murine encephalitis virus tmev vesicular stomatitis virus,3.920277695861536e-06
neurodegenerative bladder dysfunction,3.919993038754006e-06
clinical presentations,3.915758330435688e-06
temperature tsfipv,3.9137406165184285e-06
acute respiratory syndrome sarscoronaviruses sarscov proteases,3.904841655942332e-06
unusually long hydrophobic amino terminus,3.90466768817625e-06
occursin vitro,3.8918245735853555e-06
defense,3.889316980590226e-06
nuclear transport,3.888175623871149e-06
non-regenerative anemia,3.886191609182157e-06
phylogenetic analysis_x,3.885017994465205e-06
human aminopeptidase n hapn,3.882095012151384e-06
functional antigenic sites c,3.881300198984211e-06
jhmv srr7infected cultures,3.8744973879659935e-06
p28induced g0g1 cell cycle arrest,3.868254779483841e-06
virus/human/animal network,3.861762293618187e-06
amino acid mutation,3.858991942413112e-06
cyclindependent kinase cdk glycogen synthase kinase mitogenactivated protein kinase,3.858504486001116e-06
mhvinfected cells,3.855910843118878e-06
psoralentreated virus,3.8464973020323695e-06
sequencing_x,3.842107104932373e-06
protein phosphatase 1 catalytic subunit,3.8387781930773514e-06
lys48linked polyubiquitin chain debranching,3.8282080885083025e-06
extrinsic apoptosis pathway,3.826848268117059e-06
respiratory viral coinfections,3.826495702977034e-06
mannose phosphate isomerase mpi,3.820019322704279e-06
immunotherapy,3.8101597156351845e-06
antiviral transcriptional responses,3.802775913656211e-06
antibiotic-resistant cell lines,3.801116157271481e-06
cov crossspecies transmission,3.799632755096486e-06
inflammasome,3.798857167150868e-06
human wi38 cells,3.796216637775493e-06
antimhvr monoclonal antibody cc1,3.788621566791141e-06
293derived cells,3.788290947950068e-06
enzyme-linked immunosorbent assays,3.785270254642191e-06
nasopharyngeal swab,3.7782794944186137e-06
immunoglobulin fc domain,3.7767436926939634e-06
short open reading frames,3.774809150725067e-06
epidemiological survey,3.774664842609624e-06
nsp13associated deoxynucleoside triphosphatase dntpase,3.7583487099569038e-06
ppe,3.7564921096047807e-06
recombinant receptor-binding domain,3.7535222883366415e-06
u937 monocyte cells,3.7519352034900737e-06
infection control procedures,3.7512069865257283e-06
replication competence,3.7439943821477495e-06
sars coronavirus nucleocapsid protein dimer,3.7384915922773256e-06
small open reading frame,3.738455595317582e-06
inhibition hai,3.7342253594144193e-06
weanling mice,3.731333069900816e-06
genomic levels,3.7305861331363697e-06
positively charged helical groove,3.7229338174908028e-06
mice mouse hepatitis coronavirus,3.708977863286608e-06
nrs neutralization assay,3.6941220523088747e-06
transmembrane protease serine 2,3.6910825893055857e-06
alanine transaminase,3.685976872456604e-06
experimental inoculation,3.679396547892773e-06
nucleic acid chaperonelike domain,3.6755546011137895e-06
multinucleated syncytia,3.6718388271174564e-06
e2 glycoproteins partial endoglycosidase,3.6685581473799263e-06
multiple neutralizing monoclonal antibodies mabs,3.6669624881684872e-06
sustainability,3.6633307638403016e-06
amino acid_x,3.6584013590200437e-06
antiace1 antibody,3.6564710435107958e-06
analytical ultracentrifuge,3.641668720555889e-06
research activities,3.640609391383199e-06
first-line hcws,3.6347090179530185e-06
"mrna capping (nsp14,",3.6218484923648988e-06
northern blot analysis,3.617869778508411e-06
anticeacam5 antibody,3.6041434679064597e-06
adenoviral vaccine,3.6033672986702646e-06
urbani mutational repertoire,3.6007565781391295e-06
rcd,3.6001328836922483e-06
cysteine-rich amino acid clusters,3.5728316179019767e-06
cellsignaling pathways,3.5685073506491864e-06
highrisk groups,3.5681810239975866e-06
kit,3.567431979392097e-06
backbone sequences,3.563259385101747e-06
viral spike_x,3.5610105509763374e-06
230-amino acid matrix protein,3.5606475489354847e-06
s1 domain s1 s1foldon,3.558190416583242e-06
pathogen discovery programs,3.548288915633215e-06
overlapping pcr,3.5474742364797773e-06
objective,3.536275216391687e-06
n start codon sequences,3.5358447964834334e-06
black flying fox brain cells,3.5346223980802273e-06
systemic disease,3.5312331326965636e-06
contact screening,3.5283902243932715e-06
stochastic,3.5272632368455686e-06
immunohistochemical analysis,3.5231600376520762e-06
transmembrane protein m,3.5227897369447534e-06
ifn regulatory factor 3,3.5215928032082906e-06
hmpv,3.519134654285719e-06
helicase activity,3.5185232349620736e-06
lymphadenopathy syndrome,3.5168599790384243e-06
immune differences,3.5150852956604406e-06
chymotrypsin-like domains i,3.5079442457739486e-06
perinuclear,3.5079064965534756e-06
hexadecameric nsp7nsp8 complex,3.5078805916579217e-06
spike gene sequencing,3.499892592485885e-06
coronavirus prcv mrna species,3.492660542915256e-06
separation,3.489329413430308e-06
sars-cov-specific accessory proteins,3.4885056917082078e-06
cterminal flexible tail of residues,3.4884421357691665e-06
sars coronavirus aminoterminal replicase products nsp1 nsp2,3.4864206548296602e-06
operation,3.482353374772188e-06
bp,3.4804569296465545e-06
sick rabbit,3.4757170577077214e-06
phylogenetic_x,3.4752652765203635e-06
real-time polymerase chain reaction,3.4734489876952247e-06
sars-coronavirus-host,3.4724064907050834e-06
lineage c betacoronaviruses 3clpro,3.4705816463917205e-06
immunoglobulin gene sequence analyses,3.4698419312037347e-06
policy,3.4650532997358245e-06
coronavirus rna capping,3.4619516107531763e-06
syncytial giant cells,3.4552540565853235e-06
"4-hydroxyisolonchocarpin (3), papyriflavonol a (4),",3.4402834233353272e-06
sars-cov protein 6,3.437256816490359e-06
long periods,3.434372591100272e-06
chimeric particle system,3.4323250595853647e-06
canonical cleavage sites,3.4271070254026483e-06
rhesus rh macaques,3.419519349715134e-06
gko,3.419176347262475e-06
granulomatous tissue homogenates,3.4181745284327145e-06
mouse sera,3.4153025769743854e-06
life-threatening disease,3.412775326120604e-06
mers-cov amino-acid sequence,3.410201403635161e-06
mrna mrna 7 sequence analyses,3.4091726731014476e-06
strainspecific,3.4080744496295255e-06
benign,3.406991958797359e-06
ribonucleoprotein particles,3.4069288250247298e-06
restriction endonuclease,3.4055593283261423e-06
genomic sequencing,3.396256763618445e-06
glutamic acidrich domain,3.3867539556210254e-06
neuroattenuated a59 strain,3.371265396905976e-06
surveillance_x,3.3623349816099532e-06
fractionated proteins,3.3594409597915354e-06
sars-coronavirus nonstructural proteins,3.355655868876115e-06
gastroenteritis virus genome css2,3.35207552564407e-06
healthcare-acquired mers infection,3.34524347359553e-06
turkey poults,3.3408921396160285e-06
drug today,3.337322810407035e-06
copathogens oxygen,3.3356988687573955e-06
debilitated progeny,3.330439156672109e-06
filter binding assay,3.3230267763263926e-06
staff,3.3229859776631692e-06
biological pattern,3.318891666406261e-06
hlaa2,3.3147197822437136e-06
virus 27615 nucleotides nt,3.3110150138099806e-06
multiple pathways,3.308813198400014e-06
a31,3.3032353369564614e-06
allele-specific motif matching,3.2938008915840268e-06
bat populations,3.290022780770571e-06
nitric oxide synthase,3.2791125912964833e-06
feline catus,3.257203909335132e-06
generation_x,3.252433118353851e-06
mhvrdependent,3.2497710802130414e-06
cultures_x,3.2412083773599426e-06
gene 3 transcriptionassociated sequence,3.2409967723854124e-06
neurotropic murine coronavirus,3.240495484815948e-06
molecular trickery,3.227304051266036e-06
laboratory scientific studies,3.2192421832051334e-06
natural mhv infections,3.2185293568836688e-06
archaeoglobus fulgidus potential activesite residues,3.2171660040278994e-06
questionnaire,3.208370759900696e-06
cordata,3.2075267505344503e-06
acute respiratory syndrome sars coronavirus cov virions,3.2060434631523652e-06
loss_x,3.2039640148779796e-06
non-structural protein 15,3.199562234898064e-06
crystallization trials,3.19779688406568e-06
c-terminal phosphorylation cluster,3.1960781693188496e-06
positivestranded rna genomic rna,3.1956359596327074e-06
nested polymerase chain reaction npcr assays,3.1935296823657373e-06
fusion peptide inhibitors,3.1924924911755504e-06
diarrhea stools,3.1884673391967775e-06
ribonucleoprotein,3.1785450485379876e-06
viral structural proteins nucleocapsid,3.1781509538531936e-06
domestic ruminants,3.173454760708527e-06
wildtype jhm spike sjhmra59,3.1724563540465355e-06
hospitalisation,3.171197797951471e-06
fusion-defective chimeric proteins,3.155074223992522e-06
sars coronavirus receptorace2 proteins,3.1513027156754796e-06
sars-cov accessory protein,3.149638584430342e-06
transcriptional inactivity,3.1492898979379926e-06
western blot analysis,3.1431348428672567e-06
virally encoded guaninen7methyltransferase n7mtase,3.139424011081474e-06
cytoplasmic fraction,3.136799629301914e-06
ependymal cells,3.132173693784753e-06
eggs,3.130948625636177e-06
intranasal inoculations,3.122526336234594e-06
unusually labile spike protein,3.1207688664949876e-06
cleavage recognition,3.1176549088425934e-06
cardiotonic steroids,3.111630434435428e-06
wholegenome deep sequencing,3.108485422932267e-06
murine hyperimmune sera,3.1024078050862262e-06
readilyavailable continuous cell line,3.099758157270845e-06
gp3341 epitope,3.077811828691821e-06
south_x,3.0774325680481915e-06
tumor necrosis factor receptor,3.0740471182401022e-06
deisgylating activities,3.0718790365559225e-06
cyclindependent kinase cdk,3.0629734930933333e-06
cytoplasmic vesicles,3.0610816623140146e-06
clinical respiratory infection,3.060473106568312e-06
c-terminal cleavage site,3.058924315740339e-06
casein kinase iimediated,3.049781822863892e-06
natural killer cells,3.0445751954590677e-06
virus spike glycoproteins,3.0438859019863764e-06
innate defense,3.0382967168943306e-06
n-terminal transmembrane domains,3.035365982727658e-06
graftversushost disease,3.0265394940834303e-06
mrna leaderbody junction,3.022774214265725e-06
control team on-call protocols,3.0227372697890784e-06
hcov_x,3.0222157474971568e-06
columnar epithelial cells,3.0217237525632388e-06
oligomeric,3.018829155508063e-06
porcine deltacoronavirus pdcov spike protein,3.0173248776460124e-06
heexpressing di rna,3.005760264672297e-06
hcovoc43mediated,2.994991635528274e-06
information settings,2.981158311246416e-06
intensive interventions,2.9761633245376473e-06
nonlethal chronic demyelinating disease,2.968601382413174e-06
mapk kinase 3 experiments,2.9673525432803277e-06
murine dpp4,2.9664391220812943e-06
gfppscontaining sarscov,2.9597742492113577e-06
noncoding region,2.9557099618913984e-06
s450650 polypeptide,2.9556014539487402e-06
renilla luciferase rluc reporter gene,2.944084552410759e-06
consensus transcriptional initiation sequence ucuaaacu,2.9414483965488804e-06
mhc class-i peptide,2.933386935169029e-06
cytokine-associated single nucleotide polymorphisms,2.9313768797891625e-06
spike transmembrane anchor,2.9311949874933117e-06
multifocal chest radiograph,2.9297418635127137e-06
peripheral posterior lungs,2.925023514328204e-06
16 nonstructural protein nsp subunits,2.9224349373904235e-06
384well microtiter plates,2.9219415867543093e-06
virus neutralization assay,2.9145513028047403e-06
genetically stable,2.9103100396919535e-06
nddedvvtgd,2.906796427652825e-06
translational control,2.901931410356093e-06
recombination breakpoint,2.895982519961124e-06
human 293 renal epithelial cells pseudoparticles,2.8923311669762555e-06
encoded gene,2.889528402457984e-06
mnsp13 unwound,2.8670871007855505e-06
mouse immune serum,2.8669991937185226e-06
mouse central nervous system these viruses,2.862530213289836e-06
interferon alfa2a,2.8582652943215815e-06
recombinant 3clpro,2.857558745478597e-06
runx1b,2.856941608978489e-06
packaging signal,2.8542692061580833e-06
neurovirulent mhvjhm,2.8477743389416956e-06
therapeutic approaches,2.8354383193206674e-06
immunodominant non-neutralizing epitopes,2.834457022845614e-06
nsp7 nsp12 nsp13,2.832640243507285e-06
zoonotic coronavirus,2.8268761500497904e-06
national institutes,2.8260141421500137e-06
virushost coevolution,2.8080230697750828e-06
colloidal goldmediated immunoelectron microscopy,2.8078917493706856e-06
lysosomotropic,2.803403876975358e-06
cell apoptosis,2.797874831531315e-06
endoplasmic reticulumretained mutants,2.796608262916789e-06
one-step strand displacement probes,2.7922321434128874e-06
sars rna testing,2.7775075005060986e-06
pigs_x,2.7714239661902556e-06
genomic stability,2.76469113290033e-06
genotype/subtype,2.7543385883979833e-06
compliance,2.753865648581942e-06
working dogs,2.7529854540031773e-06
hcov229e coronaviruses,2.747166139491547e-06
wildtype recombinant virus rwtfipv,2.7389128506270013e-06
chronic neurological diseases,2.7368606364977457e-06
immunosenescent,2.735962377264159e-06
nonstructural protein 4 nsp4,2.7318293844548954e-06
feline coronavirus feline infectious peritonitis virus fipv,2.716208765573958e-06
oacetylesterase,2.7137349440888377e-06
higherresolution functional domain,2.7055491998326178e-06
proteomic datasets,2.7046690366992253e-06
zinc finger protein threedimensional structures,2.701750046429665e-06
medical illnesses,2.699927369035346e-06
gamma interferonactivated inhibitor,2.6957642372206964e-06
genus betacoronavirus coronavirus,2.693757676871926e-06
antiviral nucleosides,2.6860380843854905e-06
virions and infected cells,2.6814902976312855e-06
golgi retention signal,2.666138385125693e-06
cell membrane vesicles,2.66608729230666e-06
human camel and horse receptors sensitized cells,2.6644272453737727e-06
envelop contains 2 or 3 glycoproteins spike protein,2.6597280001241408e-06
purified enzyme,2.6536524844745516e-06
bilateral peripheral posterior,2.6534251455780673e-06
e3,2.6460363316124357e-06
ckchlhn00i,2.6435755523696535e-06
respiratory diseases cancer,2.638367579260281e-06
betacoronaviruses bovine coronavirus,2.6311878374683556e-06
recombinant soluble rbrfc protein,2.630958184330412e-06
seronegative sentinel,2.6300291222056653e-06
intestinal biopsy specimens,2.627358068859174e-06
lung pathology,2.6247698412839496e-06
children testing,2.6246482053229085e-06
membrane-distal region,2.6241615460113793e-06
oligonucleotide fingerprinting,2.62201003183054e-06
gene data,2.619743610292257e-06
cell cycleregulatory proteins,2.6179080083161946e-06
mechanistic studies,2.6175044899508686e-06
cytopathic mhv infections,2.6117650310792196e-06
major viral virulence factor,2.609283833698311e-06
ubiquitinlike interferon ifnstimulated gene,2.6062369887388483e-06
estimated_y,2.605635236435665e-06
consumption,2.5905132345071732e-06
oligo dtcellulose chromatography,2.5890084385113784e-06
sdav coronavirus,2.5882388506213886e-06
residues 86 and 302,2.586918163574575e-06
golgi compartments,2.5763659411476624e-06
human rectal tumor cells,2.5578259285598247e-06
european infectious bronchitis virus ibv italy,2.5560328133486147e-06
ebola mers,2.5425207630825296e-06
test sarscov nucleocapsid,2.535018307590362e-06
cns immune responses,2.533672439370015e-06
communal areas,2.528846762439627e-06
antitcov serum polyclonal antibodies,2.5268460461233242e-06
broadspectrum small molecule,2.5251327146662076e-06
genetic lineage,2.524155844692384e-06
genespecific probes,2.522309380497492e-06
hku9,2.520954081224286e-06
cov transcription,2.5198576426593233e-06
sarscovinduced,2.5166271436450775e-06
ribosomal proteins nucleolar proteins translation,2.5035681910089696e-06
signal transduction pathway,2.4991113953741144e-06
jhmv-specific cd4 t cells,2.498818785402048e-06
intra-species transmission,2.494950902093642e-06
reducing,2.477646927149508e-06
coronaviruses oronasal,2.460721726203728e-06
fusion machinery,2.4600721032406045e-06
clinical disease,2.459951169050731e-06
bnip3-promoter-luciferase reporter,2.455841558134761e-06
human viruses,2.45510056898277e-06
metalloprotease inhibition,2.454954877706381e-06
signal transduction,2.4463650161055735e-06
methodology/principal,2.4435611947599087e-06
seropositive,2.4408399918931246e-06
n-acetyl-9-o-acetylneuraminic acid,2.4389534576632432e-06
chicken tracheal organ cultures,2.4348531657847926e-06
differences_x,2.4187287087015417e-06
spikes,2.417984434682347e-06
merscov vaccines,2.4140978862101303e-06
immune-mediated lymphocyte destruction,2.4005115857527316e-06
nanoformulation,2.3979983305666564e-06
recombinant sarscov nucleocapsid proteins,2.3907118038821018e-06
nucleocapsid n protein stohlman,2.3820472098348224e-06
diagnostic assays,2.378786210285914e-06
ccr2,2.37667258532317e-06
viral n7mtases,2.373038815668111e-06
nsp14 amino acid sequence typing,2.3696634960250604e-06
positive-strand rna viruses,2.3669776299950067e-06
neuropathological lesion,2.365889158803519e-06
receptordestroying enzyme test,2.3620043714516662e-06
vitrosynthesized cterminally truncated 1a polypeptides,2.353120917623737e-06
32nucleotide nt rna motif,2.351489610407895e-06
retinoic acid-inducible gene 1,2.3477316821902965e-06
pulmonary recruitment,2.347454163019683e-06
mouseadapted sarscov,2.3432229742523455e-06
coronavirusceacam1,2.337047164505934e-06
first 649 nucleotides nt,2.3289478523557583e-06
coronavirus mouse hepatitis virus strain y mhvy,2.3213468729108835e-06
positions 360 462 472 480 487 609 613 665 743 765 and 1163 the,2.3154129337897304e-06
tolllike receptor 7 tlr7,2.3113825118932528e-06
acute hepatic failure,2.3089121863213376e-06
personal private,2.3009227890968483e-06
tumor cell cytoplasm sera,2.2993159818125346e-06
central nervous system disease,2.2935931554183693e-06
electro-mobility shift assays,2.288723857954739e-06
steroid,2.286008073163137e-06
antigenic region,2.2816655481937377e-06
viral antigens,2.2803229171205197e-06
chicken hostrelationship,2.2803229171205023e-06
amino acid 219,2.2739207597548973e-06
reverse-transcriptase polymerase chain reaction,2.2645296063846153e-06
transmembrane m glycoproteins,2.2612406740706235e-06
human coronavirus 229e nucleocapsid protein,2.2536011937228917e-06
transcription regulating sequences trss,2.253108112254525e-06
capped guanine,2.2524307240528535e-06
metabolic derangements,2.2512815171320183e-06
tge virus tgev infection rna interference,2.2483987981128214e-06
coronavirus envelope envelope glycoprotein e1,2.2481150457042795e-06
analytical ultracentrifugation method,2.243140337205189e-06
highrisk infants,2.2427231015804306e-06
renal tubular epithelial cells,2.2417546779682252e-06
peplomeric s glycoprotein gene,2.239842192672723e-06
crandell feline kidney cells,2.233220021522965e-06
fibroblasts primary astrocytes,2.2326726541860583e-06
pro- and anti-apoptotic proteins,2.224870128443413e-06
hcovnl63nh,2.2242713973365566e-06
hcovoc43,2.219383018140946e-06
nsp13 nsp14 open reading frame 5 orf5,2.2178912586434793e-06
antimhv neutralizing antibody,2.214379098235955e-06
major human coronaviruses hcovs,2.2000812067008055e-06
small interfering rna sirna library screen,2.1935406540495897e-06
viral replication enzymes,2.1874328703036245e-06
amino acids aa 331 to,2.18562967842179e-06
protein accumulation,2.1830769313046487e-06
nonstructural proteins 49 kda,2.1787438343215955e-06
orf8 proteins,2.176855837831375e-06
speciesspecific coronaviruses,2.1739531120723794e-06
bd,2.171230723861767e-06
immunoenzyme technique,2.1706930796567896e-06
mrna coding sequences,2.1665140534753756e-06
cov fidelity mutant,2.1663873451809977e-06
transcription factors irf-3,2.161577887762413e-06
eptesicus fuscus) cells,2.161184212627726e-06
coronaviridae family members,2.1608272666082253e-06
endoplasmic reticulum (rer),2.159557006442691e-06
acute respiratory syndrome-cov,2.157646573897318e-06
miniopterus pusillus,2.156370003418667e-06
serological elisas,2.1525630903355518e-06
amino terminal,2.150915213884943e-06
densely populated regions,2.1485735423585575e-06
tcellmediated,2.145736902442306e-06
nestedrtpcr and 19,2.1445285378875042e-06
sg mrna,2.138060254301736e-06
pedvcolorado,2.1380283439801667e-06
mrcc continuous heteroploid cell line,2.1271293330809255e-06
viral evolution strategy,2.126439256286728e-06
small chain variable regions,2.1194985133647224e-06
replicationcompetent,2.1185741032080822e-06
proliferative response,2.1129854871516277e-06
pathogenic variants,2.1127991940425805e-06
sequence homologies,2.0966551417855095e-06
three-stemmed mrna pseudoknot structures,2.09270188097766e-06
neutralizing indices,2.0918504185772654e-06
human coronavirus 229einfected huh7 cells,2.088923924978187e-06
chronic infections,2.0871011333959524e-06
receptorbinding loops,2.0816842241564553e-06
mbl-associated serine protease-2,2.076232068681723e-06
sarscov s protein or sprotein variants,2.073917110282278e-06
cov rdrp nsp12,2.073109816663462e-06
sdssolubilized virions,2.072707332475892e-06
lys63linked polyubiquitin chains,2.0695488937174357e-06
genetic sequences,2.0637343856189417e-06
antigenspecific iga precursor cells,2.06062355466015e-06
demyelination_x,2.0575254275304097e-06
human immunodeficiency virus type 1 hiv1,2.056606744612132e-06
host proteinderived peptide,2.0559168784840655e-06
escaperesistant protection,2.0481261412591834e-06
intestinal organoids,2.0472023099661506e-06
canine pancreatic microsomal membranes,2.0466189037960645e-06
electron microscopic examination,2.0452752010004746e-06
immunomodulatory factors,2.0432842252984244e-06
human coronaviruses nl63 hcovnl63 oc43,2.0387832629542134e-06
gamma interferon,2.0339790764140846e-06
sugar and protein receptors,2.0306011963183474e-06
secreting,2.0256229827408526e-06
subcellular localization,2.0212020273531425e-06
intergenic ig consensus sequence,2.0212020273531425e-06
pulmonary alveolar septae,2.020141459781915e-06
pancoronavirus reverse transcriptase,2.0171630845255393e-06
plasma membrane voltage gated ion channel,2.0161428150144936e-06
viral protein synthesis,2.0129195482150638e-06
bocv,2.011148401871618e-06
complementary oligonucleotide primers,2.007519553221193e-06
immunoflurorescence assay electron microscopy pcr,2.0052057266835455e-06
systematic epitope,2.0011930356399205e-06
domain protein,1.9986230525410554e-06
chick respiratory epithelium,1.99859868390138e-06
spike-specific mabs,1.9929775941883806e-06
mebus strain,1.9888156548354033e-06
merscov hujordann32012,1.9783502928440214e-06
electronic supplementary material,1.9778732115926004e-06
secretion,1.977621068709459e-06
eukaryotic proteins,1.972731598156893e-06
coronavirus oronasal,1.970842270125047e-06
transmembrane m protein,1.968336976209709e-06
b6,1.9636550845511216e-06
human airway epithelial cells,1.95736892931355e-06
hepatotropic,1.9572319324359914e-06
diagnostic platform,1.9566358973497167e-06
gel precipitation,1.95646169766284e-06
extra open reading frame orf,1.9562491277405804e-06
ubiquitinlike modifier isg15,1.9557133270232523e-06
preattachment,1.955407561123271e-06
janus family kinase jaksignal transducer,1.9436212837779927e-06
rat red blood cells rbc,1.943101388319645e-06
hospital visitors,1.9334633896782513e-06
duodenal secretion,1.931770049486536e-06
chest,1.9292049953485025e-06
rbcov,1.92617050080377e-06
brush border vesicles,1.9256841198907912e-06
known coronavirus,1.921339311485034e-06
indirect immunofluorescence assay,1.9112573434342227e-06
anticoronaviral drugs,1.9057448652647603e-06
coronavirus receptor angiotensin converting enzyme 2,1.899465477148444e-06
mouse hepatitis virus strain 3,1.890715560918173e-06
upper respiratory tract infection,1.8901338890760948e-06
epidemiologic surveys,1.8901338890760887e-06
direct infection,1.8843187067877347e-06
epithelial endothelial or hematopoietic tissues ceacam1a functions as an intercellular adhesion,1.8834757982493508e-06
receptor binding site,1.869283614337641e-06
baculovirus-infected insect cells,1.858079582967814e-06
balbc background,1.8552927692882842e-06
natural recombination,1.8545597977619419e-06
ace2 thirtyeight,1.8530204338237973e-06
retroviruses simian immunodeficiency virus,1.8507385209317186e-06
p1pro substitution,1.8461032067692332e-06
protein degradation,1.8389677728643608e-06
sarscovassociated,1.833955390962773e-06
longdistance interactions,1.8334812440842578e-06
carboxy terminus,1.8310509698998175e-06
transmembrane serine protease,1.829760288380952e-06
hcv glycoproteins,1.8285918086299006e-06
hec,1.826307525419125e-06
simultaneously,1.8190866496740038e-06
operations,1.8135560842849944e-06
mitogenactivated protein kinase rafmekerk,1.8123464628941961e-06
consistency,1.8118737949820504e-06
viral rna-dependent rna polymerase,1.8112099394734453e-06
membrane fractions,1.8099731840299136e-06
vp3,1.807494990331239e-06
factor interferon regulatory factor 3,1.8060345856413079e-06
broad spectrum inhibitors,1.796736304163852e-06
replicative positive-strand genomic rna,1.7944701051534017e-06
structural gene sequences,1.7831887038596532e-06
no signals,1.7831887038595999e-06
degenerating jejunal enterocytes,1.7803143785884907e-06
g2m phase,1.7746507837279615e-06
clinical presentation,1.7739513356221216e-06
canine coronavirus ccv,1.7695866503300841e-06
mers epidemiology,1.7577684502071978e-06
liver parenchymal cells ns2h126r,1.7480801648723119e-06
nl63 29,1.7458738948755337e-06
absence_x,1.7441372565267562e-06
perinuclear region of cells,1.742890286343408e-06
biosafety precautions,1.7428149663848244e-06
truncated n protein fragments,1.742639480952666e-06
sting-traf3-tbk1 complex,1.7320125995577699e-06
leave-one-out cross-validation,1.718570398287956e-06
cyclindependent kinase cdk inhibitor p21cip1,1.7173826555729775e-06
luminal epithelial surface,1.7171285655539079e-06
bat sars-like coronavirus,1.7070576734816706e-06
virion and 115 gml,1.7050428452834622e-06
field outbreak,1.7023689115796392e-06
protein molecules,1.693028404537841e-06
52000 unglycosylated nucleocapsid protein,1.6918245023712217e-06
mers-cov susceptibility,1.6831756903450666e-06
human angiotensin-converting enzyme 2 receptor,1.678149564218011e-06
dalbavancin oritavancin,1.6762320027194105e-06
exoribonuclease domain,1.6754722190316085e-06
nucleolus nucleoli and proteins,1.6738328711634292e-06
synonymous substitutions,1.6691552408988825e-06
rhinolophus ferrumequinum,1.6684569141518918e-06
enzymatic amplification,1.657850138881382e-06
12 open reading frames,1.6571371134793752e-06
polya tail,1.6534679223650066e-06
endosomal cholesterol,1.650809610899508e-06
stemloop 1,1.6492229902294885e-06
degree_x,1.6420008077492586e-06
16 nonstructural proteins,1.6347892512348283e-06
hcovnl63infected,1.6344776334101857e-06
m-csf levels,1.6338007538516349e-06
bone,1.6333250460344212e-06
hku39849 hanoi,1.6297025294659465e-06
abrogated,1.6265667540262512e-06
nasopharyngeal_x,1.6210556169486085e-06
omani ministry,1.620250468183232e-06
am2,1.614494372100822e-06
bat sera,1.6127599667150022e-06
nucleotide homology,1.6102552808089741e-06
ccv usda strain,1.5954832679706553e-06
hemagglutinin protein,1.5953071454635358e-06
mhvinduced encephalitis,1.5952608313526214e-06
antigenic epitopes,1.5924865101874905e-06
human enteric coronaviruslike particles,1.5911905162767937e-06
internal organs,1.590172292111221e-06
mers-cov infection,1.5888713583399025e-06
amino acid conservation,1.5884585214931878e-06
merscov receptor dipeptidyl peptidase 4 dpp4,1.5879182462266006e-06
sars cov replication cycle,1.5877487383197181e-06
cell innate immunity,1.5860291067528197e-06
coronaviral sequences,1.5856845268084941e-06
cterminus,1.5833559751353652e-06
glycan,1.5815259317479512e-06
focal pneumonitis,1.5809375779286071e-06
heterologous (rabbit) antiserum,1.5778302155177368e-06
sarsspecific memory t cells,1.5718314292395794e-06
predictive value,1.5642380285525135e-06
chinese rhesus monkeys,1.5555887695684976e-06
hydrophobic substituents,1.550590612727772e-06
mers-cov-associated infection,1.5483014874802762e-06
rosette-like structures,1.5456742853980617e-06
analytical sensitivities,1.5403781633716772e-06
cultured bovine cells,1.5387162840241184e-06
confocal imaging,1.5362478907078462e-06
informationseeking,1.5341032417805087e-06
avian-origin h7n9 influenza virus outbreak,1.5327103488096405e-06
myeloblastic leukemia,1.5321419777571996e-06
zoonotic covs,1.5273315929793503e-06
rabies virus rv,1.5228023680936422e-06
cl2 infected cells,1.521926759298416e-06
reverse transcriptase polymerase chain reaction,1.5157486984058186e-06
pneumonitis,1.5150140567075004e-06
antigenspecific neutralizing antibodies,1.5019732065623947e-06
mutation multiangle light scattering,1.4999654483767578e-06
asian,1.495269570470172e-06
lectin,1.4937449535925454e-06
mild enteritis,1.4857118651711644e-06
host astrocytes,1.4839865655465982e-06
m41,1.4791569175006198e-06
nephropathogenic strain b1648,1.4777712745723864e-06
korean wd strains,1.476159207237189e-06
multichain immune recognition receptors,1.4732478588676854e-06
acidic intracellular,1.4718739676143606e-06
nitrocellulose,1.4718735918470773e-06
enveloped singlestranded positivesense rna viruses,1.4708004401465438e-06
wild type mice,1.4661240856289642e-06
balt respiratory infection,1.4646932071561776e-06
bat ancestors,1.4585268846603647e-06
policies,1.454447407234825e-06
miniature horses,1.443281060557378e-06
mammalian cov species rdrpbased grouping units,1.4407251979043521e-06
transmissible deletions,1.437812967463461e-06
lactate dehydrogenase 23,1.4367507067806265e-06
interferon ifn interferonstimulated gene,1.4355152710640733e-06
statistical incongruence,1.4351061085340542e-06
interleukin28ab il28ab,1.433543550392758e-06
glycine 2840,1.433339832818198e-06
g1 cyclincdk complexes in,1.4271246300381045e-06
ecov,1.4204117917320386e-06
national institute,1.4196102522506013e-06
papainlike cysteine proteinase domains,1.419167167583321e-06
gait element,1.4084299887663697e-06
fluorescence doublestaining technique,1.4050719035651822e-06
infective doses,1.4016382217796973e-06
di rna replication,1.398288393626054e-06
intracellular antigen1,1.3969730940820177e-06
hev nucleotide sequence,1.3957730244760857e-06
ch,1.3950431417576971e-06
multifocal interstitial pneumonia,1.392601469473623e-06
sarsassociated coronavirus sarscov,1.3891207296586692e-06
total cell protein,1.3882873633952473e-06
lysosomal cathepsin l,1.3880217635110162e-06
bovine immune serum,1.385538600310491e-06
pathogenicity factors,1.384578137966844e-06
infectious bronchitis virus n protein,1.3841881728248408e-06
ubiquitin-specific proteases,1.3822074471044638e-06
ribosome profiling,1.3801241286426333e-06
rna motifs,1.3795251416821765e-06
sarscov angiotensin converting enzyme 2 ace2 ii,1.3770375899789122e-06
neutralizing antibody epitope,1.3757019939577572e-06
amino acids 768 and 769,1.3724018202887447e-06
neurological disorders,1.3710495647740025e-06
antigencapturing enzymelinked immunosorbent assay elisa antinucleocapsid protein antibodies,1.370419395846035e-06
nucleoli,1.3650027805868685e-06
sliii domain nucleotides,1.3644292840697692e-06
pathogenic cov,1.3629609178442203e-06
global transport,1.3618129592740737e-06
ace2silenced cell lines,1.3572347508225227e-06
alanine mutants,1.3561306550367502e-06
mhv-jhm-derived di rnas,1.3518575290778994e-06
coronaviruslike particles,1.346244186331654e-06
doublestrandedrnadependent kinase,1.3445632383376822e-06
virus norovirus,1.3428801987789942e-06
nk cells macrophages,1.340309950890944e-06
phospholipase a2,1.336644487339512e-06
hamster rat cat dog monkey and human cell lines,1.3342795475029515e-06
partial rnadependent rna polymerase gene sequence,1.3322581083714663e-06
viral spike glycoprotein rjhm,1.3271617539557187e-06
gastrointestinal dysfunction,1.326225977119999e-06
host death,1.3207204285825587e-06
cell surface serine proteases,1.3201355436509871e-06
phagocytosis,1.3175210565139102e-06
north american strain,1.3138948467499862e-06
ifa,1.3083977063398074e-06
naturally occurring flanking sequences,1.3076712149277757e-06
raw clinical samples,1.3059895120356532e-06
pathologic,1.3025813614656975e-06
jhm receptors,1.3009996699829678e-06
ibv-infected mammalian cells,1.2900677532599474e-06
nonexposed,1.2856796995406293e-06
real-time rt-pcr,1.2843699282436426e-06
9oacetyl esterase,1.2840423076357522e-06
sars-cov vaccine,1.2827128900820688e-06
comorbidity rates,1.2826816408802662e-06
fourth-generation transmission,1.2804436254872741e-06
tcovspecific antibodies,1.2748595809838097e-06
accessory proteins 3a and 3b,1.2746026231994893e-06
coronaviral n7mtase,1.2744669109461492e-06
active form,1.2742184196769219e-06
adsorbed,1.2668156101991986e-06
20nmlong homotrimers,1.2662619960196449e-06
protective immune responses,1.262103924685904e-06
merscov neutralizing antibody,1.259904644496424e-06
evolutionary selection,1.2566041642737062e-06
mosaic structure,1.254357846577589e-06
lipopolysaccharide,1.2428093063271886e-06
heterosexual controls,1.2418345539300176e-06
lopinavir/ritonavir,1.240678852109357e-06
conserved cysteine residues,1.2367052212690595e-06
p38 mapk,1.2353222424830477e-06
coronavirus nucleoprotein n protein,1.2324042335886958e-06
adult cattle,1.227557769084486e-06
127 and 95kda proteins,1.227244457762736e-06
encephalopathic disease,1.2263400631851802e-06
boundaries viral genetic,1.2241503568923697e-06
genome cdna copy,1.2221297257020673e-06
viral andor cell membranes,1.21736665673061e-06
molecular virushost,1.2141994830088033e-06
1jpr 1uaa and 1w36 pdb,1.213475818743995e-06
counterparts,1.2023287204375536e-06
ubiquitously expressed eukaryotic proteins,1.2008515927526684e-06
flaviviruses yellow fever virus yfv,1.1987835153013113e-06
studiedin vitro,1.1965823327257406e-06
left ventricular hypertrophy,1.1954953821650988e-06
cd,1.1936919269535059e-06
n514s substitution,1.1931296060013225e-06
adrenal glands,1.192337942868516e-06
runde norway,1.1841441957427909e-06
emulsions,1.182527669596864e-06
coronavirus hku1 cov,1.1723568355800636e-06
pre-fusogenic state,1.1674360179580927e-06
glutaraldehyde,1.1666308641619287e-06
lethally pathogenic,1.166172770266779e-06
hcov229e n  1 hcovnl63 n  1 hcovhku1 n  4,1.165147505835735e-06
sodium monensin,1.1650104411528843e-06
pcr inhibition,1.1631082132149642e-06
miniopterus species,1.1620719245591979e-06
surviving,1.1619610652129404e-06
evolutionary_x,1.1617525640514205e-06
vaccinia strain,1.157444344735465e-06
lineage c betacoronavirus,1.1522668096754765e-06
consensus cleavage sequence,1.1500850077517101e-06
part of nonstructural protein,1.1482095810199368e-06
electron microscopically,1.1476444441572382e-06
nsp8mediated tatase activity,1.1465462846509579e-06
c betacovs,1.146503459177473e-06
angiotensin iconverting enzyme 2 ace2,1.1428263995916968e-06
hematological measures,1.1402730445439956e-06
sars-cov cdna preparations,1.136994447667827e-06
mouse ceacam1a mceacam1a,1.1358465681103107e-06
cleavage products,1.1358267206373088e-06
pseudovirus assembly,1.1281961754164995e-06
sequence microheterogeneity,1.120646158069724e-06
viral respiratory infections,1.1190547522556625e-06
macro domains,1.1185288194157267e-06
endonucleolytic rna cleavage,1.1151585470778478e-06
comparative genomics,1.1100636036346807e-06
wound repair pathways,1.1081752248681376e-06
38nucleotide deletion,1.107417997933308e-06
highly conserved transmembrane domain,1.1050106739550905e-06
mhvpermissive cell lines,1.1010592528987817e-06
agammaglobulinaemia,1.0938521317376815e-06
selective packaging,1.092882048032761e-06
external subdomain,1.0879522450718545e-06
generated unusually group 2 antibodies,1.0854640395991626e-06
conformational changes,1.0834403829322085e-06
internally quenched fluorogenic peptides,1.0805993522862197e-06
35 kda protein 3clpro,1.0804095054113344e-06
entire nucleotide sequences,1.0765912695010206e-06
case histories,1.0750241627567575e-06
urine clinical diagnosis,1.0745152165233298e-06
molecular diagnostic methods,1.0719814867114656e-06
tongueshaped structure,1.069913222315793e-06
mhv counterpart,1.0686008998840066e-06
parainfluenza viruses 1,1.066065628067123e-06
flavonoids quercetin quercitrin,1.0649465557977066e-06
eicosanoid-derived inflammation,1.0631296784295053e-06
splicing mrna export,1.0597184169841293e-06
consensus transcription initiation signal ucuaaucuauc and uuuaaucuu,1.0558529109825538e-06
v202i substitution,1.0551201561834848e-06
dna sequence,1.053104760742062e-06
mapks p38 mapk,1.051956508649504e-06
gp3341,1.0519197541696284e-06
cytokinechemokine,1.0466659325257325e-06
head-to-tail ligation,1.046282356318273e-06
iga bcv antibodies,1.046282356318273e-06
nglycosidic linkage glycosylation,1.0452438320740096e-06
fcov isolates,1.0435526384117272e-06
cell surface complex,1.042204223191681e-06
type ii transmembrane serine,1.0367313595196696e-06
multiple kinases,1.035904115607036e-06
coronavirus  ,1.0328542801892708e-06
immunodominant site,1.0312880656409968e-06
rna products,1.0300840435076867e-06
lossoffunction,1.0285796973461749e-06
cov polymerase,1.027692022481876e-06
co-immunoprecipitated,1.0227037148023133e-06
intestinal epithelium cells,1.022069541961152e-06
nonfatal encephalomyelitis,1.0141416455962141e-06
parturition,1.0129187300387154e-06
engineering,1.012012393621548e-06
dams,1.0091737138456748e-06
ap1,1.0055958674062583e-06
n-,1.0036348576853281e-06
transmembrane segments flanked,1.001387676222382e-06
sars-related rhinolophus bat cov hku3,9.944162656132912e-07
single-stranded rnas,9.872161840281025e-07
western blotting analysis,9.85222422615589e-07
rj22infected wildtype b6,9.846502553249203e-07
ifitm-mediated restriction,9.73782452952135e-07
reference north american strain,9.735011524014295e-07
inefficient,9.626403753915538e-07
conserved sequence,9.620467443005582e-07
cov s proteins,9.554552372091355e-07
canine coronaviruses,9.496084325297936e-07
coronavirus fecv isolates,9.467158110440704e-07
membrane biotinylation ace2 protein,9.453908147026113e-07
immunofluorescence immunoelectron microscopy,9.436054305833739e-07
antigenic subgroups antigenic domain,9.426287584599041e-07
nasopharyngeal aspirates npas positive samples,9.423029111737792e-07
massachusetts prototype ibv m41 kq6,9.353555885891837e-07
coronavirus ccov strain,9.29668954634024e-07
pcdna3.1-s1 dna vaccine,9.232301366605984e-07
multiple genes stsa f1 hybrid,9.232301366605613e-07
respiratory dis orders,9.227394772905738e-07
tbk1irf3,9.225270387152366e-07
nonpharmaceutical preventive measures,9.20213077171369e-07
ceacam5,9.070232657630207e-07
serologically,9.067780421424972e-07
elisabased antibody tests,9.016227312145935e-07
open reading frames 4a,8.999757896784368e-07
nsp1516 precursors,8.972350525767187e-07
serine protease inhibitors,8.918836823164506e-07
hepatitis c virus ns3 protease,8.895196983353651e-07
bcov and brsv rna,8.88060950492175e-07
betacoronavirus antibodies,8.861300082987948e-07
parvolike viruses,8.834727472801227e-07
homologous rabbit,8.807785271661857e-07
coronavirus spike glycoproteins,8.761510371613542e-07
m336,8.754678783751548e-07
nursing education,8.749731481214393e-07
coronavirus mouse_x,8.746295777000419e-07
mers-cov-positive hcws,8.727794074138386e-07
m gene sequence,8.695382678345407e-07
multiplication,8.692293263267834e-07
brcv 255 and 440 strains,8.680354941022908e-07
lineage c betacovs,8.608283337412239e-07
signal peptide,8.596121732186593e-07
vaccination regimens,8.56762392994079e-07
immunofluorescent assay,8.551210939201813e-07
anti-pure virus or anti-crude virus animal serums,8.53690944976303e-07
clustal w program,8.523857963326566e-07
sl-cov s protein,8.517661513503653e-07
murine astrocytes,8.502065567253949e-07
okavirus family roniviridae,8.501658856008608e-07
cd8 mhcclassiipositive cells,8.491374780284392e-07
full-length spike protein,8.466778849528039e-07
pulmonary epithelial cells,8.459701440714203e-07
bronchoalveolar fluid,8.446683334073139e-07
rational attenuation,8.426717263811325e-07
immunoglobulin classes,8.345502731114845e-07
highly basic nucleocapsid (n) protein,8.320572392165838e-07
lower respiratory tract specimens,8.287699458261875e-07
one-step rrt-pcr assay,8.258680327503241e-07
interfered,8.250304525127843e-07
flexible amino acid linker,8.209009126205664e-07
nacetylneuraminic acids,8.183537677588941e-07
outer structural proteins,8.171113556369656e-07
antivirally active proteins,8.159641838038853e-07
tcovinfected,8.155521818678033e-07
high-throughput performance,8.092873895266772e-07
chronic enteric infections,8.090467512646104e-07
proteasemediated cell,8.085628426828076e-07
exon excises nucleotide mismatches,8.047147540028655e-07
wild african carnivores coronavirus rna,8.043035865747951e-07
ebola virus,8.005677285017007e-07
glycosylation dependent sites,7.976376198016824e-07
culture fluids,7.973212383682315e-07
diagnostic accuracy,7.96025127389687e-07
reverse transcriptionpcr rtpcr assays,7.956344436518404e-07
uvinactivated virus cellcell fusionblocking antibodies,7.95147281469426e-07
retroviral fusion proteins,7.950861460556105e-07
h-index,7.924322571495161e-07
porcine hemagglutinating encephalomyelitis virus,7.896393894135048e-07
t helper epitope,7.881376569823053e-07
wildtype s protein pseudotyped mlv vectors,7.842929261270989e-07
guinea fowl,7.830232691459804e-07
peptideconjugated antisense morpholino,7.755431881550132e-07
enteric bovine cov bcov strains,7.727303566473017e-07
peplomers digestion,7.681318006153509e-07
oligonucleotides pcr products,7.64139939027155e-07
negativesense genomesized rna synthesis,7.625803930291277e-07
nasal shedding,7.538068379924095e-07
viral genome merscov,7.497098224162619e-07
clinical studies,7.45394741722671e-07
seminested rtpcr,7.442404614483017e-07
human-pathogenic coronaviruses,7.437614916479674e-07
human cell line huh7,7.428559325855026e-07
hemadsorption,7.40689124178159e-07
virus internalization assay,7.382704971655602e-07
454aminoacid protein,7.37507684686033e-07
isg15 deconjugating enzyme,7.294862879426349e-07
rna genome_x,7.216616496516263e-07
oglycosylation machinery,7.180592038822983e-07
protective measures,7.179868662530572e-07
clade 2c coronaviruses,7.116866692866217e-07
protein monomers,7.115798170639503e-07
betacoronavirus structural elements,7.104846059238266e-07
furin,7.030754740845716e-07
3 positive gnn,7.028620363681063e-07
mrna species,7.027949495946768e-07
recombinant wildtype virus,6.98349557950209e-07
experimental autoimmune encephalitis,6.90988054030018e-07
northeast china,6.90684927268515e-07
electrophoresis,6.877870769501481e-07
gene upe nucleocapsid n gene,6.81781844691336e-07
chronic cardiac disease,6.806777408908471e-07
chromatin immunoprecipitation,6.769048712650828e-07
primary pig kidney cell cultures,6.754461450210987e-07
genealogy,6.731572576464403e-07
plp2,6.730805727898969e-07
high temperatures,6.6989619778566e-07
dot blot hybridization assays,6.69627432311036e-07
prb,6.666293250107727e-07
argentinean strains,6.644103229559793e-07
rankl expression,6.504907999713276e-07
losses,6.500939772430317e-07
undiluted pvp-i product,6.488825471234728e-07
bbb,6.482481799824434e-07
longitudinal studies,6.476087246137964e-07
igg1 m336 m337,6.470098547834352e-07
ccov strains,6.457248381463574e-07
acid ampa receptor antagonist,6.417386783805014e-07
structural conservation,6.413408204401559e-07
human coronaviruses sars-cov,6.363441077246524e-07
orf7b transmembrane domain,6.316802147836777e-07
enterotropic,6.308328797324259e-07
human alveolar cells,6.252354079621054e-07
angiotensinconverting enzyme 2 ace2 ace2 immunoprecipitation,6.233816347552371e-07
crosslinking,6.23094538112551e-07
stained,6.217043825046418e-07
infection mass spectrometry,6.197885219327424e-07
differential_x,6.153227046544359e-07
endocytic entry,6.14433323472842e-07
tetratricopeptide repeatsbased,6.131996722125754e-07
anti-coronavirus drug design,6.096021528435097e-07
pnicu,6.090996644313104e-07
bacterial fusion proteins,6.045122763552139e-07
brdu labelretaining cells,6.012527848577214e-07
iga molecules analysis,5.987066654576944e-07
transmembrane glycoprotein el,5.880416543791986e-07
coronavirus cov nonstructural protein 14 nsp14,5.849507444784124e-07
peak testing,5.846573742956523e-07
balbc mice,5.814810736254063e-07
ibvs,5.811443178091277e-07
protein function,5.809805326064822e-07
coronavirus sars cov spike glycoprotein,5.800826321389794e-07
enteric cvlps,5.8007241081022e-07
cell-based assays,5.756078688052059e-07
phylogenetically analysed,5.7338151167922e-07
cell death,5.724435739550264e-07
automated method,5.556482918634511e-07
nested polymerase chain reaction npcr assay,5.539378622486514e-07
contrast trypsin,5.531644021789713e-07
late october,5.530390645893572e-07
c-terminal tail of protein,5.521278463028523e-07
sars spike protein,5.515673653335767e-07
rnase protection assays,5.515457500448412e-07
luciferase reporterexpressing recombinant murine,5.490011308690942e-07
nascent negative rna strand,5.457170461005468e-07
downstream noncanonical motif,5.455325019936579e-07
sars dna vaccines,5.429503513498451e-07
ibvreplicating sites,5.400043411067411e-07
upper respiratory_x,5.381967922700992e-07
2s3stransepoxysuccinyllleucylamido3methylbutane ethyl ester,5.38032584894387e-07
golgi complex pulsechase,5.340702274681731e-07
compassionate use,5.330328140335615e-07
temperaturesensitive ubiquitinactivating enzyme e1,5.309280042332709e-07
stressinduced,5.30166746071344e-07
stat1 signal transducer and activator of transcription factor 1,5.297156705829679e-07
programmed ribosomal frameshifting,5.256872884925783e-07
infectious peritonitis virus fipv field strain trasmissible gastroenteritis virus tgev purdue,5.241637854464058e-07
putative precursor,5.196419936606453e-07
malaysia,5.163537108147803e-07
coronavirus whole genome sequence,5.154936400582425e-07
receptor-associated sars-cov pseudovirions,5.140428284770077e-07
nonneurovirulent,5.127157367607833e-07
mature receptor-binding and transmembrane fusion subunits,5.124452914228223e-07
executioner caspases,5.109087881236569e-07
heart condition,5.096564735103379e-07
sars pseudoknot,5.091347470694892e-07
nonsynonymous substitutions,5.080067309716938e-07
no deaths,5.06826043795899e-07
porcine respiratory,5.043948025428325e-07
permissivity,5.041904548193579e-07
immortalized cultures,5.039034840926961e-07
phosphorylated nucleocapsid protein n,4.999647815712679e-07
beaudette spike gene,4.928906938260324e-07
indonesian,4.906553913131177e-07
human respiratory coronaviruses hcov,4.904600812231687e-07
peripheral gcderived asc infiltrate,4.861260403872256e-07
sodium desoxycholate,4.845951333609234e-07
co-factors,4.817397661155175e-07
turkey pox virus,4.79166186820096e-07
sarscov human cov nl63,4.755976545194524e-07
persontoperson transmission,4.67455278879559e-07
n-terminal fusion peptides,4.655110387015787e-07
canine respiratory coronavirus,4.6518624740445266e-07
continuous transcription,4.639551776924345e-07
inositol-requiring enzyme 1,4.638439660020683e-07
dendritic cellspecific,4.620359101044564e-07
cird,4.583869781667153e-07
association_x,4.547642050838455e-07
aromatic amino acids,4.547642050838455e-07
viral target gene,4.491827434383482e-07
damages,4.4448030159618753e-07
in vivo,4.4333254604958505e-07
treg transfer,4.329210349352529e-07
phosphoprotein phosphoamino acid analysis,4.257058308730357e-07
s1b gene sequences,4.250387316590314e-07
infectious aetiology,4.187076392551412e-07
stem cell transplantation,4.174202266790726e-07
respiratory epithelium,4.153212365810327e-07
mdck i cells,4.151973275028389e-07
postmortem,4.1513227890576377e-07
philippines,4.143834923544229e-07
nucleotide sequence homology,4.130013658873857e-07
atpase catalytic pocket,4.129930214315527e-07
sarscov spike protein hr1,4.099283316578312e-07
npc tumor cell,4.0881591675661206e-07
rna chaperones,3.996734671021769e-07
live-attenuated coronavirus vaccines,3.945503345371607e-07
viral rtc activity,3.9391164608656174e-07
hexamerization,3.935775640237976e-07
non-immune human vl chain repertoire,3.9263622958938245e-07
open reading frame 3c,3.92130809308224e-07
viral products,3.8636874664868244e-07
signaling proteins,3.860175653477067e-07
adverse outcomes,3.816421077619734e-07
experimental support,3.8117962583621596e-07
pattern recognition receptors prrs,3.7924749011026655e-07
alveolar macrophages,3.7873384155021266e-07
merscov proteins,3.776443790263485e-07
protein intermediates,3.756455110152225e-07
sarsinfected,3.753354437704558e-07
inhibition_x,3.746793831965293e-07
human sarscov receptor,3.682250634393654e-07
alveolar damage278,3.675260339870256e-07
antisense peptide nucleic acids pnas,3.653047073393801e-07
respiratory viruses methods,3.613042037739236e-07
fluorescent syncytia,3.60751670914671e-07
crystallographic structure,3.602278095735463e-07
viral attachment proteins,3.5403009915127007e-07
receptorbinding site amino acids,3.5286048544905855e-07
erk,3.527186447194907e-07
england,3.500903330564552e-07
working group,3.500746062556136e-07
cat-associated,3.474014077305715e-07
sarscov n gene,3.451859933909358e-07
fcov-positive cats,3.437085824586941e-07
adaptive capacity,3.4169673752017973e-07
interleukin 12p40,3.413658940000472e-07
homologues,3.401049805364739e-07
nasal isolate,3.4009722831217906e-07
clone viruses,3.365412505592055e-07
helicase genes,3.3138155010090106e-07
rbd structures,3.310709209108995e-07
zinc finger 1,3.2345302510651414e-07
consensus cyaaac sequence,3.221621623091493e-07
md species,3.2116617892138647e-07
vp5,3.1550742239921787e-07
inserted,3.148823329839125e-07
major antigenic site a/b,3.1237928914871057e-07
gene 7 products,3.118302002332736e-07
aa_x,3.1124149035596134e-07
sars-cov fusion peptide sequence,3.105813643533559e-07
nucleoprotein,3.035365982727378e-07
immortalized bat cell lines,3.027394498855612e-07
conformational alterations,2.9057215890456383e-07
chrcov hku24 nucleocapsid,2.884567500051114e-07
proteinligand xray structure,2.8625666634904205e-07
lethal coronaviruses,2.8521556865001353e-07
protein conformation,2.8209544273907855e-07
welldifferentiated cultures,2.8202796433827004e-07
blood vessels distant,2.810143807130118e-07
mhv titers,2.796360886261407e-07
infectious bats,2.78989182315497e-07
asynchronously replicating cells,2.7822687759611296e-07
redundancy,2.771287417712581e-07
sarscov nsp15 snsp15,2.756795466322471e-07
genomic mutations,2.740838791691977e-07
discontinuous and linear b-cell epitopes,2.672802222801045e-07
ib vaccines,2.6383456144554375e-07
herpes simplex virus type 1 glycoprotein d,2.6302842461951116e-07
cryoelectron microscopy,2.623895749305608e-07
dilated cytoplasmic vesicles,2.6095249159655826e-07
human coronavirus 229e hcov229e replicase geneencoded nonstructural protein 13,2.5983067351451854e-07
mers-cov real-time reverse transcription pcr,2.588416963047299e-07
cellular membrane,2.56898718723983e-07
s2 cleavage products,2.5609104474123937e-07
ill travelers,2.5373300935549443e-07
antigenic variations,2.5165749836042787e-07
individual samples,2.488773806357826e-07
downstream restriction factors,2.4693336401978444e-07
nlinked sugars,2.4575032292449103e-07
virus adhesion,2.452231319394303e-07
cross-reactivity,2.434598346853535e-07
chymotrypsinlike main protease,2.419271893636884e-07
bax cytochrome c cytc,2.3821810815814295e-07
n7mtase of rna life,2.3615122173415878e-07
pipistrelle,2.3588828742763706e-07
livestock animal species,2.340408391135862e-07
ecov outbreaks,2.3235051281027547e-07
live mhvjhm,2.3182711679151078e-07
adult wd strains,2.2891681179460355e-07
evasion,2.2879347528792974e-07
destabilizing effect,2.275141970977514e-07
chronic fulminating demyelinating disease,2.269845893643929e-07
rnarna recombination,2.1906381100032194e-07
mouse hepatitis virus-a59,2.1766739468578632e-07
endodomain,2.1708333722058773e-07
known proteins,2.1681185590911578e-07
viral rna 5370,2.1485583863656318e-07
real-time quantitative pcr technology,2.0774079520244736e-07
laboratory settings,2.0193380613368112e-07
human coronavirus hcvoc 43,1.9754954184068957e-07
realtime sarsspecific pcr assays,1.9690248780136746e-07
reduces,1.9675431480310989e-07
extracorporeal virus and,1.9378642851019926e-07
k48 and k63linked polyubiquitin chains,1.9362542734180953e-07
type ii alveolar cells,1.9176319185055989e-07
mismatching nucleotide,1.8933082293344448e-07
sarscov nonstructural protein 1,1.8670977549161217e-07
early events,1.828066086365095e-07
virus-host interaction,1.8224226693101855e-07
tissue_x,1.8107382502915757e-07
rbd fragment,1.7715331966935123e-07
vm,1.7551273447641678e-07
resistant bat cell lines,1.7515937995664855e-07
phsensitive endosomal protease cathepsin l,1.705776250570345e-07
endosomal cysteine,1.6794904395143832e-07
immediate-early transcription factor egr-1,1.645870032258162e-07
reared,1.6390489099221337e-07
receptor glycoprotein human angiotensin converting enzyme 2 hace2,1.6348669374108062e-07
negatively charged endodomain residues,1.6222853839542442e-07
transmissible gastroenteritis virus antiserum,1.6217325341337158e-07
long hydrophobic domain,1.590266485678819e-07
blood natural killer cell,1.5739077647987624e-07
domain nucleotides,1.5249063318992583e-07
hku4 hr2-derived peptides,1.484641668316565e-07
polio virus,1.4365914302776068e-07
3c3clpros,1.436583023741618e-07
younger,1.4253381930760444e-07
genbank accession numbers ef424621,1.4038033589579236e-07
viral mrna cap synthesis,1.3496875254174644e-07
type i interferon response accessory protein 4a,1.321844043834288e-07
primary rat kidney cell cultures,1.301158791798794e-07
lesions_x,1.2991533675728047e-07
jhmvimmune splenocytes,1.2969894494447735e-07
attachmententry receptor,1.2829855591941152e-07
eighth open reading frame orf8,1.278297000625235e-07
antigen detection assay,1.2739591763883926e-07
cov molecular biology,1.2256670334554484e-07
cytoplasmic reticulovesicular network,1.2227752788918653e-07
bcov esterase analysis,1.2023287204377723e-07
nipah virus fusion glycoproteins,1.1881198912902816e-07
reverse transcriptase-pcr,1.1806937316419135e-07
canine herpesvirus,1.1617412081145992e-07
genedelivery vectors,1.0902770130474577e-07
terminal loop deletion,1.0771013988168095e-07
s2 fragment 6f6r,1.0504342385583168e-07
ground-glass opacities,1.0462800617548355e-07
clinical course,1.0415411589664335e-07
ecoli,1.0250300430168069e-07
tylonycteris pachypus coronavirus hku4 pipistrellus pipistrellus coronavirus,1.0046588909134152e-07
spike s gene deletion mutant,9.530608186880696e-08
th1 and proinflammatory cytokines,9.514230060451334e-08
central_x,9.433385101423322e-08
synthetic transmembrane domain,9.313262868433107e-08
antigenic difference,9.06778042142044e-08
prrsv replication,8.776961947725809e-08
lipidomics studies,8.748041881538579e-08
villous enterocytes,8.652118649312205e-08
p38 mapk sb 203580,8.571197996942404e-08
nonstructural protein nsp genes,8.245666052391315e-08
murine hepatitis virus strain a59,8.171298409759653e-08
pi-batcov-hku5,7.727349039173143e-08
orf5b,7.626449176273997e-08
type i feline coronaviruses,7.034570477859178e-08
vida frecuentemente,6.936857916990447e-08
replicase polyprotein translation,6.84168559192649e-08
clinical epidemiological,6.437818735246506e-08
cynomolgus macaques,6.372334554731221e-08
clustalw analysis,6.253585387759611e-08
l1 myeloidhistiocyte antigen neutrophils,6.149295298235536e-08
immunofluorescence slides,6.045186947620071e-08
c3,5.978012474575176e-08
n-terminal sequencing,5.975676685128846e-08
glycoprotein gp of marburg virus,5.6920940001710925e-08
ciliated lung epithelial cells foxj1stat1,5.579332810393568e-08
amino acids gly244 p4,5.182922741966877e-08
host receptor,5.0726930585769055e-08
di rnas of,5.0646513653419245e-08
brush border membrane proteins,4.987112466557313e-08
genomic rearrangement,4.9008400756744357e-08
endo-glycosidase h-resistant glycoprotein,4.7252928255436665e-08
mitochondrial,4.59960497452208e-08
human embryokidney cells,4.368031545387566e-08
bat alphacoronaviruses,4.298912015088579e-08
cd4 tgevimmune cells,4.1966859885078536e-08
dysfunction andor death,4.159817407629793e-08
mesenteric lymph node cd4 tcells,4.1418267819788235e-08
cord blood samples,3.67664985970823e-08
requirements,3.507267309359181e-08
stafftopatient transmission,3.497161963762151e-08
prototype winter dysentery,3.1296592763972415e-08
gene function,3.105817832611257e-08
deregulated,2.9006077119693382e-08
epidemiological study,2.8888905182172932e-08
virusinduced severe host,2.3682606734262267e-08
sars-cov papain-like protease,2.2726575275848382e-08
camostat,2.2607871039254215e-08
full-length viral genome sequences,2.1291562753368238e-08
reverse genetics analysis,2.126401318411821e-08
domestic,1.962130300237602e-08
global promoter,1.8099460295627068e-08
semiquantitative analysis,1.620582446357602e-08
ebola virus sarscoronavirus,1.603548096160333e-08
amino terminal s2 protein,1.5835351138022876e-08
dsrna-independent stress response pathway,1.5377914845937313e-08
polyubiquitin chains merscov plpro,1.4953195603544056e-08
anti-3a n-terminal antibody,1.4806342074613826e-08
protein gene sequence,1.465585068479725e-08
mild diarrhea,1.4163201217546485e-08
tissue culture assays,1.3714067261116292e-08
anti-sars antibodies,1.0884336008632655e-08
non-sars-associated hcovs,9.499148201276352e-09
transmembrane domain of e protein (etm),8.85331589697967e-09
rna capping mechanisms,8.407880060962288e-09
polymerase polyprotein,7.999230659377671e-09
upstream_x,7.089046977896585e-09
embryokidney cells,6.7921013718743245e-09
orthologous receptors,6.656760031502941e-09
primary cell type,6.5758973695878255e-09
mutant plp2,6.3983436098561084e-09
sars coronavirus sarscov nonstructural protein 3 nsp3,5.309200635103212e-09
interferon-inducible diphtheria toxin-like enzymes,5.162219099209422e-09
coronaviruses cvs and 2 a,4.6765728797257e-09
intransp1 cistronic element,4.241157498797055e-09
gene loci,3.074703094340696e-09
manifestation,2.8408436522176843e-09
secondsite mutation,2.7514070174024867e-09
rfp-sars-s pseudovirus,1.0378962007220693e-09
twisted hinge region,7.631632835177305e-10
feline aminopeptidase n,4.460405353004402e-10
lectin binding,4.720232947411644e-20
coronavirus replicase proteins,2.3540442855821866e-20
46-lrlgsqlsl-54 amino acid,1.6847386328793127e-20
murine_x,0.0
cea,0.0
mouse hepatitis virus_x,0.0
human_x,0.0
neisseria,0.0
interactions_x,0.0
mouse_x,0.0
iglike domains,0.0
murine coronavirus_x,0.0
domains_x,0.0
nterminal domain,0.0
ceacam1,0.0
family members,0.0
family_x,0.0
receptors_x,0.0
carcinoembryonic antigen cea,0.0
carcinoembryonic antigen,0.0
murine ceacam1 proteins,0.0
virus receptor,0.0
crystal structure_x,0.0
virusbinding residues,0.0
exploration,0.0
isoforms,0.0
sceacam1a14,0.0
murine sceacam1a14,0.0
residues_x,0.0
murine ceacam1,0.0
proteins_x,0.0
mhv_x,0.0
soluble_x,0.0
neutralizing activity,0.0
human ceacam1,0.0
architecture,0.0
structural_x,0.0
functional_x,0.0
virus_x,0.0
carcinoembryonic antigen cea family isoforms,0.0
carcinoembryonic,0.0
homophilic,0.0
heterophilic,0.0
coronavirus_x,0.0
atomic structure,0.0
ceacam1 proteins,0.0
domain_x,0.0
activities_x,0.0
binding_x,0.0
protomers,0.0
his41,0.0
rna viruses_x,0.0
cellular proteinases,0.0
coronavirus polyprotein,0.0
chymotrypsin,0.0
s1_x,0.0
cys144,0.0
viral and cellular proteinases,0.0
glutamine,0.0
asymmetric unit,0.0
coronavirus mpro,0.0
mpro selfprocessing,0.0
loop_x,0.0
protein_x,0.0
kda transmissible gastroenteritis,0.0
p1 glutamine,0.0
molecular_x,0.0
enzyme_x,0.0
sequence_x,0.0
arrangement,0.0
mutagenesis_x,0.0
substrates,0.0
study_x,0.0
transcleavage activity,0.0
active site,0.0
variations,0.0
low_x,0.0
viral main proteinase mpro a protein,0.0
classical chymotrypsin fold,0.0
side chains,0.0
resolution_x,0.0
mutual,0.0
p2 leucine residues,0.0
chymotrypsinlike fold,0.0
substrate binding,0.0
viral_x,0.0
trans,0.0
mpro,0.0
structure_x,0.0
orientation,0.0
dimers,0.0
nterminus,0.0
cellular_x,0.0
leucine residues,0.0
subsites,0.0
molecular modelling,0.0
extra domain,0.0
residue loop,0.0
data_x,0.0
sars_x,0.0
enzyme 2 ace2,0.0
outbreak_x,0.0
functional receptor,0.0
ace2_x,0.0
sproteinbinding site,0.0
sars coronavirus sarscov_x,0.0
humans_x,0.0
human cells,0.0
affinity_x,0.0
sarscov spike sproteinbinding site,0.0
palmcivet ace2,0.0
bound_x,0.0
human angiotensinconverting enzyme 2,0.0
efficiently_x,0.0
palm civets,0.0
human angiotensinconverting enzyme 2 ace2,0.0
severity_x,0.0
spike sproteinbinding,0.0
site_x,0.0
civet ace2,0.0
compare,0.0
isolated_x,0.0
sprotein residues,0.0
sarscov_x,0.0
adaptation,0.0
severe_x,0.0
civets,0.0
sprotein residues 479,0.0
molecular interactions,0.0
angiotensinconverting_x,0.0
residues conserved,0.0
giant,0.0
nsp8 rdrp,0.0
nonstructural protein 12 nsp12,0.0
rdrp domain,0.0
catalytic residues,0.0
rnas_x,0.0
nsp12,0.0
palm,0.0
complementary oligonucleotides,0.0
coronaviruses_x,0.0
fidelity,0.0
distant,0.0
nonstructural protein 12,0.0
nsp8,0.0
genome_x,0.0
rdrp activity,0.0
membranebound enzymatic complex,0.0
rna templates,0.0
homology_x,0.0
synthesis_x,0.0
rna_x,0.0
catalytic palm subdomain,0.0
rdrps of rna viruses,0.0
cognate membranebound enzymatic complex,0.0
coronavirus rdrps,0.0
cellular dnadependent rna primases,0.0
rnadependent rna polymerase,0.0
primers,0.0
cognate,0.0
primerdependent,0.0
polarities,0.0
reaction_x,0.0
domain conserved,0.0
replication_x,0.0
detectable_x,0.0
fever_x,0.0
human peripheral blood mononuclear cells,0.0
immunemediated,0.0
peripheral blood mononuclear cells,0.0
induced_x,0.0
patients_x,0.0
epithelial cells_x,0.0
patient sera,0.0
cells_x,0.0
immune cell adhesion,0.0
autoabs,0.0
acute respiratory syndromeassociated coronavirus sarscov infection,0.0
sera_x,0.0
pathogenesis_x,0.0
antis2,0.0
autoantibodies autoabs,0.0
cell_x,0.0
epitopes_x,0.0
mechanism_x,0.0
crossreactive epitopes,0.0
sarscov spike protein domain 2 s2,0.0
antiepithelial cell,0.0
preabsorption,0.0
viral effect,0.0
cytotoxicity,0.0
blood mononuclear cells,0.0
level_x,0.0
cytotoxic injury,0.0
autoimmune responses,0.0
treatment_x,0.0
crossreactive,0.0
days_x,0.0
adherence,0.0
protein domain,0.0
sarscov infection_x,0.0
binding assays,0.0
correlated_x,0.0
igg_x,0.0
onset of,0.0
pneumonia_x,0.0
detection_x,0.0
throat,0.0
fecal samples_x,0.0
alternative_x,0.0
extensive_x,0.0
laboratoryconfirmed sars,0.0
selfcollected samples,0.0
beijing china,0.0
nasopharyngeal aspirates,0.0
patient_x,0.0
pressure,0.0
quantify,0.0
reverse transcriptase polymerase chain reaction rtpcr,0.0
selfcollected throat,0.0
context_x,0.0
hospital resources,0.0
viral loads,0.0
occasional,0.0
rates_x,0.0
onset_x,0.0
detect_x,0.0
reverse transcriptase,0.0
illness_x,0.0
symptoms_x,0.0
weeks_x,0.0
acute respiratory syndrome_x,0.0
positive_x,0.0
clinical illness,0.0
institution,0.0
sarscov rtpcr,0.0
crystals,0.0
crystalline,0.0
development_x,0.0
sarscov mpro,0.0
catalytic site,0.0
structurebased inhibition studies,0.0
target_x,0.0
compounds crystals,0.0
viral polyproteins,0.0
crystallographic twofold,0.0
group_x,0.0
processing_x,0.0
conformation_x,0.0
orthorhombic space group p21212,0.0
proteinase mpro,0.0
ph 65,0.0
monomer,0.0
orthorhombic space,0.0
virus life cycle,0.0
biologically active,0.0
specific_x,0.0
coronavirus sarscov_x,0.0
membrane_x,0.0
orientational,0.0
bind_x,0.0
lysine residues,0.0
host cell_x,0.0
inhibited_x,0.0
preparation,0.0
homopentameric,0.0
virus morphogenesis,0.0
pentameric,0.0
apoptosis_x,0.0
lipid bilayers,0.0
c,0.0
consistent with,0.0
transmembrane_x,0.0
tm,0.0
reconstituted,0.0
peptide_x,0.0
double mutants,0.0
mutants_x,0.0
membrane destabilizing transmembrane tm hairpin,0.0
drug amantadine,0.0
c and n termini,0.0
homooligomerize,0.0
topology,0.0
e protein etm,0.0
sodium,0.0
parameters,0.0
lipid_x,0.0
sodium conductance channel,0.0
organization_x,0.0
small envelope protein e,0.0
activity_x,0.0
moderate,0.0
antiinfluenza drug amantadine,0.0
improve,0.0
solubility,0.0
transmembrane pore,0.0
e,0.0
flanked,0.0
small envelope protein,0.0
transmembrane tm,0.0
involvement_x,0.0
homopentameric model,0.0
nonstructural protein nsp15,0.0
p4332,0.0
viral rna synthesis sars fulllength,0.0
escherichia coli_x,0.0
peg,0.0
